HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 18JUN21:06:47:1718JUN21:06:47:17 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS IS SASDATA 9.4 X64_SR12 18JUN21:06:47:1718JUN21:06:47:17 Immunogenicity Specimen Assessments HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002700000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier ISSEQ Sequence Number ) ISREFID Reference ID 1ISTESTCDImmunogenicity Test/Exam Short Name =(ISTEST Immunogenicity Test or Examination Name E(ISCAT Category for Immunogenicity Test m ISORRES Results or Findings in Original Units  ISORRESUOriginal Units  ISORNRLOReference Range Lower Limit in Orig Unit  ISORNRHIReference Range Upper Limit in Orig Unit  ISSTRESCResult or Finding in Standard Format ISSTRESNNumeric Results/Findings in Std. Units ISSTRESUStandard Units ISSTAT Completion Status )ISREASNDReason Not Done  ISNAM Vendor Name ISSPEC Specimen Type ISMETHODMethod of Test or Examination  ISLLOQ Lower Limit of Quantitation 7VISITNUMVisit Number ?"VISIT Visit Name GVISITDY Planned Study Day of Visit iEPOCH Epoch qISDTC Date/Time of Collection ISDY Study Day of Visit/Collection/Exam  HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH08391683AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.5 AU/mL 19.5 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:23AmRNA-1273-P201ISmRNA-1273-P201-US201-1004A 1EH03212303AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.4 AU/mL 18.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1004A01EH34603178AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 AU/mL 17.2 B333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1004A@1EH36702387AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.5 AU/mL 18.5 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:11B9mRNA-1273-P201ISmRNA-1273-P201-US201-1004AP1EH08391683AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.8 ug/mL 16.8 Bug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:23AmRNA-1273-P201ISmRNA-1273-P201-US201-1004A`1EH03212303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.5 ug/mL 64.5 B@ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1004Ap1EH34603178AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.1 ug/mL 197.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH36702387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.3 ug/mL 183.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:11B9mRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH08394784AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:23AmRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH03217549AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.7 AU/mL 79.7 BO33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH42991753AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 601.5 AU/mL 601.5 C%AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH36704433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 668.6 AU/mL 668.6 C)əAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:11B9mRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH18922556AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101 AU/mL 101 BeAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:27BmRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH08394784BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:23AmRNA-1273-P201ISmRNA-1273-P201-US201-1004A1EH03217549BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1004B1EH42991753BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1004B1EH36704433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:11B9mRNA-1273-P201ISmRNA-1273-P201-US201-1004B1EH18922556AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:27BmRNA-1273-P201ISmRNA-1273-P201-US201-1004B1EH08388736 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:11AmRNA-1273-P201ISmRNA-1273-P201-US201-1007A`1EH11639847AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1007Ap1EH36700339AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH36700307AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:02B9mRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH42045602AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.5 AU/mL 2.5 A(AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T13:11AmRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH03216431AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH36701362AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH36706481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.5 AU/mL 2.5 A(AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:02B9mRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH18919484AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH42045602BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:11AmRNA-1273-P201ISmRNA-1273-P201-US201-1007A1EH03216431BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1007B1EH36701362BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1007B1EH36706481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:02B9mRNA-1273-P201ISmRNA-1273-P201-US201-1007B1EH18919484AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1007B1EH08388641 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1009A`1EH03213359AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.2 ug/mL 21.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:06BmRNA-1273-P201ISmRNA-1273-P201-US201-1009Ap1EH34606250AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 228.1 ug/mL 228.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH36701331AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197 ug/mL 197 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:35B9mRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH08394785AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH03215406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.8 AU/mL 70.8 BFAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:06BmRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH42993803AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1220.6 AU/mL 1220.6 CLIAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH36703410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1094.7 AU/mL 1094.7 CDk33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:35B9mRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH18919612AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146.6 AU/mL 146.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:09BmRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH08394785BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1009A1EH03215406BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:06BmRNA-1273-P201ISmRNA-1273-P201-US201-1009B1EH42993803BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1009B1EH36703410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:35B9mRNA-1273-P201ISmRNA-1273-P201-US201-1009B1EH18919612AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:09BmRNA-1273-P201ISmRNA-1273-P201-US201-1009B1EH41944090 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1011A`1EH03214380AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1011Ap1EH34609321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T10:33B+mRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH03213358AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T11:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH08393889AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T14:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH03215503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH42991658AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T10:33B+mRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH11601932AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T11:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH18920605AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH08393889BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1011A1EH03215503BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1011B1EH42991658BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T10:33B+mRNA-1273-P201ISmRNA-1273-P201-US201-1011B1EH11601932BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T11:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1011B1EH18920605AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1011B1EH42041475 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US201-1012A`1EH03214477AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.7 ug/mL 45.7 B-33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1012Ap1EH47516735AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 328.8 ug/mL 328.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:53B-mRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH58762422AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 266.6 ug/mL 266.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T14:03B=mRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH41948346AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH11599916AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.7 AU/mL 121.7 By33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH47517885AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1645.1 AU/mL 1645.1 CfљAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:53B-mRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH50339868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1148.9 AU/mL 1148.9 CGffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T14:03B=mRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH18921660AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.3 AU/mL 154.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH41948346BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US201-1012A1EH11599916BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1012B1EH47517885BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:53B-mRNA-1273-P201ISmRNA-1273-P201-US201-1012B1EH50339868BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T14:03B=mRNA-1273-P201ISmRNA-1273-P201-US201-1012B1EH18921660AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1012B1EH41949208 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:10AmRNA-1273-P201ISmRNA-1273-P201-US201-1014A`1EH03211276AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.9 ug/mL 17.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1014Ap1EH47514655AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.5 ug/mL 162.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:39B-mRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH58767381AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.5 ug/mL 139.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:55B;mRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH08393857AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:10AmRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH03216557AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.8 AU/mL 30.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH47517852AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 789.3 AU/mL 789.3 C1TAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:39B-mRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH58768567AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 352.5 AU/mL 352.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:55B;mRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH43366431AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.7 AU/mL 77.7 BM33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T14:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH08393857BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:10AmRNA-1273-P201ISmRNA-1273-P201-US201-1014A1EH03216557BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1014B1EH47517852BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:39B-mRNA-1273-P201ISmRNA-1273-P201-US201-1014B1EH58768567BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:55B;mRNA-1273-P201ISmRNA-1273-P201-US201-1014B1EH43366431AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T14:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1014B1EH08389633 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:59AmRNA-1273-P201ISmRNA-1273-P201-US201-1018A`1EH03212332AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1018Ap1EH47514782AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.2 ug/mL 203.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH58765332AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.4 ug/mL 130.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:32B:mRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH42045474AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:59AmRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH03218447AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19 AU/mL 19 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH47517725AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 785.7 AU/mL 785.7 C133334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH58767542AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 415 AU/mL 415 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:32B:mRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH18916415AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.4 AU/mL 36.4 B$ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:49BmRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH42045474BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:59AmRNA-1273-P201ISmRNA-1273-P201-US201-1018A1EH03218447BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1018B1EH47517725BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US201-1018B1EH58767542BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:32B:mRNA-1273-P201ISmRNA-1273-P201-US201-1018B1EH18916415AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:49BmRNA-1273-P201ISmRNA-1273-P201-US201-1018B1EH42042497 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1019A`1EH03214348AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35 ug/mL 35 B#ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1019Ap1EH47513663AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146.4 ug/mL 146.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:55B-mRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH58764342AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135 ug/mL 135 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T15:25B;mRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH41950362AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH03216527AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78.7 AU/mL 78.7 BN33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH47519901AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 586.7 AU/mL 586.7 C$33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:55B-mRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH50342973AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 512 AU/mL 512 C AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T15:25B;mRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH18921532AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.9 AU/mL 74.9 BJffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T14:52BmRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH41950362BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1019A1EH03216527BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1019B1EH47519901BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:01AmRNA-1273-P201ISmRNA-1273-P201-US201-1020A`1EH03211439AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.3 ug/mL 36.3 B$Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1020Ap1EH47516734AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 236.8 ug/mL 236.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:31B-mRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH58766389AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.8 ug/mL 167.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH42047619AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T14:01AmRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH11602061AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.5 AU/mL 121.5 ByAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH47519804AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1063.2 AU/mL 1063.2 CBs33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:31B-mRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH50342044AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 726.4 AU/mL 726.4 C-ffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH18922524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.6 AU/mL 87.6 BWAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:52BmRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH42047619BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:01AmRNA-1273-P201ISmRNA-1273-P201-US201-1020A1EH11602061BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1020B1EH47519804BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:31B-mRNA-1273-P201ISmRNA-1273-P201-US201-1020B1EH50342044BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1020B1EH18922524AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:52BmRNA-1273-P201ISmRNA-1273-P201-US201-1020B1EH42043394 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:33AmRNA-1273-P201ISmRNA-1273-P201-US201-1023A`1EH03211309AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 ug/mL 8.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1023Ap1EH47516703AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 ug/mL 9.5 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T15:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH58764470AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.6 ug/mL 8.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T16:23B;mRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH33589305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:33AmRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH03217423AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH47514815AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T15:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH50340924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T16:23B;mRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH18918430AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH33589305BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:33AmRNA-1273-P201ISmRNA-1273-P201-US201-1023A1EH03217423BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 AU/mL 11.6 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1023B1EH47514815BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T15:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1023B1EH50340924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.9 AU/mL 9.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T16:23B;mRNA-1273-P201ISmRNA-1273-P201-US201-1023B1EH18918430AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 AU/mL 8.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1023B1EH42042496 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:12AmRNA-1273-P201ISmRNA-1273-P201-US201-1028A`1EH03214509AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.7 ug/mL 29.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:55BmRNA-1273-P201ISmRNA-1273-P201-US201-1028Ap1EH56694790AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.3 ug/mL 195.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:33B,mRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH36703251AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.1 ug/mL 187.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:25B9mRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH42046467AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T10:12AmRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH03218573AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.4 AU/mL 69.4 BEfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:55BmRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH56695974AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 897.8 AU/mL 897.8 C8AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:33B,mRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH36703283AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 790.2 AU/mL 790.2 C1c33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:25B9mRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH18922653AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.8 AU/mL 87.8 BWAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T07:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH42046467BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:12AmRNA-1273-P201ISmRNA-1273-P201-US201-1028A1EH03218573BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:55BmRNA-1273-P201ISmRNA-1273-P201-US201-1028B1EH56695974BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:33B,mRNA-1273-P201ISmRNA-1273-P201-US201-1028B1EH36703283BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:25B9mRNA-1273-P201ISmRNA-1273-P201-US201-1028B1EH18922653AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T07:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1028B1EH08391681 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1029A`1EH03214382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.3 ug/mL 24.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1029Ap1EH56695844AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.7 ug/mL 128.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH58767510AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103.8 ug/mL 103.8 Bgug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:08B:mRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH41950395AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH03216397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 63.8 AU/mL 63.8 B?AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH56693798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 429.2 AU/mL 429.2 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH50339869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 297 AU/mL 297 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:08B:mRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH18921629AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.7 AU/mL 84.7 BT33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T13:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH41950395BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1029A1EH03216397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T15:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1029B1EH56693798BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1029B1EH50339869BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:08B:mRNA-1273-P201ISmRNA-1273-P201-US201-1029B1EH18921629AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.6 AU/mL 8.6 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T13:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1029B1EH42041379 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:36AmRNA-1273-P201ISmRNA-1273-P201-US201-1030A`1EH03214349AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:45BmRNA-1273-P201ISmRNA-1273-P201-US201-1030Ap1EH56695812AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.6 ug/mL 9.6 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH66098313AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:47B9mRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH08392737AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:36AmRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH03215534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:45BmRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH56695942AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH66097323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:47B9mRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH18922684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T07:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1030A1EH08392737BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1032A`1EH03212301AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1032Ap1EH36701360AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.8 ug/mL 201.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:26B+mRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH58767414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.9 ug/mL 143.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:12B:mRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH42047522AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T12:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH11599885AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.4 AU/mL 22.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH36704401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 778.1 AU/mL 778.1 C0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:26B+mRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH58767543AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 628.6 AU/mL 628.6 C'IAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:12B:mRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH18919581AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.5 AU/mL 99.5 BcAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH42047522BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1032A1EH11599885BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1032B1EH36704401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:26B+mRNA-1273-P201ISmRNA-1273-P201-US201-1032B1EH58767543BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:12B:mRNA-1273-P201ISmRNA-1273-P201-US201-1032B1EH18919581AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1032B1EH41944122 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1039A`1EH11639975AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.8 ug/mL 84.8 BTug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:41BmRNA-1273-P201ISmRNA-1273-P201-US201-1039Ap1EH36702386AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 240.4 ug/mL 240.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH36702259AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 174 ug/mL 174 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:44B9mRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH08393760AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH03216398AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.8 AU/mL 84.8 BTAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:41BmRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH36701363AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 773.8 AU/mL 773.8 C0\AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH36701234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 898.5 AU/mL 898.5 C8(AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:44B9mRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH08462344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100 AU/mL 100 BdAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:36BmRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH08393760BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1039A1EH03216398BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T12:41BmRNA-1273-P201ISmRNA-1273-P201-US201-1039B1EH36701363BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1039B1EH36701234BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:44B9mRNA-1273-P201ISmRNA-1273-P201-US201-1039B1EH08462344AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:36BmRNA-1273-P201ISmRNA-1273-P201-US201-1039B1EH41947160 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:49AmRNA-1273-P201ISmRNA-1273-P201-US201-1040A`1EH11637926AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.2 ug/mL 31.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1040Ap1EH56693893AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 175.7 ug/mL 175.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH38044673AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123.4 ug/mL 123.4 B{fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH33589273AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T14:49AmRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH03215533AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 89.5 AU/mL 89.5 BYAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH56695943AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 671.4 AU/mL 671.4 C)fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH38043778AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 629.6 AU/mL 629.6 C'YAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH18916414AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.7 AU/mL 130.7 B33330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH33589273BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:49AmRNA-1273-P201ISmRNA-1273-P201-US201-1040A1EH03215533BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH56695943BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH38043778BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH18916414AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH41946138 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies2560 MN50 20 2560 >2560 .MN50 BATTELLE SERUM B[ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:25B+mRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH46403619 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1357.645 MN50 20 2560 1357.645 CTQMN50 BATTELLE SERUM B[AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH27278397 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1357.645 MN50 20 2560 1357.645 CTQMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1040B1EH41946138 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02T11:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1041Ap1EH03212461AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15 ug/mL 15 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH56694821AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.5 ug/mL 96.5 B`ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH58768564AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.2 ug/mL 44.2 B,333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:17B9mRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH42045475AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02T11:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH11599884AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.2 AU/mL 43.2 B+333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH56693926AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 509.9 AU/mL 509.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH50341052AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.8 AU/mL 252.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:17B9mRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH42045475BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02T11:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1041A1EH11599884BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1041B1EH56693926BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US201-1041B1EH50341052BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:17B9mRNA-1273-P201ISmRNA-1273-P201-US201-1041B1EH08388608 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1042AP1EH03213327AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:14B+mRNA-1273-P201ISmRNA-1273-P201-US201-1042A`1EH58768404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T10:38B:mRNA-1273-P201ISmRNA-1273-P201-US201-1042Ap1EH00266293AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T08:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH03215404AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:14B+mRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH58766518AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T10:38B:mRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH43364542AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:07BmRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH00266293BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH03215404BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:14B+mRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH58766518BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T10:38B:mRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH43364542AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:07BmRNA-1273-P201ISmRNA-1273-P201-US201-1042A1EH00263350 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1043A`1EH03211404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1043Ap1EH34605227AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:21B+mRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH36700338AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:38B9mRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH08392865AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH03216558AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH42993802AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:21B+mRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH36706321AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:38B9mRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH18918462AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T07:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH08392865BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1043A1EH03216558BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1043B1EH42993802BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:21B+mRNA-1273-P201ISmRNA-1273-P201-US201-1043B1EH36706321BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:38B9mRNA-1273-P201ISmRNA-1273-P201-US201-1043B1EH18918462AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T07:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1043B1EH08388609 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1046A`1EH03212334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.9 ug/mL 28.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1046Ap1EH47514783AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 266.8 ug/mL 266.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH58767383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 213.9 ug/mL 213.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:26B:mRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH33587353AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH03218477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.1 AU/mL 107.1 BkAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH47516862AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1129.5 AU/mL 1129.5 CFAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH58766359AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 944.2 AU/mL 944.2 C;33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:26B:mRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH18918590AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176.5 AU/mL 176.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH33587353BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1046A1EH03218477BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1046B1EH47516862BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1046B1EH58766359BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:26B:mRNA-1273-P201ISmRNA-1273-P201-US201-1046B1EH18918590AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T12:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1046B1EH00007331 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1048A`1EH03212335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 ug/mL 19.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1048Ap1EH34607146AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.3 ug/mL 186.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:00B+mRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH36702355AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.8 ug/mL 117.8 Buug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH41950394AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T10:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH03217455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.1 AU/mL 74.1 BJAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH42993675AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 775.6 AU/mL 775.6 C0yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:00B+mRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH36704432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 381.3 AU/mL 381.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH18916383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 335.7 AU/mL 335.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:57BmRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH41950394BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1048A1EH03217455BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1048B1EH42993675BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:00B+mRNA-1273-P201ISmRNA-1273-P201-US201-1048B1EH36704432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1048B1EH18916383AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:57BmRNA-1273-P201ISmRNA-1273-P201-US201-1048B1EH42041378 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1050A`1EH03214476AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.4 ug/mL 88.4 BXfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:31BmRNA-1273-P201ISmRNA-1273-P201-US201-1050Ap1EH34604043AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH36700178AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 325.9 ug/mL 325.9 C^fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH42048642AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T07:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH03215501AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.9 AU/mL 186.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:31BmRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH42991626AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1475.1 AU/mL 1475.1 C\1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH36706448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1252 AU/mL 1252 CN@AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH18920508AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140.4 AU/mL 140.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:47BmRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH42048642BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1050A1EH03215501BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:31BmRNA-1273-P201ISmRNA-1273-P201-US201-1050B1EH42991626BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T07:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1050B1EH36706448BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US201-1050B1EH18920508AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:47BmRNA-1273-P201ISmRNA-1273-P201-US201-1050B1EH41944123 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US201-1051A`1EH03214478AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41 ug/mL 41 B)ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:50B#mRNA-1273-P201ISmRNA-1273-P201-US201-1051Ap1EH03213486AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 220.1 ug/mL 220.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH58766388AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 181.3 ug/mL 181.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:46B@mRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH33589400AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH03215535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.6 AU/mL 159.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:50B#mRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH03215500AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 796 AU/mL 796 C1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH50341949AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 620.2 AU/mL 620.2 C&33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:46B@mRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH43364382AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 181.9 AU/mL 181.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH33589400BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US201-1051A1EH03215535BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:50B#mRNA-1273-P201ISmRNA-1273-P201-US201-1051B1EH03215500BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US201-1051B1EH50341949BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:46B@mRNA-1273-P201ISmRNA-1273-P201-US201-1051B1EH43364382AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1051B1EH41945275 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1055A`1EH03215372AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.3 ug/mL 31.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1055Ap1EH47513662AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.2 ug/mL 134.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH58768533AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.3 ug/mL 97.3 BaLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:58B9mRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH08395905AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH03217453AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 116.8 AU/mL 116.8 BtAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH47517853AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 516.6 AU/mL 516.6 C IAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH50341917AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 215.4 AU/mL 215.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:58B9mRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH43367455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1036.3 AU/mL 1036.3 C@AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH08395905BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1055A1EH03217453BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1055B1EH47517853BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:42B,mRNA-1273-P201ISmRNA-1273-P201-US201-1055B1EH50341917BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:58B9mRNA-1273-P201ISmRNA-1273-P201-US201-1055B1EH43367455AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1055B1EH41946299 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:34AmRNA-1273-P201ISmRNA-1273-P201-US201-1056A`1EH03212300AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1056Ap1EH56692773AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH38043680AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 ug/mL 6.4 Affffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH41948218AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:34AmRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH11600012AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH56695815AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH38045859AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH18921501AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:09BmRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH41948218BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:34AmRNA-1273-P201ISmRNA-1273-P201-US201-1056A1EH11600012BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1056B1EH56695815BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1056B1EH38045859BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:24B9mRNA-1273-P201ISmRNA-1273-P201-US201-1056B1EH18921501AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:09BmRNA-1273-P201ISmRNA-1273-P201-US201-1056B1EH42041506 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:37AmRNA-1273-P201ISmRNA-1273-P201-US201-1057A`1EH03213455AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.6 ug/mL 10.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1057Ap1EH56694791AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 ug/mL 10 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH58762295AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 ug/mL 10.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH42048643AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.9 AU/mL 2.9 A.ffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:37AmRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH11599917AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.8 AU/mL 2.8 A,AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH65079300AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.7 AU/mL 2.7 A+333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH58766390AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH18921661AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.5 AU/mL 2.5 A(AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T16:07BmRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH42048643BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:37AmRNA-1273-P201ISmRNA-1273-P201-US201-1057A1EH11599917BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1057B1EH65079300CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1057B1EH58766390BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:10B9mRNA-1273-P201ISmRNA-1273-P201-US201-1057B1EH18921661AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T16:07BmRNA-1273-P201ISmRNA-1273-P201-US201-1057B1EH41944250 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1059A`1EH03212460AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27 ug/mL 27 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:54BmRNA-1273-P201ISmRNA-1273-P201-US201-1059Ap1EH47513791AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 228.2 ug/mL 228.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:50B-mRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH58767540AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 194.3 ug/mL 194.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:56B:mRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH42048514AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH03216396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.7 AU/mL 106.7 Bj33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:54BmRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH47517756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 839.8 AU/mL 839.8 C4|AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:50B-mRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH50342045AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 791.7 AU/mL 791.7 C1{33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:56B:mRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH43366559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 989.8 AU/mL 989.8 C=AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T09:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH42048514BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1059A1EH03216396CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:54BmRNA-1273-P201ISmRNA-1273-P201-US201-1059B1EH47517756BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:50B-mRNA-1273-P201ISmRNA-1273-P201-US201-1059B1EH50342045BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:56B:mRNA-1273-P201ISmRNA-1273-P201-US201-1059B1EH43366559AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T09:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1059B1EH42044545 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1060A`1EH03213325AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1060Ap1EH56692742AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:02B+mRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH58765462AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:06B9mRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH42046594AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH03218606AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH56693766AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:02B+mRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH58766486AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:06B9mRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH18917566AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH42046594BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:54AmRNA-1273-P201ISmRNA-1273-P201-US201-1060A1EH03218606BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1060B1EH56693766BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:02B+mRNA-1273-P201ISmRNA-1273-P201-US201-1060B1EH58766486BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:06B9mRNA-1273-P201ISmRNA-1273-P201-US201-1060B1EH18917566AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1060B1EH41946170 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1061AP1EH08389635AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1061A`1EH03211277AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.6 ug/mL 27.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:49BmRNA-1273-P201ISmRNA-1273-P201-US201-1061Ap1EH47516702AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.3 ug/mL 252.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH58766356AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146.3 ug/mL 146.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T13:27B>mRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH08393856AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T16:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH03215375AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.5 AU/mL 130.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:49BmRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH47514814AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1239.7 AU/mL 1239.7 CM{33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH50340892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 578.6 AU/mL 578.6 C$)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T13:27B>mRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH18918431AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.9 AU/mL 74.9 BJffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH08393856BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1061A1EH03215375BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:49BmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH47514814BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T12:28B,mRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH50340892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH18918431AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH42044448 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH27276444 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies678.823 MN50 20 2560 678.823 C*m+ IMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH42044448 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1061B1EH27276444 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies480 MN Endpoint Titer20 2560 480 CMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH42047521AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.3 AU/mL 15.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:27AmRNA-1273-P201ISmRNA-1273-P201-US201-1064A 1EH03213452AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.7 AU/mL 14.7 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1064A01EH47514687AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 AU/mL 13.9 AfffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T11:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1064A@1EH58767509AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.7 AU/mL 13.7 A333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:05B;mRNA-1273-P201ISmRNA-1273-P201-US201-1064AP1EH42047521AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:27AmRNA-1273-P201ISmRNA-1273-P201-US201-1064A`1EH03213452AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1064Ap1EH47514687AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T11:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH58767509AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:05B;mRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH08395936AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:27AmRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH11600013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH47516863AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T11:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH58768438AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:05B;mRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH18921533AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH08395936BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:27AmRNA-1273-P201ISmRNA-1273-P201-US201-1064A1EH11600013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1064B1EH47516863BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T11:10B-mRNA-1273-P201ISmRNA-1273-P201-US201-1064B1EH58768438BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:05B;mRNA-1273-P201ISmRNA-1273-P201-US201-1064B1EH18921533AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1064B1EH08390784 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:19AmRNA-1273-P201ISmRNA-1273-P201-US201-1065A`1EH03211278AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.8 ug/mL 20.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1065Ap1EH56695845AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 238.8 ug/mL 238.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:11B+mRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH38045729AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.6 ug/mL 168.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:56B9mRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH42045442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T12:19AmRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH03218575AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.4 AU/mL 64.4 B@fffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH56695814AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1120.8 AU/mL 1120.8 CF AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:11B+mRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH38046880AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 622.2 AU/mL 622.2 C&33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:56B9mRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH18916510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.5 AU/mL 107.5 BkAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH42045442BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:19AmRNA-1273-P201ISmRNA-1273-P201-US201-1065A1EH03218575BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1065B1EH56695814BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T12:11B+mRNA-1273-P201ISmRNA-1273-P201-US201-1065B1EH38046880BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:56B9mRNA-1273-P201ISmRNA-1273-P201-US201-1065B1EH18916510AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1065B1EH42041347 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1067A`1EH03211436AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1067Ap1EH03213487AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 ug/mL 3.9 A>ffffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:33B1mRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH58768405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:36BAmRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH33587256AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 AU/mL 8.7 A333330AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T12:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH03218444AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:33B1mRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH50340029AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.2 AU/mL 9.2 A333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:36BAmRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH43364383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T13:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH03215374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A. . .mRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH33587256BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26 AU/mL 26 BAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1067A1EH03218444CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.4 AU/mL 21.4 BffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:33B1mRNA-1273-P201ISmRNA-1273-P201-US201-1067B1EH50340029BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20 AU/mL 20 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:36BAmRNA-1273-P201ISmRNA-1273-P201-US201-1067B1EH43364383AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.5 AU/mL 14.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T13:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1067B1EH03215374BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.2 AU/mL 22.2 B333333AU/mL PPD VACCINESERUMELISA A6ffffff. . .mRNA-1273-P201ISmRNA-1273-P201-US201-1067B1EH00005283 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1068A`1EH03211279AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:42BmRNA-1273-P201ISmRNA-1273-P201-US201-1068Ap1EH56694948AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH38046721AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH33587224AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH03217452AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:42BmRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH65077253AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH38043682AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH18921500AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH33587224BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1068A1EH03217452BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:42BmRNA-1273-P201ISmRNA-1273-P201-US201-1068B1EH65077253BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1068B1EH38043682BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1068B1EH18921500AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1068B1EH42042401 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1069A`1EH03217420AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:45BmRNA-1273-P201ISmRNA-1273-P201-US201-1069Ap1EH56693796AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH58765492AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH08394913AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH03218607AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:45BmRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH65079301BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH58768566AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH18920509AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T15:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH08394913BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.1 AU/mL 11.1 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1069A1EH03218607BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:45BmRNA-1273-P201ISmRNA-1273-P201-US201-1069B1EH65079301CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.8 AU/mL 14.8 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US201-1069B1EH58768566BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:09B9mRNA-1273-P201ISmRNA-1273-P201-US201-1069B1EH18920509AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T15:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1069B1EH08389632 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1070A`1EH11639846AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US201-1070Ap1EH03214511AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:05B.mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH58764343AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:19B?mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH08394754AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH03218445AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH11602060AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:05B.mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH50342972AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:19B?mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH08394754BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:04AmRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH03218445BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US201-1070A1EH11602060BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:05B.mRNA-1273-P201ISmRNA-1273-P201-US201-1070B1EH50342972BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:19B?mRNA-1273-P201ISmRNA-1273-P201-US201-1070B1EH42043426 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1080A`1EH03213453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 76.6 ug/mL 76.6 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1080Ap1EH47516830AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 340.3 ug/mL 340.3 CDug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:38B+mRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH58766517AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 277.6 ug/mL 277.6 CYug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:07B9mRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH33589432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH03216525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 330.6 AU/mL 330.6 CAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH47517757AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1584.2 AU/mL 1584.2 Cc33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:38B+mRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH50340925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1860.2 AU/mL 1860.2 CtC33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:07B9mRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH18920477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.5 AU/mL 100.5 BdAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T14:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH33589432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1080A1EH03216525BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:53BmRNA-1273-P201ISmRNA-1273-P201-US201-1080B1EH47517757BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:38B+mRNA-1273-P201ISmRNA-1273-P201-US201-1080B1EH50340925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:07B9mRNA-1273-P201ISmRNA-1273-P201-US201-1080B1EH18920477AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T14:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1080B1EH42041474 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1084A`1EH03213326AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.7 ug/mL 14.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1084Ap1EH56692743AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 113.1 ug/mL 113.1 Bqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH38043808AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.6 ug/mL 39.6 B'ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:54B9mRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH33589272AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH03217548AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.1 AU/mL 30.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH56692871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 400.9 AU/mL 400.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH38045730AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200 AU/mL 200 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:54B9mRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH18920476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.2 AU/mL 42.2 B*333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T07:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH33589272BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:55AmRNA-1273-P201ISmRNA-1273-P201-US201-1084A1EH03217548BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1084B1EH56692871BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:40B+mRNA-1273-P201ISmRNA-1273-P201-US201-1084B1EH38045730BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:54B9mRNA-1273-P201ISmRNA-1273-P201-US201-1084B1EH18920476AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T07:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1084B1EH42043395 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1085A`1EH03214350AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.6 ug/mL 46.6 B.ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1085Ap1EH47515839AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 268.8 ug/mL 268.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:27B+mRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH58762423AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 245.4 ug/mL 245.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:40B9mRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH42047618AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH03215407AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.3 AU/mL 154.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH47517724AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1165 AU/mL 1165 CHAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:27B+mRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH50342940AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 680 AU/mL 680 C*AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:40B9mRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH43366463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.1 AU/mL 128.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T14:16BmRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH42047618BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1085A1EH03215407BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1085B1EH47517724BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 AU/mL 7.8 A|AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:27B+mRNA-1273-P201ISmRNA-1273-P201-US201-1085B1EH50342940BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:40B9mRNA-1273-P201ISmRNA-1273-P201-US201-1085B1EH43366463AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T14:16BmRNA-1273-P201ISmRNA-1273-P201-US201-1085B1EH42042400 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:30AmRNA-1273-P201ISmRNA-1273-P201-US201-1086A`1EH03214383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1086Ap1EH34609289AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:31B*mRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH36700179AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:27B8mRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH42045571AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:30AmRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH03217580AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH42994824AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:31B*mRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH36706480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:27B8mRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH03416196AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T12:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH42045571BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:30AmRNA-1273-P201ISmRNA-1273-P201-US201-1086A1EH03217580BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1086B1EH42994824BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:31B*mRNA-1273-P201ISmRNA-1273-P201-US201-1086B1EH36706480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:27B8mRNA-1273-P201ISmRNA-1273-P201-US201-1086B1EH03416196AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T12:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1086B1EH41943226 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1087A`1EH11637927AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.5 ug/mL 34.5 B"ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1087Ap1EH47513790AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 189.6 ug/mL 189.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH58766516AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.2 ug/mL 165.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:52B9mRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH08395777AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH03216430AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.2 AU/mL 131.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH47519772AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 541.9 AU/mL 541.9 C!fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH50342941AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 491 AU/mL 491 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:52B9mRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH18916382AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.3 AU/mL 75.3 BKLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T15:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH08395777BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1087A1EH03216430BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:24BmRNA-1273-P201ISmRNA-1273-P201-US201-1087B1EH47519772BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1087B1EH50342941BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T15:52B9mRNA-1273-P201ISmRNA-1273-P201-US201-1087B1EH18916382AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T15:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1087B1EH41944091 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1088AP1EH42046624AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T07:40AmRNA-1273-P201ISmRNA-1273-P201-US201-1088A`1EH03212429AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US201-1088Ap1EH03211437AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:25B0mRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH58767508AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:46B>mRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH08394912AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T07:40AmRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH11601965AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH03217454AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:25B0mRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH27601065AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:46B>mRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH43366430AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:52BmRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH08394912BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T07:40AmRNA-1273-P201ISmRNA-1273-P201-US201-1088A1EH11601965BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH03217454BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:25B0mRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH27601065BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:46B>mRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH43366430AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:52BmRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH41946267 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH43362334 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1088B1EH43362334 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1089A`1EH03213324AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.5 ug/mL 33.5 B!ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:58B$mRNA-1273-P201ISmRNA-1273-P201-US201-1089Ap1EH08464392AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 263.5 ug/mL 263.5 Cxug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T17:36B5mRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH58767511AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.9 ug/mL 252.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:00BCmRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH00268340AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T08:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH03218478AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 213.3 AU/mL 213.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:58B$mRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH08465417AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1118.4 AU/mL 1118.4 CEffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T17:36B5mRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH58765494AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 869.3 AU/mL 869.3 C6TAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:00BCmRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH43365406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 312.9 AU/mL 312.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T08:27BmRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH00268340BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1089A1EH03218478BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:58B$mRNA-1273-P201ISmRNA-1273-P201-US201-1089B1EH08465417BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T17:36B5mRNA-1273-P201ISmRNA-1273-P201-US201-1089B1EH58765494BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:00BCmRNA-1273-P201ISmRNA-1273-P201-US201-1089B1EH43365406AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T08:27BmRNA-1273-P201ISmRNA-1273-P201-US201-1089B1EH00265270 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1090A`1EH11637798AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.7 ug/mL 31.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1090Ap1EH47514654AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127.6 ug/mL 127.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH58764471AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.2 ug/mL 84.2 BT333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:33B9mRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH41950266AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T09:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH03216428AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 81.8 AU/mL 81.8 BQAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH47517884AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 424.9 AU/mL 424.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH50341020AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 258.9 AU/mL 258.9 C.fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:33B9mRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH18915519AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 91.6 AU/mL 91.6 B[AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH41950266BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:26AmRNA-1273-P201ISmRNA-1273-P201-US201-1090A1EH03216428BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1090B1EH47517884BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1090B1EH50341020BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 AU/mL 8.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:33B9mRNA-1273-P201ISmRNA-1273-P201-US201-1090B1EH18915519AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1090B1EH41944218 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1091A`1EH03213356AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1091Ap1EH47514686AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83.6 ug/mL 83.6 BSug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:30B,mRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH58768436AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.7 ug/mL 36.7 B$33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T12:48B=mRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH00266292AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH03216556AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.7 AU/mL 28.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH47519773AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 297.2 AU/mL 297.2 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:30B,mRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH58766391AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.7 AU/mL 165.7 B33330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T12:48B=mRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH43367615AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.7 AU/mL 35.7 B#33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T13:43BmRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH00266292BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US201-1091A1EH03216556BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1091B1EH47519773BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:30B,mRNA-1273-P201ISmRNA-1273-P201-US201-1091B1EH58766391BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T12:48B=mRNA-1273-P201ISmRNA-1273-P201-US201-1091B1EH43367615AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T13:43BmRNA-1273-P201ISmRNA-1273-P201-US201-1091B1EH00263223 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1092AP1EH00268437AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:50AmRNA-1273-P201ISmRNA-1273-P201-US201-1092A`1EH03214510AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.5 ug/mL 14.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:33B!mRNA-1273-P201ISmRNA-1273-P201-US201-1092Ap1EH03213357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.4 ug/mL 165.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:25B/mRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH58765365AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 136.2 ug/mL 136.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T14:17B>mRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH00268341AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:50AmRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH03216399AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52 AU/mL 52 B4AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:33B!mRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH03217421AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 728.4 AU/mL 728.4 C-fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:25B/mRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH50343069AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 700.9 AU/mL 700.9 C+fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T14:17B>mRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH43367582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104 AU/mL 104 BhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH00268341BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:50AmRNA-1273-P201ISmRNA-1273-P201-US201-1092A1EH03216399BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:33B!mRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH03217421BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:25B/mRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH50343069BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T14:17B>mRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH43367582AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH00265271 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH43361438 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies495.361 MN50 20 2560 495.361 CƧMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH00265271 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US201-1092B1EH43361438 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies320 MN Endpoint Titer20 2560 320 CMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH08391811AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.8 AU/mL 17.8 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1093A 1EH03212463AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.8 AU/mL 17.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1093A01EH03214508AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.6 AU/mL 20.6 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:45B+mRNA-1273-P201ISmRNA-1273-P201-US201-1093A@1EH58765364AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 AU/mL 19.6 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:08B9mRNA-1273-P201ISmRNA-1273-P201-US201-1093AP1EH08391811AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1093A`1EH03212463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.9 ug/mL 21.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1093Ap1EH03214508AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.5 ug/mL 195.5 BÀug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:45B+mRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH58765364AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.1 ug/mL 142.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:08B9mRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH08392706AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH11600044AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.8 AU/mL 79.8 BOAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH03216559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 846.3 AU/mL 846.3 C4AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:45B+mRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH50339997AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 613.1 AU/mL 613.1 C&QAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:08B9mRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH18919613AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 91.4 AU/mL 91.4 B[fffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH08392706BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.5 AU/mL 11.5 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1093A1EH11600044CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.3 AU/mL 13.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1093B1EH03216559BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14 AU/mL 14 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:45B+mRNA-1273-P201ISmRNA-1273-P201-US201-1093B1EH50339997BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.8 AU/mL 12.8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:08B9mRNA-1273-P201ISmRNA-1273-P201-US201-1093B1EH18919613AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.1 AU/mL 13.1 AљAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1093B1EH42044449 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:16AmRNA-1273-P201ISmRNA-1273-P201-US201-1095AP1EH03213454AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 209 ug/mL 209 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:40B.mRNA-1273-P201ISmRNA-1273-P201-US201-1095A`1EH58765493AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.1 ug/mL 191.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:45B<mRNA-1273-P201ISmRNA-1273-P201-US201-1095Ap1EH00266420AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:16AmRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH03215502AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 849.2 AU/mL 849.2 C533334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:40B.mRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH50341021AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 631.9 AU/mL 631.9 C'~fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:45B<mRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH43364543AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.2 AU/mL 77.2 BM333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH00266420BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:16AmRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH03215502BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:40B.mRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH50341021BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:45B<mRNA-1273-P201ISmRNA-1273-P201-US201-1095A1EH43364543AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1102A`1EH03212302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34 ug/mL 34 B"ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1102Ap1EH03213484AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 323.1 ug/mL 323.1 C1ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH58767380AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 263.4 ug/mL 263.4 Cvfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:25B:mRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH41948219AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH03217581AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.2 AU/mL 187.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH03216526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH50340028AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1339.7 AU/mL 1339.7 CS33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:25B:mRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH18922525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.3 AU/mL 139.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T13:44BmRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH41948219BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1102A1EH03217581BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:32BmRNA-1273-P201ISmRNA-1273-P201-US201-1102B1EH03216526BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:15B+mRNA-1273-P201ISmRNA-1273-P201-US201-1102B1EH50340028BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:25B:mRNA-1273-P201ISmRNA-1273-P201-US201-1102B1EH18922525AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T13:44BmRNA-1273-P201ISmRNA-1273-P201-US201-1102B1EH42043523 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:29AmRNA-1273-P201ISmRNA-1273-P201-US201-1103A`1EH11637799AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 ug/mL 17.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1103Ap1EH03211405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.8 ug/mL 188.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:05B,mRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH58766484AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.4 ug/mL 143.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T16:58B<mRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH42047490AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:29AmRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH03218572AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.5 AU/mL 74.5 BJAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH03217550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 855.9 AU/mL 855.9 C5~fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:05B,mRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH58768406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 686.9 AU/mL 686.9 C*fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T16:58B<mRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH03418244AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.4 AU/mL 124.4 B|fffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T15:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH42047490BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:29AmRNA-1273-P201ISmRNA-1273-P201-US201-1103A1EH03218572BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1109A`1EH03211407AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 ug/mL 9.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1109Ap1EH08462345AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH34613377AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 ug/mL 9 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH08393888AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH03216429AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH08464552AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH34611202AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH43365535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:48BmRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH08393888BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1109A1EH03216429BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1109B1EH08464552BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:51B+mRNA-1273-P201ISmRNA-1273-P201-US201-1109B1EH34611202BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1109B1EH43365535AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:48BmRNA-1273-P201ISmRNA-1273-P201-US201-1109B1EH08389761 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1113A`1EH58768437AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.2 ug/mL 21.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1113Ap1EH18922652AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202 ug/mL 202 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:36B+mRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH34613281AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127 ug/mL 127 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:50B=mRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH08395809AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH58766519AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95.1 AU/mL 95.1 B_AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH27304093AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 851.1 AU/mL 851.1 C51AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:36B+mRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH34614304AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 533.8 AU/mL 533.8 C!\AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:50B=mRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH43364510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 163.3 AU/mL 163.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T10:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH08395809BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US201-1113A1EH58766519BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1113B1EH27304093BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:36B+mRNA-1273-P201ISmRNA-1273-P201-US201-1113B1EH34614304BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:50B=mRNA-1273-P201ISmRNA-1273-P201-US201-1113B1EH43364510AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T10:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1113B1EH41946266 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:21AmRNA-1273-P201ISmRNA-1273-P201-US201-1114A`1EH03211406AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1114Ap1EH00081066AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH34611360AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH33587225AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:21AmRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH03217582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH08462505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH34611331AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH61976630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:38BmRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH33587225BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.6 AU/mL 9.6 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:21AmRNA-1273-P201ISmRNA-1273-P201-US201-1114A1EH03217582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 AU/mL 11.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1114B1EH08462505BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.8 AU/mL 11.8 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:35B+mRNA-1273-P201ISmRNA-1273-P201-US201-1114B1EH34611331BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 AU/mL 10 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US201-1114B1EH61976630AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:38BmRNA-1273-P201ISmRNA-1273-P201-US201-1114B1EH41945274 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-27T11:18AmRNA-1273-P201ISmRNA-1273-P201-US201-1116A`1EH36702354AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 ug/mL 8.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1116Ap1EH00081035AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 ug/mL 9.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:51B-mRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH09551018AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:45B;mRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH08393729AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-27T11:18AmRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH36703379AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH08462377AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:51B-mRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH34613410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:45B;mRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH43364415AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH08393729BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-27T11:18AmRNA-1273-P201ISmRNA-1273-P201-US201-1116A1EH36703379BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:23BmRNA-1273-P201ISmRNA-1273-P201-US201-1116B1EH08462377BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:51B-mRNA-1273-P201ISmRNA-1273-P201-US201-1116B1EH34613410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:45B;mRNA-1273-P201ISmRNA-1273-P201-US201-1116B1EH43364415AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:34BmRNA-1273-P201ISmRNA-1273-P201-US201-1116B1EH08390688 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1117A`1EH03214381AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1117Ap1EH08464520AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.5 ug/mL 203.5 Bˀug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:19B+mRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH58767413AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.4 ug/mL 139.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:01B9mRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH08395808AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH03218604AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 AU/mL 10.9 AfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH08465545AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 931.2 AU/mL 931.2 C:333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:19B+mRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH58765495AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 695.7 AU/mL 695.7 C+{33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:01B9mRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH43365439AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 81.9 AU/mL 81.9 BQffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:44BmRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH08395808BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:44AmRNA-1273-P201ISmRNA-1273-P201-US201-1117A1EH03218604BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1117B1EH08465545BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:19B+mRNA-1273-P201ISmRNA-1273-P201-US201-1117B1EH58765495CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:01B9mRNA-1273-P201ISmRNA-1273-P201-US201-1117B1EH43365439AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:44BmRNA-1273-P201ISmRNA-1273-P201-US201-1117B1EH08391808 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1118A`1EH03214479AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.3 ug/mL 34.3 B"Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1118Ap1EH00081034AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.9 ug/mL 167.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:30B.mRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH34611200AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157.2 ug/mL 157.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T18:19B9mRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH41948347AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH03215532AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.7 AU/mL 68.7 BD33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH08462376AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 777.1 AU/mL 777.1 C0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:30B.mRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH34613378AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 817.4 AU/mL 817.4 C3fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T18:19B9mRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH61977750AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.3 AU/mL 82.3 BRLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:21BmRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH41948347BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:32AmRNA-1273-P201ISmRNA-1273-P201-US201-1118A1EH03215532CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:37BmRNA-1273-P201ISmRNA-1273-P201-US201-1118B1EH08462376BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:30B.mRNA-1273-P201ISmRNA-1273-P201-US201-1118B1EH34613378BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T18:19B9mRNA-1273-P201ISmRNA-1273-P201-US201-1118B1EH61977750AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:21BmRNA-1273-P201ISmRNA-1273-P201-US201-1118B1EH41946298 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-27T10:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1120A`1EH36703378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:16BmRNA-1273-P201ISmRNA-1273-P201-US201-1120Ap1EH18920636AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:32B-mRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH34611201AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T16:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH56692903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-27T10:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH36706353AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:16BmRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH27306141AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:32B-mRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH34614305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T16:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH18919580AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:08BmRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH56692903BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-27T10:25AmRNA-1273-P201ISmRNA-1273-P201-US201-1120A1EH36706353BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:16BmRNA-1273-P201ISmRNA-1273-P201-US201-1120B1EH27306141BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:32B-mRNA-1273-P201ISmRNA-1273-P201-US201-1120B1EH34614305BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T16:56B;mRNA-1273-P201ISmRNA-1273-P201-US201-1120B1EH18919580AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:08BmRNA-1273-P201ISmRNA-1273-P201-US201-1120B1EH56689797 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:51AmRNA-1273-P201ISmRNA-1273-P201-US201-1121A`1EH58765367AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 ug/mL 31.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1121Ap1EH66097288AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.8 ug/mL 124.8 B|ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T17:55B,mRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH34614272AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95.5 ug/mL 95.5 B_ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:19B:mRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH42047491AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:51AmRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH50339901AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157.6 AU/mL 157.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH66099370AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 607.4 AU/mL 607.4 C%fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T17:55B,mRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH34614401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 473.8 AU/mL 473.8 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:19B:mRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH42047491BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:51AmRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH50339901BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US201-1121A1EH66099370BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T17:55B,mRNA-1273-P201ISmRNA-1273-P201-US201-1121B1EH34614401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:19B:mRNA-1273-P201ISmRNA-1273-P201-US201-1121B1EH41945147 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1122A`1EH03211310AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 ug/mL 11.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1122Ap1EH58766357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.4 ug/mL 97.4 Bafffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:34B9mRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH42045570AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH03217551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.6 AU/mL 17.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH58766358AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 400.3 AU/mL 400.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:34B9mRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH18918463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65 AU/mL 65 BAAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:54BmRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH42045570BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH03217551CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH58766358BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:34B9mRNA-1273-P201ISmRNA-1273-P201-US201-1122A1EH18918463AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:54BmRNA-1273-P201ISmRNA-1273-P201-US201-1122B1EH08389760 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1123A`1EH16846906AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.3 ug/mL 24.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1123Ap1EH00081067AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.9 ug/mL 147.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH34613248AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.8 ug/mL 135.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T13:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH42046595AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH25233432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.7 AU/mL 46.7 B.33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH08465544AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 624.2 AU/mL 624.2 C'33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH34611363AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 577 AU/mL 577 C$AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T13:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH53552157AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.3 AU/mL 152.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH42046595BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:48AmRNA-1273-P201ISmRNA-1273-P201-US201-1123A1EH25233432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1123B1EH08465544BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US201-1123B1EH34611363BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T13:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1123B1EH53552157AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1123B1EH41943099 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1124A`1EH03212333AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1124Ap1EH00078987AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:07B+mRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH58765333AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH42048673AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH03215373AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH08465416AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:07B+mRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH58768407AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH53554236AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH42048673BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1124A1EH03215373CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1124B1EH08465416BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:07B+mRNA-1273-P201ISmRNA-1273-P201-US201-1124B1EH58768407BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:49B9mRNA-1273-P201ISmRNA-1273-P201-US201-1124B1EH53554236AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1124B1EH08390657 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1125A`1EH58765335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1125Ap1EH18918558AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 119.1 ug/mL 119.1 Bwug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T07:52B,mRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH34612225AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.4 ug/mL 97.4 Bafffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T07:55B:mRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH08395776AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH58768535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.6 AU/mL 27.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH27304124AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 639.2 AU/mL 639.2 C'33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T07:52B,mRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH34612257AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 448.7 AU/mL 448.7 C 33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T07:55B:mRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH03416069AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.7 AU/mL 58.7 B:33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:36BmRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH08395776BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US201-1125A1EH58768535BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:22BmRNA-1273-P201ISmRNA-1273-P201-US201-1125B1EH27304124BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T07:52B,mRNA-1273-P201ISmRNA-1273-P201-US201-1125B1EH34612257BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T07:55B:mRNA-1273-P201ISmRNA-1273-P201-US201-1125B1EH03416069AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:36BmRNA-1273-P201ISmRNA-1273-P201-US201-1125B1EH08388640 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1126A`1EH03211308AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1126Ap1EH00079019AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH38046849AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:04B9mRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH33587384AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH03217422AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH08463401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH38045827AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:04B9mRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH53552156AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.9 AU/mL 40.9 B(fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T09:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH33587384BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1126A1EH03217422BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1126B1EH08463401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:50B+mRNA-1273-P201ISmRNA-1273-P201-US201-1126B1EH38045827BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:04B9mRNA-1273-P201ISmRNA-1273-P201-US201-1126B1EH53552156AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.8 AU/mL 20.8 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T09:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1126B1EH41944251 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:53AmRNA-1273-P201ISmRNA-1273-P201-US201-1127A`1EH03212431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.1 ug/mL 17.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1127Ap1EH00078986AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 215.5 ug/mL 215.5 B׀ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:47B+mRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH09548971AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153.6 ug/mL 153.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:16B9mRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH33587352AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T13:53AmRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH03218476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.6 AU/mL 65.6 BAAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH08464425AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1038.5 AU/mL 1038.5 C@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:47B+mRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH34612384AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 639.4 AU/mL 639.4 C'fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:16B9mRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH43365566AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.3 AU/mL 65.3 BALAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH33587352BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:53AmRNA-1273-P201ISmRNA-1273-P201-US201-1127A1EH03218476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1127B1EH08464425BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T13:47B+mRNA-1273-P201ISmRNA-1273-P201-US201-1127B1EH34612384BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:16B9mRNA-1273-P201ISmRNA-1273-P201-US201-1127B1EH43365566AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:33BmRNA-1273-P201ISmRNA-1273-P201-US201-1127B1EH08391680 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:15AmRNA-1273-P201ISmRNA-1273-P201-US201-1128A`1EH58768565AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28 ug/mL 28 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1128Ap1EH18919453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 372.5 ug/mL 372.5 CHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:37B,mRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH34613409AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 295 ug/mL 295 Cpug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH42045443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T10:15AmRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH50339996AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.2 AU/mL 134.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH18920511AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:37B,mRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH34611362AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1614.9 AU/mL 1614.9 CdffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:45B:mRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH43366558AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 416.9 AU/mL 416.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH42045443BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:15AmRNA-1273-P201ISmRNA-1273-P201-US201-1128A1EH50339996BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1128B1EH18920511CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:37B,mRNA-1273-P201ISmRNA-1273-P201-US201-1128B1EH34611362BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1130A`1EH16847034AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1130Ap1EH08462472AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 ug/mL 8.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:56B+mRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH34611361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T15:18B9mRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH42047523AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH16849947AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH08463368AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:56B+mRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH34613283AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T15:18B9mRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH43365438AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 446.9 AU/mL 446.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH42047523BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 AU/mL 8.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:03AmRNA-1273-P201ISmRNA-1273-P201-US201-1130A1EH16849947BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1130B1EH08463368BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.4 AU/mL 10.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:56B+mRNA-1273-P201ISmRNA-1273-P201-US201-1130B1EH34613283BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T15:18B9mRNA-1273-P201ISmRNA-1273-P201-US201-1130B1EH43365438BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1534.8 AU/mL 1534.8 C_AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1130B1EH41947161 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1131A`1EH16848922AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1131Ap1EH00078891AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T16:18B+mRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH34612224AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T17:05B9mRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH42047650AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH16850075AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH08464424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T16:18B+mRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH34611203AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T17:05B9mRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH53551292AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH42047650BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:31AmRNA-1273-P201ISmRNA-1273-P201-US201-1131A1EH16850075CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1131B1EH08464424BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T16:18B+mRNA-1273-P201ISmRNA-1273-P201-US201-1131B1EH34611203BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T17:05B9mRNA-1273-P201ISmRNA-1273-P201-US201-1131B1EH53551292AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:40BmRNA-1273-P201ISmRNA-1273-P201-US201-1131B1EH08388769 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1137A`1EH03212428AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 ug/mL 17.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1137Ap1EH08464521AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.2 ug/mL 159.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:37B+mRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH58767412AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.8 ug/mL 130.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19T07:46B7mRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH42048515AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH03217583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.3 AU/mL 66.3 BBLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH08463497AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 865.8 AU/mL 865.8 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:37B+mRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH50343068AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 588.9 AU/mL 588.9 C$fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19T07:46B7mRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH53554333AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78.1 AU/mL 78.1 BNAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:31BmRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH42048515BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1137A1EH03217583BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1137B1EH08463497BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T07:37B+mRNA-1273-P201ISmRNA-1273-P201-US201-1137B1EH50343068BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19T07:46B7mRNA-1273-P201ISmRNA-1273-P201-US201-1137B1EH53554333AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T07:31BmRNA-1273-P201ISmRNA-1273-P201-US201-1137B1EH08390785 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-27T10:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1138A`1EH36702258AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:11BmRNA-1273-P201ISmRNA-1273-P201-US201-1138Ap1EH00079018AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.5 ug/mL 43.5 B+ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:26B-mRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH34614400AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.2 ug/mL 36.2 B$333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:35B=mRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH56694950AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-27T10:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH36705297AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.9 AU/mL 22.9 BfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:11BmRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH08462504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 296.7 AU/mL 296.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:26B-mRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH34614432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.4 AU/mL 179.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:35B=mRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH03418116AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.6 AU/mL 43.6 B+AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH56694950BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-27T10:17AmRNA-1273-P201ISmRNA-1273-P201-US201-1138A1EH36705297BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:11BmRNA-1273-P201ISmRNA-1273-P201-US201-1138B1EH08462504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:26B-mRNA-1273-P201ISmRNA-1273-P201-US201-1138B1EH34614432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:35B=mRNA-1273-P201ISmRNA-1273-P201-US201-1138B1EH03418116AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1138B1EH56688774 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1139A`1EH11639943AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.2 ug/mL 14.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1139Ap1EH08462473AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.1 ug/mL 165.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:23B+mRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH58766485AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.3 ug/mL 171.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH08393761AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH11601933AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.3 AU/mL 72.3 BHLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH08463400AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 903.7 AU/mL 903.7 C8{33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:23B+mRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH50342077AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 766 AU/mL 766 C/AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH08393761BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH11601933CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:30BmRNA-1273-P201ISmRNA-1273-P201-US201-1139A1EH08463400BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:23B+mRNA-1273-P201ISmRNA-1273-P201-US201-1139B1EH50342077BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1139B1EH42043427 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1142A`1EH36703281AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T14:19BmRNA-1273-P201ISmRNA-1273-P201-US201-1142Ap1EH18916511AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:09B-mRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH34611328AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:08B;mRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH56693799AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T10:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH36707345AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T14:19BmRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH18922655AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:09B-mRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH34613251AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:08B;mRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH43367583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T07:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH56693799BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:46AmRNA-1273-P201ISmRNA-1273-P201-US201-1142A1EH36707345BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T14:19BmRNA-1273-P201ISmRNA-1273-P201-US201-1142B1EH18922655BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:09B-mRNA-1273-P201ISmRNA-1273-P201-US201-1142B1EH34613251BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:08B;mRNA-1273-P201ISmRNA-1273-P201-US201-1142B1EH43367583AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T07:39BmRNA-1273-P201ISmRNA-1273-P201-US201-1142B1EH56689668 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1145A`1EH03214351AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1145Ap1EH00078890AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T13:39B*mRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH58767541AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T11:50B8mRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH33589304AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH03218446AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH08464553AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T13:39B*mRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH58767415AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T11:50B8mRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH18920604AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:38BmRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH33589304BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:00AmRNA-1273-P201ISmRNA-1273-P201-US201-1145A1EH03218446BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:50BmRNA-1273-P201ISmRNA-1273-P201-US201-1145B1EH08464553BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T13:39B*mRNA-1273-P201ISmRNA-1273-P201-US201-1145B1EH58767415BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T11:50B8mRNA-1273-P201ISmRNA-1273-P201-US201-1145B1EH18920604AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:38BmRNA-1273-P201ISmRNA-1273-P201-US201-1145B1EH08390817 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1149A`1EH36701233AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 ug/mL 34.2 B"333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:58BmRNA-1273-P201ISmRNA-1273-P201-US201-1149Ap1EH00080938AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 297.2 ug/mL 297.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH34613280AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 348.1 ug/mL 348.1 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T07:42B@mRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH56694951AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH36703411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.9 AU/mL 65.9 BAffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:58BmRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH08465448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH34613282AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1388.8 AU/mL 1388.8 CVAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T07:42B@mRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH43367614AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 575.6 AU/mL 575.6 C#AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T08:11BmRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH56694951BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:28AmRNA-1273-P201ISmRNA-1273-P201-US201-1149A1EH36703411BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:58BmRNA-1273-P201ISmRNA-1273-P201-US201-1149B1EH08465448BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1149B1EH34613282BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.6 AU/mL 10.6 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T07:42B@mRNA-1273-P201ISmRNA-1273-P201-US201-1149B1EH43367614AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T08:11BmRNA-1273-P201ISmRNA-1273-P201-US201-1149B1EH56690822 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:24AmRNA-1273-P201ISmRNA-1273-P201-US201-1152A`1EH36701202AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1152Ap1EH08464393AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH34613408AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:20B@mRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH56693895AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T10:24AmRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH36705296AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH08463369AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH34612385AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:20B@mRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH18919452AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH56693895BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:24AmRNA-1273-P201ISmRNA-1273-P201-US201-1152A1EH36705296BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:00BmRNA-1273-P201ISmRNA-1273-P201-US201-1152B1EH08463369BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1152B1EH34612385BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:20B@mRNA-1273-P201ISmRNA-1273-P201-US201-1152B1EH18919452AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:05BmRNA-1273-P201ISmRNA-1273-P201-US201-1152B1EH56688805 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1153A`1EH36702226AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.2 ug/mL 82.2 BR333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1153Ap1EH00080939AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 429.7 ug/mL 429.7 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:05B+mRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH34613249AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 301.7 ug/mL 301.7 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:13B9mRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH56692902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T13:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH36706449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 435.3 AU/mL 435.3 C4AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH08463496AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:05B+mRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH34613250AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1402.4 AU/mL 1402.4 CWffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:13B9mRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH43364511AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 199 AU/mL 199 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T12:28BmRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH56692902BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:13AmRNA-1273-P201ISmRNA-1273-P201-US201-1153A1EH36706449BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:17BmRNA-1273-P201ISmRNA-1273-P201-US201-1153B1EH08463496BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:05B+mRNA-1273-P201ISmRNA-1273-P201-US201-1153B1EH34613250CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:13B9mRNA-1273-P201ISmRNA-1273-P201-US201-1153B1EH43364511AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T12:28BmRNA-1273-P201ISmRNA-1273-P201-US201-1153B1EH56690695 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:39AmRNA-1273-P201ISmRNA-1273-P201-US201-1155A`1EH58765334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1155Ap1EH18918591AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH34611232AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:35B:mRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH41948315AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:39AmRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH58768534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH18922685AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH34613379AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:35B:mRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH61978806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH41948315BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:39AmRNA-1273-P201ISmRNA-1273-P201-US201-1155A1EH58768534BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:46BmRNA-1273-P201ISmRNA-1273-P201-US201-1155B1EH18922685BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:55B+mRNA-1273-P201ISmRNA-1273-P201-US201-1155B1EH34613379BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:35B:mRNA-1273-P201ISmRNA-1273-P201-US201-1155B1EH61978806AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:26BmRNA-1273-P201ISmRNA-1273-P201-US201-1155B1EH42043522 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1156A`1EH36701330AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1156Ap1EH18921628AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH34612352AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T07:55B:mRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH08395937AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH36704305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:10BmRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH18921534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH34611234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T07:55B:mRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH18916543AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:25BmRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH08395937BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1156A1EH36704305BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-30T15:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1157A`1EH58768532AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T17:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1157Ap1EH18918559AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T17:12B+mRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH34611233AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:22B;mRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH42045603AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T15:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH50340893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T17:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH18922559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T17:12B+mRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH34614433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:22B;mRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH43366462AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH42045603BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T15:38AmRNA-1273-P201ISmRNA-1273-P201-US201-1157A1EH50340893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T17:20BmRNA-1273-P201ISmRNA-1273-P201-US201-1157B1EH18922559BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T17:12B+mRNA-1273-P201ISmRNA-1273-P201-US201-1157B1EH34614433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:22B;mRNA-1273-P201ISmRNA-1273-P201-US201-1157B1EH43366462AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:15BmRNA-1273-P201ISmRNA-1273-P201-US201-1157B1EH42042528 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1159A`1EH58765366AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 ug/mL 12.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1159Ap1EH18916542AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.3 ug/mL 108.3 BlLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH09551019AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85 ug/mL 85 BUug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:20B9mRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH33587257AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH50341948AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.7 AU/mL 61.7 B=33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH18919615AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 246.5 AU/mL 246.5 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH34612256AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 367.7 AU/mL 367.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:20B9mRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH03418117AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.3 AU/mL 44.3 B,LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T11:55BmRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH33587257BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:35AmRNA-1273-P201ISmRNA-1273-P201-US201-1159A1EH50341948BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:56BmRNA-1273-P201ISmRNA-1273-P201-US201-1159B1EH18919615BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:22B+mRNA-1273-P201ISmRNA-1273-P201-US201-1159B1EH34612256BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:20B9mRNA-1273-P201ISmRNA-1273-P201-US201-1159B1EH03418117AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T11:55BmRNA-1273-P201ISmRNA-1273-P201-US201-1159B1EH08390656 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1162AP1EH18919485AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 276.8 ug/mL 276.8 CLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:30B+mRNA-1273-P201ISmRNA-1273-P201-US201-1162A`1EH34614273AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 216.2 ug/mL 216.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T16:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1162Ap1EH50342076AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.9 AU/mL 107.9 BkffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH27306044AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1287.1 AU/mL 1287.1 CPqAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:30B+mRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH34611235AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 938.2 AU/mL 938.2 C:33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T16:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH18917567AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 457.5 AU/mL 457.5 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T16:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH50342076BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 AU/mL 10 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH27306044BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:30B+mRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH34611235BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T16:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH18917567AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T16:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1162A1EH50376886 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies678.823 MN50 20 2560 678.823 C*m+ IMN50 BATTELLE SERUM B[APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH27276446 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies14481.547MN50 640 81920 14481.547D81&MN50 BATTELLE SERUM B[ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:30B+mRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH09550984 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies10861.16 MN50 640 81920 10861.16 D*m(\MN50 BATTELLE SERUM B[AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T16:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH27276350 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1810.193 MN50 20 2560 1810.193 Cq#+ MN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T16:35BmRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH50376886 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies480 MN Endpoint Titer20 2560 480 CMN Endpoint Titer BATTELLE SERUM B(APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:18BmRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH27276446 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies10240 MN Endpoint Titer640 81920 10240 D(MN Endpoint Titer BATTELLE SERUM B(ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:30B+mRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH09550984 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies6400 MN Endpoint Titer640 81920 6400 DMN Endpoint Titer BATTELLE SERUM B(AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T16:46B9mRNA-1273-P201ISmRNA-1273-P201-US201-1162B1EH27276350 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies1280 MN Endpoint Titer20 2560 1280 CPMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T16:35BmRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH35691651AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1003A 1EH32606222AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:37B!mRNA-1273-P201ISmRNA-1273-P201-US202-1003A01EH34872466AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:55B/mRNA-1273-P201ISmRNA-1273-P201-US202-1003A@1EH22349829AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1003AP1EH35691651AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1003A`1EH32606222AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.2 ug/mL 13.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:37B!mRNA-1273-P201ISmRNA-1273-P201-US202-1003Ap1EH34872466AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.6 ug/mL 85.6 BUug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:55B/mRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH22349829AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.4 ug/mL 38.4 B&ffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH44078211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH32604303AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.1 AU/mL 41.1 B)AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:37B!mRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH43258001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 221.2 AU/mL 221.2 B333330AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:55B/mRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH22348806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.2 AU/mL 117.2 Bu333334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH61089983AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.9 AU/mL 35.9 B#fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH44078211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1003A1EH32604303BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:37B!mRNA-1273-P201ISmRNA-1273-P201-US202-1003B1EH43258001BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:55B/mRNA-1273-P201ISmRNA-1273-P201-US202-1003B1EH22348806CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1003B1EH61089983AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1003B1EH35686400 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:17AmRNA-1273-P201ISmRNA-1273-P201-US202-1004A`1EH35979287AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.7 ug/mL 26.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T08:57BmRNA-1273-P201ISmRNA-1273-P201-US202-1004Ap1EH34869394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T08:39B*mRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH30710958AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 397.4 ug/mL 397.4 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T09:21B9mRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH44078209AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T10:17AmRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH59774082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.9 AU/mL 97.9 BaffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T08:57BmRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH43257905AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T08:39B*mRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH22351015AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T09:21B9mRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH53553307AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 419.6 AU/mL 419.6 C9AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T09:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH44078209BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:17AmRNA-1273-P201ISmRNA-1273-P201-US202-1004A1EH59774082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T08:57BmRNA-1273-P201ISmRNA-1273-P201-US202-1004B1EH43257905BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T08:39B*mRNA-1273-P201ISmRNA-1273-P201-US202-1004B1EH22351015BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T09:21B9mRNA-1273-P201ISmRNA-1273-P201-US202-1004B1EH53553307AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T09:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1004B1EH44046338 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:59AmRNA-1273-P201ISmRNA-1273-P201-US202-1007A`1EH35981335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21 ug/mL 21 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1007Ap1EH34870321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.1 ug/mL 193.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:00B,mRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH22349957AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.8 ug/mL 148.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:54B;mRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH44077091AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T11:59AmRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH51415041AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.7 AU/mL 39.7 B'33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH43258929AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 791.2 AU/mL 791.2 C1s33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:00B,mRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH22353925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 676.1 AU/mL 676.1 C*AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:54B;mRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH61088926AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.6 AU/mL 108.6 BlAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:55BmRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH44077091BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:59AmRNA-1273-P201ISmRNA-1273-P201-US202-1007A1EH51415041BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1007B1EH43258929BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:00B,mRNA-1273-P201ISmRNA-1273-P201-US202-1007B1EH22353925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:54B;mRNA-1273-P201ISmRNA-1273-P201-US202-1007B1EH61088926AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:55BmRNA-1273-P201ISmRNA-1273-P201-US202-1007B1EH44046466 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:37AmRNA-1273-P201ISmRNA-1273-P201-US202-1011A`1EH35981460AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.8 ug/mL 35.8 B#ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1011Ap1EH43256880AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 224.4 ug/mL 224.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T11:18B*mRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH30708751AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 212.8 ug/mL 212.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T10:58B6mRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH44077090AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T14:37AmRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH51415169AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.1 AU/mL 121.1 ByAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH43254803AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 985.8 AU/mL 985.8 C=AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T11:18B*mRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH22351013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 780.4 AU/mL 780.4 C0fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T10:58B6mRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH61088799AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.2 AU/mL 107.2 Bk333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:22BmRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH44077090BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:37AmRNA-1273-P201ISmRNA-1273-P201-US202-1011A1EH51415169BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1011B1EH43254803BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T11:18B*mRNA-1273-P201ISmRNA-1273-P201-US202-1011B1EH22351013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T10:58B6mRNA-1273-P201ISmRNA-1273-P201-US202-1011B1EH61088799AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:22BmRNA-1273-P201ISmRNA-1273-P201-US202-1011B1EH35685376 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1012A`1EH44340255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.9 ug/mL 52.9 B4fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:43BmRNA-1273-P201ISmRNA-1273-P201-US202-1012Ap1EH34872497AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 247.5 ug/mL 247.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:47B-mRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH30710927AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 221.6 ug/mL 221.6 Bݙug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH44078113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH59774978AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.3 AU/mL 139.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:43BmRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH43258000AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 938.8 AU/mL 938.8 C:AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:47B-mRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH22347942AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 582.9 AU/mL 582.9 C$nfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH53553339AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.2 AU/mL 165.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH44078113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1012A1EH59774978BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:43BmRNA-1273-P201ISmRNA-1273-P201-US202-1012B1EH43258000BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:47B-mRNA-1273-P201ISmRNA-1273-P201-US202-1012B1EH22347942BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US202-1012B1EH53553339AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1012B1EH44047392 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:06AmRNA-1273-P201ISmRNA-1273-P201-US202-1015A`1EH35981366AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.2 ug/mL 14.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1015Ap1EH34872467AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 ug/mL 13.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T09:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH30709935AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14 ug/mL 14 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T09:27B8mRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH44076067AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T10:06AmRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH59774112AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH43259922AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T09:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH22350855AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T09:27B8mRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH53551290AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:35BmRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH44076067BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:06AmRNA-1273-P201ISmRNA-1273-P201-US202-1015A1EH59774112BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1015B1EH43259922BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T09:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1015B1EH22350855BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T09:27B8mRNA-1273-P201ISmRNA-1273-P201-US202-1015B1EH53551290AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:35BmRNA-1273-P201ISmRNA-1273-P201-US202-1015B1EH35687456 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US202-1018A@1EH22350853AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.9 AU/mL 11.9 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018AP1EH44075042AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1018A`1EH35981495AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 ug/mL 9 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T13:29B.mRNA-1273-P201ISmRNA-1273-P201-US202-1018Ap1EH41196581AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.5 ug/mL 84.5 BTug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T13:31B>mRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH22350853AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45 ug/mL 45 B-ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH44079267AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH51415040AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T13:29B.mRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH49578021AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 288.4 AU/mL 288.4 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T13:31B>mRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH22347782AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.9 AU/mL 179.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH20295822AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.7 AU/mL 34.7 B"33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH44079267BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1018A1EH51415040BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T13:29B.mRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH49578021BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T13:31B>mRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH22347782BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH20295822AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH35687552 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH30705710 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies2262.742 MN50 40 5120 2262.742 Ck;dZ MN50 BATTELLE SERUM B[AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH20292783 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH30705710 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies1600 MN Endpoint Titer40 5120 1600 CdMN Endpoint Titer BATTELLE SERUM B(AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:10BKmRNA-1273-P201ISmRNA-1273-P201-US202-1018B1EH20292783 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies200 MN Endpoint Titer20 2560 200 BMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH44075171AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.8 AU/mL 13.8 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T14:22AmRNA-1273-P201ISmRNA-1273-P201-US202-1019A 1EH35980341AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 AU/mL 12.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:16B#mRNA-1273-P201ISmRNA-1273-P201-US202-1019A01EH34872370AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.6 AU/mL 12.6 AəAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:40B.mRNA-1273-P201ISmRNA-1273-P201-US202-1019A@1EH22348805AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.4 AU/mL 13.4 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T11:20B@mRNA-1273-P201ISmRNA-1273-P201-US202-1019AP1EH44075171AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:22AmRNA-1273-P201ISmRNA-1273-P201-US202-1019A`1EH35980341AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.9 ug/mL 25.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:16B#mRNA-1273-P201ISmRNA-1273-P201-US202-1019Ap1EH34872370AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:40B.mRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH22348805AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 294.4 ug/mL 294.4 Cffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T11:20B@mRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH44078240AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T14:22AmRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH59776160AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.8 AU/mL 71.8 BGAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:16B#mRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH43255954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1679.1 AU/mL 1679.1 Ch񙙙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:40B.mRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH22349862AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1317.6 AU/mL 1317.6 CRYAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T11:20B@mRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH53553338AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.9 AU/mL 171.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH44078240BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:22AmRNA-1273-P201ISmRNA-1273-P201-US202-1019A1EH59776160BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:16B#mRNA-1273-P201ISmRNA-1273-P201-US202-1019B1EH43255954BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T08:40B.mRNA-1273-P201ISmRNA-1273-P201-US202-1019B1EH22349862CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T11:20B@mRNA-1273-P201ISmRNA-1273-P201-US202-1019B1EH53553338AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1019B1EH44047393 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1020A`1EH44339359AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:24BmRNA-1273-P201ISmRNA-1273-P201-US202-1020Ap1EH34871442AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.3 ug/mL 218.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:38B,mRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH22350980AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.1 ug/mL 149.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:20B;mRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH44078241AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH35984404AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.2 AU/mL 21.2 B333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:24BmRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH43258033AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1137.9 AU/mL 1137.9 CGffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:38B,mRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH22354052AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 643.7 AU/mL 643.7 C(;33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:20B;mRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH61089823AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.3 AU/mL 87.3 BWLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T10:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH44078241BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1020A1EH35984404BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:24BmRNA-1273-P201ISmRNA-1273-P201-US202-1020B1EH43258033BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:38B,mRNA-1273-P201ISmRNA-1273-P201-US202-1020B1EH22354052BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:20B;mRNA-1273-P201ISmRNA-1273-P201-US202-1020B1EH61089823AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T10:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1020B1EH35684384 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1021A`1EH44342334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:18BmRNA-1273-P201ISmRNA-1273-P201-US202-1021Ap1EH34872338AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:30B.mRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH22348933AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-22T09:35B7mRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH44077217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T10:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH59773984AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:18BmRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH43257873AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:30B.mRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH22350983AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-22T09:35B7mRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH53551163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T10:14BmRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH44077217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1021A1EH59773984BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:18BmRNA-1273-P201ISmRNA-1273-P201-US202-1021B1EH43257873BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:30B.mRNA-1273-P201ISmRNA-1273-P201-US202-1021B1EH22350983BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-22T09:35B7mRNA-1273-P201ISmRNA-1273-P201-US202-1021B1EH53551163AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T10:14BmRNA-1273-P201ISmRNA-1273-P201-US202-1021B1EH35685408 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1022A`1EH35982356AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:42B$mRNA-1273-P201ISmRNA-1273-P201-US202-1022Ap1EH41192455AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 ug/mL 8.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:54B3mRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH35979412AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:00BAmRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH44077185AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH51415073AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:42B$mRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH41195558AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:54B3mRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH35985431AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:00BAmRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH20297871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T11:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH44077185BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1022A1EH51415073BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:42B$mRNA-1273-P201ISmRNA-1273-P201-US202-1022B1EH41195558CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:54B3mRNA-1273-P201ISmRNA-1273-P201-US202-1022B1EH35985431BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:00BAmRNA-1273-P201ISmRNA-1273-P201-US202-1022B1EH20297871AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T11:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1022B1EH35684481 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:58AmRNA-1273-P201ISmRNA-1273-P201-US202-1031A`1EH44342430AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 ug/mL 10.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:22BmRNA-1273-P201ISmRNA-1273-P201-US202-1031Ap1EH34870320AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36 ug/mL 36 B$ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH22349828AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.7 ug/mL 28.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:28B9mRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH44074146AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:58AmRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH51413024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12 AU/mL 12 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:22BmRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH43261105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 384.4 AU/mL 384.4 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH22349831AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.4 AU/mL 190.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:28B9mRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH61089822AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 AU/mL 31.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T11:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH44074146BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:58AmRNA-1273-P201ISmRNA-1273-P201-US202-1031A1EH51413024BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:22BmRNA-1273-P201ISmRNA-1273-P201-US202-1031B1EH43261105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US202-1031B1EH22349831BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:28B9mRNA-1273-P201ISmRNA-1273-P201-US202-1031B1EH61089822AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T11:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1031B1EH44047523 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1043A`1EH32604174AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:32B mRNA-1273-P201ISmRNA-1273-P201-US202-1043Ap1EH41194532AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B/mRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH22348836AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:28B;mRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH44077059AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH32604206AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:32B mRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH41196551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B/mRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH22351877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:28B;mRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH53553306AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:55BmRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH44077059BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1043A1EH32604206BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:32B mRNA-1273-P201ISmRNA-1273-P201-US202-1043B1EH41196551BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B/mRNA-1273-P201ISmRNA-1273-P201-US202-1043B1EH22351877CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:28B;mRNA-1273-P201ISmRNA-1273-P201-US202-1043B1EH53553306AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:55BmRNA-1273-P201ISmRNA-1273-P201-US202-1043B1EH35687425 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T17:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1045A`1EH35979316AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.1 ug/mL 21.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1045Ap1EH34872339AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110.3 ug/mL 110.3 BnLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B-mRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH44342302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.9 ug/mL 40.9 B(fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:45B@mRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH44080163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T17:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH59775011AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.6 AU/mL 68.6 BDAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH43253779AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 422.3 AU/mL 422.3 CdAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B-mRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH51413153AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.2 AU/mL 218.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:45B@mRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH20295695AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.6 AU/mL 34.6 B"AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH44080163BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T17:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1045A1EH59775011BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1045B1EH43253779BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B-mRNA-1273-P201ISmRNA-1273-P201-US202-1045B1EH51413153BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:45B@mRNA-1273-P201ISmRNA-1273-P201-US202-1045B1EH20295695AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1045B1EH35684480 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1047A`1EH35979413AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1047Ap1EH34872368AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.7 ug/mL 100.7 Bd33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:51B,mRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH22350885AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.7 ug/mL 34.7 B"33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T13:45B6mRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH44078114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH59776131AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.8 AU/mL 20.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH43257874AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 324.2 AU/mL 324.2 CC33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:51B,mRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH22352005AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 330.1 AU/mL 330.1 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T13:45B6mRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH53553211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75 AU/mL 75 BKAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH44078114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1047A1EH59776131BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1047B1EH43257874BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:51B,mRNA-1273-P201ISmRNA-1273-P201-US202-1047B1EH22352005BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T13:45B6mRNA-1273-P201ISmRNA-1273-P201-US202-1047B1EH53553211AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1047B1EH44045441 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1058A`1EH44340382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.5 ug/mL 21.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:51B!mRNA-1273-P201ISmRNA-1273-P201-US202-1058Ap1EH41192615AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.9 ug/mL 132.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:12B1mRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH44341439AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.3 ug/mL 130.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH44080162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T09:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH59776163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.9 AU/mL 68.9 BDffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:51B!mRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH41194660AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 164.3 AU/mL 164.3 BLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:12B1mRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH59773089AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 456.3 AU/mL 456.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH61087902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78.3 AU/mL 78.3 BNLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH44080162BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1058A1EH59776163BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:51B!mRNA-1273-P201ISmRNA-1273-P201-US202-1058B1EH41194660BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:12B1mRNA-1273-P201ISmRNA-1273-P201-US202-1058B1EH59773089BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1058B1EH61087902AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1058B1EH35685504 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:11AmRNA-1273-P201ISmRNA-1273-P201-US202-1059A`1EH35981332AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.9 ug/mL 30.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1059Ap1EH43256976AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH30708879AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 321 ug/mL 321 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH44079136AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:11AmRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH59774115AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.4 AU/mL 141.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH43257011AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1714.1 AU/mL 1714.1 Ck!AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH22350854AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 994.3 AU/mL 994.3 C>$AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH53551291AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.7 AU/mL 74.7 BJ33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH44079136BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:11AmRNA-1273-P201ISmRNA-1273-P201-US202-1059A1EH59774115BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1059B1EH43257011BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1059B1EH22350854BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 AU/mL 10.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1059B1EH53551291AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1059B1EH35685409 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1061A`1EH44341438AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:00BmRNA-1273-P201ISmRNA-1273-P201-US202-1061Ap1EH34869299AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH30708878AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 ug/mL 6.4 Affffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:38B8mRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH42304646AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH59776130AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:00BmRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH43256979AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH22349991AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:38B8mRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH20296845AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T10:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH42304646BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1061A1EH59776130BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:00BmRNA-1273-P201ISmRNA-1273-P201-US202-1061B1EH43256979BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:40B*mRNA-1273-P201ISmRNA-1273-P201-US202-1061B1EH22349991BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:38B8mRNA-1273-P201ISmRNA-1273-P201-US202-1061B1EH20296845AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T10:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1061B1EH42305670 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1062A`1EH32607405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1062Ap1EH41190438AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:54B,mRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH30708911AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.6 ug/mL 8.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:04B6mRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH44078208AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T10:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH32606351AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH41196708AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:54B,mRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH22351908AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:04B6mRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH20296748AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T11:11BmRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH44078208BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1062A1EH32606351BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1062B1EH41196708BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:54B,mRNA-1273-P201ISmRNA-1273-P201-US202-1062B1EH22351908CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:04B6mRNA-1273-P201ISmRNA-1273-P201-US202-1062B1EH20296748AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T11:11BmRNA-1273-P201ISmRNA-1273-P201-US202-1062B1EH35686528 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1063A`1EH32605356AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.9 ug/mL 28.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:21B"mRNA-1273-P201ISmRNA-1273-P201-US202-1063Ap1EH41196549AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 242 ug/mL 242 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:50B0mRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH44341310AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.7 ug/mL 179.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B?mRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH44077089AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH32606254AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.9 AU/mL 147.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:21B"mRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH49578117AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 812 AU/mL 812 C2AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:50B0mRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH59773987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 534.5 AU/mL 534.5 C!hAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B?mRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH61087934AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.9 AU/mL 190.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH44077089BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1063A1EH32606254BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:21B"mRNA-1273-P201ISmRNA-1273-P201-US202-1063B1EH49578117BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:50B0mRNA-1273-P201ISmRNA-1273-P201-US202-1063B1EH59773987BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B?mRNA-1273-P201ISmRNA-1273-P201-US202-1063B1EH61087934AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1063B1EH44047521 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1064A`1EH32606223AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.9 ug/mL 34.9 B"fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B mRNA-1273-P201ISmRNA-1273-P201-US202-1064Ap1EH41195653AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 248.2 ug/mL 248.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:45B,mRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH35982485AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 211.3 ug/mL 211.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH44080131AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T08:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH32606255AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.8 AU/mL 88.8 BXAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B mRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH49580196AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 725.6 AU/mL 725.6 C-YAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:45B,mRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH59775139AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 705.6 AU/mL 705.6 C,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH61087903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.2 AU/mL 124.2 B|333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:52BmRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH44080131BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:08AmRNA-1273-P201ISmRNA-1273-P201-US202-1064A1EH32606255BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B mRNA-1273-P201ISmRNA-1273-P201-US202-1064B1EH49580196BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:45B,mRNA-1273-P201ISmRNA-1273-P201-US202-1064B1EH59775139BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US202-1064B1EH61087903AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:52BmRNA-1273-P201ISmRNA-1273-P201-US202-1064B1EH44046498 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1067A`1EH44340254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37.6 ug/mL 37.6 B%ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US202-1067Ap1EH41196677AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 209.7 ug/mL 209.7 Bѳ33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T10:19B.mRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH35982516AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152 ug/mL 152 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:15B?mRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH44079233AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T11:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH51413152AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.2 AU/mL 134.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH41194630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 963.6 AU/mL 963.6 C<9AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T10:19B.mRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH59773059AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 642.3 AU/mL 642.3 C($AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:15B?mRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH61090846AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.9 AU/mL 108.9 BlffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:05BmRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH44079233BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1067A1EH51413152BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.3 AU/mL 10.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:05B mRNA-1273-P201ISmRNA-1273-P201-US202-1067B1EH41194630BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T10:19B.mRNA-1273-P201ISmRNA-1273-P201-US202-1067B1EH59773059BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:15B?mRNA-1273-P201ISmRNA-1273-P201-US202-1067B1EH61090846AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.1 AU/mL 11.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:05BmRNA-1273-P201ISmRNA-1273-P201-US202-1067B1EH35687584 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1068A`1EH35979286AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 ug/mL 19.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1068Ap1EH43256977AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 129.7 ug/mL 129.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B,mRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH22347908AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.2 ug/mL 112.2 Bp333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T16:51B:mRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH44080289AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH51414016AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.3 AU/mL 42.3 B*LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH43256883AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 447.8 AU/mL 447.8 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B,mRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH22348935AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 349 AU/mL 349 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T16:51B:mRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH09450548AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 91.2 AU/mL 91.2 B[333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH44080289BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1068A1EH51414016BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1068B1EH43256883BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:50B,mRNA-1273-P201ISmRNA-1273-P201-US202-1068B1EH22348935BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T16:51B:mRNA-1273-P201ISmRNA-1273-P201-US202-1068B1EH09450548AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T15:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1068B1EH44047362 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1073A`1EH32607276AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 ug/mL 12.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:05BmRNA-1273-P201ISmRNA-1273-P201-US202-1073Ap1EH43255985AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.7 ug/mL 13.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:48B-mRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH44341407AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.8 ug/mL 14.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:59B<mRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH42306694AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH32605198AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:05BmRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH43253778AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:48B-mRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH59775106AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:59B<mRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH20297870AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.9 AU/mL 77.9 BMffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T08:32BmRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH42306694BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1073A1EH32605198BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:05BmRNA-1273-P201ISmRNA-1273-P201-US202-1073B1EH43253778BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:48B-mRNA-1273-P201ISmRNA-1273-P201-US202-1073B1EH59775106BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:59B<mRNA-1273-P201ISmRNA-1273-P201-US202-1073B1EH20297870BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.3 AU/mL 154.3 BLAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T08:32BmRNA-1273-P201ISmRNA-1273-P201-US202-1073B1EH42305574 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:25AmRNA-1273-P201ISmRNA-1273-P201-US202-1074A`1EH32604175AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.4 ug/mL 21.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:08B$mRNA-1273-P201ISmRNA-1273-P201-US202-1074Ap1EH41156782AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 318.8 ug/mL 318.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:33B2mRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH22347940AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 255.7 ug/mL 255.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:36B@mRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH35753986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:25AmRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH57679013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.1 AU/mL 137.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:08B$mRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH22350886AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1027.1 AU/mL 1027.1 C@1AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:36B@mRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH20296877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 371.3 AU/mL 371.3 C4AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH35753986BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:25AmRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH57679013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:08B$mRNA-1273-P201ISmRNA-1273-P201-US202-1074A1EH22350886BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:36B@mRNA-1273-P201ISmRNA-1273-P201-US202-1074B1EH20296877AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1074B1EH35686529 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1078A`1EH35980340AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1078Ap1EH43255857AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH44339263AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:04B:mRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH42306695AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH59776128AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH43255987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH51413120AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:04B:mRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH53553210AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH42306695BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1078A1EH59776128BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1078B1EH43255987BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US202-1078B1EH51413120BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:04B:mRNA-1273-P201ISmRNA-1273-P201-US202-1078B1EH53553210AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1078B1EH42305671 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1080A`1EH35979446AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.3 ug/mL 33.3 B!Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:04B"mRNA-1273-P201ISmRNA-1273-P201-US202-1080Ap1EH41190566AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 300.5 ug/mL 300.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:51B0mRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH35980468AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.6 ug/mL 225.6 Bᙙug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T10:31B@mRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH44080257AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH59773985AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 119.7 AU/mL 119.7 Bw33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:04B"mRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH41196679AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 961 AU/mL 961 C<AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:51B0mRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH51413121AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 934 AU/mL 934 C:`AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T10:31B@mRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH53553178AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 316.8 AU/mL 316.8 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:44BmRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH44080257BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1080A1EH59773985BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:04B"mRNA-1273-P201ISmRNA-1273-P201-US202-1080B1EH41196679BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:51B0mRNA-1273-P201ISmRNA-1273-P201-US202-1080B1EH51413121BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1082Ap1EH35979319AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:02B#mRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH41193604AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:26B2mRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH35981364AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:59BBmRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH45202449AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10T10:39BdmRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH44077218AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH59776000AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:02B#mRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH49578116AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:26B2mRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH59772931AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:59BBmRNA-1273-P201ISmRNA-1273-P201-US202-1082A1EH45202481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10T10:39BdmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH61089855AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.9 AU/mL 88.9 BXffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:58BmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH44077218BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH59776000BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:02B#mRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH49578116BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:26B2mRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH59772931BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:59BBmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH45202481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10T10:39BdmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH61089855AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25 AU/mL 25 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:58BmRNA-1273-P201ISmRNA-1273-P201-US202-1082B1EH44044323 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T15:57AmRNA-1273-P201ISmRNA-1273-P201-US202-1084A`1EH35981463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 ug/mL 12.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:49B!mRNA-1273-P201ISmRNA-1273-P201-US202-1084Ap1EH41191591AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.3 ug/mL 218.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:10B.mRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH22351012AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 196.8 ug/mL 196.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:23B<mRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH44079235AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T15:57AmRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH59773954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 AU/mL 17.2 B333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:49B!mRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH49580164AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 768.6 AU/mL 768.6 C0 AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:10B.mRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH22352004AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 645.4 AU/mL 645.4 C(VfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:23B<mRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH61091004AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.8 AU/mL 197.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T10:33BmRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH44079235BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T15:57AmRNA-1273-P201ISmRNA-1273-P201-US202-1084A1EH59773954BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:49B!mRNA-1273-P201ISmRNA-1273-P201-US202-1084B1EH49580164BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:10B.mRNA-1273-P201ISmRNA-1273-P201-US202-1084B1EH22352004BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:23B<mRNA-1273-P201ISmRNA-1273-P201-US202-1084B1EH61091004AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T10:33BmRNA-1273-P201ISmRNA-1273-P201-US202-1084B1EH35686560 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1089A`1EH35979447AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1089Ap1EH41194501AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH35979285AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:30B:mRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH44074019AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH59773091AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH41195655AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH59775136AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:30B:mRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH61088957AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:50BmRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH44074019BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1089A1EH59773091BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1089B1EH41195655BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US202-1089B1EH59775136BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:30B:mRNA-1273-P201ISmRNA-1273-P201-US202-1089B1EH61088957AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:50BmRNA-1273-P201ISmRNA-1273-P201-US202-1089B1EH44044291 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1090A`1EH32607372AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.8 ug/mL 11.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:53B#mRNA-1273-P201ISmRNA-1273-P201-US202-1090Ap1EH43255984AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.3 ug/mL 104.3 BhLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:51B1mRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH22347909AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.8 ug/mL 88.8 BXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH44078115AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH32606383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.1 AU/mL 15.1 A񙙙AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:53B#mRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH43255859AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 317.3 AU/mL 317.3 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:51B1mRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH22347783AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 198.9 AU/mL 198.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH61089951AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78.6 AU/mL 78.6 BNAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T16:32BmRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH44078115BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1090A1EH32606383BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:53B#mRNA-1273-P201ISmRNA-1273-P201-US202-1090B1EH43255859BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:51B1mRNA-1273-P201ISmRNA-1273-P201-US202-1090B1EH22347783BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US202-1090B1EH61089951AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T16:32BmRNA-1273-P201ISmRNA-1273-P201-US202-1090B1EH44047394 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:21AmRNA-1273-P201ISmRNA-1273-P201-US202-1093A`1EH44340415AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.4 ug/mL 26.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:40B"mRNA-1273-P201ISmRNA-1273-P201-US202-1093Ap1EH41194629AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 283.3 ug/mL 283.3 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:24B1mRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH35979414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 209.3 ug/mL 209.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BAmRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH44077057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:21AmRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH51415200AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.3 AU/mL 131.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:40B"mRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH49577988AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1276.4 AU/mL 1276.4 COffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:24B1mRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH59773952AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 955.5 AU/mL 955.5 C;AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BAmRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH61089982AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140.8 AU/mL 140.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH44077057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:21AmRNA-1273-P201ISmRNA-1273-P201-US202-1093A1EH51415200BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 AU/mL 9 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:40B"mRNA-1273-P201ISmRNA-1273-P201-US202-1093B1EH49577988BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:24B1mRNA-1273-P201ISmRNA-1273-P201-US202-1093B1EH59773952BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.1 AU/mL 15.1 A񙙙AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BAmRNA-1273-P201ISmRNA-1273-P201-US202-1093B1EH61089982AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 AU/mL 11.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1093B1EH44044418 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1094A`1EH44076163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1094Ap1EH20298797AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T09:02BmRNA-1273-P201ISmRNA-1273-P201-US202-1094A1EH44076163BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1094A1EH20298797AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T09:02BmRNA-1273-P201ISmRNA-1273-P201-US202-1094A1EH44045345 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1096A`1EH32607404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 ug/mL 8.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1096Ap1EH43256849AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:42B+mRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH30708750AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:13B7mRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH42304550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH32606350AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH43260081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:42B+mRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH22354085AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:13B7mRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH20295823AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T13:18BmRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH42304550BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1096A1EH32606350BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1096B1EH43260081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:42B+mRNA-1273-P201ISmRNA-1273-P201-US202-1096B1EH22354085BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:13B7mRNA-1273-P201ISmRNA-1273-P201-US202-1096B1EH20295823AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:15AmRNA-1273-P201ISmRNA-1273-P201-US202-1099Ap1EH35981494AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.9 ug/mL 30.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:52BmRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH41191463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 284.6 ug/mL 284.6 Cəug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH30710831AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 236.8 ug/mL 236.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:25B8mRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH66165939AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.9 ug/mL 154.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-07T09:40BCmRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH44079107AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:15AmRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH59776033AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 92.7 AU/mL 92.7 B\33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:52BmRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH41193478AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 831.3 AU/mL 831.3 C3AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH22348839AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 827.5 AU/mL 827.5 C3AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:25B8mRNA-1273-P201ISmRNA-1273-P201-US202-1099A1EH57740344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 601 AU/mL 601 C%AU/mL PPD VACCINESERUMELISA AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-07T09:40BCmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH53551162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83 AU/mL 83 BSAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH44079107BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:15AmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH59776033BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:52BmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH41193478BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH22348839BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:25B8mRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH57740344BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-07T09:40BCmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH53551162AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1099B1EH44044419 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1101A`1EH35979445AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.4 ug/mL 48.4 B0ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T10:34B mRNA-1273-P201ISmRNA-1273-P201-US202-1101Ap1EH41191590AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252 ug/mL 252 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH35980437AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204 ug/mL 204 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:58B:mRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH44080130AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH59774113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.4 AU/mL 152.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T10:34B mRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH41193638AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1154.1 AU/mL 1154.1 CH!AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH51414017AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 923.7 AU/mL 923.7 C933334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:58B:mRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH61087806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 545.2 AU/mL 545.2 C"33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH44080130BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1101A1EH59774113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T10:34B mRNA-1273-P201ISmRNA-1273-P201-US202-1101B1EH41193638BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US202-1101B1EH51414017BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T13:58B:mRNA-1273-P201ISmRNA-1273-P201-US202-1101B1EH61087806AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1101B1EH44045344 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:31AmRNA-1273-P201ISmRNA-1273-P201-US202-1107Ap1EH35979415AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH41192583AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:43B-mRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH22347780AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:14B7mRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH46435350AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T08:56BemRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH44079139AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:31AmRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH51415072AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH41196678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:43B-mRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH22347910AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:14B7mRNA-1273-P201ISmRNA-1273-P201-US202-1107A1EH46433463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T08:56BemRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH20298893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:00BmRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH44079139BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:31AmRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH51415072BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:47BmRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH41196678BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:43B-mRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH22347910BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:14B7mRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH46433463BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T08:56BemRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH20298893AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:00BmRNA-1273-P201ISmRNA-1273-P201-US202-1107B1EH35685536 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1111A`1EH22348837AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T10:05B,mRNA-1273-P201ISmRNA-1273-P201-US202-1111Ap1EH41195685AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T09:20B<mRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH30710926AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T09:48BGmRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH44077216AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T08:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH22348838AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T10:05B,mRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH41194534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T09:20B<mRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH20296876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T08:44BmRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH44077216BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH22348838CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T10:05B,mRNA-1273-P201ISmRNA-1273-P201-US202-1111A1EH41194534BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T09:20B<mRNA-1273-P201ISmRNA-1273-P201-US202-1111B1EH20296876AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T08:44BmRNA-1273-P201ISmRNA-1273-P201-US202-1111B1EH44045443 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1114A`1EH30710830AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.4 ug/mL 12.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:42B"mRNA-1273-P201ISmRNA-1273-P201-US202-1114Ap1EH17084577AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.5 ug/mL 156.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:16B/mRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH61193222AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.1 ug/mL 111.1 Boug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:17B=mRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH44078082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH22348967AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.6 AU/mL 30.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:42B"mRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH17085473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 936.2 AU/mL 936.2 C:33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:16B/mRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH52765709AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 536.2 AU/mL 536.2 C!33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:17B=mRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH09452725AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125.8 AU/mL 125.8 B}AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH44078082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1114A1EH22348967CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:42B"mRNA-1273-P201ISmRNA-1273-P201-US202-1114B1EH17085473BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:16B/mRNA-1273-P201ISmRNA-1273-P201-US202-1114B1EH52765709BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:17B=mRNA-1273-P201ISmRNA-1273-P201-US202-1114B1EH09452725AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1114B1EH44047363 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1115A`1EH35979444AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.6 ug/mL 26.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US202-1115Ap1EH17084417AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.9 ug/mL 193.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B2mRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH52764684AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153.5 ug/mL 153.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:01B@mRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH44077088AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH59772963AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.9 AU/mL 70.9 BFffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH17085568AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 997.5 AU/mL 997.5 C>XAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B2mRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH52766764AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 849.3 AU/mL 849.3 C5AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:01B@mRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH09452695AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.9 AU/mL 145.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T09:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH44077088BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:04AmRNA-1273-P201ISmRNA-1273-P201-US202-1115A1EH59772963BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US202-1115B1EH17085568BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B2mRNA-1273-P201ISmRNA-1273-P201-US202-1115B1EH52766764BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:01B@mRNA-1273-P201ISmRNA-1273-P201-US202-1115B1EH09452695AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T09:49BmRNA-1273-P201ISmRNA-1273-P201-US202-1115B1EH44044290 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1121A`1EH32607277AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 ug/mL 34.2 B"333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1121Ap1EH43255856AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.1 ug/mL 252.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:56B*mRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH35980436AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 241.7 ug/mL 241.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:35B@mRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH44080258AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T14:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH32604334AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.4 AU/mL 131.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:40BmRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH43259953AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1019.9 AU/mL 1019.9 C?fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:56B*mRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH59776161AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1067 AU/mL 1067 CBAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:35B@mRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH20298892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 374.1 AU/mL 374.1 CaAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:31BmRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH44080258BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:55AmRNA-1273-P201ISmRNA-1273-P201-US202-1121A1EH32604334BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:56B*mRNA-1273-P201ISmRNA-1273-P201-US202-1121B1EH59776161BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:35B@mRNA-1273-P201ISmRNA-1273-P201-US202-1121B1EH20298892AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:31BmRNA-1273-P201ISmRNA-1273-P201-US202-1121B1EH44045474 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1130A`1EH22347781AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US202-1130Ap1EH17086593AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:15B0mRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH61191303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:28B?mRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH44074114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH22353924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH17087616AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:15B0mRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH52765836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:28B?mRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH09449495AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:25BmRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH44074114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1130A1EH22353924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US202-1130B1EH17087616BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:15B0mRNA-1273-P201ISmRNA-1273-P201-US202-1130B1EH52765836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:28B?mRNA-1273-P201ISmRNA-1273-P201-US202-1130B1EH09449495AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:25BmRNA-1273-P201ISmRNA-1273-P201-US202-1130B1EH35686561 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1133A`1EH30708910AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:23B"mRNA-1273-P201ISmRNA-1273-P201-US202-1133Ap1EH17086465AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.8 ug/mL 33.8 B!ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:44B1mRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH61191175AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.4 ug/mL 21.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:14B?mRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH44076162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH22348965AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:23B"mRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH17085569AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.8 AU/mL 148.8 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:44B1mRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH52766892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.3 AU/mL 112.3 BpLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:14B?mRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH09450647AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.2 AU/mL 14.2 A333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:50BmRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH44076162BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US202-1133A1EH22348965BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:23B"mRNA-1273-P201ISmRNA-1273-P201-US202-1133B1EH17085569BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:44B1mRNA-1273-P201ISmRNA-1273-P201-US202-1133B1EH52766892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:14B?mRNA-1273-P201ISmRNA-1273-P201-US202-1133B1EH09450647AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:50BmRNA-1273-P201ISmRNA-1273-P201-US202-1133B1EH35685505 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1135A`1EH35981367AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.3 ug/mL 13.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:57B!mRNA-1273-P201ISmRNA-1273-P201-US202-1135Ap1EH41189415AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.8 ug/mL 14.8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:52B.mRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH22347812AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.3 ug/mL 14.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH44074018AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH35985589AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:57B!mRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH41196582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:52B.mRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH22352037AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:41B<mRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH53553179AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:29BmRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH44074018BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:48AmRNA-1273-P201ISmRNA-1273-P201-US202-1135A1EH35985589BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:57B!mRNA-1273-P201ISmRNA-1273-P201-US202-1135B1EH41196582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1137A`1EH44341311AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.5 ug/mL 15.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1137Ap1EH66165907AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.5 ug/mL 33.5 B!ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T16:26BHmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH44078112AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T15:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH59774114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH57737273AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.9 AU/mL 25.9 BfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T16:26BHmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH20295726AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.4 AU/mL 15.4 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T11:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH44078112BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH59774114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH57737273BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T16:26BHmRNA-1273-P201ISmRNA-1273-P201-US202-1137A1EH20295726AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-31T11:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1137B1EH44047489 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1138A`1EH32604302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US202-1138Ap1EH41193636AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH40929455AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:31BDmRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH44079104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH32604302BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH41196710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH40930319AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:31BDmRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH61088798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH44079104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1138A1EH32604302CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US202-1138B1EH41196710BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US202-1138B1EH40930319BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T09:31BDmRNA-1273-P201ISmRNA-1273-P201-US202-1138B1EH61088798AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1138B1EH35684353 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:24AmRNA-1273-P201ISmRNA-1273-P201-US202-1144Ap1EH44339390AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:25B mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH41190439AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:54B/mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH66162867AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-31T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH44080129AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T10:24AmRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH59772962AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:25B mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH49580165AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:54B/mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH57739321AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.1 AU/mL 3.1 A1AU/mL PPD VACCINESERUMELISA AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-31T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH20298925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1144A1EH44080129BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:24AmRNA-1273-P201ISmRNA-1273-P201-US202-1144B1EH59772962BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:25B mRNA-1273-P201ISmRNA-1273-P201-US202-1144B1EH49580165CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T13:54B/mRNA-1273-P201ISmRNA-1273-P201-US202-1144B1EH57739321BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-31T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US202-1144B1EH20298925AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1144B1EH35687457 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1145A`1EH32605357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.3 ug/mL 25.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:30B$mRNA-1273-P201ISmRNA-1273-P201-US202-1145Ap1EH41196676AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 257.5 ug/mL 257.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:08B1mRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH40929454AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 158.8 ug/mL 158.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:55BFmRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH44080256AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH32605199AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.6 AU/mL 71.6 BGAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:30B$mRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH41196711AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 673.7 AU/mL 673.7 C*33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:08B1mRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH40930446AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 666.9 AU/mL 666.9 C)fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:55BFmRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH09450551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.8 AU/mL 187.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T09:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH44080256BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:10AmRNA-1273-P201ISmRNA-1273-P201-US202-1145A1EH32605199BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:30B$mRNA-1273-P201ISmRNA-1273-P201-US202-1145B1EH41196711BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.1 AU/mL 12.1 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:08B1mRNA-1273-P201ISmRNA-1273-P201-US202-1145B1EH40930446BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 AU/mL 11.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:55BFmRNA-1273-P201ISmRNA-1273-P201-US202-1145B1EH09450551AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T09:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1145B1EH35687553 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1147A`1EH35979317AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18 ug/mL 18 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T16:52B!mRNA-1273-P201ISmRNA-1273-P201-US202-1147Ap1EH41193637AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259.3 ug/mL 259.3 C4ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:25B0mRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH35981492AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200.4 ug/mL 200.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:28B<mRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH44076194AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH59776035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.5 AU/mL 46.5 B.AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T16:52B!mRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH41196583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1225 AU/mL 1225 CLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:25B0mRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH59776162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 951.7 AU/mL 951.7 C;{33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:28B<mRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH61087775AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.4 AU/mL 87.4 BWfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH44076194BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:00AmRNA-1273-P201ISmRNA-1273-P201-US202-1147A1EH59776035BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T16:52B!mRNA-1273-P201ISmRNA-1273-P201-US202-1147B1EH41196583BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:25B0mRNA-1273-P201ISmRNA-1273-P201-US202-1147B1EH59776162BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:28B<mRNA-1273-P201ISmRNA-1273-P201-US202-1147B1EH61087775AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:56BmRNA-1273-P201ISmRNA-1273-P201-US202-1147B1EH44045346 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:09AmRNA-1273-P201ISmRNA-1273-P201-US202-1151Ap1EH35979318AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.5 ug/mL 33.5 B!ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:35B mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH66165810AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 297.5 ug/mL 297.5 Cug/mL PPD VACCINESERUMELISA A>ffffffA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-23T15:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH44342303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 229.8 ug/mL 229.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:50B9mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH44074147AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T16:09AmRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH59774979AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.3 AU/mL 142.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:35B mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH57740440AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1138.6 AU/mL 1138.6 CG)AU/mL PPD VACCINESERUMELISA AA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-23T15:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH35985460AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1460.6 AU/mL 1460.6 C[IAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:50B9mRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH61089854AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200.9 AU/mL 200.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:59BmRNA-1273-P201ISmRNA-1273-P201-US202-1151A1EH44074147BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:09AmRNA-1273-P201ISmRNA-1273-P201-US202-1151B1EH59774979BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:35B mRNA-1273-P201ISmRNA-1273-P201-US202-1151B1EH57740440BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-23T15:26B.mRNA-1273-P201ISmRNA-1273-P201-US202-1151B1EH35985460BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 AU/mL 8.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:50B9mRNA-1273-P201ISmRNA-1273-P201-US202-1151B1EH61089854AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:59BmRNA-1273-P201ISmRNA-1273-P201-US202-1151B1EH44046370 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:54AmRNA-1273-P201ISmRNA-1273-P201-US202-1154A`1EH44340286AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78.7 ug/mL 78.7 BN33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T14:22B"mRNA-1273-P201ISmRNA-1273-P201-US202-1154Ap1EH41193477AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 400.1 ug/mL 400.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T08:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH44339391AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 301.6 ug/mL 301.6 Cٙug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:39BCmRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH44079106AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:54AmRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH59775107AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 263.2 AU/mL 263.2 Cs33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T14:22B"mRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH41193639AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1551.9 AU/mL 1551.9 C`ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T08:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH59775138AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1127.7 AU/mL 1127.7 CF{33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:39BCmRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH61091005AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 102.6 AU/mL 102.6 BfAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:29BmRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH44079106BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:54AmRNA-1273-P201ISmRNA-1273-P201-US202-1154A1EH59775107BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T14:22B"mRNA-1273-P201ISmRNA-1273-P201-US202-1154B1EH41193639BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T08:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1154B1EH59775138BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:39BCmRNA-1273-P201ISmRNA-1273-P201-US202-1154B1EH61091005AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:29BmRNA-1273-P201ISmRNA-1273-P201-US202-1154B1EH35685377 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T17:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1155Ap1EH35980308AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T15:13B$mRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH41195652AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T09:28B4mRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH40927407AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T08:19BBmRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH66164883AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17T10:49BGmRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH44074115AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.3 AU/mL 3.3 A4AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T17:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH59772930AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T15:13B$mRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH41195527AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.3 AU/mL 3.3 A4AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T09:28B4mRNA-1273-P201ISmRNA-1273-P201-US202-1155A1EH40928271AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:19AmRNA-1273-P201ISmRNA-1273-P201-US202-1161A`1EH32605228AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:41BmRNA-1273-P201ISmRNA-1273-P201-US202-1161Ap1EH41195525AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH35982517AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:28B:mRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH44078081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T16:19AmRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH32607246AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:41BmRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH41194663AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH59773955AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:28B:mRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH20298796AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH44078081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:19AmRNA-1273-P201ISmRNA-1273-P201-US202-1161A1EH32607246BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:41BmRNA-1273-P201ISmRNA-1273-P201-US202-1161B1EH41194663CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US202-1161B1EH59773955BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:28B:mRNA-1273-P201ISmRNA-1273-P201-US202-1161B1EH20298796AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:30BmRNA-1273-P201ISmRNA-1273-P201-US202-1161B1EH44045442 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1162Ap1EH41194628AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-24T11:42B/mRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH30707886AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:30B@mRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH44078080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T12:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH41195526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-24T11:42B/mRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH22347911AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:30B@mRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH01092797AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T11:17BmRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH44078080BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH41195526BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-24T11:42B/mRNA-1273-P201ISmRNA-1273-P201-US202-1162A1EH22347911BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 AU/mL 8.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:30B@mRNA-1273-P201ISmRNA-1273-P201-US202-1162B1EH01092797AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T11:17BmRNA-1273-P201ISmRNA-1273-P201-US202-1162B1EH44045473 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1164A`1EH35980469AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.1 ug/mL 69.1 BEug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1164Ap1EH41192486AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 313.3 ug/mL 313.3 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T10:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH30710798AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 362.6 ug/mL 362.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T10:47B@mRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH44076066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T08:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH59776001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 174.2 AU/mL 174.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH41194631AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1238.2 AU/mL 1238.2 CMc33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T10:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH22347814AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1011 AU/mL 1011 C?0AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T10:47B@mRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH45201585AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 184.8 AU/mL 184.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH44076066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1164A1EH59776001BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1164B1EH41194631BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T10:50B2mRNA-1273-P201ISmRNA-1273-P201-US202-1164B1EH22347814BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T10:47B@mRNA-1273-P201ISmRNA-1273-P201-US202-1164B1EH45201585AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1164B1EH35684512 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1166Ap1EH44340287AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:09B!mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH41190406AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101.4 ug/mL 101.4 Befffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:40B1mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH22349988AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 81.2 ug/mL 81.2 BQ333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH44080160AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T12:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH59776003AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.5 AU/mL 31.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:09B!mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH41195687AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 436.8 AU/mL 436.8 CLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:40B1mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH22348966AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 348.9 AU/mL 348.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH09452693AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29 AU/mL 29 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T09:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1166A1EH44080160CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1166B1EH59776003BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:09B!mRNA-1273-P201ISmRNA-1273-P201-US202-1166B1EH41195687BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T10:40B1mRNA-1273-P201ISmRNA-1273-P201-US202-1166B1EH22348966BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1166B1EH09452693AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T09:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1166B1EH35686432 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1167A`1EH32607373AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37.7 ug/mL 37.7 B%33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:21BmRNA-1273-P201ISmRNA-1273-P201-US202-1167Ap1EH41192614AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 308.1 ug/mL 308.1 CAug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:24B+mRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH44342463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 300.2 ug/mL 300.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T18:00B:mRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH44079105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH32606382AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 299.9 AU/mL 299.9 CfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:21BmRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH41193510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1701.7 AU/mL 1701.7 Cj[33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:24B+mRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH51415201AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1848.5 AU/mL 1848.5 CsAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T18:00B:mRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH20296749AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 854.2 AU/mL 854.2 C5c33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T15:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH44079105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1167A1EH32606382BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:21BmRNA-1273-P201ISmRNA-1273-P201-US202-1167B1EH41193510BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T14:24B+mRNA-1273-P201ISmRNA-1273-P201-US202-1167B1EH51415201BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T18:00B:mRNA-1273-P201ISmRNA-1273-P201-US202-1167B1EH20296749AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T15:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1167B1EH44046499 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1175A`1EH35980309AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1175Ap1EH41194533AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:28B/mRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH44340414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:56B9mRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH44079137AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH51412993AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH41196709AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:28B/mRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH35980439AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:56B9mRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH61087935AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.8 AU/mL 104.8 BhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T13:27BmRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH44079137BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1175A1EH51412993BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:13BmRNA-1273-P201ISmRNA-1273-P201-US202-1175B1EH41196709CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:28B/mRNA-1273-P201ISmRNA-1273-P201-US202-1175B1EH35980439BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:56B9mRNA-1273-P201ISmRNA-1273-P201-US202-1175B1EH61087935AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.3 AU/mL 75.3 BKLAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T13:27BmRNA-1273-P201ISmRNA-1273-P201-US202-1175B1EH44047361 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:36AmRNA-1273-P201ISmRNA-1273-P201-US202-1179A`1EH44341406AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.9 ug/mL 14.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1179Ap1EH41193476AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150 ug/mL 150 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:57B,mRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH35979284AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.6 ug/mL 112.6 Bpug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:39B:mRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH44077058AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:36AmRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH59775137AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.9 AU/mL 48.9 B0fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH41195686AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 537.6 AU/mL 537.6 C!AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:57B,mRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH35984565AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 393.7 AU/mL 393.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:39B:mRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH20295694AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.1 AU/mL 67.1 BCAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH44077058BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:36AmRNA-1273-P201ISmRNA-1273-P201-US202-1179A1EH59775137BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1179B1EH41195686BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1180A`1EH35982388AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.9 ug/mL 19.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1180Ap1EH41190407AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 344.5 ug/mL 344.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T14:36B/mRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH44339262AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 258.9 ug/mL 258.9 C.fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T15:02B=mRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH44080290AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T16:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH59776032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.6 AU/mL 75.6 BKAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH41194503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 936.2 AU/mL 936.2 C:33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T14:36B/mRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH51415168AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1371.6 AU/mL 1371.6 CUAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T15:02B=mRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH53551259AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 315 AU/mL 315 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T14:48BmRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH44080290BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1180A1EH59776032BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1180B1EH41194503BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T14:36B/mRNA-1273-P201ISmRNA-1273-P201-US202-1180B1EH51415168BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T15:02B=mRNA-1273-P201ISmRNA-1273-P201-US202-1180B1EH53551259AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T14:48BmRNA-1273-P201ISmRNA-1273-P201-US202-1180B1EH44047490 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1182A`1EH35981493AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48 ug/mL 48 B0ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:14BmRNA-1273-P201ISmRNA-1273-P201-US202-1182Ap1EH41195557AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 403.2 ug/mL 403.2 C333333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:41B+mRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH22347941AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 360 ug/mL 360 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:12B6mRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH44078210AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T09:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH35980310AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 284.7 AU/mL 284.7 C33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:14BmRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH41196550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1431.3 AU/mL 1431.3 CYtAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:41B+mRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH22349990AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1423.5 AU/mL 1423.5 CXAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:12B6mRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH53551258AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 316.7 AU/mL 316.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:43BmRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH44078210BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1182A1EH35980310BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:14BmRNA-1273-P201ISmRNA-1273-P201-US202-1182B1EH41196550BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:41B+mRNA-1273-P201ISmRNA-1273-P201-US202-1182B1EH22349990BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:12B6mRNA-1273-P201ISmRNA-1273-P201-US202-1182B1EH53551258AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:43BmRNA-1273-P201ISmRNA-1273-P201-US202-1182B1EH44046339 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1185A`1EH35981333AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T16:20B$mRNA-1273-P201ISmRNA-1273-P201-US202-1185Ap1EH17084544AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:01B5mRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH52764685AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH44079234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T13:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH51412992AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T16:20B$mRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH17087489AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:01B5mRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH52764812AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH09451670AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH44079234BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:45AmRNA-1273-P201ISmRNA-1273-P201-US202-1185A1EH51412992BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T16:20B$mRNA-1273-P201ISmRNA-1273-P201-US202-1185B1EH17087489BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:01B5mRNA-1273-P201ISmRNA-1273-P201-US202-1185B1EH52764812CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1185B1EH09451670AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1185B1EH44046467 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1186A`1EH22349989AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14 ug/mL 14 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:03B mRNA-1273-P201ISmRNA-1273-P201-US202-1186Ap1EH17084576AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83.4 ug/mL 83.4 BSfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH61191334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.6 ug/mL 72.6 BHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:46B=mRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH44077186AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH22348934AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.6 AU/mL 30.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:03B mRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH17085441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 542.1 AU/mL 542.1 C!ᙙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH52766860AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 306.4 AU/mL 306.4 C&fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:46B=mRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH45200529AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.1 AU/mL 99.1 BcAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T14:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH44077186BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1186A1EH22348934BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:03B mRNA-1273-P201ISmRNA-1273-P201-US202-1186B1EH17085441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US202-1186B1EH52766860BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:46B=mRNA-1273-P201ISmRNA-1273-P201-US202-1186B1EH45200529AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T14:15BmRNA-1273-P201ISmRNA-1273-P201-US202-1186B1EH44044451 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1189A`1EH30709934AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:51B mRNA-1273-P201ISmRNA-1273-P201-US202-1189Ap1EH41194500AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:09B+mRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH66162866AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH44076195AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH22351876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:51B mRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH41193606AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:09B+mRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH57738296AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH01091732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH44076195BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:13AmRNA-1273-P201ISmRNA-1273-P201-US202-1189A1EH22351876BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:51B mRNA-1273-P201ISmRNA-1273-P201-US202-1189B1EH41193606BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:09B+mRNA-1273-P201ISmRNA-1273-P201-US202-1189B1EH57738296BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:37B<mRNA-1273-P201ISmRNA-1273-P201-US202-1189B1EH01091732AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1189B1EH35684513 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:02AmRNA-1273-P201ISmRNA-1273-P201-US202-1190A`1EH22350852AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:29B"mRNA-1273-P201ISmRNA-1273-P201-US202-1190Ap1EH17084545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57 ug/mL 57 B9ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:16B0mRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH61193351AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.8 ug/mL 33.8 B!ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:28B=mRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH44080161AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:02AmRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH22347815AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:29B"mRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH17085440AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.6 AU/mL 195.6 BÙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:16B0mRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH52766861AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.4 AU/mL 148.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:28B=mRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH09452598AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.4 AU/mL 52.4 B4ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:34BmRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH44080161BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:02AmRNA-1273-P201ISmRNA-1273-P201-US202-1190A1EH22347815BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:29B"mRNA-1273-P201ISmRNA-1273-P201-US202-1190B1EH17085440BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:16B0mRNA-1273-P201ISmRNA-1273-P201-US202-1190B1EH52766861BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:28B=mRNA-1273-P201ISmRNA-1273-P201-US202-1190B1EH09452598AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:34BmRNA-1273-P201ISmRNA-1273-P201-US202-1190B1EH35684385 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1192A`1EH22348804AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.2 ug/mL 13.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:40B mRNA-1273-P201ISmRNA-1273-P201-US202-1192Ap1EH41189543AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105.6 ug/mL 105.6 Biug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:39B.mRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH66162738AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.8 ug/mL 104.8 Bhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH44080259AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH22354053AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19 AU/mL 19 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:40B mRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH41194502AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 651.8 AU/mL 651.8 C(AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:39B.mRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH57739448BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 597.6 AU/mL 597.6 C%YAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH41193508AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 161.3 AU/mL 161.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH44080259BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:30AmRNA-1273-P201ISmRNA-1273-P201-US202-1192A1EH22354053BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:40B mRNA-1273-P201ISmRNA-1273-P201-US202-1192B1EH41194502BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:39B.mRNA-1273-P201ISmRNA-1273-P201-US202-1192B1EH57739448CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US202-1192B1EH41193508AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1192B1EH44045314 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1196A`1EH22349861AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:41B!mRNA-1273-P201ISmRNA-1273-P201-US202-1196Ap1EH23398539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:44B0mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH61192231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH60131511AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH22351014AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:41B!mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH23403656AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:44B0mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH52766893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH60131511BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:07AmRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH22351014BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:41B!mRNA-1273-P201ISmRNA-1273-P201-US202-1196A1EH23403656BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:44B0mRNA-1273-P201ISmRNA-1273-P201-US202-1196B1EH52766893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:45B=mRNA-1273-P201ISmRNA-1273-P201-US202-1196B1EH60129302 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:26AmRNA-1273-P201ISmRNA-1273-P201-US202-1198A`1EH35982389AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.3 ug/mL 10.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:18B%mRNA-1273-P201ISmRNA-1273-P201-US202-1198Ap1EH66164915AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T12:05B3mRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH61193255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:39BAmRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH44077184AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T10:26AmRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH51413025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:18B%mRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH57737369AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T12:05B3mRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH52765740AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:39BAmRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH44077184BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:26AmRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH51413025BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:18B%mRNA-1273-P201ISmRNA-1273-P201-US202-1198A1EH57737369BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 AU/mL 8.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T12:05B3mRNA-1273-P201ISmRNA-1273-P201-US202-1198B1EH52765740BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:39BAmRNA-1273-P201ISmRNA-1273-P201-US202-1198B1EH44046371 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:33AmRNA-1273-P201ISmRNA-1273-P201-US202-1205A`1EH22349860AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 ug/mL 17.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:18B$mRNA-1273-P201ISmRNA-1273-P201-US202-1205Ap1EH17086497AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 268.7 ug/mL 268.7 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:35B/mRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH61191174AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.1 ug/mL 203.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:13B=mRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH44080128AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:33AmRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH22349959AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.2 AU/mL 96.2 B`333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:18B$mRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH17085601AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1690.8 AU/mL 1690.8 CiAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:35B/mRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH52764844AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1114.4 AU/mL 1114.4 CEffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:13B=mRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH53551131AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 313.7 AU/mL 313.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:44BmRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH44080128BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:33AmRNA-1273-P201ISmRNA-1273-P201-US202-1205A1EH22349959BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:18B$mRNA-1273-P201ISmRNA-1273-P201-US202-1205B1EH17085601BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:35B/mRNA-1273-P201ISmRNA-1273-P201-US202-1205B1EH52764844BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:13B=mRNA-1273-P201ISmRNA-1273-P201-US202-1205B1EH53551131AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:44BmRNA-1273-P201ISmRNA-1273-P201-US202-1205B1EH35686401 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1206A`1EH44342431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36B"mRNA-1273-P201ISmRNA-1273-P201-US202-1206Ap1EH66163859AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T10:09B1mRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH61191206AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:59BEmRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH07375013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH59773090AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36B"mRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH57738297AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T10:09B1mRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH52766765AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:59BEmRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH09449655AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH07375013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:28AmRNA-1273-P201ISmRNA-1273-P201-US202-1206A1EH59773090BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36B"mRNA-1273-P201ISmRNA-1273-P201-US202-1206B1EH57738297BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T10:09B1mRNA-1273-P201ISmRNA-1273-P201-US202-1206B1EH52766765BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:59BEmRNA-1273-P201ISmRNA-1273-P201-US202-1206B1EH09449655AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:37BmRNA-1273-P201ISmRNA-1273-P201-US202-1206B1EH15732775 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1207A`1EH44340383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:01B*mRNA-1273-P201ISmRNA-1273-P201-US202-1207Ap1EH66164787AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:16B7mRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH61191302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:47BFmRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH44077056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH51416064AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:01B*mRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH57740312AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:16B7mRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH52764717AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:47BFmRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH09451574AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH44077056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:35AmRNA-1273-P201ISmRNA-1273-P201-US202-1207A1EH51416064BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:01B*mRNA-1273-P201ISmRNA-1273-P201-US202-1207B1EH57740312BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:16B7mRNA-1273-P201ISmRNA-1273-P201-US202-1207B1EH52764717BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:47BFmRNA-1273-P201ISmRNA-1273-P201-US202-1207B1EH09451574AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1207B1EH44045472 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1208Ap1EH30710799AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 ug/mL 17.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:02BmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH66165778AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.2 ug/mL 151.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07T09:24B&mRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH61191335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99 ug/mL 99 Bcug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:48BFmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH07375908AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH22353957AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.6 AU/mL 72.6 BHAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:02BmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH57740313AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 818.8 AU/mL 818.8 C3,AU/mL PPD VACCINESERUMELISA AAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07T09:24B&mRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH52767756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 378.7 AU/mL 378.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:48BFmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH09449526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140.9 AU/mL 140.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:26BmRNA-1273-P201ISmRNA-1273-P201-US202-1208A1EH07375908BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US202-1208B1EH22353957BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:02BmRNA-1273-P201ISmRNA-1273-P201-US202-1208B1EH57740313BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07T09:24B&mRNA-1273-P201ISmRNA-1273-P201-US202-1208B1EH52767756BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:48BFmRNA-1273-P201ISmRNA-1273-P201-US202-1208B1EH09449526AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:26BmRNA-1273-P201ISmRNA-1273-P201-US202-1208B1EH15732774 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1211A`1EH22348964AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.7 ug/mL 15.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1211Ap1EH17086464AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.2 ug/mL 70.2 BF333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B+mRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH61192359AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45 ug/mL 45 B-ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:27B7mRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH07373828AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH22348807AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.3 AU/mL 58.3 B:LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH17087521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 324 AU/mL 324 C@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B+mRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH52767757AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.4 AU/mL 225.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:27B7mRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH09451671AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.4 AU/mL 104.4 BhfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH07373828BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:53AmRNA-1273-P201ISmRNA-1273-P201-US202-1211A1EH22348807BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:09BmRNA-1273-P201ISmRNA-1273-P201-US202-1211B1EH17087521BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B+mRNA-1273-P201ISmRNA-1273-P201-US202-1211B1EH52767757BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:27B7mRNA-1273-P201ISmRNA-1273-P201-US202-1211B1EH09451671AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:45BmRNA-1273-P201ISmRNA-1273-P201-US202-1211B1EH15732871 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1214Ap1EH30708783AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:51BmRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH17086592AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 62.4 ug/mL 62.4 B>ffffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:25B.mRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH57739289AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 59.1 ug/mL 59.1 B;ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T15:39B8mRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH46435351AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.4 ug/mL 56.4 B8ffffffug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T15:26BNmRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH44080288AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH22349863AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19 AU/mL 19 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:51BmRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH17087520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 327.3 AU/mL 327.3 CtAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:25B.mRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH57740441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 302.7 AU/mL 302.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T15:39B8mRNA-1273-P201ISmRNA-1273-P201-US202-1214A1EH46438420AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 247.7 AU/mL 247.7 B33330AU/mL PPD VACCINESERUMELISA AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T15:26BNmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH20297742AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 89.5 AU/mL 89.5 BYAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T16:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH44080288BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:44AmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH22349863BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T14:51BmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH17087520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:25B.mRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH57740441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T15:39B8mRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH46438420BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11T15:26BNmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH20297742AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T16:10BmRNA-1273-P201ISmRNA-1273-P201-US202-1214B1EH44047491 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:01AmRNA-1273-P201ISmRNA-1273-P201-US202-1215A`1EH30707887AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.2 ug/mL 13.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:36B$mRNA-1273-P201ISmRNA-1273-P201-US202-1215Ap1EH23397545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.3 ug/mL 70.3 BFLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:10B4mRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH45199536AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.6 ug/mL 66.6 BBug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T15:04BHmRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH44078243AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:01AmRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH22349958AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61 AU/mL 61 B=AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:36B$mRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH23401608AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.4 AU/mL 202.4 BfffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:10B4mRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH45199506AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 280.7 AU/mL 280.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T15:04BHmRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH09452724AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95.5 AU/mL 95.5 B_AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH44078243BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:01AmRNA-1273-P201ISmRNA-1273-P201-US202-1215A1EH22349958BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:36B$mRNA-1273-P201ISmRNA-1273-P201-US202-1215B1EH23401608BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:10B4mRNA-1273-P201ISmRNA-1273-P201-US202-1215B1EH45199506BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T15:04BHmRNA-1273-P201ISmRNA-1273-P201-US202-1215B1EH09452724AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1215B1EH44044322 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:34AmRNA-1273-P201ISmRNA-1273-P201-US202-1216A`1EH35981462AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16 ug/mL 16 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:58B!mRNA-1273-P201ISmRNA-1273-P201-US202-1216Ap1EH41190567AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 337.1 ug/mL 337.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:42B,mRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH61193350AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 206.8 ug/mL 206.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:36B:mRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH60129463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T09:34AmRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH59775010AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 59.6 AU/mL 59.6 B;AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:58B!mRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH49580068AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1486.3 AU/mL 1486.3 C\AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:42B,mRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH52767788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 883.9 AU/mL 883.9 C7>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:36B:mRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH01091605AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 306.2 AU/mL 306.2 C#33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH60129463BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:34AmRNA-1273-P201ISmRNA-1273-P201-US202-1216A1EH59775010BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:58B!mRNA-1273-P201ISmRNA-1273-P201-US202-1216B1EH49580068BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:42B,mRNA-1273-P201ISmRNA-1273-P201-US202-1216B1EH52767788BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:36B:mRNA-1273-P201ISmRNA-1273-P201-US202-1216B1EH01091605AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:46BmRNA-1273-P201ISmRNA-1273-P201-US202-1216B1EH60130485 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:51AmRNA-1273-P201ISmRNA-1273-P201-US202-1217A`1EH30710959AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.7 ug/mL 12.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:58BmRNA-1273-P201ISmRNA-1273-P201-US202-1217Ap1EH17084449AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 175.1 ug/mL 175.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH61190183AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127.3 ug/mL 127.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:48B;mRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH07376004AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T11:51AmRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH22353956AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.9 AU/mL 144.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:58BmRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH17087617AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1162.9 AU/mL 1162.9 CHffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH52765708AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 605.6 AU/mL 605.6 C%ٙAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:48B;mRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH61088956AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 170.3 AU/mL 170.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH07376004BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:51AmRNA-1273-P201ISmRNA-1273-P201-US202-1217A1EH22353956BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:58BmRNA-1273-P201ISmRNA-1273-P201-US202-1217B1EH17087617BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US202-1217B1EH52765708BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:48B;mRNA-1273-P201ISmRNA-1273-P201-US202-1217B1EH61088956AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:54BmRNA-1273-P201ISmRNA-1273-P201-US202-1217B1EH15733766 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1218A`1EH22348932AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.7 ug/mL 29.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T17:09B mRNA-1273-P201ISmRNA-1273-P201-US202-1218Ap1EH17084448AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.4 ug/mL 191.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH52766732AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 166.1 ug/mL 166.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:08B9mRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH60129462AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH22354084AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118.7 AU/mL 118.7 Bv33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T17:09B mRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH17085472AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1151 AU/mL 1151 CGAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH52767789AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 809.6 AU/mL 809.6 C2AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:08B9mRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH09451703AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.3 AU/mL 192.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:24BmRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH60129462BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1218A1EH22354084BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T17:09B mRNA-1273-P201ISmRNA-1273-P201-US202-1218B1EH17085472BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:33B-mRNA-1273-P201ISmRNA-1273-P201-US202-1218B1EH52767789BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:08B9mRNA-1273-P201ISmRNA-1273-P201-US202-1218B1EH09451703AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:24BmRNA-1273-P201ISmRNA-1273-P201-US202-1218B1EH60132533 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1219A`1EH44342335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:08B mRNA-1273-P201ISmRNA-1273-P201-US202-1219Ap1EH41192454AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:33B.mRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH61193383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:16BBmRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH60131510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T09:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH59774080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:08B mRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH49578148AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:33B.mRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH52766733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:16BBmRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH01089684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:34BmRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH60131510BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:50AmRNA-1273-P201ISmRNA-1273-P201-US202-1219A1EH59774080BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:08B mRNA-1273-P201ISmRNA-1273-P201-US202-1219B1EH49578148BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:33B.mRNA-1273-P201ISmRNA-1273-P201-US202-1219B1EH52766733BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:16BBmRNA-1273-P201ISmRNA-1273-P201-US202-1219B1EH01089684AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:34BmRNA-1273-P201ISmRNA-1273-P201-US202-1219B1EH60132532 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1220A`1EH22350981AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13 ug/mL 13 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1220Ap1EH17086624AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.5 ug/mL 149.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:38B-mRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH61192358AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.7 ug/mL 130.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH07373956AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH22347943AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.6 AU/mL 15.6 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH17087648AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 887.6 AU/mL 887.6 C7yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:38B-mRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH52764716AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 596.7 AU/mL 596.7 C%K33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH09452599AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.1 AU/mL 142.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:08BmRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH07373956BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:38AmRNA-1273-P201ISmRNA-1273-P201-US202-1220A1EH22347943BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US202-1220B1EH17087648BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:38B-mRNA-1273-P201ISmRNA-1273-P201-US202-1220B1EH52764716CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US202-1220B1EH09452599AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US202-1222A`1EH22347813AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:17BmRNA-1273-P201ISmRNA-1273-P201-US202-1222Ap1EH17086496AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:10B,mRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH61193254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:29B7mRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH07373957AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH22350982AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:17BmRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH17085600AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:10B,mRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH52764845AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:29B7mRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH45200432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T10:57BmRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH07373957BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US202-1222A1EH22350982BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T12:29B7mRNA-1273-P201ISmRNA-1273-P201-US202-1222B1EH45200432AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T10:57BmRNA-1273-P201ISmRNA-1273-P201-US202-1222B1EH15732870 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH35981334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.8 ug/mL 31.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH66165906AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.7 ug/mL 36.7 B$33334ug/mL PPD VACCINESERUMELISA A>ffffffAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05T12:48BmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH57739288AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:50B+mRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH61190310AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 456 ug/mL 456 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:00B<mRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH07373861AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH59774083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.7 AU/mL 252.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH57737400AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 294.8 AU/mL 294.8 ClAU/mL PPD VACCINESERUMELISA AAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05T12:48BmRNA-1273-P201ISmRNA-1273-P201-US202-1226A1EH57737401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1997.3 AU/mL 1997.3 C|AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:50B+mRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH52767885AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:00B<mRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH07373861BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:40AmRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH59774083BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:04BmRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH57737400BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05T12:48BmRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH57737401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:50B+mRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH52767885BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 AU/mL 9.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:00B<mRNA-1273-P201ISmRNA-1273-P201-US202-1226B1EH15732903 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:14AmRNA-1273-P201ISmRNA-1273-P201-US202-1230A`1EH35981365AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1230Ap1EH41192487AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42 ug/mL 42 B*ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B(mRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH61191207AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.1 ug/mL 28.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH07375909AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:14AmRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH35980342AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.3 AU/mL 30.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH49580069AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176.1 AU/mL 176.1 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B(mRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH52764813AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.8 AU/mL 147.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH29468696AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.1 AU/mL 188.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-15T11:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH07375909BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:14AmRNA-1273-P201ISmRNA-1273-P201-US202-1230A1EH35980342BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:23BmRNA-1273-P201ISmRNA-1273-P201-US202-1230B1EH49580069BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:20B(mRNA-1273-P201ISmRNA-1273-P201-US202-1230B1EH52764813BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:50B<mRNA-1273-P201ISmRNA-1273-P201-US202-1230B1EH29468696AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-15T11:42BmRNA-1273-P201ISmRNA-1273-P201-US202-1230B1EH15734918 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:12AmRNA-1273-P201ISmRNA-1273-P201-US202-1232A`1EH35981461AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.7 ug/mL 16.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T10:42B mRNA-1273-P201ISmRNA-1273-P201-US202-1232Ap1EH23399434AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 166.6 ug/mL 166.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:13B,mRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH45197466AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.1 ug/mL 128.1 Bug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10T12:44BCmRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH60131383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:12AmRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH59774081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 53 AU/mL 53 B5AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T10:42B mRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH23402504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 702.4 AU/mL 702.4 C+fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:13B,mRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH09449623AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.7 AU/mL 66.7 BB33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH60131383BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:12AmRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH59774081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T10:42B mRNA-1273-P201ISmRNA-1273-P201-US202-1232A1EH23402504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:13B,mRNA-1273-P201ISmRNA-1273-P201-US202-1232B1EH09449623AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:36BmRNA-1273-P201ISmRNA-1273-P201-US202-1232B1EH60130484 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T12:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1234A`1EH35982484AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1234Ap1EH17086625AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.1 ug/mL 20.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:17B*mRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH61193382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.1 ug/mL 23.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:50B;mRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH07373860AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 AU/mL 9.8 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T12:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH59776034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.6 AU/mL 26.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH17087488AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.7 AU/mL 82.7 BR33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:17B*mRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH52765741AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86 AU/mL 86 BVAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:50B;mRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH09449494AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.5 AU/mL 43.5 B+AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:16BmRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH07373860BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T12:05AmRNA-1273-P201ISmRNA-1273-P201-US202-1234A1EH59776034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US202-1234B1EH17087488CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US203-1001AP1EH42206235AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.3 ug/mL 12.3 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1001A`1EH05244960AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.5 ug/mL 11.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:50B!mRNA-1273-P201ISmRNA-1273-P201-US203-1001Ap1EH17930290AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:49B0mRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH05243904AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:22B>mRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH42210456AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH05244066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:50B!mRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH26316979AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:49B0mRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH05243906AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:22B>mRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH03488822AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH42210456BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1001A1EH05244066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:50B!mRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH26316979BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:49B0mRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH05243906CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH03488822AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH33820699 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH03484821 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1001B1EH03484821 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T07:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1002A`1EH03509303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.1 ug/mL 15.1 A񙙙ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:52B mRNA-1273-P201ISmRNA-1273-P201-US203-1002Ap1EH26313873AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.7 ug/mL 168.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:47B/mRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH03509397AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.3 ug/mL 130.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:58B<mRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH50599944AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T07:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH03513367AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.8 AU/mL 46.8 B.AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:52B mRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH26318896AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 747.3 AU/mL 747.3 C.AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:47B/mRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH11895957AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 735.8 AU/mL 735.8 C-AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:58B<mRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH58764330AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.3 AU/mL 134.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH50599944BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T07:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1002A1EH03513367BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T07:52B mRNA-1273-P201ISmRNA-1273-P201-US203-1002B1EH26318896BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:47B/mRNA-1273-P201ISmRNA-1273-P201-US203-1002B1EH11895957BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T07:58B<mRNA-1273-P201ISmRNA-1273-P201-US203-1002B1EH58764330AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1002B1EH59022368 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1004A`1EH03509430AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.5 ug/mL 25.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:14B mRNA-1273-P201ISmRNA-1273-P201-US203-1004Ap1EH29662345AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 219.9 ug/mL 219.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH44118022AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.1 ug/mL 165.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:41BCmRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH42209304AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH11895989AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 155 AU/mL 155 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:14B mRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH29659147AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1313.1 AU/mL 1313.1 CRAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH44119207AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 785 AU/mL 785 C1AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:41BCmRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH03488948AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.8 AU/mL 112.8 BpAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:59BmRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH42209304BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1004A1EH11895989BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:14B mRNA-1273-P201ISmRNA-1273-P201-US203-1004B1EH29659147BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1004B1EH44119207BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:41BCmRNA-1273-P201ISmRNA-1273-P201-US203-1004B1EH03488948AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:59BmRNA-1273-P201ISmRNA-1273-P201-US203-1004B1EH33820698 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1009A`1EH03509301AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1009Ap1EH17930387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:56B+mRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH03506199AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH50597896AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH11896855AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH26316818AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:56B+mRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH11898004AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH37003288AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH50597896BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1009A1EH11896855BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1009B1EH26316818BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:56B+mRNA-1273-P201ISmRNA-1273-P201-US203-1009B1EH11898004BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1009B1EH37003288AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1009B1EH59022464 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:13AmRNA-1273-P201ISmRNA-1273-P201-US203-1011A`1EH03509398AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11 ug/mL 11 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:27B"mRNA-1273-P201ISmRNA-1273-P201-US203-1011Ap1EH29656234AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118.7 ug/mL 118.7 Bv33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:21B1mRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH63276087AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105.9 ug/mL 105.9 Biffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:00BEmRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH42208442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:13AmRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH11897909AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.1 AU/mL 41.1 B)AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:27B"mRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH29660200AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 742.2 AU/mL 742.2 C.c33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:21B1mRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH63279126AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 392.9 AU/mL 392.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:00BEmRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH42208442BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:13AmRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH11897909BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:27B"mRNA-1273-P201ISmRNA-1273-P201-US203-1011A1EH29660200BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:21B1mRNA-1273-P201ISmRNA-1273-P201-US203-1011B1EH63279126BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:00BEmRNA-1273-P201ISmRNA-1273-P201-US203-1011B1EH33823801 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1012A`1EH03511317AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.6 ug/mL 32.6 B ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1012Ap1EH26313745AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 461.6 ug/mL 461.6 Cٙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH03508278AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 267.9 ug/mL 267.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:15B9mRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH42211385AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T14:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH11898037AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 158.7 AU/mL 158.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH26313875AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1513.5 AU/mL 1513.5 C^AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH03512503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1164.3 AU/mL 1164.3 CHAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:15B9mRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH58767368AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 116.6 AU/mL 116.6 BtAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH42211385BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1012A1EH11898037BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1012B1EH26313875BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1012B1EH03512503BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:15B9mRNA-1273-P201ISmRNA-1273-P201-US203-1012B1EH58767368AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1012B1EH33822906 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1013A`1EH05245056AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.4 ug/mL 28.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1013Ap1EH26312722AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.7 ug/mL 154.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH05243041AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 133.3 ug/mL 133.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH42209432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH05243010AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.4 AU/mL 86.4 BVfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH26315794AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 767.8 AU/mL 767.8 C/AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH05246082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 626.7 AU/mL 626.7 C'+33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH03488791AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.8 AU/mL 160.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH42209432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1013A1EH05243010BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1013B1EH26315794BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1013B1EH05246082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US203-1013B1EH03488791AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1013B1EH33821881 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1014A`1EH03507253AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:31B mRNA-1273-P201ISmRNA-1273-P201-US203-1014Ap1EH17931411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.6 ug/mL 9.6 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:15B.mRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH05243008AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:15B<mRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH42212408AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH03510454AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:31B mRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH26318899AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:15B.mRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH05245059AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:15B<mRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH03487894AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH42212408BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1014A1EH03510454BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:31B mRNA-1273-P201ISmRNA-1273-P201-US203-1014B1EH26318899BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T14:15B.mRNA-1273-P201ISmRNA-1273-P201-US203-1014B1EH05245059BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:15B<mRNA-1273-P201ISmRNA-1273-P201-US203-1014B1EH03487894AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1014B1EH33822874 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1016A`1EH03510452AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.4 ug/mL 27.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:36BmRNA-1273-P201ISmRNA-1273-P201-US203-1016Ap1EH17930291AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 185.7 ug/mL 185.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:19B)mRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH03508374AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.1 ug/mL 183.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:35B6mRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH59048112AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH03511478AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.7 AU/mL 56.7 B833334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:36BmRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH26315954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1105.7 AU/mL 1105.7 CE33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:19B)mRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH03512375AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 999.6 AU/mL 999.6 C>yAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T15:35B6mRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH03485878AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 155.5 AU/mL 155.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH59048112BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US203-1016A1EH03511478BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-05-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1019A`1EH03507252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:51B#mRNA-1273-P201ISmRNA-1273-P201-US203-1019Ap1EH64323605AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.5 ug/mL 186.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:26B2mRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH03512372AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.4 ug/mL 145.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:25B?mRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH42211512BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH03510294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.8 AU/mL 16.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:51B#mRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH64323606AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 572 AU/mL 572 C#AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:26B2mRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH11894837AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 402.6 AU/mL 402.6 C)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:25B?mRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH03486868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.6 AU/mL 114.6 BrAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH42211512CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1019A1EH03510294BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:51B#mRNA-1273-P201ISmRNA-1273-P201-US203-1019B1EH64323606BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:26B2mRNA-1273-P201ISmRNA-1273-P201-US203-1019B1EH11894837BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:25B?mRNA-1273-P201ISmRNA-1273-P201-US203-1019B1EH03486868AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T08:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1019B1EH33820827 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1020A`1EH03507380AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.1 ug/mL 45.1 B-ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US203-1020Ap1EH17928371AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 279.1 ug/mL 279.1 Cqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:35B0mRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH44121092AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 214.9 ug/mL 214.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:38BCmRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH42212377AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T12:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH11894965AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.1 AU/mL 104.1 BhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH26319922AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1503.3 AU/mL 1503.3 C]AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:35B0mRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH35760262AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1116.1 AU/mL 1116.1 CEAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:38BCmRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH03486869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.4 AU/mL 22.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH42212377BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1020A1EH11894965BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US203-1020B1EH26319922BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:35B0mRNA-1273-P201ISmRNA-1273-P201-US203-1020B1EH35760262CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:38BCmRNA-1273-P201ISmRNA-1273-P201-US203-1020B1EH03486869AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1020B1EH33821849 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:38AmRNA-1273-P201ISmRNA-1273-P201-US203-1021A`1EH05245057AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 ug/mL 11.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1021Ap1EH29659305AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160 ug/mL 160 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:20B.mRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH44120103AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.6 ug/mL 143.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:38B<mRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH50597929AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:38AmRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH05245058AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.1 AU/mL 34.1 B"AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH29662219AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 668.3 AU/mL 668.3 C)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:20B.mRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH35760295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 490.7 AU/mL 490.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:38B<mRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH58764298AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.2 AU/mL 66.2 BB333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH50597929BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:38AmRNA-1273-P201ISmRNA-1273-P201-US203-1021A1EH05245058BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1021B1EH29662219BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:20B.mRNA-1273-P201ISmRNA-1273-P201-US203-1021B1EH35760295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:38B<mRNA-1273-P201ISmRNA-1273-P201-US203-1021B1EH58764298AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1021B1EH59021473 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T11:57AmRNA-1273-P201ISmRNA-1273-P201-US203-1022A`1EH05245985AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:25B mRNA-1273-P201ISmRNA-1273-P201-US203-1022Ap1EH26312720AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:00B.mRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH03511348AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:12B<mRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH42209337AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T11:57AmRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH05244962AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:25B mRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH26317969AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:00B.mRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH03510455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:12B<mRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH55940150AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH42209337BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T11:57AmRNA-1273-P201ISmRNA-1273-P201-US203-1022A1EH05244962BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:25B mRNA-1273-P201ISmRNA-1273-P201-US203-1022B1EH26317969BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:00B.mRNA-1273-P201ISmRNA-1273-P201-US203-1022B1EH03510455BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:12B<mRNA-1273-P201ISmRNA-1273-P201-US203-1022B1EH55940150AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1022B1EH33821722 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1023A`1EH03507351AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:42B#mRNA-1273-P201ISmRNA-1273-P201-US203-1023Ap1EH29662216AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH03510325AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:22B<mRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH42211480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T10:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH11897012AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.5 AU/mL 2.5 A(AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:42B#mRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH29662218AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH11894932AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.9 AU/mL 1.9 AffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:22B<mRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH03488950AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.7 AU/mL 44.7 B,33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:22BmRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH42211480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T10:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1023A1EH11897012BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T11:42B#mRNA-1273-P201ISmRNA-1273-P201-US203-1023B1EH29662218BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T10:27B1mRNA-1273-P201ISmRNA-1273-P201-US203-1023B1EH11894932BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:22B<mRNA-1273-P201ISmRNA-1273-P201-US203-1023B1EH03488950AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.3 AU/mL 11.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:22BmRNA-1273-P201ISmRNA-1273-P201-US203-1023B1EH33822907 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1026A`1EH03509269AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.6 ug/mL 80.6 BPug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T13:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1026Ap1EH26313746AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 457.2 ug/mL 457.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T15:45B.mRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH05245088AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 370.7 ug/mL 370.7 C+33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH42210457AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH11895828AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 334.6 AU/mL 334.6 C陙AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T13:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH26319923AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1949.6 AU/mL 1949.6 CyٙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T15:45B.mRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH05244034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1360.7 AU/mL 1360.7 CU 33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH03486871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123.2 AU/mL 123.2 B{333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T16:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH42210457BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1026A1EH11895828BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T13:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1026B1EH26319923BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T15:45B.mRNA-1273-P201ISmRNA-1273-P201-US203-1026B1EH05244034CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T08:13B9mRNA-1273-P201ISmRNA-1273-P201-US203-1026B1EH03486871AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T16:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1026B1EH33823929 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:55AmRNA-1273-P201ISmRNA-1273-P201-US203-1027A`1EH05245089AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.2 ug/mL 48.2 B0333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1027Ap1EH26314930AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.3 ug/mL 160.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:23B-mRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH44120070AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 138.4 ug/mL 138.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:23B<mRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH42209464AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T07:55AmRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH05244931AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 182.7 AU/mL 182.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH26318866AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 938.7 AU/mL 938.7 C:33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:23B-mRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH64325781AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.2 AU/mL 135.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH42209464BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:55AmRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH05244931BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1027A1EH26318866BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:23B-mRNA-1273-P201ISmRNA-1273-P201-US203-1027B1EH64325781AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1027B1EH33823768 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1029A`1EH03511316AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:32B$mRNA-1273-P201ISmRNA-1273-P201-US203-1029Ap1EH64325652AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T07:57B2mRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH44118023AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B@mRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH50600104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.9 AU/mL 1.9 AffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH03511446AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:32B$mRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH64326708AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T07:57B2mRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH35759140AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B@mRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH03488919AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:16BmRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH50600104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1029A1EH03511446BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:32B$mRNA-1273-P201ISmRNA-1273-P201-US203-1029B1EH64326708CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T07:57B2mRNA-1273-P201ISmRNA-1273-P201-US203-1029B1EH35759140BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B@mRNA-1273-P201ISmRNA-1273-P201-US203-1029B1EH03488919AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:16BmRNA-1273-P201ISmRNA-1273-P201-US203-1029B1EH59021314 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1030AP1EH50597000AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1030A`1EH03509396AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.7 ug/mL 26.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1030Ap1EH26315793AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 194.4 ug/mL 194.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:19B+mRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH44119046AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.8 ug/mL 117.8 Buug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:33B>mRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH50594986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH11897013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.3 AU/mL 69.3 BELAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH26319889AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 929.6 AU/mL 929.6 C:AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:19B+mRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH35761317AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 522.8 AU/mL 522.8 C AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:33B>mRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH03487799AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.8 AU/mL 64.8 B@AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH50594986BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1030A1EH11897013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH26319889BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:19B+mRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH35761317BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:33B>mRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH03487799AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH59021346 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH03482773 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1030B1EH03482773 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies160 MN Endpoint Titer20 2560 160 BMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH50596904AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.1 AU/mL 13.1 AљAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1033A 1EH03509300AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 AU/mL 12.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1033A01EH26313776AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12 AU/mL 12 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:12B+mRNA-1273-P201ISmRNA-1273-P201-US203-1033A@1EH44121222AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:18B:mRNA-1273-P201ISmRNA-1273-P201-US203-1033AP1EH50596904AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1033A`1EH03509300AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.1 ug/mL 18.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1033Ap1EH26313776AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 219.1 ug/mL 219.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:12B+mRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH44121222AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.3 ug/mL 203.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:18B:mRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH50600968AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH11895860AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.1 AU/mL 46.1 B.AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH26319890AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 771.7 AU/mL 771.7 C0;33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:12B+mRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH35761285AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 980.3 AU/mL 980.3 C=DAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:18B:mRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH55940151AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.1 AU/mL 109.1 BmAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH50600968BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:47AmRNA-1273-P201ISmRNA-1273-P201-US203-1033A1EH11895860BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1033B1EH26319890BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:12B+mRNA-1273-P201ISmRNA-1273-P201-US203-1033B1EH35761285CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:18B:mRNA-1273-P201ISmRNA-1273-P201-US203-1033B1EH55940151AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1033B1EH59020321 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1035Ap1EH03512468AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.3 ug/mL 11.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH17929395AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.9 ug/mL 124.9 B|ffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:55B,mRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH05243937AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115 ug/mL 115 Bsug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:20B:mRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH63279125AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.9 ug/mL 32.9 B fffffug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T13:50BjmRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH42211384AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T11:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH11894964AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.5 AU/mL 17.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH26318995AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 500.4 AU/mL 500.4 CFfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:55B,mRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH05244035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 383.4 AU/mL 383.4 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:20B:mRNA-1273-P201ISmRNA-1273-P201-US203-1035A1EH63280308AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.5 AU/mL 150.5 BAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T13:50BjmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH03487925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.3 AU/mL 85.3 BULAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH42211384BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH11894964BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH26318995BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:55B,mRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH05244035BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:20B:mRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH63280308BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T13:50BjmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH03487925AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1035B1EH33820858 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1037A`1EH03507221AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.3 ug/mL 23.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1037Ap1EH55939254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 249.5 ug/mL 249.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:10B.mRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH03506327AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.5 ug/mL 191.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH50598920AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH11894805AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71 AU/mL 71 BGAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH64323637AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1167 AU/mL 1167 CHAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:10B.mRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH03513397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 979.9 AU/mL 979.9 C=>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH03488949AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.1 AU/mL 135.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH50598920BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1037A1EH11894805BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1037B1EH64323637BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:10B.mRNA-1273-P201ISmRNA-1273-P201-US203-1037B1EH03513397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US203-1037B1EH03488949AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T13:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1037B1EH59020449 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1038A`1EH03510293AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1038Ap1EH55940279AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:15B-mRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH44120071AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH42209336AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH03512374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH64324660AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:15B-mRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH35761188AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH03486742AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T07:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH42209336BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1038A1EH03512374BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1038B1EH64324660BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:15B-mRNA-1273-P201ISmRNA-1273-P201-US203-1038B1EH35761188CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US203-1038B1EH03486742AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T07:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1038B1EH33822779 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1040A`1EH03506358AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1040Ap1EH17929363AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:55B-mRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH05242913AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B:mRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH42210360AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH11896885AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH26313906AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:55B-mRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH05243042AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B:mRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH55942198AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T07:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH42210360BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:40AmRNA-1273-P201ISmRNA-1273-P201-US203-1040A1EH11896885BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1040B1EH26313906BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:55B-mRNA-1273-P201ISmRNA-1273-P201-US203-1040B1EH05243042BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B:mRNA-1273-P201ISmRNA-1273-P201-US203-1040B1EH55942198AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T07:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1040B1EH33820730 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1041A`1EH03508247AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1041Ap1EH26313777AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:03B,mRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH44121127AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:47B;mRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH50596907AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH03513495AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH26318897AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:03B,mRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH35758118AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:47B;mRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH03488823AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T14:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH50596907BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:14AmRNA-1273-P201ISmRNA-1273-P201-US203-1041A1EH03513495BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1041B1EH26318897BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:03B,mRNA-1273-P201ISmRNA-1273-P201-US203-1041B1EH35758118BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:47B;mRNA-1273-P201ISmRNA-1273-P201-US203-1041B1EH03488823AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T14:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1041B1EH59019427 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:23AmRNA-1273-P201ISmRNA-1273-P201-US203-1042A`1EH03508279AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.6 ug/mL 31.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:48B!mRNA-1273-P201ISmRNA-1273-P201-US203-1042Ap1EH55940119AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 396.2 ug/mL 396.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH03510324AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 293.7 ug/mL 293.7 C[33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:13B=mRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH50599977AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T15:23AmRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH03513399AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.4 AU/mL 145.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:48B!mRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH64324788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1831.3 AU/mL 1831.3 CrtAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH03512471AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1287.1 AU/mL 1287.1 CPqAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:13B=mRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH03486740AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 271.6 AU/mL 271.6 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH50599977CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:23AmRNA-1273-P201ISmRNA-1273-P201-US203-1042A1EH03513399BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:48B!mRNA-1273-P201ISmRNA-1273-P201-US203-1042B1EH64324788BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T12:26B,mRNA-1273-P201ISmRNA-1273-P201-US203-1042B1EH03512471BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:13B=mRNA-1273-P201ISmRNA-1273-P201-US203-1042B1EH03486740AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1042B1EH59021442 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1043A`1EH03507348AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1043Ap1EH55939127AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.8 ug/mL 10.8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:50B,mRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH44119047AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T15:41B9mRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH59047954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T15:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH03511477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH64325685AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:50B,mRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH35758119AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T15:41B9mRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH45366459AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:19BmRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH59047954BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1043A1EH03511477BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1043B1EH64325685BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:50B,mRNA-1273-P201ISmRNA-1273-P201-US203-1043B1EH35758119CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T15:41B9mRNA-1273-P201ISmRNA-1273-P201-US203-1043B1EH45366459AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:19BmRNA-1273-P201ISmRNA-1273-P201-US203-1043B1EH50660531 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1045A@1EH50597928AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1045AP1EH50597928BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1045A`1EH59019424 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1047A`1EH03511445AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.5 ug/mL 31.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:03BmRNA-1273-P201ISmRNA-1273-P201-US203-1047Ap1EH26312851AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 238.2 ug/mL 238.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:08B+mRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH03513364AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 232.4 ug/mL 232.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:55B9mRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH42212376AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T13:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH03511349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.2 AU/mL 147.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:03BmRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH26319891AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1046.6 AU/mL 1046.6 CAiAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:08B+mRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH03511318AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1255.5 AU/mL 1255.5 CNxAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:55B9mRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH03486773AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.9 AU/mL 192.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T12:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH42212376BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1047A1EH03511349BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:03BmRNA-1273-P201ISmRNA-1273-P201-US203-1047B1EH26319891BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T13:08B+mRNA-1273-P201ISmRNA-1273-P201-US203-1047B1EH03511318BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:55B9mRNA-1273-P201ISmRNA-1273-P201-US203-1047B1EH03486773AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T12:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1047B1EH33822747 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1048A`1EH03510453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1048Ap1EH64325653AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:25B/mRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH03506231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH42208411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH11898005AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH64325654AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:25B/mRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH11895956AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH55940246AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH42208411BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1048A1EH11898005BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1048B1EH64325654BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:25B/mRNA-1273-P201ISmRNA-1273-P201-US203-1048B1EH11895956CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1048B1EH55940246AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1048B1EH33821880 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US203-1049A`1EH03513492AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:04BmRNA-1273-P201ISmRNA-1273-P201-US203-1049Ap1EH17931314AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:18B,mRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH05246113AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:40B:mRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH42210329AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH03511319AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:04BmRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH26316850AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:18B,mRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH05245986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:40B:mRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH03486901AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 467.3 AU/mL 467.3 C4AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH42210329BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:32AmRNA-1273-P201ISmRNA-1273-P201-US203-1049A1EH03511319BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:04BmRNA-1273-P201ISmRNA-1273-P201-US203-1049B1EH26316850BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:18B,mRNA-1273-P201ISmRNA-1273-P201-US203-1049B1EH05245986CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T16:40B:mRNA-1273-P201ISmRNA-1273-P201-US203-1049B1EH03486901AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US203-1050AP1EH42207259AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:49AmRNA-1273-P201ISmRNA-1273-P201-US203-1050A`1EH05246080AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 55.2 ug/mL 55.2 B7333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1050Ap1EH29656235AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 250.3 ug/mL 250.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:41B,mRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH44120198AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.6 ug/mL 191.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:55B>mRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH42211513AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:49AmRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH05243907AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 122.2 AU/mL 122.2 Bz333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH29660329AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1382.2 AU/mL 1382.2 CVc33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:41B,mRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH35758215AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 969.2 AU/mL 969.2 C<33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:55B>mRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH03486772AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.5 AU/mL 121.5 ByAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH42211513BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:49AmRNA-1273-P201ISmRNA-1273-P201-US203-1050A1EH05243907BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH29660329BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T08:41B,mRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH35758215CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:55B>mRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH03486772AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH33820731 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH11842590 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies678.823 MN50 20 2560 678.823 C*m+ IMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH33820731 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1050B1EH11842590 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies480 MN Endpoint Titer20 2560 480 CMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH42207258AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.9 AU/mL 23.9 BfffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1051A 1EH03507383AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.1 AU/mL 20.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1051A01EH26312880AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.7 AU/mL 19.7 B33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:49B+mRNA-1273-P201ISmRNA-1273-P201-US203-1051A@1EH03506198AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21 AU/mL 21 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:20B9mRNA-1273-P201ISmRNA-1273-P201-US203-1051AP1EH42207258AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1051A`1EH03507383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1051Ap1EH26312880AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.7 ug/mL 142.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:49B+mRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH03506198AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.1 ug/mL 128.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:20B9mRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH42206395AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH03512343AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.5 AU/mL 20.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH26318993AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 711.1 AU/mL 711.1 C,qAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:49B+mRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH03510423AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 552.6 AU/mL 552.6 C"AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:20B9mRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH03485751AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.9 AU/mL 143.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH42206395BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1051A1EH03512343CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T14:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1051B1EH26318993BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:49B+mRNA-1273-P201ISmRNA-1273-P201-US203-1051B1EH03510423BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:20B9mRNA-1273-P201ISmRNA-1273-P201-US203-1051B1EH03485751AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1051B1EH33821848 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1056A`1EH03508405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.3 ug/mL 94.3 B^Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:31BmRNA-1273-P201ISmRNA-1273-P201-US203-1056Ap1EH26314896AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 386.2 ug/mL 386.2 C#33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:48B,mRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH05244065AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 356 ug/mL 356 C@ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH50598024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH11896852AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 240.5 AU/mL 240.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:31BmRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH26320048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:48B,mRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH05246083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH37005497AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 397.7 AU/mL 397.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:52BmRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH50598024BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14 AU/mL 14 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1056A1EH11896852BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 AU/mL 9.8 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:31BmRNA-1273-P201ISmRNA-1273-P201-US203-1056B1EH26320048BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.6 AU/mL 12.6 AəAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:48B,mRNA-1273-P201ISmRNA-1273-P201-US203-1056B1EH05246083BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.2 AU/mL 13.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US203-1056B1EH37005497AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.2 AU/mL 14.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:52BmRNA-1273-P201ISmRNA-1273-P201-US203-1056B1EH59020417 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1057A`1EH03510292AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20 ug/mL 20 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1057Ap1EH26312753AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 303.6 ug/mL 303.6 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH44119045AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.2 ug/mL 203.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:15B:mRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH59049137AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH11896980AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 76.6 AU/mL 76.6 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH26316946AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1797.3 AU/mL 1797.3 CpTAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH35759141AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1258.3 AU/mL 1258.3 CNAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:15B:mRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH03488790AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.1 AU/mL 135.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:08BmRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH59049137BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1057A1EH11896980BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T07:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1057B1EH26316946BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1057B1EH35759141BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:15B:mRNA-1273-P201ISmRNA-1273-P201-US203-1057B1EH03488790AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1058A`1EH03513365AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1058Ap1EH26313905AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:25B-mRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH03509428AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:35B=mRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH42211481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH03511447AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH26320019AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:25B-mRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH03512502AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:35B=mRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH03485846AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T15:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH42211481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1058A1EH03511447BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1058B1EH26320019BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:25B-mRNA-1273-P201ISmRNA-1273-P201-US203-1058B1EH03512502BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:35B=mRNA-1273-P201ISmRNA-1273-P201-US203-1058B1EH03485846AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T15:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1058B1EH33821753 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:19AmRNA-1273-P201ISmRNA-1273-P201-US203-1060A`1EH03507220AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.5 ug/mL 74.5 BJug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1060Ap1EH55942295AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 301.2 ug/mL 301.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T16:10B+mRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH05243905AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 170 ug/mL 170 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:20B7mRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH50599049AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:19AmRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH11895861AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 307.5 AU/mL 307.5 C8AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH64324756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1126.4 AU/mL 1126.4 CFfffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T16:10B+mRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH05245090AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 855.2 AU/mL 855.2 C5s33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:20B7mRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH37003417AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.3 AU/mL 112.3 BpLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH50599049BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:19AmRNA-1273-P201ISmRNA-1273-P201-US203-1060A1EH11895861BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1060B1EH64324756BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T16:10B+mRNA-1273-P201ISmRNA-1273-P201-US203-1060B1EH05245090BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:20B7mRNA-1273-P201ISmRNA-1273-P201-US203-1060B1EH37003417AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1060B1EH59021315 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1062A`1EH03507255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.3 ug/mL 94.3 B^Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1062Ap1EH55942326AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 217.3 ug/mL 217.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH03508375AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.2 ug/mL 225.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:07B7mRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH50600073AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH11896981AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 248.1 AU/mL 248.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH64325812AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1002.9 AU/mL 1002.9 C>fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH11896853AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1138.8 AU/mL 1138.8 CG,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:07B7mRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH03486774AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.2 AU/mL 162.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH50600073BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:28AmRNA-1273-P201ISmRNA-1273-P201-US203-1062A1EH11896981BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T16:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1062B1EH64325812BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1062B1EH11896853CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:07B7mRNA-1273-P201ISmRNA-1273-P201-US203-1062B1EH03486774AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1062B1EH59020416 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:17AmRNA-1273-P201ISmRNA-1273-P201-US203-1063A`1EH03512469AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.4 ug/mL 87.4 BWfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:52BmRNA-1273-P201ISmRNA-1273-P201-US203-1063Ap1EH26312850AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 302.1 ug/mL 302.1 Cᙙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:58B+mRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH05244961AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.3 ug/mL 218.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH50599048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:17AmRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH11894836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.1 AU/mL 167.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:52BmRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH26315922AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1428.6 AU/mL 1428.6 CYIAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:58B+mRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH05244963AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 893.5 AU/mL 893.5 C7AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH03487926AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 184.1 AU/mL 184.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH50599048BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:17AmRNA-1273-P201ISmRNA-1273-P201-US203-1063A1EH11894836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:52BmRNA-1273-P201ISmRNA-1273-P201-US203-1063B1EH26315922BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:58B+mRNA-1273-P201ISmRNA-1273-P201-US203-1063B1EH05244963BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1063B1EH03487926AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:32BmRNA-1273-P201ISmRNA-1273-P201-US203-1063B1EH59021472 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1066A`1EH03511444AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13 ug/mL 13 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1066Ap1EH26315824AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142 ug/mL 142 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH03507349AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125.4 ug/mL 125.4 B}fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:47B:mRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH42209465AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH11894806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37 AU/mL 37 B%AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH26316977AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 621.5 AU/mL 621.5 C&AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH03510295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 530.1 AU/mL 530.1 C!!AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:47B:mRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH45364411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.4 AU/mL 193.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH42209465BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1066A1EH11894806BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1066B1EH26316977BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1066B1EH03510295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:47B:mRNA-1273-P201ISmRNA-1273-P201-US203-1066B1EH45364411AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1066B1EH33822875 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1071A`1EH03506326AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1071Ap1EH55941175AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:30B,mRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH44118054AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:30B:mRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH59050160AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH03511476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.9 AU/mL 1.9 AffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH64323636AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:30B,mRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH35759109AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:30B:mRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH03486902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T13:19BmRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH59050160BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1071A1EH03511476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T07:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1071B1EH64323636BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:30B,mRNA-1273-P201ISmRNA-1273-P201-US203-1071B1EH35759109CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T09:30B:mRNA-1273-P201ISmRNA-1273-P201-US203-1071B1EH03486902AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T13:19BmRNA-1273-P201ISmRNA-1273-P201-US203-1071B1EH50661522 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:06AmRNA-1273-P201ISmRNA-1273-P201-US203-1072A`1EH03512341AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20 ug/mL 20 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:07B"mRNA-1273-P201ISmRNA-1273-P201-US203-1072Ap1EH64323732AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 255.7 ug/mL 255.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:44B3mRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH16891054AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157.8 ug/mL 157.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T14:33BBmRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH59049136AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T12:06AmRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH03510326AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.2 AU/mL 48.2 B0333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:07B"mRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH64326709AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 474.8 AU/mL 474.8 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:44B3mRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH25273517AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 602.8 AU/mL 602.8 C%AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T14:33BBmRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH03487924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.1 AU/mL 186.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH59049136BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:06AmRNA-1273-P201ISmRNA-1273-P201-US203-1072A1EH03510326BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:07B"mRNA-1273-P201ISmRNA-1273-P201-US203-1072B1EH64326709BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:44B3mRNA-1273-P201ISmRNA-1273-P201-US203-1072B1EH25273517BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T14:33BBmRNA-1273-P201ISmRNA-1273-P201-US203-1072B1EH03487924AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1073A`1EH03513396AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32 ug/mL 32 B ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:56BmRNA-1273-P201ISmRNA-1273-P201-US203-1073Ap1EH17928243AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 209 ug/mL 209 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:59B,mRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH44118183AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.7 ug/mL 149.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T17:53B@mRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH50600072AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH11898036AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.8 AU/mL 87.8 BWAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:56BmRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH26320017AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 743.3 AU/mL 743.3 C.tAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:59B,mRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH35760165AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 743.2 AU/mL 743.2 C.s33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T17:53B@mRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH03486741AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.1 AU/mL 117.1 BuAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T12:54BmRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH50600072BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:45AmRNA-1273-P201ISmRNA-1273-P201-US203-1073A1EH11898036BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:56BmRNA-1273-P201ISmRNA-1273-P201-US203-1073B1EH26320017BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:59B,mRNA-1273-P201ISmRNA-1273-P201-US203-1073B1EH35760165CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T17:53B@mRNA-1273-P201ISmRNA-1273-P201-US203-1073B1EH03486741AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T12:54BmRNA-1273-P201ISmRNA-1273-P201-US203-1073B1EH59019426 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1074Ap1EH27264011AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-15T15:23AmRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH03512373AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:43BmRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH26314931AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH05244930AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH50599976AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH03511351AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:43BmRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH26319920AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH05243938AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1074A1EH03487766AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:51BmRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH50599976BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH03511351BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:43BmRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH26319920BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:24B+mRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH05243938BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:30B9mRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH03487766AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:51BmRNA-1273-P201ISmRNA-1273-P201-US203-1074B1EH59019298 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1079A`1EH03507222AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.4 ug/mL 22.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1079Ap1EH55941302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.7 ug/mL 144.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:15B,mRNA-1273-P201ISmRNA-1273-P201-US203-1079A1EH44119174AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.5 ug/mL 121.5 Byug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T10:22B:mRNA-1273-P201ISmRNA-1273-P201-US203-1079A1EH50598056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T15:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1079A1EH03513526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.8 AU/mL 60.8 BffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:46AmRNA-1273-P201ISmRNA-1273-P201-US203-1080A`1EH03512501AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.5 ug/mL 56.5 B8ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:09BmRNA-1273-P201ISmRNA-1273-P201-US203-1080Ap1EH64323733AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.4 ug/mL 145.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH44121223AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.9 ug/mL 115.9 Bsffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:22B@mRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH42211353AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:46AmRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH11894807AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 271.9 AU/mL 271.9 CfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:09BmRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH64324629AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 735.4 AU/mL 735.4 C-fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH35761316AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 610.7 AU/mL 610.7 C&+33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:22B@mRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH03485718AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.4 AU/mL 117.4 BufffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:27BmRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH42211353BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:46AmRNA-1273-P201ISmRNA-1273-P201-US203-1080A1EH11894807BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:09BmRNA-1273-P201ISmRNA-1273-P201-US203-1080B1EH64324629BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:01B+mRNA-1273-P201ISmRNA-1273-P201-US203-1080B1EH35761316BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:22B@mRNA-1273-P201ISmRNA-1273-P201-US203-1080B1EH03485718AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:27BmRNA-1273-P201ISmRNA-1273-P201-US203-1080B1EH33820826 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T11:36AmRNA-1273-P201ISmRNA-1273-P201-US203-1081Ap1EH05243040AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH26313904AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:15B)mRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH44118055AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 ug/mL 6.4 Affffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:16B=mRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH63281204AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.4 ug/mL 28.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-31T10:13BYmRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH59050034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T11:36AmRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH05243043AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH26320049AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:15B)mRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH35760134AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:16B=mRNA-1273-P201ISmRNA-1273-P201-US203-1081A1EH63282228AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.4 AU/mL 27.4 BffffffAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-31T10:13BYmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH03488821AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 AU/mL 10.9 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T17:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH59050034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T11:36AmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH05243043BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:30BmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH26320049BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:15B)mRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH35760134CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:16B=mRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH63282228BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.9 AU/mL 16.9 BfffffAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-31T10:13BYmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH03488821AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T17:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1081B1EH50659475 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-10T13:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1084A`1EH03509399AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.8 ug/mL 21.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:39BmRNA-1273-P201ISmRNA-1273-P201-US203-1084Ap1EH55942294AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.2 ug/mL 173.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH44120199AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 136.6 ug/mL 136.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B9mRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH50599945AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-10T13:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH11897876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.3 AU/mL 97.3 BaLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:39BmRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH64325655AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 669.2 AU/mL 669.2 C)33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH35758212AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 699.4 AU/mL 699.4 C+fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B9mRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH03485750AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.2 AU/mL 74.2 BJ333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:43BmRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH50599945BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-10T13:42AmRNA-1273-P201ISmRNA-1273-P201-US203-1084A1EH11897876BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:39BmRNA-1273-P201ISmRNA-1273-P201-US203-1084B1EH64325655BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US203-1084B1EH35758212CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:35B9mRNA-1273-P201ISmRNA-1273-P201-US203-1084B1EH03485750AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:43BmRNA-1273-P201ISmRNA-1273-P201-US203-1084B1EH59020289 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1085AP1EH50597033AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1085A`1EH03512340AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1085Ap1EH58762282AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:45B/mRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH03508246AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:48B>mRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH50597034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH11897908AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH58767401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:45B/mRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH11895829AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:48B>mRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH03488918AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH50597034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1085A1EH11897908CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH58767401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:45B/mRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH11895829BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:48B>mRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH03488918AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH59022369 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH03481748 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1085B1EH03481748 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:09AmRNA-1273-P201ISmRNA-1273-P201-US203-1086A`1EH05246081AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 ug/mL 12.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:18B mRNA-1273-P201ISmRNA-1273-P201-US203-1086Ap1EH58762378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.5 ug/mL 147.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH50606093AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 126.7 ug/mL 126.7 B~33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:24B<mRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH50597003AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:09AmRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH05245954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:18B mRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH58766345AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 874.3 AU/mL 874.3 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH50607279AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 633.1 AU/mL 633.1 C'AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:24B<mRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH03485847AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.3 AU/mL 145.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH50597003BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:09AmRNA-1273-P201ISmRNA-1273-P201-US203-1086A1EH05245954BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:18B mRNA-1273-P201ISmRNA-1273-P201-US203-1086B1EH58766345CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US203-1086B1EH50607279BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:24B<mRNA-1273-P201ISmRNA-1273-P201-US203-1086B1EH03485847AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:23BmRNA-1273-P201ISmRNA-1273-P201-US203-1086B1EH59020288 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:59AmRNA-1273-P201ISmRNA-1273-P201-US203-1089A`1EH44119076AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:48B"mRNA-1273-P201ISmRNA-1273-P201-US203-1089Ap1EH58767400AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 ug/mL 8.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:26B1mRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH50609165AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:37B?mRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH50601096AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.8 AU/mL 1.8 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:59AmRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH35761189AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:48B"mRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH58767499AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:26B1mRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH58990733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:37B?mRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH37003320AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH50601096BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:59AmRNA-1273-P201ISmRNA-1273-P201-US203-1089A1EH35761189BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:48B"mRNA-1273-P201ISmRNA-1273-P201-US203-1089B1EH58767499BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:26B1mRNA-1273-P201ISmRNA-1273-P201-US203-1089B1EH58990733BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:37B?mRNA-1273-P201ISmRNA-1273-P201-US203-1089B1EH37003320AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:26BmRNA-1273-P201ISmRNA-1273-P201-US203-1089B1EH59022465 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1091A`1EH03506230AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.7 ug/mL 52.7 B433334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:53B mRNA-1273-P201ISmRNA-1273-P201-US203-1091Ap1EH58762250AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 292.6 ug/mL 292.6 CIug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH50609325AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.7 ug/mL 150.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH50601097AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH03510327AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.2 AU/mL 130.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:53B mRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH58765481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH58990732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1247.3 AU/mL 1247.3 CMAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH03487927AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.4 AU/mL 171.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH50601097BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1091A1EH03510327CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:53B mRNA-1273-P201ISmRNA-1273-P201-US203-1091B1EH58765481CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US203-1091B1EH58990732BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1091B1EH03487927AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1091B1EH59021474 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1092A`1EH03507223AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:27BmRNA-1273-P201ISmRNA-1273-P201-US203-1092Ap1EH58765353AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:54B-mRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH03508406AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:58B9mRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH59047985AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH03513524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:27BmRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH58766344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:54B-mRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH11894804AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:58B9mRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH03488789AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH59047985BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1092A1EH03513524CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:27BmRNA-1273-P201ISmRNA-1273-P201-US203-1092B1EH58766344BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:54B-mRNA-1273-P201ISmRNA-1273-P201-US203-1092B1EH11894804BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:58B9mRNA-1273-P201ISmRNA-1273-P201-US203-1092B1EH03488789AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1092B1EH50659506 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1093A`1EH44119205AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.3 ug/mL 19.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1093Ap1EH55941303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 221.1 ug/mL 221.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH50608142AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153 ug/mL 153 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T12:28BBmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH65346573AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH35760292AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95.1 AU/mL 95.1 B_AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH64326677AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1039.7 AU/mL 1039.7 C@33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH58993805AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 849.9 AU/mL 849.9 C5fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T12:28BBmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH37006361AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127.7 AU/mL 127.7 B33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:29BmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH65346573BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1093A1EH35760292CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1093B1EH64326677BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1093B1EH58993805BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T12:28BBmRNA-1273-P201ISmRNA-1273-P201-US203-1093B1EH37006361AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:29BmRNA-1273-P201ISmRNA-1273-P201-US203-1093B1EH65339436 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1095A`1EH03509268AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1095Ap1EH55942327AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:23B,mRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH50607117AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:55B6mRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH50597897AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T08:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH11897877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH64323607AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:23B,mRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH50609295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:55B6mRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH03486900AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH50597897BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1095A1EH11897877BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:35BmRNA-1273-P201ISmRNA-1273-P201-US203-1095B1EH64323607BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:23B,mRNA-1273-P201ISmRNA-1273-P201-US203-1095B1EH50609295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:55B6mRNA-1273-P201ISmRNA-1273-P201-US203-1095B1EH03486900AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1095B1EH59019395 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1096A`1EH03509431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.8 ug/mL 23.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:28B mRNA-1273-P201ISmRNA-1273-P201-US203-1096Ap1EH58762251AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 220.5 ug/mL 220.5 B܀ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:22B.mRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH50603055AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 163.9 ug/mL 163.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:27B<mRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH50597002AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH11896884AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.3 AU/mL 132.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:28B mRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH58765480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1187.1 AU/mL 1187.1 CJ1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:22B.mRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH50607150AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 812.4 AU/mL 812.4 C2fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:27B<mRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH03487895AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.6 AU/mL 149.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH50597002BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1096A1EH11896884BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:28B mRNA-1273-P201ISmRNA-1273-P201-US203-1096B1EH58765480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:22B.mRNA-1273-P201ISmRNA-1273-P201-US203-1096B1EH50607150BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:27B<mRNA-1273-P201ISmRNA-1273-P201-US203-1096B1EH03487895AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:48BmRNA-1273-P201ISmRNA-1273-P201-US203-1096B1EH59022337 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1097A`1EH44119044AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:40B#mRNA-1273-P201ISmRNA-1273-P201-US203-1097Ap1EH58762410AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.9 ug/mL 35.9 B#fffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:11B.mRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH50605231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.4 ug/mL 28.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:46BAmRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH03148857AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH44121255AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 AU/mL 8.9 AfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:40B#mRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH58767498AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 239.5 AU/mL 239.5 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:11B.mRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH58992652AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.5 AU/mL 139.5 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:46BAmRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH37005369AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.6 AU/mL 34.6 B"AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T13:54BmRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH03148857BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1097A1EH44121255BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:40B#mRNA-1273-P201ISmRNA-1273-P201-US203-1097B1EH58767498BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:11B.mRNA-1273-P201ISmRNA-1273-P201-US203-1097B1EH58992652BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:46BAmRNA-1273-P201ISmRNA-1273-P201-US203-1097B1EH37005369AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T13:54BmRNA-1273-P201ISmRNA-1273-P201-US203-1097B1EH03147833 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1098Ap1EH26318865AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-14T14:42BmRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH44121126AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH58764459AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:36B/mRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH50606094AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:03B9mRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH59050032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH35761157AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH58765323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:36B/mRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH50607151AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:03B9mRNA-1273-P201ISmRNA-1273-P201-US203-1098A1EH03485879AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:50BmRNA-1273-P201ISmRNA-1273-P201-US203-1098B1EH59050032BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:24AmRNA-1273-P201ISmRNA-1273-P201-US203-1098B1EH35761157BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US203-1098B1EH58765323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:36B/mRNA-1273-P201ISmRNA-1273-P201-US203-1098B1EH50607151BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1100A`1EH44118182AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:55B"mRNA-1273-P201ISmRNA-1273-P201-US203-1100Ap1EH58762411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T16:38B2mRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH50607148AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T16:38B@mRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH65344557AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH35759236AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:55B"mRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH58767529AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T16:38B2mRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH58992684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T16:38B@mRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH37005465AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH65344557BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1100A1EH35759236BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T15:55B"mRNA-1273-P201ISmRNA-1273-P201-US203-1100B1EH58767529BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T16:38B2mRNA-1273-P201ISmRNA-1273-P201-US203-1100B1EH58992684BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T16:38B@mRNA-1273-P201ISmRNA-1273-P201-US203-1100B1EH37005465AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:49BmRNA-1273-P201ISmRNA-1273-P201-US203-1100B1EH65339437 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:37AmRNA-1273-P201ISmRNA-1273-P201-US203-1101A`1EH44119079AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.2 ug/mL 9.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US203-1101Ap1EH58763434AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125.8 ug/mL 125.8 B}ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:50B3mRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH50609324AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.6 ug/mL 98.6 Bbug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T16:10BAmRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH42209305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:37AmRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH35760293AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.5 AU/mL 18.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH58768521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 496.7 AU/mL 496.7 C 33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:50B3mRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH58992813AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 170.2 AU/mL 170.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T16:10BAmRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH42209305BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:37AmRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH35760293BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US203-1101A1EH58768521BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:50B3mRNA-1273-P201ISmRNA-1273-P201-US203-1101B1EH58992813BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T16:10BAmRNA-1273-P201ISmRNA-1273-P201-US203-1101B1EH33820859 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1102A`1EH44120228AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:47B!mRNA-1273-P201ISmRNA-1273-P201-US203-1102Ap1EH58767497AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:27B0mRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH50608271AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:50B:mRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH65345582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.7 AU/mL 2.7 A+333334AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH35758213AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:47B!mRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH58765322AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.5 AU/mL 2.5 A(AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:27B0mRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH50606127AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:50B:mRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH37005368AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.2 AU/mL 15.2 A333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T16:16BmRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH65345582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T16:00AmRNA-1273-P201ISmRNA-1273-P201-US203-1102A1EH35758213BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T16:47B!mRNA-1273-P201ISmRNA-1273-P201-US203-1102B1EH58765322BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:27B0mRNA-1273-P201ISmRNA-1273-P201-US203-1102B1EH50606127BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:50B:mRNA-1273-P201ISmRNA-1273-P201-US203-1102B1EH37005368AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.1 AU/mL 14.1 AᙙAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T16:16BmRNA-1273-P201ISmRNA-1273-P201-US203-1102B1EH65341453 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1103A`1EH44121093AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T16:44B mRNA-1273-P201ISmRNA-1273-P201-US203-1103Ap1EH64323604AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T15:51B.mRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH50605230AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T16:29B<mRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH42210328AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH35758085AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T16:44B mRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH64325684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T15:51B.mRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH58992653AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T16:29B<mRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH50605103AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 221.3 AU/mL 221.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T17:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH42210328BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1103A1EH35758085CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T16:44B mRNA-1273-P201ISmRNA-1273-P201-US203-1103B1EH64325684BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T15:51B.mRNA-1273-P201ISmRNA-1273-P201-US203-1103B1EH58992653BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T16:29B<mRNA-1273-P201ISmRNA-1273-P201-US203-1103B1EH50605103AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.1 AU/mL 69.1 BEAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T17:11BmRNA-1273-P201ISmRNA-1273-P201-US203-1103B1EH33822778 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1104A`1EH44120230AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.4 ug/mL 19.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:26B$mRNA-1273-P201ISmRNA-1273-P201-US203-1104Ap1EH58764299AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.4 ug/mL 203.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:25B2mRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH50603182AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.6 ug/mL 160.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:38B=mRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH50594955AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH35759269AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 87.7 AU/mL 87.7 BW33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:26B$mRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH58768424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1006.5 AU/mL 1006.5 C>AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:25B2mRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH58990636AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 840.6 AU/mL 840.6 C4AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:38B=mRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH03486870AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.9 AU/mL 141.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH50594955BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1104A1EH35759269BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T12:26B$mRNA-1273-P201ISmRNA-1273-P201-US203-1104B1EH58768424BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:25B2mRNA-1273-P201ISmRNA-1273-P201-US203-1104B1EH58990636BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:38B=mRNA-1273-P201ISmRNA-1273-P201-US203-1104B1EH03486870AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1104B1EH59022497 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1105A`1EH05242882AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.5 ug/mL 36.5 B$ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:12B!mRNA-1273-P201ISmRNA-1273-P201-US203-1105Ap1EH58764426AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 249.9 ug/mL 249.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:14B.mRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH50609292AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 226.5 ug/mL 226.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:00B<mRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH50598921AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH05244067AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159 AU/mL 159 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:12B!mRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH58766504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1894.2 AU/mL 1894.2 Cvc33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:14B.mRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH58991756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1202.4 AU/mL 1202.4 CK&ffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:00B<mRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH03488916AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 92.3 AU/mL 92.3 B\LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH50598921BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1105A1EH05244067BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:12B!mRNA-1273-P201ISmRNA-1273-P201-US203-1105B1EH58766504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:14B.mRNA-1273-P201ISmRNA-1273-P201-US203-1105B1EH58991756BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:00B<mRNA-1273-P201ISmRNA-1273-P201-US203-1105B1EH03488916AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:10BmRNA-1273-P201ISmRNA-1273-P201-US203-1105B1EH59021347 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1106A`1EH03510421AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 ug/mL 31.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1106Ap1EH58764331AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 255.2 ug/mL 255.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:14B/mRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH50607116AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.9 ug/mL 204.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:15B?mRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH50600105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH11896854AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.6 AU/mL 152.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH58768520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1103.6 AU/mL 1103.6 CDAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:14B/mRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH50606254AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 792.9 AU/mL 792.9 C1fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:15B?mRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH37003448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.4 AU/mL 165.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T12:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH50600105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:04AmRNA-1273-P201ISmRNA-1273-P201-US203-1106A1EH11896854BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T16:34B"mRNA-1273-P201ISmRNA-1273-P201-US203-1106B1EH58768520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T12:14B/mRNA-1273-P201ISmRNA-1273-P201-US203-1106B1EH50606254BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:15B?mRNA-1273-P201ISmRNA-1273-P201-US203-1106B1EH37003448AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T12:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1106B1EH59020448 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1107A`1EH05244032AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.5 ug/mL 17.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1107Ap1EH58765449AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 236.9 ug/mL 236.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:22B+mRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH50606252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110.6 ug/mL 110.6 Bnug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:18BBmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH50594859AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH05245987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.4 AU/mL 71.4 BGfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH58766376AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 794.3 AU/mL 794.3 C1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:22B+mRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH50607119AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 465.2 AU/mL 465.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:18BBmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH37003289AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.1 AU/mL 71.1 BGAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH50594859BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:05AmRNA-1273-P201ISmRNA-1273-P201-US203-1107A1EH05245987BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:15BmRNA-1273-P201ISmRNA-1273-P201-US203-1107B1EH58766376BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T10:22B+mRNA-1273-P201ISmRNA-1273-P201-US203-1107B1EH50607119BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:18BBmRNA-1273-P201ISmRNA-1273-P201-US203-1107B1EH37003289AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1107B1EH59019299 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1108AP1EH44119172AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1108A`1EH50607244AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.9 ug/mL 106.9 Bjffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:12B6mRNA-1273-P201ISmRNA-1273-P201-US203-1108Ap1EH65344526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH35758087AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.3 AU/mL 17.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH58767370AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 556.1 AU/mL 556.1 C"AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:22B.mRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH58992812AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 412.1 AU/mL 412.1 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:12B6mRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH37003416AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.4 AU/mL 117.4 BufffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:44BmRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH65344526BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:43AmRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH35758087BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:18BmRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH58767370BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:22B.mRNA-1273-P201ISmRNA-1273-P201-US203-1108A1EH58992812BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:12B6mRNA-1273-P201ISmRNA-1273-P201-US203-1108B1EH37003416AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:44BmRNA-1273-P201ISmRNA-1273-P201-US203-1108B1EH65341484 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1109A`1EH03507381AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.4 ug/mL 14.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:20B mRNA-1273-P201ISmRNA-1273-P201-US203-1109Ap1EH58765448AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.3 ug/mL 107.3 BkLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:15B/mRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH50606223AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.3 ug/mL 109.3 BmLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH50597035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH03513527AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.3 AU/mL 48.3 B0LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:20B mRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH58766377AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 404.7 AU/mL 404.7 CK33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:15B/mRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH58990637AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 502.2 AU/mL 502.2 Cc33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH03486903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.9 AU/mL 54.9 B6fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH50597035CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:15AmRNA-1273-P201ISmRNA-1273-P201-US203-1109A1EH03513527BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:20B mRNA-1273-P201ISmRNA-1273-P201-US203-1109B1EH58766377BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:15B/mRNA-1273-P201ISmRNA-1273-P201-US203-1109B1EH58990637BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:11B<mRNA-1273-P201ISmRNA-1273-P201-US203-1109B1EH03486903AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:20BmRNA-1273-P201ISmRNA-1273-P201-US203-1109B1EH59022336 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1110AP1EH50594856AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1110A`1EH03510420AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:23B!mRNA-1273-P201ISmRNA-1273-P201-US203-1110Ap1EH55942199AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:26B/mRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH50607245AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:25B>mRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH50600969AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH03513525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:23B!mRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH64326837AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:26B/mRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH58991628AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:25B>mRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH03485719AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T11:34BmRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH50600969BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1110A1EH03513525CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:23B!mRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH64326837BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:26B/mRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH58991628BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:25B>mRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH03485719AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T11:34BmRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH59022496 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH03483828 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US203-1110B1EH03483828 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1111A`1EH03509270AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:01B mRNA-1273-P201ISmRNA-1273-P201-US203-1111Ap1EH64325780AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.1 ug/mL 68.1 BDug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:17B1mRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH50606095AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.8 ug/mL 58.8 B:ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:22B9mRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH50594858AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH03513398AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 AU/mL 13.9 AfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:01B mRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH64326836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 244.9 AU/mL 244.9 BffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:17B1mRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH50609198AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.4 AU/mL 149.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:22B9mRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH37004313AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 59.3 AU/mL 59.3 B;LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T12:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH50594858BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:50AmRNA-1273-P201ISmRNA-1273-P201-US203-1111A1EH03513398BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:01B mRNA-1273-P201ISmRNA-1273-P201-US203-1111B1EH64326836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T10:17B1mRNA-1273-P201ISmRNA-1273-P201-US203-1111B1EH50609198CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T11:22B9mRNA-1273-P201ISmRNA-1273-P201-US203-1111B1EH37004313AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-01T12:58BmRNA-1273-P201ISmRNA-1273-P201-US203-1111B1EH59020320 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1112A`1EH03509302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.5 ug/mL 13.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:56B mRNA-1273-P201ISmRNA-1273-P201-US203-1112Ap1EH58764427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.8 ug/mL 135.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:40B/mRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH50608269AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 119.8 ug/mL 119.8 Bwug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T18:45BEmRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH50594987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH03511350AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57.3 AU/mL 57.3 B9LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:56B mRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH58766505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 631.6 AU/mL 631.6 C'yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:40B/mRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH50607118AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 467.9 AU/mL 467.9 C>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T18:45BEmRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH03487767AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 388.5 AU/mL 388.5 CHAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T17:03BmRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH50594987CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:53AmRNA-1273-P201ISmRNA-1273-P201-US203-1112A1EH03511350BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:56B mRNA-1273-P201ISmRNA-1273-P201-US203-1112B1EH58766505BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:40B/mRNA-1273-P201ISmRNA-1273-P201-US203-1112B1EH50607118BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T18:45BEmRNA-1273-P201ISmRNA-1273-P201-US203-1112B1EH03487767AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T17:03BmRNA-1273-P201ISmRNA-1273-P201-US203-1112B1EH59021443 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T12:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1114A`1EH03512342AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 ug/mL 12.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34BmRNA-1273-P201ISmRNA-1273-P201-US203-1114Ap1EH58767369AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.3 ug/mL 148.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:20B,mRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH50607276AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.1 ug/mL 97.1 Baug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:07B:mRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH03146808AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.9 AU/mL 14.9 AfffffhAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T12:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH03512342BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.2 AU/mL 54.2 B6333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34BmRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH58767528AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 807.6 AU/mL 807.6 C2yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:20B,mRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH58991660AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 528.8 AU/mL 528.8 C! AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:07B:mRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH37005496AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.1 AU/mL 112.1 BpAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH03146808BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T12:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1114A1EH03512342CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:34BmRNA-1273-P201ISmRNA-1273-P201-US203-1114B1EH58767528BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T08:20B,mRNA-1273-P201ISmRNA-1273-P201-US203-1114B1EH58991660BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:07B:mRNA-1273-P201ISmRNA-1273-P201-US203-1114B1EH37005496AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1114B1EH03147832 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1116A`1EH44118180AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:48B mRNA-1273-P201ISmRNA-1273-P201-US203-1116Ap1EH58762283AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:19B/mRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH50609293AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:45B=mRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH50596906AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T08:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH35758117AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:48B mRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH58768552AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:19B/mRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH50608175AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:45B=mRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH03485877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:42BmRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH50596906BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14 AU/mL 14 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:02AmRNA-1273-P201ISmRNA-1273-P201-US203-1116A1EH35758117BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.1 AU/mL 39.1 B'AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:48B mRNA-1273-P201ISmRNA-1273-P201-US203-1116B1EH58768552BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 49.5 AU/mL 49.5 B1AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:19B/mRNA-1273-P201ISmRNA-1273-P201-US203-1116B1EH50608175BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.8 AU/mL 33.8 B!AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:45B=mRNA-1273-P201ISmRNA-1273-P201-US203-1116B1EH03485877AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 55.6 AU/mL 55.6 B7AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:42BmRNA-1273-P201ISmRNA-1273-P201-US203-1116B1EH59019425 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:10AmRNA-1273-P201ISmRNA-1273-P201-US203-1121A`1EH03509271AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:37BmRNA-1273-P201ISmRNA-1273-P201-US203-1121Ap1EH58762379AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101.1 ug/mL 101.1 Beug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:14B*mRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH50608300AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.7 ug/mL 32.7 B 33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:23B8mRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH03146809AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:10AmRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH03513494AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.1 AU/mL 12.1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:37BmRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH58767371AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 393.6 AU/mL 393.6 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:14B*mRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH58990765AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.3 AU/mL 195.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:23B8mRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH03487798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.7 AU/mL 64.7 B@33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH03146809BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:10AmRNA-1273-P201ISmRNA-1273-P201-US203-1121A1EH03513494BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:37BmRNA-1273-P201ISmRNA-1273-P201-US203-1121B1EH58767371BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:14B*mRNA-1273-P201ISmRNA-1273-P201-US203-1121B1EH58990765BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:23B8mRNA-1273-P201ISmRNA-1273-P201-US203-1121B1EH03487798AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1121B1EH03145784 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1122A`1EH44121254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.6 ug/mL 18.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1122Ap1EH58765320AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 184.3 ug/mL 184.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T12:25B.mRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH50608301AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.1 ug/mL 48.1 B0ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH59048977AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH35760294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.1 AU/mL 77.1 BMAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH58765354AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 536.3 AU/mL 536.3 C!AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T12:25B.mRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH50609199AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 785.9 AU/mL 785.9 C1fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH03488788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 269.9 AU/mL 269.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:01BmRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH59048977BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:20AmRNA-1273-P201ISmRNA-1273-P201-US203-1122A1EH35760294BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:13BmRNA-1273-P201ISmRNA-1273-P201-US203-1122B1EH58765354BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T12:25B.mRNA-1273-P201ISmRNA-1273-P201-US203-1122B1EH50609199BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US203-1122B1EH03488788AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:01BmRNA-1273-P201ISmRNA-1273-P201-US203-1122B1EH50662418 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1124A`1EH03507254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T17:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1124Ap1EH55942166AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:09B.mRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH50609197AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH59049008AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH03512470AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T17:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH64325813AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:09B.mRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH58991757AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH03486775AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T17:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH59049008BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:48AmRNA-1273-P201ISmRNA-1273-P201-US203-1124A1EH03512470BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T17:25BmRNA-1273-P201ISmRNA-1273-P201-US203-1124B1EH64325813BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:09B.mRNA-1273-P201ISmRNA-1273-P201-US203-1124B1EH58991757BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:54B9mRNA-1273-P201ISmRNA-1273-P201-US203-1124B1EH03486775AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T17:00BmRNA-1273-P201ISmRNA-1273-P201-US203-1124B1EH50660402 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1125A`1EH03506359AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:17B!mRNA-1273-P201ISmRNA-1273-P201-US203-1125Ap1EH58761387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:21B/mRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH50608140AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:54B<mRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH50598057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH03510422AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:17B!mRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH58768392AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:21B/mRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH50608174AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:54B<mRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH03486743AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:38BmRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH50598057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:54AmRNA-1273-P201ISmRNA-1273-P201-US203-1125A1EH03510422BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:17B!mRNA-1273-P201ISmRNA-1273-P201-US203-1125B1EH58768392BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:21B/mRNA-1273-P201ISmRNA-1273-P201-US203-1125B1EH50608174BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:54B<mRNA-1273-P201ISmRNA-1273-P201-US203-1125B1EH03486743AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:38BmRNA-1273-P201ISmRNA-1273-P201-US203-1125B1EH59019394 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1128Ap1EH44121095AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.4 ug/mL 22.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:44BmRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH58764458AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies . NOT DONEREFER TO EVENT CL-2933 PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH50439297AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 270.8 ug/mL 270.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH05244064AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 166.6 ug/mL 166.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:21B9mRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH03148856AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH35760263AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.4 AU/mL 67.4 BCfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:44BmRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH50444449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 917.2 AU/mL 917.2 C9S33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH05243011AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 731.3 AU/mL 731.3 C-AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:21B9mRNA-1273-P201ISmRNA-1273-P201-US203-1128A1EH37003449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.8 AU/mL 191.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH03148856BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH35760263BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:44BmRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH50444449BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:00B+mRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH05243011CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:21B9mRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH37003449AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:40BmRNA-1273-P201ISmRNA-1273-P201-US203-1128B1EH03145785 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:29AmRNA-1273-P201ISmRNA-1273-P201-US203-1129A`1EH44118151AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1129Ap1EH58765321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH50606124AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:40B;mRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH03148953AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T13:29AmRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH35758214AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH58768393AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH50607246AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:40B;mRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH37005336AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T14:04BmRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH03148953BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:29AmRNA-1273-P201ISmRNA-1273-P201-US203-1129A1EH35758214CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T14:45BmRNA-1273-P201ISmRNA-1273-P201-US203-1129B1EH58768393BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:00B-mRNA-1273-P201ISmRNA-1273-P201-US203-1129B1EH50607246BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:40B;mRNA-1273-P201ISmRNA-1273-P201-US203-1129B1EH37005336AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T14:04BmRNA-1273-P201ISmRNA-1273-P201-US203-1129B1EH03145912 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1131A`1EH44119173AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:46BmRNA-1273-P201ISmRNA-1273-P201-US203-1131Ap1EH58763435AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH50609196AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:33B9mRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH65343503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH35758247AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:46BmRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH58766473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH50609294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:33B9mRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH37003321AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.6 AU/mL 94.6 B^AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T11:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH65343503BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 AU/mL 8.8 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:30AmRNA-1273-P201ISmRNA-1273-P201-US203-1131A1EH35758247CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T10:46BmRNA-1273-P201ISmRNA-1273-P201-US203-1131B1EH58766473BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US203-1131B1EH50609294BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:33B9mRNA-1273-P201ISmRNA-1273-P201-US203-1131B1EH37003321AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.2 AU/mL 152.2 B333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T11:28BmRNA-1273-P201ISmRNA-1273-P201-US203-1131B1EH65339564 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:25AmRNA-1273-P201ISmRNA-1273-P201-US204-1002A`1EH19202084AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.1 ug/mL 36.1 B$ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1002Ap1EH63278262AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 248.9 ug/mL 248.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH00011292AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.4 ug/mL 190.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B9mRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH59047955AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T10:25AmRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH19207303AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.9 AU/mL 141.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH63281174AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1145.5 AU/mL 1145.5 CGAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH00015516AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 666.5 AU/mL 666.5 C)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B9mRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH59047955BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:25AmRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH19207303BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1002A1EH63281174BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:14B+mRNA-1273-P201ISmRNA-1273-P201-US204-1002B1EH00015516BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B9mRNA-1273-P201ISmRNA-1273-P201-US204-1002B1EH50659347 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1003A`1EH19205158AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.3 ug/mL 33.3 B!Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1003Ap1EH07344188AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 129.9 ug/mL 129.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:12B+mRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH00008381AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.2 ug/mL 99.2 Bc333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH59048082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH19208359AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 133 AU/mL 133 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH07347230AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 457.7 AU/mL 457.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:12B+mRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH00012445AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 287.2 AU/mL 287.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH60141573AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79 AU/mL 79 BOAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T14:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH59048082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1003A1EH19208359BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1003B1EH07347230BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:12B+mRNA-1273-P201ISmRNA-1273-P201-US204-1003B1EH00012445BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1003B1EH60141573AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T14:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1003B1EH50660530 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1005A`1EH19205159AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T11:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1005Ap1EH08688831AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T11:01B+mRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH00011452AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:52B=mRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH59050003AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH19208230AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T11:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH00330773AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T11:01B+mRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH00011295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:52B=mRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH27599929AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:41BmRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH59050003BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1005A1EH19208230BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T11:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1005B1EH00330773BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T11:01B+mRNA-1273-P201ISmRNA-1273-P201-US204-1005B1EH00011295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:52B=mRNA-1273-P201ISmRNA-1273-P201-US204-1005B1EH27599929AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:41BmRNA-1273-P201ISmRNA-1273-P201-US204-1005B1EH50662546 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1006A`1EH19205156AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.1 ug/mL 27.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1006Ap1EH07344189AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 269 ug/mL 269 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:24B-mRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH00008383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.1 ug/mL 187.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:52B;mRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH59050131AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH27591844AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.1 AU/mL 70.1 BFAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH07346239AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 956.5 AU/mL 956.5 C;AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:24B-mRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH00014397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 692.4 AU/mL 692.4 C+FfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:52B;mRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH27599001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.7 AU/mL 60.7 B<33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH59050131BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1006A1EH27591844BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1006B1EH07346239BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:24B-mRNA-1273-P201ISmRNA-1273-P201-US204-1006B1EH00014397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T10:52B;mRNA-1273-P201ISmRNA-1273-P201-US204-1006B1EH27599001AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1006B1EH50661523 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1007A`1EH19202182AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.2 ug/mL 68.2 BD333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:41BmRNA-1273-P201ISmRNA-1273-P201-US204-1007Ap1EH00329780AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.5 ug/mL 186.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:35B+mRNA-1273-P201ISmRNA-1273-P201-US204-1007A1EH00010396AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.3 ug/mL 148.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:32B9mRNA-1273-P201ISmRNA-1273-P201-US204-1007A1EH42208443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T10:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1007A1EH19206182AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 205.6 AU/mL 205.6 B͙AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:41BmRNA-1273-P201ISmRNA-1273-P201-US204-1007A1EH00329751AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 739.8 AU/mL 739.8 C.ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1008A`1EH19204230AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47 ug/mL 47 B/ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US204-1008Ap1EH63276215AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 412.8 ug/mL 412.8 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:22B-mRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH52736163AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 270 ug/mL 270 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:43BHmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH59050129AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH27590789AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.4 AU/mL 160.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH63281334AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1674.7 AU/mL 1674.7 Ch33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:22B-mRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH52739235AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 848.3 AU/mL 848.3 C5AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:43BHmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH19216571AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 383.3 AU/mL 383.3 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH59050129BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1008A1EH27590789BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:32BmRNA-1273-P201ISmRNA-1273-P201-US204-1008B1EH63281334BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:22B-mRNA-1273-P201ISmRNA-1273-P201-US204-1008B1EH52739235BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:43BHmRNA-1273-P201ISmRNA-1273-P201-US204-1008B1EH19216571AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1008B1EH50662577 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1010A`1EH19203236AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.9 ug/mL 29.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:36B mRNA-1273-P201ISmRNA-1273-P201-US204-1010Ap1EH66096299AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 256.6 ug/mL 256.6 C ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH00011453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 182.8 ug/mL 182.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH42206266AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH27592708AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 138.3 AU/mL 138.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:36B mRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH66099211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 985.5 AU/mL 985.5 C=AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH00014525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 664.6 AU/mL 664.6 C)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH27598904AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.6 AU/mL 73.6 BIAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:48BmRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH42206266BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1010A1EH27592708BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T08:36B mRNA-1273-P201ISmRNA-1273-P201-US204-1010B1EH66099211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US204-1010B1EH00014525BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1010B1EH27598904AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:48BmRNA-1273-P201ISmRNA-1273-P201-US204-1010B1EH33822905 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1011A`1EH19206180AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.4 ug/mL 40.4 B(ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1011Ap1EH07346236AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 ug/mL 10.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH00309397AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 ug/mL 9.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T07:32BNmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH59049104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH19206151AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.4 AU/mL 144.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH07344287AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH00309431AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T07:32BNmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH27601048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:18BmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH59049104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1011A1EH19206151BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1011B1EH07344287BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US204-1011B1EH00309431BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T07:32BNmRNA-1273-P201ISmRNA-1273-P201-US204-1011B1EH27601048AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:18BmRNA-1273-P201ISmRNA-1273-P201-US204-1011B1EH50661395 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:23AmRNA-1273-P201ISmRNA-1273-P201-US204-1012A`1EH19202085AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.1 ug/mL 44.1 B,ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:20B$mRNA-1273-P201ISmRNA-1273-P201-US204-1012Ap1EH50412689AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 253.5 ug/mL 253.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T13:23B4mRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH44120229AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 280.5 ug/mL 280.5 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:29BBmRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH59051153AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:23AmRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH19207334AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 290.7 AU/mL 290.7 C+33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:20B$mRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH50411699AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1391.5 AU/mL 1391.5 CVAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T13:23B4mRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH35758244AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1078 AU/mL 1078 CC`AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:29BBmRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH60140711AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 303.1 AU/mL 303.1 C񙙙AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH59051153BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:23AmRNA-1273-P201ISmRNA-1273-P201-US204-1012A1EH19207334BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:20B$mRNA-1273-P201ISmRNA-1273-P201-US204-1012B1EH50411699BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 AU/mL 9 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T13:23B4mRNA-1273-P201ISmRNA-1273-P201-US204-1012B1EH35758244BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:29BBmRNA-1273-P201ISmRNA-1273-P201-US204-1012B1EH60140711AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1012B1EH50659379 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1013A`1EH19207173AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.1 ug/mL 29.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1013Ap1EH07344284AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 170.5 ug/mL 170.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:22B0mRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH00010302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131 ug/mL 131 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B<mRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH42212504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.3 AU/mL 3.3 A4AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH19208358AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88 AU/mL 88 BXAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH07345214AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 358.7 AU/mL 358.7 Ck33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:22B0mRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH00015389AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 568.2 AU/mL 568.2 C#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B<mRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH27598905AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.6 AU/mL 47.6 B/AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH42212504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 AU/mL 9 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1013A1EH19208358BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1013B1EH07345214BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:22B0mRNA-1273-P201ISmRNA-1273-P201-US204-1013B1EH00015389BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B<mRNA-1273-P201ISmRNA-1273-P201-US204-1013B1EH27598905AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T09:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1013B1EH33823897 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:05AmRNA-1273-P201ISmRNA-1273-P201-US204-1014A`1EH19203205AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1014Ap1EH07442449AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH19206149AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T08:10B6mRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH42206394AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T15:05AmRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH19209252AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH05248057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH19207174AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T08:10B6mRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH50412592AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH42206394BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T15:05AmRNA-1273-P201ISmRNA-1273-P201-US204-1014A1EH19209252BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1014B1EH05248057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:15B.mRNA-1273-P201ISmRNA-1273-P201-US204-1014B1EH19207174BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21T08:10B6mRNA-1273-P201ISmRNA-1273-P201-US204-1014B1EH50412592AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T08:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1014B1EH33823896 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1016Ap1EH19205254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.2 ug/mL 9.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T13:09B+mRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH50410545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.8 ug/mL 44.8 B,ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T08:17B9mRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH52736034AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.5 ug/mL 33.5 B!ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T12:15BHmRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH42208315AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH27592837AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.8 AU/mL 10.8 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T13:09B+mRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH58796048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 256.9 AU/mL 256.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T08:17B9mRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH61122689AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.3 AU/mL 134.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T12:15BHmRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH42208315BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1016A1EH27592837BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T13:09B+mRNA-1273-P201ISmRNA-1273-P201-US204-1016B1EH58796048BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T08:17B9mRNA-1273-P201ISmRNA-1273-P201-US204-1016B1EH61122689CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T12:15BHmRNA-1273-P201ISmRNA-1273-P201-US204-1016B1EH33821752 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1019A`1EH19205126AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 ug/mL 6.4 Affffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1019Ap1EH30513165AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH52737185AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:24BHmRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH36015104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T14:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH30513165BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH52739075AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:24BHmRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH60142724AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.3 AU/mL 25.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T15:32BmRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH36015104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH30513165CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1019A1EH52739075BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:24BHmRNA-1273-P201ISmRNA-1273-P201-US204-1019B1EH60142724AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 AU/mL 10.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T15:32BmRNA-1273-P201ISmRNA-1273-P201-US204-1019B1EH44369026 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US204-1020A`1EH19202054AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1020Ap1EH07345309AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 ug/mL 8.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:42B+mRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH44121252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:10B@mRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH36015264AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH19206310AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH07345215AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:42B+mRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH35760261AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:10B@mRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH60143652AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.5 AU/mL 27.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T15:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH36015264BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US204-1020A1EH19206310BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1020B1EH07345215BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T15:42B+mRNA-1273-P201ISmRNA-1273-P201-US204-1020B1EH35760261BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:10B@mRNA-1273-P201ISmRNA-1273-P201-US204-1020B1EH60143652AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 AU/mL 8.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T15:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1020B1EH44367875 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:18AmRNA-1273-P201ISmRNA-1273-P201-US204-1022AP1EH19205125AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1022A`1EH44119077AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:00B=mRNA-1273-P201ISmRNA-1273-P201-US204-1022Ap1EH36013089AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T12:18AmRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH19207335AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH35760132AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:00B=mRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH60138662AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.8 AU/mL 84.8 BTAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:19BmRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH36013089BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:18AmRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH19207335BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH35760132BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:00B=mRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH60138662AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.4 AU/mL 48.4 B0ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:19BmRNA-1273-P201ISmRNA-1273-P201-US204-1022A1EH44371107 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:02AmRNA-1273-P201ISmRNA-1273-P201-US204-1023A`1EH19206181AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 ug/mL 19.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:07BmRNA-1273-P201ISmRNA-1273-P201-US204-1023Ap1EH46432311AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115 ug/mL 115 Bsug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:31B-mRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH00009276AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.2 ug/mL 47.2 B/333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:40B9mRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH59048976AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:02AmRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH27593764AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 62 AU/mL 62 B>AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:07BmRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH46435510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 379.9 AU/mL 379.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:31B-mRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH00015421AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 350.9 AU/mL 350.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:40B9mRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH36027524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.8 AU/mL 75.8 BKAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH60141604AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.2 AU/mL 47.2 B/333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1023A1EH59048976BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:02AmRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH27593764BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T16:07BmRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH46435510BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:31B-mRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH00015421BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:40B9mRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH36027524BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH60141604AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1023B1EH50660370 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1024A`1EH19204132AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.2 ug/mL 47.2 B/333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1024Ap1EH07346204AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 370.5 ug/mL 370.5 C(ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:00B,mRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH00009404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 395.6 ug/mL 395.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B7mRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH36015233AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T14:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH27593861AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 163.2 AU/mL 163.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH07345183AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1553.6 AU/mL 1553.6 CaAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:00B,mRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH00012317AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1316.7 AU/mL 1316.7 CRK33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B7mRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH36026374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 602.9 AU/mL 602.9 C%fffffAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-24T12:07BrmRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH50410640AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 285 AU/mL 285 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:06BmRNA-1273-P201ISmRNA-1273-P201-US204-1024A1EH36015233BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH27593861BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH07345183BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:00B,mRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH00012317BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:33B7mRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH36026374BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-24T12:07BrmRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH50410640AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:06BmRNA-1273-P201ISmRNA-1273-P201-US204-1024B1EH44370083 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1025A`1EH19205252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1025Ap1EH30508076AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH00011293AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH42211352AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH27593892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH30510223AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH00009406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH50410513AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T16:17BmRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH42211352BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1025A1EH27593892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1025B1EH30510223BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1025B1EH00009406BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1025B1EH50410513AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T16:17BmRNA-1273-P201ISmRNA-1273-P201-US204-1025B1EH33820857 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1026A`1EH19206308AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.4 ug/mL 31.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:43BmRNA-1273-P201ISmRNA-1273-P201-US204-1026Ap1EH00327733AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 261.9 ug/mL 261.9 C^fffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:09B*mRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH00010398AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.4 ug/mL 173.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:56B8mRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH59047984AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH19207204AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140 AU/mL 140 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:43BmRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH00327735AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 877.8 AU/mL 877.8 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:09B*mRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH00011423AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 719.1 AU/mL 719.1 C,񙙙AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:56B8mRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH19215386AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.6 AU/mL 99.6 BcAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:21BmRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH59047984BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1026A1EH19207204BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T13:43BmRNA-1273-P201ISmRNA-1273-P201-US204-1026B1EH00327735BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:09B*mRNA-1273-P201ISmRNA-1273-P201-US204-1026B1EH00011423BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:56B8mRNA-1273-P201ISmRNA-1273-P201-US204-1026B1EH19215386AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:21BmRNA-1273-P201ISmRNA-1273-P201-US204-1026B1EH50662450 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1027A`1EH19203108AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.1 ug/mL 28.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1027Ap1EH07347229AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 430.5 ug/mL 430.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:23B+mRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH00009405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 301.2 ug/mL 301.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:18B9mRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH59048113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T12:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH19209254AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.4 AU/mL 114.4 BrfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH07347262AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1520.9 AU/mL 1520.9 C_ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:23B+mRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH00014366AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1222.8 AU/mL 1222.8 CLlAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:18B9mRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH36025508AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 372.7 AU/mL 372.7 CK33333AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28T11:22BxmRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH50409619AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200.3 AU/mL 200.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:57BmRNA-1273-P201ISmRNA-1273-P201-US204-1027A1EH59048113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T12:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH19209254BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH07347262BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:23B+mRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH00014366BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T14:18B9mRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH36025508BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28T11:22BxmRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH50409619AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:57BmRNA-1273-P201ISmRNA-1273-P201-US204-1027B1EH50662547 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1029A`1EH19205284AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1029Ap1EH07346205AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:21B+mRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH00008350AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH42208314AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH27593860AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH07344190AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:21B+mRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH00014492AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH50409522AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.1 AU/mL 28.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T11:29BmRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH42208314BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1029A1EH27593860BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T10:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1029B1EH07344190BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T10:21B+mRNA-1273-P201ISmRNA-1273-P201-US204-1029B1EH00014492BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:29B9mRNA-1273-P201ISmRNA-1273-P201-US204-1029B1EH50409522AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32 AU/mL 32 B AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T11:29BmRNA-1273-P201ISmRNA-1273-P201-US204-1029B1EH33823928 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1030A`1EH19202055AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.5 ug/mL 27.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1030Ap1EH30509198AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.2 ug/mL 114.2 Br333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH00010430AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 90.8 ug/mL 90.8 BZug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH59051025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T14:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH19209350AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.1 AU/mL 64.1 B@AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH30513293AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 431.7 AU/mL 431.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH00012444AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 355.4 AU/mL 355.4 C6fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH50409651AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 53.3 AU/mL 53.3 B5LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:17BmRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH59051025BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T14:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1030A1EH19209350BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 AU/mL 11.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1030B1EH30513293BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 AU/mL 12.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:41B,mRNA-1273-P201ISmRNA-1273-P201-US204-1030B1EH00012444BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1030B1EH50409651AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.3 AU/mL 10.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:17BmRNA-1273-P201ISmRNA-1273-P201-US204-1030B1EH50662578 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:57AmRNA-1273-P201ISmRNA-1273-P201-US204-1034A`1EH19204261AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1034Ap1EH19204260AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:18B/mRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH05245952AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:25BBmRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH59051152AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T13:57AmRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH19208327AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH19209351AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:18B/mRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH05242883AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:25BBmRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH36027559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28T14:41BxmRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH60143780AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:33BmRNA-1273-P201ISmRNA-1273-P201-US204-1034A1EH59051152BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:57AmRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH19208327BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:14B mRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH19209351BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:18B/mRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH05242883BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:25BBmRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH36027559BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28T14:41BxmRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH60143780AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:33BmRNA-1273-P201ISmRNA-1273-P201-US204-1034B1EH50661555 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1036Ap1EH19202213AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.3 ug/mL 30.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH07439539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 220.2 ug/mL 220.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH00011421AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.5 ug/mL 152.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:14B9mRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH36024453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.6 ug/mL 149.6 Bug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-10T17:08BFmRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH59049105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH19209222AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 102.5 AU/mL 102.5 BfAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH05249178AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 695.4 AU/mL 695.4 C+vfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH00013373AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 442.5 AU/mL 442.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:14B9mRNA-1273-P201ISmRNA-1273-P201-US204-1036A1EH36027526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 378.9 AU/mL 378.9 CfffffAU/mL PPD VACCINESERUMELISA AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-10T17:08BFmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH50409617AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.9 AU/mL 69.9 BEffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH59049105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH19209222BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH05249178BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH00013373BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:14B9mRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH36027526BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-10T17:08BFmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH50409617AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1036B1EH50660498 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1041A`1EH19204134AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.7 ug/mL 22.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:21B$mRNA-1273-P201ISmRNA-1273-P201-US204-1041Ap1EH19203238AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.4 ug/mL 197.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:50B/mRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH44120231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 169.1 ug/mL 169.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:00B@mRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH42209433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH19206278AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.9 AU/mL 134.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:21B$mRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH19209221AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1314.9 AU/mL 1314.9 CR.ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:50B/mRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH35758086AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 760.5 AU/mL 760.5 C/AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:00B@mRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH60138534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.4 AU/mL 134.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T16:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH42209433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:37AmRNA-1273-P201ISmRNA-1273-P201-US204-1041A1EH19206278BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:21B$mRNA-1273-P201ISmRNA-1273-P201-US204-1041B1EH19209221BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:50B/mRNA-1273-P201ISmRNA-1273-P201-US204-1041B1EH35758086BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:00B@mRNA-1273-P201ISmRNA-1273-P201-US204-1041B1EH60138534AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T16:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1041B1EH33821721 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1042A`1EH19206276AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:36B$mRNA-1273-P201ISmRNA-1273-P201-US204-1042Ap1EH19204231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 ug/mL 8.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:52B/mRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH44121221AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH42212505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T16:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH19207207AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:36B$mRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH27591716AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:52B/mRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH35759268AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH60144677AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T16:46BmRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH42212505BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T16:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1042A1EH19207207BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:36B$mRNA-1273-P201ISmRNA-1273-P201-US204-1042B1EH27591716BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T14:52B/mRNA-1273-P201ISmRNA-1273-P201-US204-1042B1EH35759268BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1042B1EH60144677AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T16:46BmRNA-1273-P201ISmRNA-1273-P201-US204-1042B1EH33823800 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1043A01EH36012162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T16:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1043A@1EH36012162BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1043AP1EH44371106 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1046AP1EH36012033AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1046A`1EH19204262AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.1 ug/mL 16.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:14BmRNA-1273-P201ISmRNA-1273-P201-US204-1046Ap1EH07344157AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.7 ug/mL 144.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B)mRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH52738082AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45 ug/mL 45 B-ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:52B>mRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH36013185AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH19207300AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.5 AU/mL 61.5 B=AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:14BmRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH07344286AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 523.7 AU/mL 523.7 C 33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B)mRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH52737186AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 392.7 AU/mL 392.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:52B>mRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH60141733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 63.7 AU/mL 63.7 B?33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T10:08BmRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH36013185BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1046A1EH19207300BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:14BmRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH07344286BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B)mRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH52737186BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:52B>mRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH60141733AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T10:08BmRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH44368003 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH51754023 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies905.097 MN50 20 2560 905.097 C8O;dMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T10:08BmRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH44368003 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1046B1EH51754023 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies640 MN Endpoint Titer20 2560 640 C(MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T10:08BmRNA-1273-P201ISmRNA-1273-P201-US204-1047A ISALL All Immunogenicity Assessments Serum SARS-CoV-2 Binding Antibodies . NOT DONE .AVisit 8 Day 209 B .mRNA-1273-P201ISmRNA-1273-P201-US204-1047A 1EH42206361AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27 AU/mL 27 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1047A01EH19202086AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24 AU/mL 24 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1047A@1EH30507150AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.7 AU/mL 21.7 B33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:17B,mRNA-1273-P201ISmRNA-1273-P201-US204-1047AP1EH44121094AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.4 AU/mL 22.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1047A`1EH36021415AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.7 AU/mL 30.7 B33333AU/mL PPD VACCINESERUMELISA AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13T10:00BImRNA-1273-P201ISmRNA-1273-P201-US204-1047Ap1EH42206361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH19202086AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.1 ug/mL 19.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH30507150AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123.4 ug/mL 123.4 B{fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:17B,mRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH44121094AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.4 ug/mL 98.4 Bbfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH36021415AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105.1 ug/mL 105.1 Biug/mL PPD VACCINESERUMELISA A>ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13T10:00BImRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH42206267AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH19207206AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.4 AU/mL 85.4 BUfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH30510126AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 488.6 AU/mL 488.6 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:17B,mRNA-1273-P201ISmRNA-1273-P201-US204-1047A1EH35760166AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 446.3 AU/mL 446.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH36025478AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 294.9 AU/mL 294.9 CnfffffAU/mL PPD VACCINESERUMELISA AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13T10:00BImRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH42206267BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH19207206BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH30510126BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:17B,mRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH35760166BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH36025478BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13T10:00BImRNA-1273-P201ISmRNA-1273-P201-US204-1047B1EH33821720 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1048A`1EH19205286AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45 ug/mL 45 B-ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:13BmRNA-1273-P201ISmRNA-1273-P201-US204-1048Ap1EH19202183AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 334.5 ug/mL 334.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:16B.mRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH44119204AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 265.5 ug/mL 265.5 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:36B?mRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH59050002AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH19206311AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 281.8 AU/mL 281.8 CAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:13BmRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH19209381AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1826.9 AU/mL 1826.9 Cr.ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:16B.mRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH35758116AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1155.5 AU/mL 1155.5 CH8AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:36B?mRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH50410673AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.4 AU/mL 201.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH59050002BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:10AmRNA-1273-P201ISmRNA-1273-P201-US204-1048A1EH19206311BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T15:13BmRNA-1273-P201ISmRNA-1273-P201-US204-1048B1EH19209381BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:16B.mRNA-1273-P201ISmRNA-1273-P201-US204-1048B1EH35758116BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T16:36B?mRNA-1273-P201ISmRNA-1273-P201-US204-1048B1EH50410673AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1048B1EH50659346 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1049A`1EH19202215AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.4 ug/mL 18.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:40B)mRNA-1273-P201ISmRNA-1273-P201-US204-1049Ap1EH50409618AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.3 ug/mL 150.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH00307380AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118.8 ug/mL 118.8 Bvug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T11:27BEmRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH36013217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH19209383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.7 AU/mL 67.7 BC33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:40B)mRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH58794128AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 548.1 AU/mL 548.1 C"AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH00309302AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 410.2 AU/mL 410.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T11:27BEmRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH36013217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH19209383BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:40B)mRNA-1273-P201ISmRNA-1273-P201-US204-1049A1EH58794128BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1049B1EH00309302BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T11:27BEmRNA-1273-P201ISmRNA-1273-P201-US204-1049B1EH44374016 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1051A`1EH19205157AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99 ug/mL 99 Bcug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1051Ap1EH63280148AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH00009372AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 408.1 ug/mL 408.1 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:38B8mRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH59050130AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH27590692AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 338.7 AU/mL 338.7 C+33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH63279287AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1995.4 AU/mL 1995.4 C|ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH00011327AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1387.1 AU/mL 1387.1 CVAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:38B8mRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH50408626AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 594.8 AU/mL 594.8 C%,AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T16:28BmRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH59050130BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1051A1EH27590692BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T11:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1051B1EH63279287BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:19AmRNA-1273-P201ISmRNA-1273-P201-US204-1053A`1EH19208196AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16 ug/mL 16 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:28B$mRNA-1273-P201ISmRNA-1273-P201-US204-1053Ap1EH19205285AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.3 ug/mL 104.3 BhLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:34B4mRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH52736131AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.1 ug/mL 72.1 BHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:49BFmRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH59051185AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T12:19AmRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH19207332AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 AU/mL 34.2 B"333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:28B$mRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH19209253AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259.3 AU/mL 259.3 C4AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:34B4mRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH52739074AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.8 AU/mL 190.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:49BFmRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH60140583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.9 AU/mL 56.9 B8fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1053A1EH59051185BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:34B4mRNA-1273-P201ISmRNA-1273-P201-US204-1053B1EH52739074BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T08:49BFmRNA-1273-P201ISmRNA-1273-P201-US204-1053B1EH60140583AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1053B1EH50663440 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:19AmRNA-1273-P201ISmRNA-1273-P201-US204-1055A@1EH36012065AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:19AmRNA-1273-P201ISmRNA-1273-P201-US204-1055AP1EH36012065BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:19AmRNA-1273-P201ISmRNA-1273-P201-US204-1055A`1EH44368930 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1056Ap1EH19204133AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13 ug/mL 13 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH07439507AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.2 ug/mL 13.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:11B+mRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH00008254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.8 ug/mL 12.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:46B;mRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH59048083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH19208326AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH05249082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:11B+mRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH00013372AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:46B;mRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH59048083CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1056A1EH19208326BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1056B1EH05249082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T10:11B+mRNA-1273-P201ISmRNA-1273-P201-US204-1056B1EH00013372BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T09:46B;mRNA-1273-P201ISmRNA-1273-P201-US204-1056B1EH50662451 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:32AmRNA-1273-P201ISmRNA-1273-P201-US204-1058A@1EH59051057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:32AmRNA-1273-P201ISmRNA-1273-P201-US204-1058AP1EH59051057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:32AmRNA-1273-P201ISmRNA-1273-P201-US204-1058A`1EH50659378 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1059A01EH59051056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1059A@1EH59051056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1059AP1EH50660499 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1060A`1EH19203111AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 ug/mL 9.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1060Ap1EH07347357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.9 ug/mL 186.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH52736162AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.7 ug/mL 104.7 Bh33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T08:39BNmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH59051184AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH27591813AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH07345182AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 522.6 AU/mL 522.6 C AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH61120513AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 492.5 AU/mL 492.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T08:39BNmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH50409521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.6 AU/mL 179.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:39BmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH59051184BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1060A1EH27591813BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1060B1EH07345182BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US204-1060B1EH61120513BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T08:39BNmRNA-1273-P201ISmRNA-1273-P201-US204-1060B1EH50409521AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:39BmRNA-1273-P201ISmRNA-1273-P201-US204-1060B1EH50662579 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1061Ap1EH19209220AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:32B#mRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH19208325AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176 ug/mL 176 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T15:40B3mRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH61090953AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101.6 ug/mL 101.6 Beug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T17:23BImRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH19205124AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffff. .BLINDED TREATMENT 2020-06-16T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH59049009AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH19207205AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.2 AU/mL 36.2 B$333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:32B#mRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH19207302AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 644.6 AU/mL 644.6 C(IAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T15:40B3mRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH61090826AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 429.8 AU/mL 429.8 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T17:23BImRNA-1273-P201ISmRNA-1273-P201-US204-1061A1EH60143653AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.4 AU/mL 32.4 B ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T16:56BmRNA-1273-P201ISmRNA-1273-P201-US204-1061B1EH27591812AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA A. .BLINDED TREATMENT 2020-06-16T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1061B1EH59049009BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1061B1EH19207205BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:32B#mRNA-1273-P201ISmRNA-1273-P201-US204-1061B1EH19207302BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1062A`1EH19203079AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.5 ug/mL 11.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1062Ap1EH07439378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11 ug/mL 11 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:27B+mRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH00010303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 ug/mL 11.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH59047986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH27590821AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH05248154AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:27B+mRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH00009247AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH50409488AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T09:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH59047986BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1062A1EH27590821BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T10:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1062B1EH05248154BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:27B+mRNA-1273-P201ISmRNA-1273-P201-US204-1062B1EH00009247BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1062B1EH50409488AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T09:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1062B1EH50661427 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1064AP1EH19204102AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:31B%mRNA-1273-P201ISmRNA-1273-P201-US204-1064A`1EH36012066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T16:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1064Ap1EH27590693AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.4 AU/mL 20.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:31B%mRNA-1273-P201ISmRNA-1273-P201-US204-1064A1EH36012066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T16:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1064A1EH27590693BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T15:31B%mRNA-1273-P201ISmRNA-1273-P201-US204-1064A1EH44369059 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T17:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1071A`1EH19205287AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.7 ug/mL 14.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:06B#mRNA-1273-P201ISmRNA-1273-P201-US204-1071Ap1EH19204263AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.2 ug/mL 97.2 Ba333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH52739201AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.4 ug/mL 47.4 B/ffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T10:34BCmRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH36012192AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T17:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH19208231AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.2 AU/mL 42.2 B*333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:06B#mRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH19206279AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 373.7 AU/mL 373.7 C[33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH52739203AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.4 AU/mL 202.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T10:34BCmRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH60143781AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.2 AU/mL 42.2 B*333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T11:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH36012192BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T17:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1071A1EH19208231BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:06B#mRNA-1273-P201ISmRNA-1273-P201-US204-1071B1EH19206279BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1071B1EH52739203BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T10:34BCmRNA-1273-P201ISmRNA-1273-P201-US204-1071B1EH60143781AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T11:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1071B1EH44368035 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1073A`1EH19202212AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26 ug/mL 26 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1073Ap1EH07346333AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 169.6 ug/mL 169.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:22B+mRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH00010269AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.3 ug/mL 99.3 BcLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T16:48B8mRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH59050161AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH19209255AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 90.8 AU/mL 90.8 BZAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH07346334AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 538.4 AU/mL 538.4 C!fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:22B+mRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH00015517AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 324 AU/mL 324 C@AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T16:48B8mRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH50409649AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.5 AU/mL 19.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T07:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH59050161BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1073A1EH19209255BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T16:03BmRNA-1273-P201ISmRNA-1273-P201-US204-1073B1EH07346334BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:22B+mRNA-1273-P201ISmRNA-1273-P201-US204-1073B1EH00015517CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T16:48B8mRNA-1273-P201ISmRNA-1273-P201-US204-1073B1EH50409649AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T07:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1073B1EH50661394 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1075A`1EH19207172AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.1 ug/mL 16.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:49BmRNA-1273-P201ISmRNA-1273-P201-US204-1075Ap1EH19202087AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 172.8 ug/mL 172.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH08434871AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.8 ug/mL 143.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:50B9mRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH59051024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH27590661AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.5 AU/mL 45.5 B-AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:49BmRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH19208198AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 622.5 AU/mL 622.5 C&AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH00012476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 443.5 AU/mL 443.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:50B9mRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH50410672AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 92.5 AU/mL 92.5 B\AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:26BmRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH59051024BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1075A1EH27590661BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:49BmRNA-1273-P201ISmRNA-1273-P201-US204-1075B1EH19208198BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:35B2mRNA-1273-P201ISmRNA-1273-P201-US204-1075B1EH00012476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:50B9mRNA-1273-P201ISmRNA-1273-P201-US204-1075B1EH50410672AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T10:26BmRNA-1273-P201ISmRNA-1273-P201-US204-1075B1EH50659474 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:29AmRNA-1273-P201ISmRNA-1273-P201-US204-1076A`1EH19203207AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.2 ug/mL 33.2 B!333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:43B#mRNA-1273-P201ISmRNA-1273-P201-US204-1076Ap1EH40179727AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 209.9 ug/mL 209.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:47B2mRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH05245953AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.7 ug/mL 162.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:34BAmRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH59050033AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:29AmRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH27591684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.5 AU/mL 71.5 BGAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:43B#mRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH48562189AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 511.4 AU/mL 511.4 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:47B2mRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH05246114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 467.1 AU/mL 467.1 C1AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:34BAmRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH60140582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95.3 AU/mL 95.3 B_LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH59050033BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:29AmRNA-1273-P201ISmRNA-1273-P201-US204-1076A1EH27591684BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:43B#mRNA-1273-P201ISmRNA-1273-P201-US204-1076B1EH48562189BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:47B2mRNA-1273-P201ISmRNA-1273-P201-US204-1076B1EH05246114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:34BAmRNA-1273-P201ISmRNA-1273-P201-US204-1076B1EH60140582AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1076B1EH50661554 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1077A`1EH19208197AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.9 ug/mL 31.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1077Ap1EH30508204AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.9 ug/mL 204.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:25B*mRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH00010300AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 178.8 ug/mL 178.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH36014114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH19206150AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127.6 AU/mL 127.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH30510255AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 931.6 AU/mL 931.6 C:9AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:25B*mRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH00013341AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 696.7 AU/mL 696.7 C+33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH36014114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH19206150BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1077A1EH30510255BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:25B*mRNA-1273-P201ISmRNA-1273-P201-US204-1077B1EH00013341BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:38B7mRNA-1273-P201ISmRNA-1273-P201-US204-1077B1EH44370082 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1078A`1EH19203078AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1078Ap1EH30509071AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:35B*mRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH00010429AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH36013057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH19209349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH30510222AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:35B*mRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH00014493AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH27602073AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T11:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH36013057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1078A1EH19209349BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1078B1EH30510222BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T13:35B*mRNA-1273-P201ISmRNA-1273-P201-US204-1078B1EH00014493BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T15:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1078B1EH27602073AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T11:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1078B1EH44370979 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1079A`1EH19206277AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.3 ug/mL 31.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:01B#mRNA-1273-P201ISmRNA-1273-P201-US204-1079Ap1EH50412560AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 198.3 ug/mL 198.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:23B4mRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH52738050AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154 ug/mL 154 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:34BBmRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH36015137AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T16:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH19207333AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.1 AU/mL 132.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:01B#mRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH58795025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 785.3 AU/mL 785.3 C1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:23B4mRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH52739107AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 598.3 AU/mL 598.3 C%dAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:34BBmRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH60138535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 136.2 AU/mL 136.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:44BmRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH36015137BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1079A1EH19207333BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1080A`1EH19208228AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.4 ug/mL 27.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1080Ap1EH07347261AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176.9 ug/mL 176.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B*mRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH00009277AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.3 ug/mL 145.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:38B8mRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH36012067AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T17:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH27592869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.3 AU/mL 117.3 BuLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH07345341AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 662.6 AU/mL 662.6 C)iAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B*mRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH00013500AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 548.9 AU/mL 548.9 C"NfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:38B8mRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH50411667AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.1 AU/mL 33.1 B!AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T15:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH36012067BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1080A1EH27592869BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T16:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1080B1EH07345341BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T16:00B*mRNA-1273-P201ISmRNA-1273-P201-US204-1080B1EH00013500BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T17:38B8mRNA-1273-P201ISmRNA-1273-P201-US204-1080B1EH50411667AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T15:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1080B1EH44370978 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1084A`1EH19204103AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.8 ug/mL 23.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:26BmRNA-1273-P201ISmRNA-1273-P201-US204-1084Ap1EH07345181AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 222.6 ug/mL 222.6 Bޙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH52736002AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.8 ug/mL 173.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:20B?mRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH36012193AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH27590660AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.4 AU/mL 117.4 BufffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:26BmRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH07347231AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 865.8 AU/mL 865.8 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH52737155AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 907.8 AU/mL 907.8 C8AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:20B?mRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH60142628AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 122.3 AU/mL 122.3 BzLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:16BmRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH36012193BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1084A1EH27590660BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T12:26BmRNA-1273-P201ISmRNA-1273-P201-US204-1084B1EH07347231BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T13:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1084B1EH52737155BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:20B?mRNA-1273-P201ISmRNA-1273-P201-US204-1084B1EH60142628AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:16BmRNA-1273-P201ISmRNA-1273-P201-US204-1084B1EH44374017 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1086A`1EH19205255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1086Ap1EH40177806AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH52738083AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH36014115AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T09:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH27593733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH48564364AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH52739234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH36014115BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:42AmRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH27593733BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1086A1EH48564364BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:30B,mRNA-1273-P201ISmRNA-1273-P201-US204-1086B1EH52739234CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US204-1086B1EH44369027 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:48AmRNA-1273-P201ISmRNA-1273-P201-US204-1088Ap1EH19208229AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.1 ug/mL 29.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:24B!mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH50411537AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.8 ug/mL 252.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:44B2mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH52737184AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.6 ug/mL 192.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH36022311AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.4 ug/mL 124.4 B|fffffhug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T17:58BcmRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH36015265AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:48AmRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH27592741AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.6 AU/mL 139.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:24B!mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH58795056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 997.3 AU/mL 997.3 C>TAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:44B2mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH61120512AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 659 AU/mL 659 C)0AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1088A1EH36024358AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 549.3 AU/mL 549.3 C"TAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T17:58BcmRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH36027396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 422.2 AU/mL 422.2 Cc33333AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-29T10:34BrmRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH36015265BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.6 AU/mL 8.6 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:48AmRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH27592741BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:24B!mRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH58795056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:44B2mRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH61120512BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH36024358BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14T17:58BcmRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH36027396BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-29T10:34BrmRNA-1273-P201ISmRNA-1273-P201-US204-1088B1EH44371075 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1089A`1EH19202214AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 ug/mL 9.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:39B!mRNA-1273-P201ISmRNA-1273-P201-US204-1089Ap1EH50411698AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T13:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH52738178AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 ug/mL 8.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:16B=mRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH36014082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T09:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH19207175AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:39B!mRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH50412563AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T13:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH52737059AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:16B=mRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH60141605AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T13:29BmRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH36014082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1089A1EH19207175BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:39B!mRNA-1273-P201ISmRNA-1273-P201-US204-1089B1EH50412563BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T13:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1089B1EH52737059BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:16B=mRNA-1273-P201ISmRNA-1273-P201-US204-1089B1EH60141605AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:24AmRNA-1273-P201ISmRNA-1273-P201-US204-1090A`1EH19203239AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 ug/mL 3.9 A>ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:40B!mRNA-1273-P201ISmRNA-1273-P201-US204-1090Ap1EH50412561AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:52B2mRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH52738210AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH36014210AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:24AmRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH19209223AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:40B!mRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH58796208AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:52B2mRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH61122560AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH36026535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25T15:08BnmRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH60142597AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:44BmRNA-1273-P201ISmRNA-1273-P201-US204-1090A1EH36014210BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:24AmRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH19209223CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:40B!mRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH58796208BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:52B2mRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH61122560BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:05B@mRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH36026535BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25T15:08BnmRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH60142597AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:44BmRNA-1273-P201ISmRNA-1273-P201-US204-1090B1EH44369923 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1091AP1EH44374050AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 ug/mL 10.5 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-10T11:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1091A`1EH19208324AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.4 ug/mL 46.4 B.ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1091Ap1EH50409648AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.9 ug/mL 162.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:48B0mRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH52736035AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128 ug/mL 128 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:22B>mRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH36014241AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-10T11:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH27592836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.8 AU/mL 179.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH58797105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 515.5 AU/mL 515.5 C 8AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T14:48B0mRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH61120640AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 469.6 AU/mL 469.6 CYAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:22B>mRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH36024326AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 199.7 AU/mL 199.7 Bdz33330AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25T14:59BlmRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH60144805AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.3 AU/mL 130.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:59BmRNA-1273-P201ISmRNA-1273-P201-US204-1091A1EH36014241CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-10T11:16AmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH27592836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH58797105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH36024326BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25T14:59BlmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH60144805AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:59BmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH44368898 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH51752967 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies339.411 MN50 20 2560 339.411 C6tjMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:59BmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH44368898 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1091B1EH51752967 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies240 MN Endpoint Titer20 2560 240 BMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:59BmRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH44373026AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130.6 AU/mL 130.6 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092A 1EH19203076AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72 AU/mL 72 BHAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092A01EH50412721AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.2 AU/mL 56.2 B8333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092A@1EH52737056AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.1 AU/mL 44.1 B,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092AP1EH44373026AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.7 ug/mL 108.7 Bl33334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092A`1EH19203076AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 414.3 ug/mL 414.3 Cug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092Ap1EH50412721AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 416.8 ug/mL 416.8 C ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH52737056AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 382 ug/mL 382 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH36012163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 161.8 AU/mL 161.8 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH19209380AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1038.8 AU/mL 1038.8 C@AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH50410546AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1440.1 AU/mL 1440.1 CZAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH52737027AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1337.9 AU/mL 1337.9 CSffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH60138631AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.7 AU/mL 204.7 B̳33330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH36012163CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.9 AU/mL 30.9 BfffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092A1EH19209380BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30 AU/mL 30 BAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH50410546BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25 AU/mL 25 BAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH52737027BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.5 AU/mL 23.5 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH60138631AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH44371969 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies2715.29 MN50 40 5120 2715.29 C =pMN50 BATTELLE SERUM B[A Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH27559949 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies7240.773 MN50 80 10240 7240.773 DHSMN50 BATTELLE SERUM B[APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH58766523 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies36203.867MN50 160 81920 36203.867DkEMN50 BATTELLE SERUM B[ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH52732066 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies21722.32 MN50 160 81920 21722.32 DTQMN50 BATTELLE SERUM B[AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH51753988 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies2262.742 MN50 20 20480 2262.742 Ck;dZ MN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH44371969 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies1920 MN Endpoint Titer40 5120 1920 CxMN Endpoint Titer BATTELLE SERUM B(A Visit 1 Day 1 ASCREENING 2020-06-08T15:39AmRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH27559949 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies5120 MN Endpoint Titer80 10240 5120 DMN Endpoint Titer BATTELLE SERUM B(APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14T12:13B%mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH58766523 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies25600 MN Endpoint Titer160 81920 25600 DdMN Endpoint Titer BATTELLE SERUM B(ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T09:17B2mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH52732066 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies15360 MN Endpoint Titer160 81920 15360 D<MN Endpoint Titer BATTELLE SERUM B(AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:50B@mRNA-1273-P201ISmRNA-1273-P201-US204-1092B1EH51753988 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies960 MN Endpoint Titer20 20480 960 C<MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH36012032AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1094A 1EH00008222AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1094A01EH27601976AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:45B/mRNA-1273-P201ISmRNA-1273-P201-US204-1094A@1EH52738051AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:36B8mRNA-1273-P201ISmRNA-1273-P201-US204-1094AP1EH36012032AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1094A`1EH00008222AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.1 ug/mL 24.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1094Ap1EH27601976AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.8 ug/mL 142.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:45B/mRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH52738051AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123.5 ug/mL 123.5 B{ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:36B8mRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH36013088AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH00011455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.2 AU/mL 131.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH27603097AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 605.2 AU/mL 605.2 C%33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:45B/mRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH52739202AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 487.8 AU/mL 487.8 C|AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:36B8mRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH60144645AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103 AU/mL 103 BgAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T13:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH36013088BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1094A1EH00011455BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1094B1EH27603097BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:45B/mRNA-1273-P201ISmRNA-1273-P201-US204-1094B1EH52739202BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:36B8mRNA-1273-P201ISmRNA-1273-P201-US204-1094B1EH60144645AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T13:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1094B1EH44367906 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1096A`1EH00008382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.6 ug/mL 16.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T07:45BmRNA-1273-P201ISmRNA-1273-P201-US204-1096Ap1EH61091889AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259.4 ug/mL 259.4 C6fffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T07:13B.mRNA-1273-P201ISmRNA-1273-P201-US204-1096A1EH08693948AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 288.2 ug/mL 288.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T07:16B9mRNA-1273-P201ISmRNA-1273-P201-US204-1096A1EH48562316AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T07:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1096A1EH00012349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.9 AU/mL 60.9 BffffffA Visit 1 Day 1 ASCREENING 2020-06-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1100A`1EH00010399AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.4 ug/mL 25.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T07:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1100Ap1EH50408627AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 342.7 ug/mL 342.7 Ck33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T07:09B,mRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH13664385AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 360 ug/mL 360 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:11B:mRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH40180911AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH00009279AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.7 AU/mL 137.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T07:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH58794002AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1095.5 AU/mL 1095.5 CDxAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T07:09B,mRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH13665441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 924.8 AU/mL 924.8 C9AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:11B:mRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH60141575AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.9 AU/mL 156.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH40180911BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T07:47AmRNA-1273-P201ISmRNA-1273-P201-US204-1100A1EH00009279BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T07:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1100B1EH58794002BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T07:09B,mRNA-1273-P201ISmRNA-1273-P201-US204-1100B1EH13665441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:11B:mRNA-1273-P201ISmRNA-1273-P201-US204-1100B1EH60141575AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1100B1EH40176684 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1102A`1EH19203109AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1102Ap1EH50409616AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:44B+mRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH00307221AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:33B6mRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH36015232AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH19209382AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH58797073AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:44B+mRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH00310294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:33B6mRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH60140551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T11:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH36015232BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1102A1EH19209382BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T12:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1102B1EH58797073BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:44B+mRNA-1273-P201ISmRNA-1273-P201-US204-1102B1EH00310294BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:33B6mRNA-1273-P201ISmRNA-1273-P201-US204-1102B1EH60140551AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T11:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1102B1EH44369954 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1103A`1EH19208356AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1103Ap1EH50411569AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.4 ug/mL 64.4 B@fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:20B(mRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH52737057AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 ug/mL 31.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH36012034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH27593732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH58796177AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 250.4 AU/mL 250.4 BfffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:20B(mRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH52737187AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.1 AU/mL 144.1 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH60144676AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.5 AU/mL 26.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH36012034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:59AmRNA-1273-P201ISmRNA-1273-P201-US204-1103A1EH27593732BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1103B1EH58796177BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:20B(mRNA-1273-P201ISmRNA-1273-P201-US204-1103B1EH52737187BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1103B1EH60144676AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 Affffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1104A`1EH19205253AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.7 ug/mL 15.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1104Ap1EH50409489AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.7 ug/mL 137.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:11B(mRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH52738179AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110.4 ug/mL 110.4 Bnfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:43B6mRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH36014113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH27590788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71 AU/mL 71 BGAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH58796176AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 799.5 AU/mL 799.5 C1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:11B(mRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH61122561AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 515.6 AU/mL 515.6 C 9AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:43B6mRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH60144644AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.8 AU/mL 47.8 B/AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:15BmRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH36014113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:11AmRNA-1273-P201ISmRNA-1273-P201-US204-1104A1EH27590788BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:53BmRNA-1273-P201ISmRNA-1273-P201-US204-1104B1EH58796176BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04T09:11B(mRNA-1273-P201ISmRNA-1273-P201-US204-1104B1EH61122561BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:43B6mRNA-1273-P201ISmRNA-1273-P201-US204-1104B1EH60144644AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:15BmRNA-1273-P201ISmRNA-1273-P201-US204-1104B1EH44368899 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:14.mRNA-1273-P201ISmRNA-1273-P201-US204-1105A01EH40177710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3 AU/mL 3 A0AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T14:14.mRNA-1273-P201ISmRNA-1273-P201-US204-1105A@1EH40177710BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:14.mRNA-1273-P201ISmRNA-1273-P201-US204-1106A ISALL All Immunogenicity Assessments Serum SARS-CoV-2 Binding Antibodies . NOT DONE .AVisit 8 Day 209 B .mRNA-1273-P201ISmRNA-1273-P201-US204-1106A 1EH33852461AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1106A01EH00010271AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:58B!mRNA-1273-P201ISmRNA-1273-P201-US204-1106A@1EH50411571AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:15B/mRNA-1273-P201ISmRNA-1273-P201-US204-1106AP1EH61089801AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:49B=mRNA-1273-P201ISmRNA-1273-P201-US204-1106A`1EH33852461AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 ug/mL 9 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1106Ap1EH00010271AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.6 ug/mL 13.6 Aٙug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:58B!mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH50411571AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 127.7 ug/mL 127.7 B33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:15B/mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH61089801AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.1 ug/mL 43.1 B+ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:49B=mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH33851407AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH00009278AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.6 AU/mL 29.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:58B!mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH50410514AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 417 AU/mL 417 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:15B/mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH61087915AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 323.3 AU/mL 323.3 C4AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:49B=mRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH33851407BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:03AmRNA-1273-P201ISmRNA-1273-P201-US204-1106A1EH00009278BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:58B!mRNA-1273-P201ISmRNA-1273-P201-US204-1106B1EH50410514BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:15B/mRNA-1273-P201ISmRNA-1273-P201-US204-1106B1EH61087915BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T10:49B=mRNA-1273-P201ISmRNA-1273-P201-US204-1106B1EH33852556 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T16:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1107A`1EH00008221AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.7 ug/mL 11.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:39B mRNA-1273-P201ISmRNA-1273-P201-US204-1107Ap1EH50412720AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.2 ug/mL 193.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH08691871AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 126.1 ug/mL 126.1 B~ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH33849359AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T16:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH00011326AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.7 AU/mL 36.7 B$33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:39B mRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH50412691AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 664.2 AU/mL 664.2 C)33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH08697917AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 517.1 AU/mL 517.1 C QAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH60141732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.6 AU/mL 98.6 BbAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH33849359BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T16:22AmRNA-1273-P201ISmRNA-1273-P201-US204-1107A1EH00011326CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:39B mRNA-1273-P201ISmRNA-1273-P201-US204-1107B1EH50412691BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B.mRNA-1273-P201ISmRNA-1273-P201-US204-1107B1EH08697917BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:52B<mRNA-1273-P201ISmRNA-1273-P201-US204-1107B1EH60141732AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1107B1EH33850381 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:08AmRNA-1273-P201ISmRNA-1273-P201-US204-1108A`1EH00008253AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.5 ug/mL 21.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1108Ap1EH50411666AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 387.8 ug/mL 387.8 CffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:19B.mRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH08693950AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 278.6 ug/mL 278.6 Ciug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:17B<mRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH36013216AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:08AmRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH00013469AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.8 AU/mL 56.8 B8AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH58795057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1467.3 AU/mL 1467.3 C[AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:19B.mRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH08694846AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1792.1 AU/mL 1792.1 CpAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:17B<mRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH60141701AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.8 AU/mL 204.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH36013216BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:08AmRNA-1273-P201ISmRNA-1273-P201-US204-1108A1EH00013469CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:38B mRNA-1273-P201ISmRNA-1273-P201-US204-1108B1EH58795057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:19B.mRNA-1273-P201ISmRNA-1273-P201-US204-1108B1EH08694846BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:17B<mRNA-1273-P201ISmRNA-1273-P201-US204-1108B1EH60141701AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1108B1EH44368034 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1109A`1EH00008351AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.7 ug/mL 11.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:19B mRNA-1273-P201ISmRNA-1273-P201-US204-1109Ap1EH50411539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.6 ug/mL 183.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:56B.mRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH08694940AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.5 ug/mL 149.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:26B9mRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH36014240AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH00014364AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.5 AU/mL 24.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:19B mRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH50412690AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 741.8 AU/mL 741.8 C.\AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:56B.mRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH00310454AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 726.9 AU/mL 726.9 C-nfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:26B9mRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH27599928AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 93.1 AU/mL 93.1 B]AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH36014240BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:33AmRNA-1273-P201ISmRNA-1273-P201-US204-1109A1EH00014364BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:19B mRNA-1273-P201ISmRNA-1273-P201-US204-1109B1EH50412690BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:56B.mRNA-1273-P201ISmRNA-1273-P201-US204-1109B1EH08694847CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:26B9mRNA-1273-P201ISmRNA-1273-P201-US204-1109B1EH27599928AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1109B1EH44368002 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1111A`1EH00008252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1111Ap1EH19215387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.2 ug/mL 61.2 B=333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:49B-mRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH00308404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 59.8 ug/mL 59.8 B;ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:11B<mRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH40177839AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH00014524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.5 AU/mL 16.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH27599002AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 289 AU/mL 289 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:49B-mRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH00310326AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 199.9 AU/mL 199.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:11B<mRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH60143620AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.7 AU/mL 72.7 BH33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:43BmRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH40177839BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1111A1EH00014524BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1111B1EH27599002BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:49B-mRNA-1273-P201ISmRNA-1273-P201-US204-1111B1EH00310326BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:11B<mRNA-1273-P201ISmRNA-1273-P201-US204-1111B1EH60143620AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:43BmRNA-1273-P201ISmRNA-1273-P201-US204-1111B1EH40175630 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1112A`1EH00010301AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.9 ug/mL 38.9 B&fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:25B!mRNA-1273-P201ISmRNA-1273-P201-US204-1112Ap1EH19217562AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 273.6 ug/mL 273.6 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:36B6mRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH36021254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 317 ug/mL 317 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:30BDmRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH36012035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH00011422AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.1 AU/mL 142.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:25B!mRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH27602969AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1407.9 AU/mL 1407.9 CWffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:36B6mRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH36025479AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1111.5 AU/mL 1111.5 CExAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:30BDmRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH19215547AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.3 AU/mL 159.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH36012035BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:34AmRNA-1273-P201ISmRNA-1273-P201-US204-1112A1EH00011422BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:25B!mRNA-1273-P201ISmRNA-1273-P201-US204-1112B1EH27602969BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:36B6mRNA-1273-P201ISmRNA-1273-P201-US204-1112B1EH36025479BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:30BDmRNA-1273-P201ISmRNA-1273-P201-US204-1112B1EH19215547AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1112B1EH44369955 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodiesffffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1113A`1EH00008220AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 ug/mL 19.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1113Ap1EH61094931AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.3 ug/mL 202.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:34B-mRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH61090952AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.6 ug/mL 168.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:45B9mRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH40180782AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T10:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH00011454AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.3 AU/mL 82.3 BRLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH52732945AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 788 AU/mL 788 C1@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:34B-mRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH61089931AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 606.8 AU/mL 606.8 C%AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:45B9mRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH60144772AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 262 AU/mL 262 C`AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T17:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH40180782BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1113A1EH00011454BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1113B1EH52732945BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:34B-mRNA-1273-P201ISmRNA-1273-P201-US204-1113B1EH61089931BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:45B9mRNA-1273-P201ISmRNA-1273-P201-US204-1113B1EH60144772AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T17:42BmRNA-1273-P201ISmRNA-1273-P201-US204-1113B1EH40173614 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1114A`1EH44118181AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:28B'mRNA-1273-P201ISmRNA-1273-P201-US204-1114Ap1EH27602072AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T07:21B6mRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH00306199AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 ug/mL 8.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T07:27BDmRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH33851406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH35760133AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:28B'mRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH27600058AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T07:21B6mRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH08693813AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T07:27BDmRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH19217467AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH33851406BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:15AmRNA-1273-P201ISmRNA-1273-P201-US204-1114A1EH35760133BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:28B'mRNA-1273-P201ISmRNA-1273-P201-US204-1114B1EH27600058BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T07:21B6mRNA-1273-P201ISmRNA-1273-P201-US204-1114B1EH08693813BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T07:27BDmRNA-1273-P201ISmRNA-1273-P201-US204-1114B1EH19217467AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1114B1EH33850508 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1115AP1EH40178732AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1115A`1EH52739232AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:34B#mRNA-1273-P201ISmRNA-1273-P201-US204-1115Ap1EH27601080AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:35B1mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH00304150AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:59B>mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH48562188AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH52737154AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:34B#mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH27601083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:35B1mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH00309270AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:59B>mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH48562188BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T12:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH52737154BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:34B#mRNA-1273-P201ISmRNA-1273-P201-US204-1115A1EH27601083BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:35B1mRNA-1273-P201ISmRNA-1273-P201-US204-1115B1EH00309270BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:59B>mRNA-1273-P201ISmRNA-1273-P201-US204-1115B1EH40175662 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1115B1EH44381348 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US204-1115B1EH44381348 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1117A`1EH00008348AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.3 ug/mL 15.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:52B!mRNA-1273-P201ISmRNA-1273-P201-US204-1117Ap1EH19214522AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 390.5 ug/mL 390.5 Chug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH08692895AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 243.4 ug/mL 243.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:30B=mRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH33849358AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.2 AU/mL 3.2 A3333334AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH00012316AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.7 AU/mL 85.7 BU33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:52B!mRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH27598874AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1494.3 AU/mL 1494.3 C]dAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH08695868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1080.7 AU/mL 1080.7 CC33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:30B=mRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH60143621AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 174.3 AU/mL 174.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH33849358BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:40AmRNA-1273-P201ISmRNA-1273-P201-US204-1117A1EH00012316BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:52B!mRNA-1273-P201ISmRNA-1273-P201-US204-1117B1EH27598874BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US204-1117B1EH08695868BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:30B=mRNA-1273-P201ISmRNA-1273-P201-US204-1117B1EH60143621AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1117B1EH33852429 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T16:20AmRNA-1273-P201ISmRNA-1273-P201-US204-1118Ap1EH07344285AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.1 ug/mL 25.1 Bug/mL PPD VACCINESERUMELISA A>ffffffA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-15T15:28BmRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH00009244AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37.6 ug/mL 37.6 B%ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH50411665AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 321.9 ug/mL 321.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:58B+mRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH61087912AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.4 ug/mL 193.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH40178702AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T16:20AmRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH00013340AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.9 AU/mL 147.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH58795185AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1775.8 AU/mL 1775.8 CnAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:58B+mRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH52737026AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 258.8 AU/mL 258.8 C,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1118A1EH60143622AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 133.6 AU/mL 133.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T16:37BmRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH40178702BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T16:20AmRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH00013340BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH58795185BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:58B+mRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH61090827BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T15:38B9mRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH60143622AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T16:37BmRNA-1273-P201ISmRNA-1273-P201-US204-1118B1EH40176780 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodiesffffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1119A`1EH00008349AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1119Ap1EH27598872AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88 ug/mL 88 BXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:02B,mRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH00307252AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.8 ug/mL 86.8 BVug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:23B:mRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH40180910AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH00009246AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.2 AU/mL 14.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH27605017AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 198.5 AU/mL 198.5 BƀAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:02B,mRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH00310455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 229.7 AU/mL 229.7 B33330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:23B:mRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH60138630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.4 AU/mL 47.4 B/ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH40180910BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US204-1119A1EH00009246BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1119B1EH27605017BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:02B,mRNA-1273-P201ISmRNA-1273-P201-US204-1119B1EH00310455BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:23B:mRNA-1273-P201ISmRNA-1273-P201-US204-1119B1EH60138630AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1119B1EH40175631 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1120A`1EH00011420AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.4 ug/mL 14.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1120Ap1EH50410512AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123 ug/mL 123 B{ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B*mRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH08694814AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.7 ug/mL 94.7 B^33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:16B8mRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH48564237AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH00009407AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 49.9 AU/mL 49.9 B1fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH50412595AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 507 AU/mL 507 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B*mRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH08695838AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 434.8 AU/mL 434.8 C,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:16B8mRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH60141574AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.4 AU/mL 68.4 BDfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T15:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH48564237BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1120A1EH00009407BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1120B1EH50412595BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:20B*mRNA-1273-P201ISmRNA-1273-P201-US204-1120B1EH08695838BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:16B8mRNA-1273-P201ISmRNA-1273-P201-US204-1120B1EH60141574AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T15:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1120B1EH40173711 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1121A`1EH00011325AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T18:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1121Ap1EH19217594AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:12B-mRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH08694845AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:12B8mRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH40179759AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T15:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH00012318AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T18:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH27598906AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:12B-mRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH08697021AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:12B8mRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH27600024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T15:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH40179759BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:09AmRNA-1273-P201ISmRNA-1273-P201-US204-1121A1EH00012318BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T18:12BmRNA-1273-P201ISmRNA-1273-P201-US204-1121B1EH27598906BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:12B-mRNA-1273-P201ISmRNA-1273-P201-US204-1121B1EH08697021BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:12B8mRNA-1273-P201ISmRNA-1273-P201-US204-1121B1EH27600024AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T15:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1121B1EH40176685 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1122A`1EH00010268AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 102.6 ug/mL 102.6 Bfug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:33BmRNA-1273-P201ISmRNA-1273-P201-US204-1122Ap1EH50409520AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 380.1 ug/mL 380.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH08693822AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 244.7 ug/mL 244.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH40180750AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T08:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH00011294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 546.9 AU/mL 546.9 C".fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:33BmRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH58795024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1923.9 AU/mL 1923.9 Cx>ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH08695997AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1225.1 AU/mL 1225.1 CLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH60141700AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.6 AU/mL 144.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:23BmRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH40180750BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T08:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1122A1EH00011294CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:33BmRNA-1273-P201ISmRNA-1273-P201-US204-1122B1EH58795024CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:18B+mRNA-1273-P201ISmRNA-1273-P201-US204-1122B1EH08695997BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US204-1122B1EH60141700AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:23BmRNA-1273-P201ISmRNA-1273-P201-US204-1122B1EH40174732 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1123A`1EH19208357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 ug/mL 31.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1123Ap1EH52736003AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.9 ug/mL 187.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH08691901AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.1 ug/mL 139.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH36015105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH19206183AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.6 AU/mL 183.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH61122688AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1125.3 AU/mL 1125.3 CFTAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH08698941AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 653.1 AU/mL 653.1 C(љAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH60143748AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.8 AU/mL 97.8 BaAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH36015105BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:45AmRNA-1273-P201ISmRNA-1273-P201-US204-1123A1EH19206183BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:05BmRNA-1273-P201ISmRNA-1273-P201-US204-1123B1EH61122688CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:28B+mRNA-1273-P201ISmRNA-1273-P201-US204-1123B1EH08698941BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T08:20B9mRNA-1273-P201ISmRNA-1273-P201-US204-1123B1EH60143748AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:27BmRNA-1273-P201ISmRNA-1273-P201-US204-1123B1EH44369922 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:01AmRNA-1273-P201ISmRNA-1273-P201-US204-1125A`1EH00010270AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22 ug/mL 22 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:56BmRNA-1273-P201ISmRNA-1273-P201-US204-1125Ap1EH50409523AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259.5 ug/mL 259.5 C8ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:40B+mRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH00304311AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.7 ug/mL 195.7 Bó33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:52B:mRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH40178863AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T15:01AmRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH00014396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 91.5 AU/mL 91.5 B[AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:56BmRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH58794032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1626.6 AU/mL 1626.6 CeAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:40B+mRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH08693908AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 999.3 AU/mL 999.3 C>tAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:52B:mRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH27599032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107 AU/mL 107 BkAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:24BmRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH40178863BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:01AmRNA-1273-P201ISmRNA-1273-P201-US204-1125A1EH00014396BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:56BmRNA-1273-P201ISmRNA-1273-P201-US204-1125B1EH58794032BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 AU/mL 8.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:40B+mRNA-1273-P201ISmRNA-1273-P201-US204-1125B1EH08693908BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:52B:mRNA-1273-P201ISmRNA-1273-P201-US204-1125B1EH27599032AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:24BmRNA-1273-P201ISmRNA-1273-P201-US204-1125B1EH40173583 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:56AmRNA-1273-P201ISmRNA-1273-P201-US204-1126A`1EH00010397AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 123.3 ug/mL 123.3 B{Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:30B!mRNA-1273-P201ISmRNA-1273-P201-US204-1126Ap1EH27600921AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH00307349AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH36014211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:56AmRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH00015420AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 450.9 AU/mL 450.9 C.fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:30B!mRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH27599930AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2003.5 AU/mL 2003.5 C}8AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH08691764AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1521 AU/mL 1521 C_AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH60144804AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176.1 AU/mL 176.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH36014211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:56AmRNA-1273-P201ISmRNA-1273-P201-US204-1126A1EH00015420BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:30B!mRNA-1273-P201ISmRNA-1273-P201-US204-1126B1EH27599930CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US204-1126B1EH08691764BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:45B@mRNA-1273-P201ISmRNA-1273-P201-US204-1126B1EH60144804AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1126B1EH44367907 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1127A`1EH19203204AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.7 ug/mL 13.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:54BmRNA-1273-P201ISmRNA-1273-P201-US204-1127Ap1EH50412593AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.1 ug/mL 137.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH08691869AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.8 ug/mL 40.8 B(ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:53B<mRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH36013184AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH19207301AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.9 AU/mL 41.9 B)fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:54BmRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH58797104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 515.9 AU/mL 515.9 C >fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH08695837AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 360.6 AU/mL 360.6 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:53B<mRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH60143749AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.1 AU/mL 86.1 BVAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH36013184BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:46AmRNA-1273-P201ISmRNA-1273-P201-US204-1127A1EH19207301BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:54BmRNA-1273-P201ISmRNA-1273-P201-US204-1127B1EH58797104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T11:30B+mRNA-1273-P201ISmRNA-1273-P201-US204-1127B1EH08695837BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:53B<mRNA-1273-P201ISmRNA-1273-P201-US204-1127B1EH60143749AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T11:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1127B1EH44371968 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:51AmRNA-1273-P201ISmRNA-1273-P201-US204-1130A`1EH19203206AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.3 ug/mL 16.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1130Ap1EH50411538AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.4 ug/mL 61.4 B=ffffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH00309301AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33 ug/mL 33 B!ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T11:19B6mRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH33849486AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:51AmRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH27593765AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32 AU/mL 32 B AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH58797232AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 245.1 AU/mL 245.1 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH00308279AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.9 AU/mL 149.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T11:19B6mRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH60142596AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.5 AU/mL 13.5 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T11:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH33849486BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:51AmRNA-1273-P201ISmRNA-1273-P201-US204-1130A1EH27593765BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1130B1EH58797232BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:10B+mRNA-1273-P201ISmRNA-1273-P201-US204-1130B1EH00308279BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T11:19B6mRNA-1273-P201ISmRNA-1273-P201-US204-1130B1EH60142596AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T11:09BmRNA-1273-P201ISmRNA-1273-P201-US204-1130B1EH33852428 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:06AmRNA-1273-P201ISmRNA-1273-P201-US204-1131A`1EH52737153AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.2 ug/mL 21.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1131Ap1EH61094064AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 227.3 ug/mL 227.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T08:55B:mRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH17938441AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45 ug/mL 45 B-ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-15T15:20BOmRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH40180879AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T14:06AmRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH52738211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74 AU/mL 74 BJAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH52732944AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 700.4 AU/mL 700.4 C+fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T08:55B:mRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH17938442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 476 AU/mL 476 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-15T15:20BOmRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH40180879BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:06AmRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH52738211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:25B+mRNA-1273-P201ISmRNA-1273-P201-US204-1131A1EH52732944BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T08:55B:mRNA-1273-P201ISmRNA-1273-P201-US204-1131B1EH17938442BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-15T15:20BOmRNA-1273-P201ISmRNA-1273-P201-US204-1131B1EH40173615 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1132A`1EH00009245AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:15B mRNA-1273-P201ISmRNA-1273-P201-US204-1132Ap1EH50409491AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:18B.mRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH08692765AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:16B=mRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH36013056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH00014365AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:15B mRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH58796080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:18B.mRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH08696892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:16B=mRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH60140550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T14:22BmRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH36013056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:58AmRNA-1273-P201ISmRNA-1273-P201-US204-1132A1EH00014365BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:15B mRNA-1273-P201ISmRNA-1273-P201-US204-1132B1EH58796080CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:18B.mRNA-1273-P201ISmRNA-1273-P201-US204-1132B1EH08696892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1136A`1EH44120102AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 ug/mL 12.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T14:57B"mRNA-1273-P201ISmRNA-1273-P201-US204-1136Ap1EH19217595AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.9 ug/mL 150.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:54B1mRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH36024357AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.2 ug/mL 156.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T13:23B?mRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH40180783AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T11:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH35758245AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 53.7 AU/mL 53.7 B533334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T14:57B"mRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH27605049AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 835.7 AU/mL 835.7 C4;33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:54B1mRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH36024359AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 759.4 AU/mL 759.4 C/vfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T13:23B?mRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH60140678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167 AU/mL 167 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T13:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH40180783BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:27AmRNA-1273-P201ISmRNA-1273-P201-US204-1136A1EH35758245BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T14:57B"mRNA-1273-P201ISmRNA-1273-P201-US204-1136B1EH27605049BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T13:54B1mRNA-1273-P201ISmRNA-1273-P201-US204-1136B1EH36024359BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T13:23B?mRNA-1273-P201ISmRNA-1273-P201-US204-1136B1EH60140678AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T13:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1136B1EH40176653 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1138A`1EH19203110AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.3 ug/mL 13.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1138Ap1EH50411697AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.4 ug/mL 80.4 BPfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:13B+mRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH00308372AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.9 ug/mL 58.9 B:fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH36012194AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH19209348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.9 AU/mL 25.9 BfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH50412594AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 336.6 AU/mL 336.6 C AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:13B+mRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH00308374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 270.6 AU/mL 270.6 C陙AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH60140710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.4 AU/mL 32.4 B ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH36012194BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:14AmRNA-1273-P201ISmRNA-1273-P201-US204-1138A1EH19209348BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:10BmRNA-1273-P201ISmRNA-1273-P201-US204-1138B1EH50412594BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:13B+mRNA-1273-P201ISmRNA-1273-P201-US204-1138B1EH00308374BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T10:24B6mRNA-1273-P201ISmRNA-1273-P201-US204-1138B1EH60140710AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T10:25BmRNA-1273-P201ISmRNA-1273-P201-US204-1138B1EH44369058 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:52AmRNA-1273-P201ISmRNA-1273-P201-US204-1139A`1EH08436919AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.1 ug/mL 14.1 Aᙙug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1139Ap1EH50411568AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153.3 ug/mL 153.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:07B,mRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH08694813AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.4 ug/mL 45.4 B-ffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:17B:mRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH40178862AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T13:52AmRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH00009375AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.7 AU/mL 56.7 B833334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH58794161AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 519.6 AU/mL 519.6 C yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:07B,mRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH08699037AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 316.9 AU/mL 316.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:17B:mRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH60140679AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.6 AU/mL 58.6 B:AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T16:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH40178862BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:52AmRNA-1273-P201ISmRNA-1273-P201-US204-1139A1EH00009375BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:51BmRNA-1273-P201ISmRNA-1273-P201-US204-1139B1EH58794161BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:07B,mRNA-1273-P201ISmRNA-1273-P201-US204-1139B1EH08699037CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T17:17B:mRNA-1273-P201ISmRNA-1273-P201-US204-1139B1EH60140679AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T16:35BmRNA-1273-P201ISmRNA-1273-P201-US204-1139B1EH40174636 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1142A`1EH00008255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1142Ap1EH27601977AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:18B,mRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH00309396AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:13B:mRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH40178734AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH00009374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH27603128AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:18B,mRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH08691893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:13B:mRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH40178734BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:35AmRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH00009374BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US204-1142A1EH27603128BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:18B,mRNA-1273-P201ISmRNA-1273-P201-US204-1142B1EH08691893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:13B:mRNA-1273-P201ISmRNA-1273-P201-US204-1142B1EH40173582 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1144A`1EH00009373AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.6 ug/mL 15.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:36B!mRNA-1273-P201ISmRNA-1273-P201-US204-1144Ap1EH00306231AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.3 ug/mL 192.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH08691743AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.3 ug/mL 165.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:12B=mRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH36015136AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T13:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH00012348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.4 AU/mL 65.4 BAfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:36B!mRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH08691860AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 895.4 AU/mL 895.4 C7fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH08699036AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 744.7 AU/mL 744.7 C.33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:12B=mRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH27599000AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 230.8 AU/mL 230.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:34BmRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH36015136BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:55AmRNA-1273-P201ISmRNA-1273-P201-US204-1144A1EH00012348BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T11:36B!mRNA-1273-P201ISmRNA-1273-P201-US204-1144B1EH08691860BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:35B/mRNA-1273-P201ISmRNA-1273-P201-US204-1144B1EH08699036BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T14:12B=mRNA-1273-P201ISmRNA-1273-P201-US204-1144B1EH27599000AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T13:34BmRNA-1273-P201ISmRNA-1273-P201-US204-1144B1EH44370946 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1145AP1EH00010428AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.6 ug/mL 12.6 Aəug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1145A`1EH00304279AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.1 ug/mL 143.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1145Ap1EH40178831AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH00013501AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.7 AU/mL 30.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH00310327AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 774.1 AU/mL 774.1 C0aAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH40178831BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:50AmRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH00013501BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH00310327BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B:mRNA-1273-P201ISmRNA-1273-P201-US204-1145A1EH40175759 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1146A`1EH00010431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:18BmRNA-1273-P201ISmRNA-1273-P201-US204-1146Ap1EH61094065AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T07:15B+mRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH00309300AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:22B8mRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH40179886AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH00015549AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:18BmRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH52732050AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T07:15B+mRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH00308375AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:22B8mRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH19217434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH40179886BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:44AmRNA-1273-P201ISmRNA-1273-P201-US204-1146A1EH00015549BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:18BmRNA-1273-P201ISmRNA-1273-P201-US204-1146B1EH52732050BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T07:15B+mRNA-1273-P201ISmRNA-1273-P201-US204-1146B1EH00308375BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:22B8mRNA-1273-P201ISmRNA-1273-P201-US204-1146B1EH19217434AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1146B1EH40176813 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:28AmRNA-1273-P201ISmRNA-1273-P201-US204-1149A`1EH44118150AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.6 ug/mL 17.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T12:02BmRNA-1273-P201ISmRNA-1273-P201-US204-1149Ap1EH50412688AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.9 ug/mL 156.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:55B-mRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH00305335AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.3 ug/mL 149.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T15:57B;mRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH40177711AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:28AmRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH35761284AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.9 AU/mL 39.9 B'fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T12:02BmRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH50410515AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 682.5 AU/mL 682.5 C*AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:55B-mRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH00307383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 739.7 AU/mL 739.7 C.;33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T15:57B;mRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH27600025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 163.8 AU/mL 163.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T16:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH40177711BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:28AmRNA-1273-P201ISmRNA-1273-P201-US204-1149A1EH35761284BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T12:02BmRNA-1273-P201ISmRNA-1273-P201-US204-1149B1EH50410515BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 AU/mL 8.8 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:55B-mRNA-1273-P201ISmRNA-1273-P201-US204-1149B1EH00307383BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 AU/mL 11.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T15:57B;mRNA-1273-P201ISmRNA-1273-P201-US204-1149B1EH27600025AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 AU/mL 8.8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T16:40BmRNA-1273-P201ISmRNA-1273-P201-US204-1149B1EH40174733 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T10:43AmRNA-1273-P201ISmRNA-1273-P201-US204-1150A`1EH00011324AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.9 ug/mL 20.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US204-1150Ap1EH27598873AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 234.9 ug/mL 234.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:55B3mRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH36026501AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 246 ug/mL 246 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T11:24B@mRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH40178735AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T10:43AmRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH00013468AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.4 AU/mL 61.4 B=ffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH27601946AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1006.7 AU/mL 1006.7 C>33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:55B3mRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH36025381AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 805.3 AU/mL 805.3 C2TAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T11:24B@mRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH19215418AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108 AU/mL 108 BlAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH40178735BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T10:43AmRNA-1273-P201ISmRNA-1273-P201-US204-1150A1EH00013468BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US204-1150B1EH27601946BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:55B3mRNA-1273-P201ISmRNA-1273-P201-US204-1150B1EH36025381BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T11:24B@mRNA-1273-P201ISmRNA-1273-P201-US204-1150B1EH19215418AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T10:36BmRNA-1273-P201ISmRNA-1273-P201-US204-1150B1EH40176781 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1151A`1EH44121253AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1151Ap1EH27601945AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH36021414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH40179887AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH35759108AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH27602074AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH36025348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH60142629AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T13:50BmRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH40179887BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:30AmRNA-1273-P201ISmRNA-1273-P201-US204-1151A1EH35759108BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:47BmRNA-1273-P201ISmRNA-1273-P201-US204-1151B1EH27602074BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US204-1151B1EH36025348BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T15:05B:mRNA-1273-P201ISmRNA-1273-P201-US204-1151B1EH60142629AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T13:50BmRNA-1273-P201ISmRNA-1273-P201-US204-1151B1EH40175789 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T14:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1152A`1EH44121125AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US204-1152Ap1EH19215514AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:10B-mRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH00304310AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH40177838AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T14:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH35758084AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH27600922AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:10B-mRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH00307254AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH60138503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:13BmRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH40177838BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T14:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1152A1EH35758084BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:38BmRNA-1273-P201ISmRNA-1273-P201-US204-1152B1EH27600922BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T10:10B-mRNA-1273-P201ISmRNA-1273-P201-US204-1152B1EH00307254BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:22B;mRNA-1273-P201ISmRNA-1273-P201-US204-1152B1EH60138503AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:13BmRNA-1273-P201ISmRNA-1273-P201-US204-1152B1EH40173741 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodiesffffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1155A`1EH44121124AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.8 ug/mL 30.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1155Ap1EH19217466AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.4 ug/mL 131.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH00304183AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118.2 ug/mL 118.2 Bv333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:46B9mRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH40178830AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH35761156AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 95 AU/mL 95 B_AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH27603001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 645 AU/mL 645 C(PAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH00309399AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 529.5 AU/mL 529.5 C!AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:46B9mRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH60142756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.2 AU/mL 60.2 B<333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH40178830BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:04AmRNA-1273-P201ISmRNA-1273-P201-US204-1155A1EH35761156BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:55BmRNA-1273-P201ISmRNA-1273-P201-US204-1155B1EH27603001CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T13:17B+mRNA-1273-P201ISmRNA-1273-P201-US204-1155B1EH00309399BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:46B9mRNA-1273-P201ISmRNA-1273-P201-US204-1155B1EH60142756AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:31BmRNA-1273-P201ISmRNA-1273-P201-US204-1155B1EH40174764 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1166A`1EH44119078AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1166Ap1EH19215515AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:45B+mRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH00308277AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH40180878AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH35760167AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH27599003AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:45B+mRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH08691765AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH27601081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH40180878BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:49AmRNA-1273-P201ISmRNA-1273-P201-US204-1166A1EH35760167BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:11BmRNA-1273-P201ISmRNA-1273-P201-US204-1166B1EH27599003BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:45B+mRNA-1273-P201ISmRNA-1273-P201-US204-1166B1EH08691765BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US204-1166B1EH27601081AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:30BmRNA-1273-P201ISmRNA-1273-P201-US204-1166B1EH40174637 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1001A`1EH61971506AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48 ug/mL 48 B0ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1001Ap1EH45418553AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 347.1 ug/mL 347.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:00B*mRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH00012347AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 287.9 ug/mL 287.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:39B8mRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH44140583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH53543962AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.8 AU/mL 191.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH45421624AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1278.8 AU/mL 1278.8 COAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:00B*mRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH08398905AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1198.4 AU/mL 1198.4 CJffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:39B8mRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH44081193AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183 AU/mL 183 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T08:18BmRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH44140583BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1001A1EH53543962BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1001B1EH45421624BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1002A`1EH61970611AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.3 ug/mL 40.3 B(Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1002Ap1EH64064541AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 205.1 ug/mL 205.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:54B.mRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH08396952AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.3 ug/mL 173.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:17B8mRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH44140678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH53546043AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 198.2 AU/mL 198.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH64063519AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 815.5 AU/mL 815.5 C2AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:54B.mRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH08396859AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 878.1 AU/mL 878.1 C6ᙙAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:17B8mRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH35697834AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 91.9 AU/mL 91.9 B[ffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:06BmRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH44140678BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1002A1EH53546043BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T09:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1002B1EH64063519BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:54B.mRNA-1273-P201ISmRNA-1273-P201-US205-1002B1EH08396859BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:17B8mRNA-1273-P201ISmRNA-1273-P201-US205-1002B1EH35697834AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T13:06BmRNA-1273-P201ISmRNA-1273-P201-US205-1002B1EH35757061 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:19AmRNA-1273-P201ISmRNA-1273-P201-US205-1003A`1EH61969552AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.8 ug/mL 21.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-23T09:58BmRNA-1273-P201ISmRNA-1273-P201-US205-1003Ap1EH37032122AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 172.3 ug/mL 172.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T09:23B+mRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH61970482AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.9 ug/mL 112.9 Bpffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:40B=mRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH44138502AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T12:19AmRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH53544090AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72.5 AU/mL 72.5 BHAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-23T09:58BmRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH45420730AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 483.1 AU/mL 483.1 C1AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T09:23B+mRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH53543963AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 411.8 AU/mL 411.8 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:40B=mRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH44138502BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T12:19AmRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH53544090BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-23T09:58BmRNA-1273-P201ISmRNA-1273-P201-US205-1003A1EH45420730BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10T09:23B+mRNA-1273-P201ISmRNA-1273-P201-US205-1003B1EH53543963BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:40B=mRNA-1273-P201ISmRNA-1273-P201-US205-1003B1EH35757060 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T11:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1008A`1EH53545144AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.8 ug/mL 42.8 B*ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:08B!mRNA-1273-P201ISmRNA-1273-P201-US205-1008Ap1EH37034170AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 273.9 ug/mL 273.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:36B.mRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH08399000AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 324.2 ug/mL 324.2 CC33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH44138663AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.8 AU/mL 16.8 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T11:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH53547035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167 AU/mL 167 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:08B!mRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH45423771AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1425.6 AU/mL 1425.6 CYAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:36B.mRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH08397976AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1176.8 AU/mL 1176.8 CIAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH51689600AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 577.5 AU/mL 577.5 C$AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T15:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH44138663BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T11:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1008A1EH53547035BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:08B!mRNA-1273-P201ISmRNA-1273-P201-US205-1008B1EH45423771BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T09:36B.mRNA-1273-P201ISmRNA-1273-P201-US205-1008B1EH08397976BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1008B1EH51689600AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T15:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1008B1EH35756070 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1009A`1EH53546009AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.8 ug/mL 21.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:22BmRNA-1273-P201ISmRNA-1273-P201-US205-1009Ap1EH45417529AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 230.8 ug/mL 230.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH00015514AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.4 ug/mL 162.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:40B@mRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH44141732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH53544986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.3 AU/mL 86.3 BVLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:22BmRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH45422745AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1015.4 AU/mL 1015.4 C?vfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH08400056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 786.3 AU/mL 786.3 C1$AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:40B@mRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH45168806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110 AU/mL 110 BnAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH44141732BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1009A1EH53544986BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:22BmRNA-1273-P201ISmRNA-1273-P201-US205-1009B1EH45422745BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1009B1EH08400056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:40B@mRNA-1273-P201ISmRNA-1273-P201-US205-1009B1EH45168806AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1009B1EH35756039 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1010A`1EH61970451AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.1 ug/mL 30.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:46BmRNA-1273-P201ISmRNA-1273-P201-US205-1010Ap1EH45419545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.6 ug/mL 197.6 Břug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:02B,mRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH00013464AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.2 ug/mL 179.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH00067727AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T12:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH53544123AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118 AU/mL 118 BvAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:46BmRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH45421627AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 756.1 AU/mL 756.1 C/AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:02B,mRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH08397848AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 947.1 AU/mL 947.1 C;1AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH57674780AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 386.4 AU/mL 386.4 C&fffffAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02T11:09B{mRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH35697835AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 311.6 AU/mL 311.6 CyAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T12:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1010A1EH00067727BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T12:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH53544123BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:46BmRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH45421627BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T09:02B,mRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH08397848BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T09:03B:mRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH57674780BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02T11:09B{mRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH35697835AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T12:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1010B1EH08493190 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US205-1011A`1EH53544121AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 ug/mL 10.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:51B#mRNA-1273-P201ISmRNA-1273-P201-US205-1011Ap1EH64062652AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.7 ug/mL 168.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:26B-mRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH00014394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 126.4 ug/mL 126.4 B~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH00065551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH53549113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37.1 AU/mL 37.1 B%AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:51B#mRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH64061470AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 845.3 AU/mL 845.3 C4AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:26B-mRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH08399032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 660.6 AU/mL 660.6 C)IAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH32867505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.1 AU/mL 84.1 BTAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T11:10BmRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH00065551BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US205-1011A1EH53549113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:51B#mRNA-1273-P201ISmRNA-1273-P201-US205-1011B1EH64061470BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:26B-mRNA-1273-P201ISmRNA-1273-P201-US205-1011B1EH08399032BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1011B1EH32867505AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T11:10BmRNA-1273-P201ISmRNA-1273-P201-US205-1011B1EH08493191 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:32AmRNA-1273-P201ISmRNA-1273-P201-US205-1012A`1EH61968562AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.3 ug/mL 40.3 B(Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:08BmRNA-1273-P201ISmRNA-1273-P201-US205-1012Ap1EH64064669AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 337.4 ug/mL 337.4 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:55B.mRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH00014363AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 240.4 ug/mL 240.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:16B8mRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH00067598AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:32AmRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH53546138AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 161.7 AU/mL 161.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:08BmRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH64063647AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1957.7 AU/mL 1957.7 Cz[33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:55B.mRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH08396953AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1858.4 AU/mL 1858.4 Ct&ffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:16B8mRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH45166630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 254.5 AU/mL 254.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:06BmRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH00067598BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:32AmRNA-1273-P201ISmRNA-1273-P201-US205-1012A1EH53546138BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:08BmRNA-1273-P201ISmRNA-1273-P201-US205-1012B1EH64063647BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:55B.mRNA-1273-P201ISmRNA-1273-P201-US205-1012B1EH08396953BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T12:16B8mRNA-1273-P201ISmRNA-1273-P201-US205-1012B1EH45166630AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:06BmRNA-1273-P201ISmRNA-1273-P201-US205-1012B1EH08492037 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T11:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1013A`1EH61971475AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 ug/mL 17.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1013Ap1EH45418523AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.3 ug/mL 204.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:06B)mRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH08398872AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.4 ug/mL 202.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:31B9mRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH00067726AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T11:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH53543994AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.4 AU/mL 66.4 BBfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH45423768AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1168 AU/mL 1168 CIAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:06B)mRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH08396856AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 902 AU/mL 902 C8`AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:31B9mRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH45167780AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.5 AU/mL 139.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T09:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH00067726BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T11:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1013A1EH53543994BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1013B1EH45423768BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T12:06B)mRNA-1273-P201ISmRNA-1273-P201-US205-1013B1EH08396856BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:31B9mRNA-1273-P201ISmRNA-1273-P201-US205-1013B1EH45167780AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T09:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1013B1EH08491142 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:03AmRNA-1273-P201ISmRNA-1273-P201-US205-1017A`1EH53542969AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.7 ug/mL 27.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:03B!mRNA-1273-P201ISmRNA-1273-P201-US205-1017Ap1EH32867473AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 205.7 ug/mL 205.7 Bͳ33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:20B/mRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH00015512AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 164.3 ug/mL 164.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:36B7mRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH52464816AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:03AmRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH53543098AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 170.4 AU/mL 170.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:03B!mRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH32873616AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 996.3 AU/mL 996.3 C>DAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:20B/mRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH08397979AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 856.6 AU/mL 856.6 C5AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:36B7mRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH51687552AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.4 AU/mL 104.4 BhfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH52464816BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:03AmRNA-1273-P201ISmRNA-1273-P201-US205-1017A1EH53543098BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:03B!mRNA-1273-P201ISmRNA-1273-P201-US205-1017B1EH32873616BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:20B/mRNA-1273-P201ISmRNA-1273-P201-US205-1017B1EH08397979BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1018A`1EH53545017AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.7 ug/mL 46.7 B.33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1018Ap1EH32869520AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 216.8 ug/mL 216.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:15B-mRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH00014523AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 164 ug/mL 164 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T09:22B;mRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH00066702AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T08:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH53545019AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 229.7 AU/mL 229.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH32872467AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 854.8 AU/mL 854.8 C5lAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:15B-mRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH08399034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 661.4 AU/mL 661.4 C)VfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T09:22B;mRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH51689472AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 120.5 AU/mL 120.5 BxAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:17BmRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH00066702BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T08:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1018A1EH53545019BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1018B1EH32872467BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:15B-mRNA-1273-P201ISmRNA-1273-P201-US205-1018B1EH08399034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T09:22B;mRNA-1273-P201ISmRNA-1273-P201-US205-1018B1EH51689472AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:17BmRNA-1273-P201ISmRNA-1273-P201-US205-1018B1EH08491046 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-09T09:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1019A`1EH61968531AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.6 ug/mL 31.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1019Ap1EH64062492AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 332.1 ug/mL 332.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:41B*mRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH00015386AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193 ug/mL 193 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:39B?mRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH52463664AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-09T09:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH53550137AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.7 AU/mL 179.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH64063646AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1723.3 AU/mL 1723.3 CkAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:41B*mRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH08396986AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 989.3 AU/mL 989.3 C=AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:39B?mRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH45169670AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.3 AU/mL 131.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:45BmRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH52463664BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-09T09:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1019A1EH53550137BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1019B1EH64063646BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T15:41B*mRNA-1273-P201ISmRNA-1273-P201-US205-1019B1EH08396986BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T15:39B?mRNA-1273-P201ISmRNA-1273-P201-US205-1019B1EH45169670AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:45BmRNA-1273-P201ISmRNA-1273-P201-US205-1019B1EH60823600 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:59AmRNA-1273-P201ISmRNA-1273-P201-US205-1020A`1EH53546040AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.8 ug/mL 17.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:28BmRNA-1273-P201ISmRNA-1273-P201-US205-1020Ap1EH37032986AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.1 ug/mL 71.1 BGug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:28B)mRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH00013368AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.6 ug/mL 33.6 B!ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:58B=mRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH44141575AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T10:59AmRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH53543995AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.5 AU/mL 39.5 B'AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:28BmRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH45423802AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 199.5 AU/mL 199.5 BǀAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:28B)mRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH08399899AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.3 AU/mL 135.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:58B=mRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH45167653AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.2 AU/mL 23.2 B333333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T14:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH44141575BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:59AmRNA-1273-P201ISmRNA-1273-P201-US205-1020A1EH53543995BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:28BmRNA-1273-P201ISmRNA-1273-P201-US205-1020B1EH45423802BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:28B)mRNA-1273-P201ISmRNA-1273-P201-US205-1020B1EH08399899BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T14:58B=mRNA-1273-P201ISmRNA-1273-P201-US205-1020B1EH45167653AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T14:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1020B1EH35755141 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1022A`1EH53542937AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:52B#mRNA-1273-P201ISmRNA-1273-P201-US205-1022Ap1EH32868529AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:24B1mRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH00015515AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:32B9mRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH52462769AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH53545146AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:52B#mRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH32870418AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:24B1mRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH08396858AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:32B9mRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH51687425AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH52462769BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1022A1EH53545146BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:52B#mRNA-1273-P201ISmRNA-1273-P201-US205-1022B1EH32870418CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:24B1mRNA-1273-P201ISmRNA-1273-P201-US205-1022B1EH08396858BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T08:32B9mRNA-1273-P201ISmRNA-1273-P201-US205-1022B1EH51687425AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1022B1EH60822544 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1024A`1EH61969584AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17 ug/mL 17 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:27B$mRNA-1273-P201ISmRNA-1273-P201-US205-1024Ap1EH32866323AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 93.5 ug/mL 93.5 B]ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:16B2mRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH08396824AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.9 ug/mL 43.9 B+fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH44139685AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH53549241AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74.9 AU/mL 74.9 BJffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:27B$mRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH32870576AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 351.7 AU/mL 351.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:16B2mRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH08398904AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.5 AU/mL 195.5 BÀAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH51689504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.8 AU/mL 47.8 B/AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:46BmRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH44139685BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1024A1EH53549241BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:27B$mRNA-1273-P201ISmRNA-1273-P201-US205-1024B1EH32870576BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:16B2mRNA-1273-P201ISmRNA-1273-P201-US205-1024B1EH08398904BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1024B1EH51689504AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:24AmRNA-1273-P201ISmRNA-1273-P201-US205-1025A`1EH61970610AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.7 ug/mL 34.7 B"33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:30B#mRNA-1273-P201ISmRNA-1273-P201-US205-1025Ap1EH32866450AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 253.5 ug/mL 253.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:13B1mRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH00015547AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 260.8 ug/mL 260.8 CLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:19B8mRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH00067630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T11:24AmRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH53544091AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.9 AU/mL 143.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:30B#mRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH32871441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1122.7 AU/mL 1122.7 CF+33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:13B1mRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH08398907AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1670.3 AU/mL 1670.3 ChdAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:19B8mRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH45166599AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 321.4 AU/mL 321.4 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T15:34BmRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH00067630BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:24AmRNA-1273-P201ISmRNA-1273-P201-US205-1025A1EH53544091BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:30B#mRNA-1273-P201ISmRNA-1273-P201-US205-1025B1EH32871441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:13B1mRNA-1273-P201ISmRNA-1273-P201-US205-1025B1EH08398907BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T08:19B8mRNA-1273-P201ISmRNA-1273-P201-US205-1025B1EH45166599AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T15:34BmRNA-1273-P201ISmRNA-1273-P201-US205-1025B1EH08492196 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:16AmRNA-1273-P201ISmRNA-1273-P201-US205-1026A`1EH53542968AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.5 ug/mL 30.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1026Ap1EH45416603AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 244.3 ug/mL 244.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:27B+mRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH00012314AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.4 ug/mL 191.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:26B@mRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH44140551AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:16AmRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH53547034AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 120.1 AU/mL 120.1 BxAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH45422776AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1198.6 AU/mL 1198.6 CJ陙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:27B+mRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH08396955AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 753.6 AU/mL 753.6 C/AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:26B@mRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH44081288AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.1 AU/mL 192.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH44140551BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:16AmRNA-1273-P201ISmRNA-1273-P201-US205-1026A1EH53547034BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1026B1EH45422776BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T09:27B+mRNA-1273-P201ISmRNA-1273-P201-US205-1026B1EH08396955BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:26B@mRNA-1273-P201ISmRNA-1273-P201-US205-1026B1EH44081288AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1026B1EH35755044 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1027A`1EH53544984AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.7 ug/mL 22.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1027Ap1EH64062621AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 212.7 ug/mL 212.7 BԳ33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:56B,mRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH00015417AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 169.9 ug/mL 169.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T10:35B6mRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH00067599AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T12:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH53545018AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 62.6 AU/mL 62.6 B>AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH64064701AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 801.4 AU/mL 801.4 C2fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:56B,mRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH08397851AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 573.7 AU/mL 573.7 C#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T10:35B6mRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH51690656AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57.8 AU/mL 57.8 B9AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH00067599BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1027A1EH53545018BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1027B1EH64064701BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:56B,mRNA-1273-P201ISmRNA-1273-P201-US205-1027B1EH08397851BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T10:35B6mRNA-1273-P201ISmRNA-1273-P201-US205-1027B1EH51690656AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1027B1EH08494245 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:13AmRNA-1273-P201ISmRNA-1273-P201-US205-1028A`1EH53545016AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.1 ug/mL 33.1 B!ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-02T09:45BmRNA-1273-P201ISmRNA-1273-P201-US205-1028Ap1EH45417657AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27 ug/mL 27 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-16T11:15B+mRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH00012443AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.2 ug/mL 19.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:26B6mRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH44139654AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:13AmRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH53543099AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.3 AU/mL 107.3 BkLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-02T09:45BmRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH45423673AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.1 AU/mL 79.1 BOAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-16T11:15B+mRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH08398875AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 61.4 AU/mL 61.4 B=ffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:26B6mRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH44082313AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 AU/mL 7.6 AyAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:05BmRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH44139654BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:13AmRNA-1273-P201ISmRNA-1273-P201-US205-1028A1EH53543099BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-02T09:45BmRNA-1273-P201ISmRNA-1273-P201-US205-1028B1EH45423673BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-16T11:15B+mRNA-1273-P201ISmRNA-1273-P201-US205-1028B1EH08398875BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T11:26B6mRNA-1273-P201ISmRNA-1273-P201-US205-1028B1EH44082313AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:05BmRNA-1273-P201ISmRNA-1273-P201-US205-1028B1EH35755172 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US205-1029A`1EH53545112AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.3 ug/mL 26.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T11:50B$mRNA-1273-P201ISmRNA-1273-P201-US205-1029Ap1EH32866355AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.3 ug/mL 201.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH00015387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 181.7 ug/mL 181.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH44141574AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH53547066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 78 AU/mL 78 BNAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T11:50B$mRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH32872464AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 769.9 AU/mL 769.9 C0fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH08398874AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 630 AU/mL 630 C'`AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH51690657AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.9 AU/mL 134.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH44141574BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US205-1029A1EH53547066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T11:50B$mRNA-1273-P201ISmRNA-1273-P201-US205-1029B1EH32872464CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US205-1029B1EH08398874BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T12:27B9mRNA-1273-P201ISmRNA-1273-P201-US205-1029B1EH51690657AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1029B1EH35757220 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:53AmRNA-1273-P201ISmRNA-1273-P201-US205-1030A`1EH53546137AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.9 ug/mL 41.9 B)fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:24B"mRNA-1273-P201ISmRNA-1273-P201-US205-1030Ap1EH32869392AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.6 ug/mL 197.6 Břug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:32B1mRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH00012315AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.1 ug/mL 159.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:37B?mRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH44138631AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:53AmRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH53548089AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 138.8 AU/mL 138.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:24B"mRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH32872625AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 825.9 AU/mL 825.9 C3fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:32B1mRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH08396826AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 649.8 AU/mL 649.8 C(AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:37B?mRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH51690625AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.3 AU/mL 112.3 BpLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH44138631BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:53AmRNA-1273-P201ISmRNA-1273-P201-US205-1030A1EH53548089BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T12:24B"mRNA-1273-P201ISmRNA-1273-P201-US205-1030B1EH32872625CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:32B1mRNA-1273-P201ISmRNA-1273-P201-US205-1030B1EH08396826BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:37B?mRNA-1273-P201ISmRNA-1273-P201-US205-1030B1EH51690625AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1030B1EH35757188 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1031A`1EH53543961AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.7 ug/mL 35.7 B#33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1031Ap1EH37033019AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 333.3 ug/mL 333.3 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:44B+mRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH00013498AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 238.7 ug/mL 238.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH52461617AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH53547193AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.4 AU/mL 167.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH45423643AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1176.9 AU/mL 1176.9 CIffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:44B+mRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH08397880AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1078.5 AU/mL 1078.5 CChAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH44084233AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 163 AU/mL 163 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH52461617BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1031A1EH53547193CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T14:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1031B1EH45423643BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:44B+mRNA-1273-P201ISmRNA-1273-P201-US205-1031B1EH08397880BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T14:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1031B1EH44084233AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1031B1EH60821681 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US205-1032A`1EH61971507AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 ug/mL 17.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1032Ap1EH45416472AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.8 ug/mL 137.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:33B,mRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH61968402AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.5 ug/mL 96.5 B`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH41950267AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH53547033AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.8 AU/mL 28.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH45421754AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 378.5 AU/mL 378.5 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:33B,mRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH53547163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.7 AU/mL 201.7 Bɳ33330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH45167620AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.6 AU/mL 31.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH41950267BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:35AmRNA-1273-P201ISmRNA-1273-P201-US205-1032A1EH53547033BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1032B1EH45421754BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T08:33B,mRNA-1273-P201ISmRNA-1273-P201-US205-1032B1EH53547163BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1032B1EH45167620AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T08:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1032B1EH41946171 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:42AmRNA-1273-P201ISmRNA-1273-P201-US205-1033A`1EH61969586AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.1 ug/mL 31.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:45B"mRNA-1273-P201ISmRNA-1273-P201-US205-1033Ap1EH64061629AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 241.4 ug/mL 241.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH00015513AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 187.5 ug/mL 187.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:26B7mRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH00065679AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T14:42AmRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH53548184AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 74 AU/mL 74 BJAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:45B"mRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH64062653AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1078.3 AU/mL 1078.3 CCdAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH08397850AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 657.4 AU/mL 657.4 C)fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:26B7mRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH45166629AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.7 AU/mL 114.7 Br33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH00065679BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:42AmRNA-1273-P201ISmRNA-1273-P201-US205-1033A1EH53548184BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:45B"mRNA-1273-P201ISmRNA-1273-P201-US205-1033B1EH64062653BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1033B1EH08397850BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T15:26B7mRNA-1273-P201ISmRNA-1273-P201-US205-1033B1EH45166629AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T12:40BmRNA-1273-P201ISmRNA-1273-P201-US205-1033B1EH08494212 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1034A`1EH61971474AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.9 ug/mL 19.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1034Ap1EH45416475AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.5 ug/mL 147.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B)mRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH00015546AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 112.8 ug/mL 112.8 Bpug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:00B9mRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH52462640AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH53550105AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.8 AU/mL 38.8 B&AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH45420571AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 566.4 AU/mL 566.4 C#ffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B)mRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH08399002AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 473.2 AU/mL 473.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:00B9mRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH32866451AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83 AU/mL 83 BSAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T09:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH52462640BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1034A1EH53550105CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1034B1EH45420571BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:51B)mRNA-1273-P201ISmRNA-1273-P201-US205-1034B1EH08399002BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T12:00B9mRNA-1273-P201ISmRNA-1273-P201-US205-1034B1EH32866451AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T09:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1034B1EH60821649 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1035Ap1EH61971603AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:27B#mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH64064668AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:19B,mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH08398873AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH66098199AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03T15:28B\mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH00065550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH53550136AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:27B#mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH64063550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.9 AU/mL 1.9 AffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:19B,mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH08396987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US205-1035A1EH57671836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03T15:28B\mRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH46434445AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.6 AU/mL 42.6 B*AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02T12:35BymRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH51688449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.6 AU/mL 86.6 BVAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH00065550BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH53550136BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:27B#mRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH64063550BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:19B,mRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH08396987BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T11:26B9mRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH57671836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03T15:28B\mRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH46434445BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.6 AU/mL 12.6 AəAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02T12:35BymRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH51688449AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.8 AU/mL 14.8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T11:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1035B1EH08491014 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1036A`1EH61969554AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1036Ap1EH32867346AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:42B.mRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH00012474AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:33B<mRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH00067758AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T14:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH53549083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH32870448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:42B.mRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH08399928AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:33B<mRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH44083208AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.4 AU/mL 40.4 B(ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T12:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH00067758BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T14:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1036A1EH53549083BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1036B1EH32870448BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T13:42B.mRNA-1273-P201ISmRNA-1273-P201-US205-1036B1EH08399928BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:33B<mRNA-1273-P201ISmRNA-1273-P201-US205-1036B1EH44083208AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 49.6 AU/mL 49.6 B1AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-18T12:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1036B1EH08494116 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:15AmRNA-1273-P201ISmRNA-1273-P201-US205-1038A@1EH61970578AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 ug/mL 17.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:04BmRNA-1273-P201ISmRNA-1273-P201-US205-1038AP1EH00066733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T15:15AmRNA-1273-P201ISmRNA-1273-P201-US205-1038A`1EH53549114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.5 AU/mL 65.5 BAAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:04BmRNA-1273-P201ISmRNA-1273-P201-US205-1038Ap1EH00066733BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:15AmRNA-1273-P201ISmRNA-1273-P201-US205-1038A1EH53549114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T14:04BmRNA-1273-P201ISmRNA-1273-P201-US205-1038A1EH08492069 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1040AP1EH00068620AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 ug/mL 12.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:07AmRNA-1273-P201ISmRNA-1273-P201-US205-1040A`1EH53543096AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.3 ug/mL 23.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:17B!mRNA-1273-P201ISmRNA-1273-P201-US205-1040Ap1EH32866483AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.8 ug/mL 218.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH00013497AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.6 ug/mL 149.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH00068780AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:07AmRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH53546010AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.5 AU/mL 80.5 BPAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:17B!mRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH32870545AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 763.5 AU/mL 763.5 C/AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH44053645AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 494.2 AU/mL 494.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH45169700AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41 AU/mL 41 B)AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:09BmRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH00068780BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:07AmRNA-1273-P201ISmRNA-1273-P201-US205-1040A1EH53546010BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:17B!mRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH32870545BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:17B/mRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH44053645BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH45169700AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:09BmRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH08491143 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH36779015 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1357.645 MN50 20 2560 1357.645 CTQMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:09BmRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH08491143 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1040B1EH36779015 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies800 MN Endpoint Titer20 2560 800 C2MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T13:09BmRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH44139653AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:00AmRNA-1273-P201ISmRNA-1273-P201-US205-1042A 1EH61969427AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1042A01EH37035066AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1042A@1EH00013338AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:57B:mRNA-1273-P201ISmRNA-1273-P201-US205-1042AP1EH44139653AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.7 ug/mL 7.7 A{333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:00AmRNA-1273-P201ISmRNA-1273-P201-US205-1042A`1EH61969427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.4 ug/mL 12.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1042Ap1EH37035066AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.4 ug/mL 106.4 Bjfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH00013338AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.7 ug/mL 79.7 BO33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:57B:mRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH44140711AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:00AmRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH53545115AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 AU/mL 17.2 B333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH45421592AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 476.7 AU/mL 476.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH08398008AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 185.3 AU/mL 185.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:57B:mRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH45168678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.2 AU/mL 36.2 B$333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:33BmRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH44140711BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:00AmRNA-1273-P201ISmRNA-1273-P201-US205-1042A1EH53545115BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T12:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1042B1EH45421592BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T14:45B,mRNA-1273-P201ISmRNA-1273-P201-US205-1042B1EH08398008BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T14:57B:mRNA-1273-P201ISmRNA-1273-P201-US205-1042B1EH45168678AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:33BmRNA-1273-P201ISmRNA-1273-P201-US205-1042B1EH35755045 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:29AmRNA-1273-P201ISmRNA-1273-P201-US205-1043A`1EH53543992AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.2 ug/mL 18.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1043Ap1EH37035162AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 304.6 ug/mL 304.6 C ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:25B+mRNA-1273-P201ISmRNA-1273-P201-US205-1043A1EH00013370AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 222.2 ug/mL 222.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:13B7mRNA-1273-P201ISmRNA-1273-P201-US205-1043A1EH00065583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T12:29AmRNA-1273-P201ISmRNA-1273-P201-US205-1043A1EH53547161AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.6 AU/mL 60.6 BffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:13B7mRNA-1273-P201ISmRNA-1273-P201-US205-1043B1EH32867376AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T09:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1043B1EH08494213 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1044A`1EH61969426AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:53B mRNA-1273-P201ISmRNA-1273-P201-US205-1044Ap1EH64064573AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:04B*mRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH00013339AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:32B6mRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH00067759AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH53543066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.8 AU/mL 1.8 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:53B mRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH64061502AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:04B*mRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH08399897AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:32B6mRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH51687586AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.8 AU/mL 1.8 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH00067759BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1044A1EH53543066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T10:53B mRNA-1273-P201ISmRNA-1273-P201-US205-1044B1EH64061502BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T14:04B*mRNA-1273-P201ISmRNA-1273-P201-US205-1044B1EH08399897BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:32B6mRNA-1273-P201ISmRNA-1273-P201-US205-1044B1EH51687586AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1044B1EH08493094 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-10T12:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1045Ap1EH61971634AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20 ug/mL 20 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T15:10BmRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH32869552AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 238.7 ug/mL 238.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:36B*mRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH00015418AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.8 ug/mL 156.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:48B8mRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH52464785AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-10T12:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH53545147AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.1 AU/mL 67.1 BCAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T15:10BmRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH32872592AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 585.9 AU/mL 585.9 C$fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:36B*mRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH08396984AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 655.1 AU/mL 655.1 C(񙙙AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:48B8mRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH52464785BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-10T12:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1045A1EH53545147BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T15:10BmRNA-1273-P201ISmRNA-1273-P201-US205-1045B1EH32872592CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:36B*mRNA-1273-P201ISmRNA-1273-P201-US205-1045B1EH08396984BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:48B8mRNA-1273-P201ISmRNA-1273-P201-US205-1045B1EH60823568 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-09T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1048A`1EH61971635AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.6 ug/mL 21.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:44B mRNA-1273-P201ISmRNA-1273-P201-US205-1048Ap1EH32868402AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 194.3 ug/mL 194.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T13:34B1mRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH00014522AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 181.3 ug/mL 181.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH00065710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-09T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH53549112AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.6 AU/mL 99.6 BcAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:44B mRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH32873617AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 738.6 AU/mL 738.6 C.)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T13:34B1mRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH08398009AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 864.1 AU/mL 864.1 C6AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH51684515AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.2 AU/mL 131.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH00065710BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-09T12:21AmRNA-1273-P201ISmRNA-1273-P201-US205-1048A1EH53549112BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:44B mRNA-1273-P201ISmRNA-1273-P201-US205-1048B1EH32873617BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T13:34B1mRNA-1273-P201ISmRNA-1273-P201-US205-1048B1EH08398009BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T13:34B:mRNA-1273-P201ISmRNA-1273-P201-US205-1048B1EH51684515AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T13:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1048B1EH08494244 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1050A`1EH53543097AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.2 ug/mL 17.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:17BmRNA-1273-P201ISmRNA-1273-P201-US205-1050Ap1EH32868403AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.6 ug/mL 202.6 Bʙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:54B,mRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH00015419AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.7 ug/mL 144.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:32B;mRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH52463792AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH53549209AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.8 AU/mL 45.8 B-AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:17BmRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH32873520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 849.4 AU/mL 849.4 C5fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:54B,mRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH08399898AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 591.5 AU/mL 591.5 C$AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:32B;mRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH44083209AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.5 AU/mL 131.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:50BmRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH52463792CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:58AmRNA-1273-P201ISmRNA-1273-P201-US205-1050A1EH53549209BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:17BmRNA-1273-P201ISmRNA-1273-P201-US205-1050B1EH32873520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:54B,mRNA-1273-P201ISmRNA-1273-P201-US205-1050B1EH08399898BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:32B;mRNA-1273-P201ISmRNA-1273-P201-US205-1050B1EH44083209AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:50BmRNA-1273-P201ISmRNA-1273-P201-US205-1050B1EH60824592 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1054A`1EH53542936AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29 ug/mL 29 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:07BmRNA-1273-P201ISmRNA-1273-P201-US205-1054Ap1EH44083336AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 178.4 ug/mL 178.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:18B+mRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH00012346AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.9 ug/mL 152.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:03B9mRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH42205349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH53546169AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.9 AU/mL 75.9 BKffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:07BmRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH44081291AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1025.3 AU/mL 1025.3 C@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:18B+mRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH08400025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 681.1 AU/mL 681.1 C*AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:03B9mRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH45169702AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 130 AU/mL 130 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T08:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH42205349BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1054A1EH53546169BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T10:07BmRNA-1273-P201ISmRNA-1273-P201-US205-1054B1EH44081291BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:18B+mRNA-1273-P201ISmRNA-1273-P201-US205-1054B1EH08400025BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1055A`1EH53544089AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.6 ug/mL 9.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:34B#mRNA-1273-P201ISmRNA-1273-P201-US205-1055Ap1EH44084361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:59B.mRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH00013466AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 ug/mL 9.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:50B=mRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH52461744AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH53547162AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:34B#mRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH44081322AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:59B.mRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH08399001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:50B=mRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH45167748AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:01BmRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH52461744BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:49AmRNA-1273-P201ISmRNA-1273-P201-US205-1055A1EH53547162BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:34B#mRNA-1273-P201ISmRNA-1273-P201-US205-1055B1EH44081322BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T07:59B.mRNA-1273-P201ISmRNA-1273-P201-US205-1055B1EH08399001BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T07:50B=mRNA-1273-P201ISmRNA-1273-P201-US205-1055B1EH45167748AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:01BmRNA-1273-P201ISmRNA-1273-P201-US205-1055B1EH60823697 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1057A`1EH61971601AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1057Ap1EH44082184AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.8 ug/mL 42.8 B*ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:41B+mRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH00013496AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.3 ug/mL 39.3 B'Lug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:12B<mRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH52462768AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH53546042AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20 AU/mL 20 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH44081323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 276 AU/mL 276 C@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:41B+mRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH08396827AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.4 AU/mL 171.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:12B<mRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH51687554AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.9 AU/mL 26.9 BfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T08:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH52462768BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:45AmRNA-1273-P201ISmRNA-1273-P201-US205-1057A1EH53546042BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T08:31BmRNA-1273-P201ISmRNA-1273-P201-US205-1057B1EH44081323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T10:41B+mRNA-1273-P201ISmRNA-1273-P201-US205-1057B1EH08396827CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:12B<mRNA-1273-P201ISmRNA-1273-P201-US205-1057B1EH51687554AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T08:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1057B1EH60821521 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1059A`1EH53545145AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.1 ug/mL 22.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:42B mRNA-1273-P201ISmRNA-1273-P201-US205-1059Ap1EH44081289AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.4 ug/mL 135.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:00B.mRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH00015416AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.5 ug/mL 117.5 Buug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T15:07B6mRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH42207397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T13:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH53550265AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.7 AU/mL 48.7 B033334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:42B mRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH44083210AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 679.6 AU/mL 679.6 C*yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:00B.mRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH08400024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 503.8 AU/mL 503.8 C|AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T15:07B6mRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH45167654AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.6 AU/mL 159.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH42207397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1059A1EH53550265BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T12:42B mRNA-1273-P201ISmRNA-1273-P201-US205-1059B1EH44083210BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T15:00B.mRNA-1273-P201ISmRNA-1273-P201-US205-1059B1EH08400024BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T15:07B6mRNA-1273-P201ISmRNA-1273-P201-US205-1059B1EH45167654AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1059B1EH42207236 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1060A`1EH53545113AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.7 ug/mL 26.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:15B!mRNA-1273-P201ISmRNA-1273-P201-US205-1060Ap1EH44081320AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 192.2 ug/mL 192.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:43B.mRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH00013467AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.5 ug/mL 152.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T12:55B<mRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH52462736AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH53547032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.5 AU/mL 100.5 BdAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:15B!mRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH44083211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 885.7 AU/mL 885.7 C7[33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:43B.mRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH08400027AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 733.6 AU/mL 733.6 C-ٙAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T12:55B<mRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH45168679AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200.9 AU/mL 200.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH52462736BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1060A1EH53547032BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:15B!mRNA-1273-P201ISmRNA-1273-P201-US205-1060B1EH44083211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.7 AU/mL 7.7 A{333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T12:43B.mRNA-1273-P201ISmRNA-1273-P201-US205-1060B1EH08400027BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T12:55B<mRNA-1273-P201ISmRNA-1273-P201-US205-1060B1EH45168679AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1060B1EH60821553 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1063A`1EH53546168AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1063Ap1EH44082216AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:51B+mRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH00013369AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 ug/mL 6.4 Affffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH44140710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH53546139AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH44084393AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:51B+mRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH08398906AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH44140710BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH53546139BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1063A1EH44084393BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:51B+mRNA-1273-P201ISmRNA-1273-P201-US205-1063B1EH08398906BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1063B1EH35755013 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:06AmRNA-1273-P201ISmRNA-1273-P201-US205-1064A`1EH61968563AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.2 ug/mL 15.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US205-1064Ap1EH66422917AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.3 ug/mL 106.3 BjLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:32B-mRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH47546413AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.9 ug/mL 71.9 BGffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:52B:mRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH52462608AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T09:06AmRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH53546011AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 76.5 AU/mL 76.5 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH66423975AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 467.4 AU/mL 467.4 C6fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:32B-mRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH47547439AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 196.8 AU/mL 196.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:52B:mRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH45168676AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.4 AU/mL 98.4 BbfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:24BmRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH52462608BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:06AmRNA-1273-P201ISmRNA-1273-P201-US205-1064A1EH53546011BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US205-1064B1EH66423975BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:32B-mRNA-1273-P201ISmRNA-1273-P201-US205-1064B1EH47547439BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T08:52B:mRNA-1273-P201ISmRNA-1273-P201-US205-1064B1EH45168676AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T09:24BmRNA-1273-P201ISmRNA-1273-P201-US205-1064B1EH60818610 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1066A`1EH61970579AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.4 ug/mL 12.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1066Ap1EH44083337AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.9 ug/mL 75.9 BKffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:29B(mRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH00015544AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 62.1 ug/mL 62.1 B>ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:20B6mRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH42205348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH53549211AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.5 AU/mL 19.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH44083243AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 294.6 AU/mL 294.6 CiAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:29B(mRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH08397849AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.3 AU/mL 193.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:20B6mRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH51690496AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.4 AU/mL 80.4 BPfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH42205348BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T09:05AmRNA-1273-P201ISmRNA-1273-P201-US205-1066A1EH53549211BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1066B1EH44083243BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:29B(mRNA-1273-P201ISmRNA-1273-P201-US205-1066B1EH08397849BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:20B6mRNA-1273-P201ISmRNA-1273-P201-US205-1066B1EH51690496AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1066B1EH42205188 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T12:30AmRNA-1273-P201ISmRNA-1273-P201-US205-1068A`1EH61969457AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T12:18BmRNA-1273-P201ISmRNA-1273-P201-US205-1068Ap1EH44081192AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.3 ug/mL 46.3 B.Lug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:09B+mRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH00014491AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 66.6 ug/mL 66.6 BBug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:57B9mRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH44140550AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T12:30AmRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH53542971AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.7 AU/mL 21.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T12:18BmRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH44084392AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 373.1 AU/mL 373.1 CQAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:09B+mRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH08397977AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 280 AU/mL 280 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:57B9mRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH45168677AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.3 AU/mL 45.3 B-LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH44140550BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T12:30AmRNA-1273-P201ISmRNA-1273-P201-US205-1068A1EH53542971BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T12:18BmRNA-1273-P201ISmRNA-1273-P201-US205-1068B1EH44084392BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T10:09B+mRNA-1273-P201ISmRNA-1273-P201-US205-1068B1EH08397977BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T11:57B9mRNA-1273-P201ISmRNA-1273-P201-US205-1068B1EH45168677AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1068B1EH35754022 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1069AP1EH42205221AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1069A`1EH61970450AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.7 ug/mL 21.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:26B!mRNA-1273-P201ISmRNA-1273-P201-US205-1069Ap1EH35699883AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 235.5 ug/mL 235.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:16B+mRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH08396825AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.7 ug/mL 160.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:52B>mRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH42207396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH53548185AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.7 AU/mL 96.7 B`33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:26B!mRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH44081163AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1521.1 AU/mL 1521.1 C_AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:16B+mRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH08396954AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 847.7 AU/mL 847.7 C433334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:52B>mRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH45169669AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.9 AU/mL 197.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T14:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH42207396BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1069A1EH53548185BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:26B!mRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH44081163BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T12:16B+mRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH08396954BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T08:52B>mRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH45169669AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T14:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH33823910 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH36780198 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1357.645 MN50 20 2560 1357.645 CTQMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T14:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH33823910 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1069B1EH36780198 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies960 MN Endpoint Titer20 2560 960 C<MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T14:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH60824723AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.8 AU/mL 21.8 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T08:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1070A 1EH53544985AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.8 AU/mL 15.8 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US205-1070A01EH58039463AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.1 AU/mL 15.1 A񙙙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:05B-mRNA-1273-P201ISmRNA-1273-P201-US205-1070A@1EH00014362AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.6 AU/mL 15.6 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B;mRNA-1273-P201ISmRNA-1273-P201-US205-1070AP1EH60824723AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T08:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1070A`1EH53544985AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US205-1070Ap1EH58039463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.6 ug/mL 47.6 B/ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:05B-mRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH00014362AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.7 ug/mL 31.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B;mRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH52462609AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T08:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH53544122AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH66427013AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 341.6 AU/mL 341.6 CYAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:05B-mRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH08396985AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 172.4 AU/mL 172.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B;mRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH45166727AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1362.4 AU/mL 1362.4 CU&ffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH52462609BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T08:54AmRNA-1273-P201ISmRNA-1273-P201-US205-1070A1EH53544122BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:34B"mRNA-1273-P201ISmRNA-1273-P201-US205-1070B1EH66427013BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:05B-mRNA-1273-P201ISmRNA-1273-P201-US205-1070B1EH08396985BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:38B;mRNA-1273-P201ISmRNA-1273-P201-US205-1070B1EH45166727AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1070B1EH60820658 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1071A`1EH61968435AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.5 ug/mL 11.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1071Ap1EH44084264AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.3 ug/mL 154.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH00014490AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.4 ug/mL 104.4 Bhfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH44138503AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH53547160AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.5 AU/mL 17.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH44083370AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 797.9 AU/mL 797.9 C1fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH08399929AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 485 AU/mL 485 CPAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH51687457AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 90.3 AU/mL 90.3 BZLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T14:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH44138503BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1071A1EH53547160BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1071B1EH44083370BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T14:34B,mRNA-1273-P201ISmRNA-1273-P201-US205-1071B1EH08399929CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:55B9mRNA-1273-P201ISmRNA-1273-P201-US205-1071B1EH51687457AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T14:26BmRNA-1273-P201ISmRNA-1273-P201-US205-1071B1EH35757189 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:36AmRNA-1273-P201ISmRNA-1273-P201-US205-1072A`1EH61971632AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1072Ap1EH58037414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B+mRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH66097334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 298.3 ug/mL 298.3 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21T08:41BNmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH57674781AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:36AmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH53548057AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH66422791AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B+mRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH57673757AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 262.6 AU/mL 262.6 CiAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21T08:41BNmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH45167621AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.1 AU/mL 46.1 B.AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:52BmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH57674781BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:36AmRNA-1273-P201ISmRNA-1273-P201-US205-1072A1EH53548057BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:49BmRNA-1273-P201ISmRNA-1273-P201-US205-1072B1EH66422791BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B+mRNA-1273-P201ISmRNA-1273-P201-US205-1072B1EH57673757CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.5 AU/mL 100.5 BdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21T08:41BNmRNA-1273-P201ISmRNA-1273-P201-US205-1072B1EH45167621AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.8 AU/mL 28.8 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:52BmRNA-1273-P201ISmRNA-1273-P201-US205-1072B1EH66093110 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1073A`1EH61969459AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.7 ug/mL 7.7 A{333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T11:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1073Ap1EH58037382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T13:44B-mRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH47547437AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:19B9mRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH57673788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T12:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH53547064AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T11:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH66420902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T13:44B-mRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH47548591AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:19B9mRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH45169798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:04BmRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH57673788BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:57AmRNA-1273-P201ISmRNA-1273-P201-US205-1073A1EH53547064BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T11:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1073B1EH66420902BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T13:44B-mRNA-1273-P201ISmRNA-1273-P201-US205-1073B1EH47548591BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:19B9mRNA-1273-P201ISmRNA-1273-P201-US205-1073B1EH45169798AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T14:04BmRNA-1273-P201ISmRNA-1273-P201-US205-1073B1EH66097172 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:14AmRNA-1273-P201ISmRNA-1273-P201-US205-1074A`1EH53544088AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.8 ug/mL 25.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1074Ap1EH44084232AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 435.5 ug/mL 435.5 C8ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:30B+mRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH00012442AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 332.8 ug/mL 332.8 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:22B9mRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH42206212AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T09:14AmRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH53550233AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.8 AU/mL 142.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH44081290AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:30B+mRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH08400026AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1927.8 AU/mL 1927.8 Cx|AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:22B9mRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH51688577AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 628.9 AU/mL 628.9 C'NfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T09:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH42206212BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:14AmRNA-1273-P201ISmRNA-1273-P201-US205-1074A1EH53550233BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-30T14:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1075A`1EH53544120AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.6 ug/mL 27.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1075Ap1EH44083240AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 210.5 ug/mL 210.5 BҀug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH47546541AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.6 ug/mL 144.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:17B;mRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH52464784AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T14:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH53549208AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110.9 AU/mL 110.9 BnffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH44082314AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1496.9 AU/mL 1496.9 C]ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH47546542AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 873.1 AU/mL 873.1 C6AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:17B;mRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH45168775AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.5 AU/mL 151.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH52464784BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T14:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1075A1EH53549208BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T12:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1075B1EH44082314BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:10B,mRNA-1273-P201ISmRNA-1273-P201-US205-1075B1EH47546542BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T12:17B;mRNA-1273-P201ISmRNA-1273-P201-US205-1075B1EH45168775AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T12:19BmRNA-1273-P201ISmRNA-1273-P201-US205-1075B1EH60822545 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1077A`1EH47547405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.8 ug/mL 12.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1077Ap1EH44083368AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 126.3 ug/mL 126.3 B~Lug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:54B+mRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH00015545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.1 ug/mL 96.1 B`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:43B9mRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH44140679AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH47546415AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.6 AU/mL 36.6 B$AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH44082315AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 668.7 AU/mL 668.7 C)33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:54B+mRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH08396857AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 434.2 AU/mL 434.2 C#33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:43B9mRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH45166756AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153.1 AU/mL 153.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T09:08BmRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH44140679BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1077A1EH47546415BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1077B1EH44082315BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:54B+mRNA-1273-P201ISmRNA-1273-P201-US205-1077B1EH08396857BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T08:43B9mRNA-1273-P201ISmRNA-1273-P201-US205-1077B1EH45166756AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T09:08BmRNA-1273-P201ISmRNA-1273-P201-US205-1077B1EH35757093 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T14:11AmRNA-1273-P201ISmRNA-1273-P201-US205-1078A`1EH53543064AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.8 ug/mL 22.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1078Ap1EH44081160AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 211.4 ug/mL 211.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:07B,mRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH00013465AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.8 ug/mL 141.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B8mRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH44138662AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T14:11AmRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH53549080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83.2 AU/mL 83.2 BS333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH44084234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 612 AU/mL 612 C&@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:07B,mRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH08399896AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 652 AU/mL 652 C(AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B8mRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH51689505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 166.2 AU/mL 166.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:15BmRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH44138662BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T14:11AmRNA-1273-P201ISmRNA-1273-P201-US205-1078A1EH53549080BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1078B1EH44084234BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:07B,mRNA-1273-P201ISmRNA-1273-P201-US205-1078B1EH08399896BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B8mRNA-1273-P201ISmRNA-1273-P201-US205-1078B1EH51689505AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:15BmRNA-1273-P201ISmRNA-1273-P201-US205-1078B1EH35755173 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1081A`1EH61968530AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.4 ug/mL 15.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1081Ap1EH44082185AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104 ug/mL 104 Bhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:46B+mRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH00013499AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.2 ug/mL 84.2 BT333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH52461745AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.2 AU/mL 3.2 A3333334AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T11:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH53550232AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.6 AU/mL 29.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH44082217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 559.6 AU/mL 559.6 C"AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:46B+mRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH08399035BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 371.6 AU/mL 371.6 C9AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH45168804AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105.7 AU/mL 105.7 Bi33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH52461745BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T11:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1081A1EH53550232BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T09:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1081B1EH44082217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:46B+mRNA-1273-P201ISmRNA-1273-P201-US205-1081B1EH08399035AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:50B9mRNA-1273-P201ISmRNA-1273-P201-US205-1081B1EH45168804AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1081B1EH60823601 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1084A`1EH61968434AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.5 ug/mL 13.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1084Ap1EH44083369AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157 ug/mL 157 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T15:08B+mRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH47548558AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.1 ug/mL 47.1 B/ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T14:19B@mRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH44141733AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T11:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH53544987AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.6 AU/mL 20.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH44081195AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 552.5 AU/mL 552.5 C"AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T15:08B+mRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH47548463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 367.1 AU/mL 367.1 C񙙙AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T14:19B@mRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH45166628AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.6 AU/mL 128.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:13BmRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH44141733BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1084A1EH53544987BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1084B1EH44081195BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T15:08B+mRNA-1273-P201ISmRNA-1273-P201-US205-1084B1EH47548463BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T14:19B@mRNA-1273-P201ISmRNA-1273-P201-US205-1084B1EH45166628AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:13BmRNA-1273-P201ISmRNA-1273-P201-US205-1084B1EH35756167 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1085AP1EH52463632AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 ug/mL 8.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1085A`1EH47547564AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.8 ug/mL 20.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T09:44BmRNA-1273-P201ISmRNA-1273-P201-US205-1085Ap1EH44083241AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 241.4 ug/mL 241.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH47549485AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 214.1 ug/mL 214.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH52464688AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.2 AU/mL 3.2 A3333334AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T10:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH47546414AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.6 AU/mL 64.6 B@AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T09:44BmRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH44082344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1086.2 AU/mL 1086.2 CC33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH47548590AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 869.8 AU/mL 869.8 C6\AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH45166757AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.3 AU/mL 156.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH52464688BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1085A1EH47546414BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T09:44BmRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH44082344BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:17B+mRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH47548590BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:26B>mRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH45166757AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH60823728 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH45162628 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies2715.29 MN50 80 81920 2715.29 C =pMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH60823728 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US205-1085B1EH45162628 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies1920 MN Endpoint Titer80 81920 1920 CxMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH66097302AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1086A 1EH47547565AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1086A01EH58039431AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 AU/mL 10.7 A333330AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T11:28B,mRNA-1273-P201ISmRNA-1273-P201-US205-1086A@1EH47546511AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.4 AU/mL 15.4 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1086AP1EH66097302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1086A`1EH47547565AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1086Ap1EH58039431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T11:28B,mRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH47546511AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH57671869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH47549455AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH66420870AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T11:28B,mRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH47549487AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH45166598AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH57671869BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1086A1EH47549455BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1086B1EH66420870BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T11:28B,mRNA-1273-P201ISmRNA-1273-P201-US205-1086B1EH47549487BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T11:01B<mRNA-1273-P201ISmRNA-1273-P201-US205-1086B1EH45166598AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T09:42BmRNA-1273-P201ISmRNA-1273-P201-US205-1086B1EH66095158 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:44AmRNA-1273-P201ISmRNA-1273-P201-US205-1087A`1EH47546382AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.9 ug/mL 9.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1087Ap1EH66423844AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 ug/mL 9.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:18B,mRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH47546383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:41BAmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH52462641AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T09:44AmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH47547567AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH66422822AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:18B,mRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH47547438AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:41BAmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH45167622AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:00BmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH52462641BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:44AmRNA-1273-P201ISmRNA-1273-P201-US205-1087A1EH47547567BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T08:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1087B1EH66422822BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:18B,mRNA-1273-P201ISmRNA-1273-P201-US205-1087B1EH47547438BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:41BAmRNA-1273-P201ISmRNA-1273-P201-US205-1087B1EH45167622AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:00BmRNA-1273-P201ISmRNA-1273-P201-US205-1087B1EH60821648 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T12:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1088A`1EH47549612AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 431.6 ug/mL 431.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1088Ap1EH44084360AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 398 ug/mL 398 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:04B+mRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH00014395AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 289.6 ug/mL 289.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:10B9mRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH00066574AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.5 AU/mL 135.5 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T12:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH47549486AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH44081194AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:04B+mRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH08399003AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1671.6 AU/mL 1671.6 ChyAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:10B9mRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH00066574BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.2 AU/mL 41.2 B)333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T12:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH47549486BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.8 AU/mL 27.8 BAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1088A1EH44081194BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.7 AU/mL 25.7 B33333AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:04B+mRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH08399003BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.6 AU/mL 23.6 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:10B9mRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH08492165 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1357.645 MN50 20 2560 1357.645 CTQMN50 BATTELLE SERUM B[A Visit 1 Day 1 ASCREENING 2020-06-30T12:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH39162924 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies14481.547MN50 5120 65536014481.547D81&MN50 BATTELLE SERUM C\(APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH35697832 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies28963.094MN50 5120 32768028963.094Dq#bMMN50 BATTELLE SERUM C\(ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:04B+mRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH08434706 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies14481.547MN50 2560 32768014481.547D81&MN50 BATTELLE SERUM C\(AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:10B9mRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH08492165 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies960 MN Endpoint Titer20 2560 960 C<MN Endpoint Titer BATTELLE SERUM B(A Visit 1 Day 1 ASCREENING 2020-06-30T12:22AmRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH39162924 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies10240 MN Endpoint Titer5120 65536010240 D(MN Endpoint Titer BATTELLE SERUM BAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:32BmRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH35697832 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies15360 MN Endpoint Titer5120 32768015360 D<MN Endpoint Titer BATTELLE SERUM BApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:04B+mRNA-1273-P201ISmRNA-1273-P201-US205-1088B1EH08434706 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies7680 MN Endpoint Titer2560 3276807680 DMN Endpoint Titer BATTELLE SERUM BAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:10B9mRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH44140677AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.9 AU/mL 52.9 B4fffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1089A 1EH47549484AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 51.5 AU/mL 51.5 B3AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1089A01EH66420901AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 51.3 AU/mL 51.3 B3LAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B,mRNA-1273-P201ISmRNA-1273-P201-US205-1089A@1EH47549613AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 51.7 AU/mL 51.7 B333334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:01B:mRNA-1273-P201ISmRNA-1273-P201-US205-1089AP1EH44140677AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1089A`1EH47549484AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1089Ap1EH66420901AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B,mRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH47549613AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:01B:mRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH44140582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH47552525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH66424868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B,mRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH47550476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:01B:mRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH45169799AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:41BmRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH44140582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:23AmRNA-1273-P201ISmRNA-1273-P201-US205-1089A1EH47552525BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1089B1EH66424868BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:08B,mRNA-1273-P201ISmRNA-1273-P201-US205-1089B1EH47550476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:01B:mRNA-1273-P201ISmRNA-1273-P201-US205-1089B1EH45169799AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:41BmRNA-1273-P201ISmRNA-1273-P201-US205-1089B1EH35754119 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T11:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1092A`1EH47549581AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1092Ap1EH44082312AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 76.5 ug/mL 76.5 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:30B+mRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH47548430AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.8 ug/mL 50.8 B2ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T09:20B;mRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH46434476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T11:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH47547534AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH44083339AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 322.5 AU/mL 322.5 C(AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:30B+mRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH47552524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 206.2 AU/mL 206.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T09:20B;mRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH51687424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.6 AU/mL 42.6 B*AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:00BmRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH46434476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T11:28AmRNA-1273-P201ISmRNA-1273-P201-US205-1092A1EH47547534BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:35BmRNA-1273-P201ISmRNA-1273-P201-US205-1092B1EH44083339BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T09:30B+mRNA-1273-P201ISmRNA-1273-P201-US205-1092B1EH47552524BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T09:20B;mRNA-1273-P201ISmRNA-1273-P201-US205-1092B1EH51687424AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:00BmRNA-1273-P201ISmRNA-1273-P201-US205-1092B1EH38048812 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1093A`1EH53543065AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.1 ug/mL 17.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:59BmRNA-1273-P201ISmRNA-1273-P201-US205-1093Ap1EH66421764AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.3 ug/mL 77.3 BMLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T14:56B.mRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH47548431AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.7 ug/mL 41.7 B)33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH44139526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH53549081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.5 AU/mL 48.5 B0AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:59BmRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH66421895AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 281.5 AU/mL 281.5 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T14:56B.mRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH47552652AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 239.4 AU/mL 239.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH57674812AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.9 AU/mL 107.9 BkffffhAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-01T11:05BXmRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH45168807AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.9 AU/mL 38.9 B&fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T12:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1093A1EH44139526BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:01AmRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH53549081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T09:59BmRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH66421895BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T14:56B.mRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH47552652BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T09:21B:mRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH57674812BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-01T11:05BXmRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH45168807AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T12:20BmRNA-1273-P201ISmRNA-1273-P201-US205-1093B1EH35753991 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T10:55AmRNA-1273-P201ISmRNA-1273-P201-US205-1094A`1EH61971505AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.9 ug/mL 19.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1094Ap1EH66422820AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 252.9 ug/mL 252.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:57B+mRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH47549453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.6 ug/mL 171.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:48B:mRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH46433293AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T10:55AmRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH53549240AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 81.1 AU/mL 81.1 BQAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH66424836AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1020.5 AU/mL 1020.5 C?AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:57B+mRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH47550477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 671.3 AU/mL 671.3 C)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:48B:mRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH45169671AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.7 AU/mL 124.7 B|33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T11:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH46433293BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T10:55AmRNA-1273-P201ISmRNA-1273-P201-US205-1094A1EH53549240BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1094B1EH66424836BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:57B+mRNA-1273-P201ISmRNA-1273-P201-US205-1094B1EH47550477BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T09:48B:mRNA-1273-P201ISmRNA-1273-P201-US205-1094B1EH45169671AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T11:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1094B1EH38047916 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1095A`1EH61969458AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.4 ug/mL 16.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:41BmRNA-1273-P201ISmRNA-1273-P201-US205-1095Ap1EH35699882AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 265 ug/mL 265 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:15B*mRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH00013371AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 158 ug/mL 158 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH52462737AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH53550264AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.7 AU/mL 34.7 B"33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:41BmRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH44083338AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1716.5 AU/mL 1716.5 CkHAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:15B*mRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH08397881AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 873.7 AU/mL 873.7 C633334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH45167652AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.6 AU/mL 147.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:44BmRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH52462737BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:41AmRNA-1273-P201ISmRNA-1273-P201-US205-1095A1EH53550264BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T11:41BmRNA-1273-P201ISmRNA-1273-P201-US205-1095B1EH44083338BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:15B*mRNA-1273-P201ISmRNA-1273-P201-US205-1095B1EH08397881BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US205-1095B1EH45167652AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:44BmRNA-1273-P201ISmRNA-1273-P201-US205-1095B1EH60821520 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1096A`1EH53543993AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.9 ug/mL 39.9 B'fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1096Ap1EH58039334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 367.6 ug/mL 367.6 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:10B+mRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH47546510AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 284.2 ug/mL 284.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:56B9mRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH44139527AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH53546170AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146.9 AU/mL 146.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH66423942AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1521.9 AU/mL 1521.9 C_ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:10B+mRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH47549582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1249 AU/mL 1249 CNAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:56B9mRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH45168646AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 287.2 AU/mL 287.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T09:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH44139527BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 AU/mL 11.6 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1096A1EH53546170BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 AU/mL 12.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:30BmRNA-1273-P201ISmRNA-1273-P201-US205-1096B1EH66423942BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 AU/mL 12.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:10B+mRNA-1273-P201ISmRNA-1273-P201-US205-1096B1EH47549582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.5 AU/mL 14.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:56B9mRNA-1273-P201ISmRNA-1273-P201-US205-1096B1EH45168646AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 AU/mL 10.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T09:38BmRNA-1273-P201ISmRNA-1273-P201-US205-1096B1EH35754118 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1097A`1EH53546008AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.2 ug/mL 28.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1097Ap1EH66420900AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.1 ug/mL 142.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:39B+mRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH47549580AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.6 ug/mL 111.6 Boug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:17B9mRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH52464689AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T09:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH53548216AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 138 AU/mL 138 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH66422790AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 675.9 AU/mL 675.9 C*>fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:39B+mRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH47547407AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 393.1 AU/mL 393.1 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:17B9mRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH52464689BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH53548216BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:37BmRNA-1273-P201ISmRNA-1273-P201-US205-1097A1EH66422790BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T09:39B+mRNA-1273-P201ISmRNA-1273-P201-US205-1097B1EH47547407BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T09:17B9mRNA-1273-P201ISmRNA-1273-P201-US205-1097B1EH60820531 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1098A`1EH61971504AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T09:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1098Ap1EH58036263AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:43B,mRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH66097175AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:27BAmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH57673916AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH53546171AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T09:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH66421767AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:43B,mRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH57671709AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:27BAmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH45169829AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.8 AU/mL 10.8 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T09:29BmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH57673916BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:26AmRNA-1273-P201ISmRNA-1273-P201-US205-1098A1EH53546171BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T09:14BmRNA-1273-P201ISmRNA-1273-P201-US205-1098B1EH66421767BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T14:43B,mRNA-1273-P201ISmRNA-1273-P201-US205-1098B1EH57671709BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:27BAmRNA-1273-P201ISmRNA-1273-P201-US205-1098B1EH45169829AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.7 AU/mL 24.7 B33333AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T09:29BmRNA-1273-P201ISmRNA-1273-P201-US205-1098B1EH66095286 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:12AmRNA-1273-P201ISmRNA-1273-P201-US205-1099A`1EH61969585AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.1 ug/mL 23.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T10:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1099Ap1EH58037287AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 222.6 ug/mL 222.6 Bޙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T12:03B+mRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH47548588AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 180.5 ug/mL 180.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:14B;mRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH00067631AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T12:12AmRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH53550104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.9 AU/mL 109.9 BmffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T10:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH66427044AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1030.7 AU/mL 1030.7 C@k33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T12:03B+mRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH47549614AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 761.7 AU/mL 761.7 C/33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:14B;mRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH51687553AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.2 AU/mL 197.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:53BmRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH00067631BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:12AmRNA-1273-P201ISmRNA-1273-P201-US205-1099A1EH53550104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T10:23BmRNA-1273-P201ISmRNA-1273-P201-US205-1099B1EH66427044BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T12:03B+mRNA-1273-P201ISmRNA-1273-P201-US205-1099B1EH47549614BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:14B;mRNA-1273-P201ISmRNA-1273-P201-US205-1099B1EH51687553AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:53BmRNA-1273-P201ISmRNA-1273-P201-US205-1099B1EH08493062 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T10:50AmRNA-1273-P201ISmRNA-1273-P201-US205-1100A`1EH61969456AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31.8 ug/mL 31.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:33B"mRNA-1273-P201ISmRNA-1273-P201-US205-1100Ap1EH66421797AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 229.2 ug/mL 229.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T12:08B0mRNA-1273-P201ISmRNA-1273-P201-US205-1100A1EH66100278AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.8 ug/mL 167.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:21BEmRNA-1273-P201ISmRNA-1273-P201-US205-1100A1EH52464657AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T10:50AmRNA-1273-P201ISmRNA-1273-P201-US205-1100A1EH53542970AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 120.8 AU/mL 120.8 BxAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T11:33B"mRNA-1273-P201ISmRNA-1273-P201-US205-1100A1EH66420775AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1001.1 AU/mL 1001.1 C>AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T12:08B0mRNA-1273-P201ISmRNA-1273-P201-US205-1100A1EH57671740AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 755.8 AU/mL 755.8 C/ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T08:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1101A`1EH53543960AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21 ug/mL 21 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US205-1101Ap1EH32869394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:58B4mRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH26294424AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 317.6 ug/mL 317.6 Cٙug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T15:10BCmRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH52461616AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T08:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH53549082AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101.5 AU/mL 101.5 BeAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH32873489AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1421 AU/mL 1421 CXAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:58B4mRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH26293433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1147.5 AU/mL 1147.5 CGAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T15:10BCmRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH45167750AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 194.5 AU/mL 194.5 B€AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T12:50BmRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH52461616BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T08:52AmRNA-1273-P201ISmRNA-1273-P201-US205-1101A1EH53549082BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US205-1101B1EH32873489BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:58B4mRNA-1273-P201ISmRNA-1273-P201-US205-1101B1EH26293433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T15:10BCmRNA-1273-P201ISmRNA-1273-P201-US205-1101B1EH45167750AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T12:50BmRNA-1273-P201ISmRNA-1273-P201-US205-1101B1EH60823696 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:56AmRNA-1273-P201ISmRNA-1273-P201-US205-1102A`1EH61969553AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1102Ap1EH66420869AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 175.5 ug/mL 175.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:45B+mRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH47547532AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.3 ug/mL 111.3 BoLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH57671708AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:56AmRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH53547192AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.8 AU/mL 29.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH66422823AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 831.6 AU/mL 831.6 C3AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:45B+mRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH47550604AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 504.5 AU/mL 504.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH51689473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.9 AU/mL 30.9 BfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH57671708BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:56AmRNA-1273-P201ISmRNA-1273-P201-US205-1102A1EH53547192BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T08:43BmRNA-1273-P201ISmRNA-1273-P201-US205-1102B1EH66422823BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:45B+mRNA-1273-P201ISmRNA-1273-P201-US205-1102B1EH47550604BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T08:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1102B1EH51689473AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T08:48BmRNA-1273-P201ISmRNA-1273-P201-US205-1102B1EH66096311 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1103A`1EH53546136AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 ug/mL 11.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:29BmRNA-1273-P201ISmRNA-1273-P201-US205-1103Ap1EH58039303AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.5 ug/mL 85.5 BUug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:25B,mRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH47547436AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.5 ug/mL 48.5 B0ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH44138630AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH53549210AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11 AU/mL 11 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:29BmRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH66420774AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 442 AU/mL 442 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:25B,mRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH47547406AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 235.4 AU/mL 235.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH45166759AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 69.8 AU/mL 69.8 BEAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:47BmRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH44138630BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T14:39AmRNA-1273-P201ISmRNA-1273-P201-US205-1103A1EH53549210BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T08:29BmRNA-1273-P201ISmRNA-1273-P201-US205-1103B1EH66420774BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:25B,mRNA-1273-P201ISmRNA-1273-P201-US205-1103B1EH47547406BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T09:18B9mRNA-1273-P201ISmRNA-1273-P201-US205-1103B1EH45166759AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:47BmRNA-1273-P201ISmRNA-1273-P201-US205-1103B1EH35756166 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T12:09AmRNA-1273-P201ISmRNA-1273-P201-US205-1104A01EH46432397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T12:09AmRNA-1273-P201ISmRNA-1273-P201-US205-1104A@1EH46432397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T12:09AmRNA-1273-P201ISmRNA-1273-P201-US205-1104AP1EH38048908 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:46AmRNA-1273-P201ISmRNA-1273-P201-US205-1105A`1EH61969555AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:39BmRNA-1273-P201ISmRNA-1273-P201-US205-1105Ap1EH66423813AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103.2 ug/mL 103.2 Bg333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH47547404AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 83.2 ug/mL 83.2 BS333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T14:59B9mRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH52461713AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T13:46AmRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH53542938AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 AU/mL 34.2 B"333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:39BmRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH66424996AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 451.2 AU/mL 451.2 C333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH47549615AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 382.8 AU/mL 382.8 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T14:59B9mRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH57673884AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 284.3 AU/mL 284.3 CAU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-30T09:38B[mRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH51686563AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.1 AU/mL 135.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:34BmRNA-1273-P201ISmRNA-1273-P201-US205-1105A1EH52461713BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:46AmRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH53542938BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:39BmRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH66424996BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH47549615CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T14:59B9mRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH57673884BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-30T09:38B[mRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH51686563AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:34BmRNA-1273-P201ISmRNA-1273-P201-US205-1105B1EH60820659 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T10:29AmRNA-1273-P201ISmRNA-1273-P201-US205-1106A`1EH61970483AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.6 ug/mL 17.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1106Ap1EH66423845AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.5 ug/mL 150.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:20B,mRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH47549452AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41 ug/mL 41 B)ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:33B:mRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH00068781AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T10:29AmRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH53542939AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.9 AU/mL 75.9 BKffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH66421925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 647.6 AU/mL 647.6 C(yAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:20B,mRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH47549583AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 437.1 AU/mL 437.1 CQAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:33B:mRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH51687456AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.2 AU/mL 115.2 Bs333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-02T10:22BmRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH00068781BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T10:29AmRNA-1273-P201ISmRNA-1273-P201-US205-1106A1EH53542939BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:36BmRNA-1273-P201ISmRNA-1273-P201-US205-1106B1EH66421925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:20B,mRNA-1273-P201ISmRNA-1273-P201-US205-1106B1EH47549583BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:33B:mRNA-1273-P201ISmRNA-1273-P201-US205-1106B1EH51687456AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-02T10:22BmRNA-1273-P201ISmRNA-1273-P201-US205-1106B1EH08491015 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1107A`1EH61971600AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.8 ug/mL 10.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1107Ap1EH66422821AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.8 ug/mL 77.8 BMug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH47547533AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.3 ug/mL 44.3 B,Lug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:23B:mRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH52463793AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T13:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH53548217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH66421798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 389.4 AU/mL 389.4 CVfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH47547535AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 145.9 AU/mL 145.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:23B:mRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH45168647AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.6 AU/mL 22.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:57BmRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH52463793BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:40AmRNA-1273-P201ISmRNA-1273-P201-US205-1107A1EH53548217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:27BmRNA-1273-P201ISmRNA-1273-P201-US205-1107B1EH66421798BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US205-1107B1EH47547535BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:23B:mRNA-1273-P201ISmRNA-1273-P201-US205-1107B1EH45168647AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:57BmRNA-1273-P201ISmRNA-1273-P201-US205-1107B1EH60824593 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1108A`1EH61971602AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.3 ug/mL 18.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T13:40B$mRNA-1273-P201ISmRNA-1273-P201-US205-1108Ap1EH32866354AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 231.9 ug/mL 231.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T13:59B3mRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH26292376AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 228.8 ug/mL 228.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T14:26BAmRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH57671868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH53547065AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57.8 AU/mL 57.8 B9AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T13:40B$mRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH32871600AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1061.9 AU/mL 1061.9 CB^ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T13:59B3mRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH26295321AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1033 AU/mL 1033 C@AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T14:26BAmRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH51690624AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125 AU/mL 125 B}AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T13:03BmRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH57671868BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:31AmRNA-1273-P201ISmRNA-1273-P201-US205-1108A1EH53547065BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T13:40B$mRNA-1273-P201ISmRNA-1273-P201-US205-1108B1EH32871600BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T13:59B3mRNA-1273-P201ISmRNA-1273-P201-US205-1108B1EH26295321BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T14:26BAmRNA-1273-P201ISmRNA-1273-P201-US205-1108B1EH51690624AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T13:03BmRNA-1273-P201ISmRNA-1273-P201-US205-1108B1EH66096310 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T14:50AmRNA-1273-P201ISmRNA-1273-P201-US205-1109A`1EH61968403AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.2 ug/mL 24.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T12:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1109Ap1EH44081321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.2 ug/mL 149.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:23B-mRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH47548559AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.7 ug/mL 135.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T15:02B;mRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH00065678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.4 AU/mL 2.4 A&ffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T14:50AmRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH53548088AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.1 AU/mL 94.1 B^AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T12:16BmRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH44083371AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 701.4 AU/mL 701.4 C+fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T15:23B-mRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH47547566AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 717.4 AU/mL 717.4 C,fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T15:02B;mRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH45166631AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125.7 AU/mL 125.7 B}33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T14:02BmRNA-1273-P201ISmRNA-1273-P201-US205-1109A1EH00065678BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:02AmRNA-1273-P201ISmRNA-1273-P201-US205-1111A`1EH53546041AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:01BmRNA-1273-P201ISmRNA-1273-P201-US205-1111Ap1EH32868531AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.2 ug/mL 41.2 B)333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T14:49B2mRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH47546540AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.5 ug/mL 40.5 B(ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH57672764AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:02AmRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH53545114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 AU/mL 8.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:01BmRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH32872593AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 385.4 AU/mL 385.4 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T14:49B2mRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH47548462AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 349.5 AU/mL 349.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH51687426AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.7 AU/mL 98.7 Bb33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T13:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH57672764BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:02AmRNA-1273-P201ISmRNA-1273-P201-US205-1111A1EH53545114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:01BmRNA-1273-P201ISmRNA-1273-P201-US205-1111B1EH32872593BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T14:49B2mRNA-1273-P201ISmRNA-1273-P201-US205-1111B1EH47548462BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:24B9mRNA-1273-P201ISmRNA-1273-P201-US205-1111B1EH51687426AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T13:12BmRNA-1273-P201ISmRNA-1273-P201-US205-1111B1EH66095159 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T10:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1112A`1EH61971633AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1112Ap1EH66422949AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:59B+mRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH47548461AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:02B9mRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH44139684AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T10:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH53548056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH66423846AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:59B+mRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH47549454AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:02B9mRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH45166758AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T10:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH44139684BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T10:38AmRNA-1273-P201ISmRNA-1273-P201-US205-1112A1EH53548056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:54BmRNA-1273-P201ISmRNA-1273-P201-US205-1112B1EH66423846BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:59B+mRNA-1273-P201ISmRNA-1273-P201-US205-1112B1EH47549454BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:02B9mRNA-1273-P201ISmRNA-1273-P201-US205-1112B1EH45166758AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T10:21BmRNA-1273-P201ISmRNA-1273-P201-US205-1112B1EH35756038 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1001AP1EH00366729AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T17:32AmRNA-1273-P201ISmRNA-1273-P201-US206-1001A`1EH05604410AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.3 ug/mL 30.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30B%mRNA-1273-P201ISmRNA-1273-P201-US206-1001Ap1EH35730450AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 286.5 ug/mL 286.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T12:15B6mRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH28640424AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 260.7 ug/mL 260.7 CK33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH00367658AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T17:32AmRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH05609528AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 162.7 AU/mL 162.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30B%mRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH44113968AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1263.3 AU/mL 1263.3 CNAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T12:15B6mRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH20286632AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1177.6 AU/mL 1177.6 CIAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH48596117AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 300.3 AU/mL 300.3 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH00367658CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T17:32AmRNA-1273-P201ISmRNA-1273-P201-US206-1001A1EH05609528BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T13:30B%mRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH44113968BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T12:15B6mRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH20286632BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH48596117AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH00362537 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH40212503 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies3620.387 MN50 160 81920 3620.387 CF1&xMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH00362537 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1001B1EH40212503 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies2560 MN Endpoint Titer160 81920 2560 CMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T14:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH58723484AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.3 AU/mL 11.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:42AmRNA-1273-P201ISmRNA-1273-P201-US206-1003A 1EH05606458AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:30B!mRNA-1273-P201ISmRNA-1273-P201-US206-1003A01EH47515680AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US206-1003A@1EH28640393AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:05B=mRNA-1273-P201ISmRNA-1273-P201-US206-1003AP1EH58723484AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:42AmRNA-1273-P201ISmRNA-1273-P201-US206-1003A`1EH05606458AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:30B!mRNA-1273-P201ISmRNA-1273-P201-US206-1003Ap1EH47515680AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH28640393AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:05B=mRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH58818566AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:42AmRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH05610521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:30B!mRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH47514785AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH28645419AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:05B=mRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH35732658AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:47BmRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH58818566BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:42AmRNA-1273-P201ISmRNA-1273-P201-US206-1003A1EH05610521BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:30B!mRNA-1273-P201ISmRNA-1273-P201-US206-1003B1EH47514785BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:58B/mRNA-1273-P201ISmRNA-1273-P201-US206-1003B1EH28645419BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:05B=mRNA-1273-P201ISmRNA-1273-P201-US206-1003B1EH35732658AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:47BmRNA-1273-P201ISmRNA-1273-P201-US206-1003B1EH50435109 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:01AmRNA-1273-P201ISmRNA-1273-P201-US206-1006A`1EH28641418AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.6 ug/mL 40.6 B(ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1006Ap1EH39847073AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 214.6 ug/mL 214.6 B֙ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:33B2mRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH28640296AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195.4 ug/mL 195.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:16B9mRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH00364715AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:01AmRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH28646410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.3 AU/mL 225.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH39853184AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1082.4 AU/mL 1082.4 CCffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:33B2mRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH28646411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1084.9 AU/mL 1084.9 CCffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:16B9mRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH35730578AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 89.5 AU/mL 89.5 BYAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T10:44BmRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH00364715BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:01AmRNA-1273-P201ISmRNA-1273-P201-US206-1006A1EH28646410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T10:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1006B1EH39853184BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:33B2mRNA-1273-P201ISmRNA-1273-P201-US206-1006B1EH28646411BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T10:16B9mRNA-1273-P201ISmRNA-1273-P201-US206-1006B1EH35730578AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T10:44BmRNA-1273-P201ISmRNA-1273-P201-US206-1006B1EH00361609 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1008AP1EH00366632AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1008A`1EH05604378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 285 ug/mL 285 Cug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:30B"mRNA-1273-P201ISmRNA-1273-P201-US206-1008Ap1EH39130147AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 439.5 ug/mL 439.5 Cxug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:15B0mRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH28641322AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 361.5 ug/mL 361.5 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T13:37B>mRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH00364682AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH05609529AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1666.1 AU/mL 1666.1 Ch!AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:30B"mRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH47514656AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:15B0mRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH28644362AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1795.5 AU/mL 1795.5 Cp8AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T13:37B>mRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH35731506AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 814 AU/mL 814 C2AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH00364682BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1008A1EH05609529BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:30B"mRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH47514656BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:15B0mRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH28644362BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T13:37B>mRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH35731506AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH00363657 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH35726387 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies21722.32 MN50 640 81920 21722.32 DTQMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH00363657 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1008B1EH35726387 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies12800 MN Endpoint Titer640 81920 12800 D2MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH08655013AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T17:28AmRNA-1273-P201ISmRNA-1273-P201-US206-1009A 1EH05606427AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:45B#mRNA-1273-P201ISmRNA-1273-P201-US206-1009A01EH39846017AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:02B2mRNA-1273-P201ISmRNA-1273-P201-US206-1009A@1EH28640426AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:17B?mRNA-1273-P201ISmRNA-1273-P201-US206-1009AP1EH08655013AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:28AmRNA-1273-P201ISmRNA-1273-P201-US206-1009A`1EH05606427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.5 ug/mL 22.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:45B#mRNA-1273-P201ISmRNA-1273-P201-US206-1009Ap1EH39846017AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.5 ug/mL 204.5 B̀ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:02B2mRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH28640426AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.4 ug/mL 144.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:17B?mRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH08655876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T17:28AmRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH48234624AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1043 AU/mL 1043 CA0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:02B2mRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH28646568AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 625.4 AU/mL 625.4 C'fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:17B?mRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH44115985AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.4 AU/mL 144.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:34BmRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH08655876BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:28AmRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH48234624BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T14:02B2mRNA-1273-P201ISmRNA-1273-P201-US206-1009A1EH28646568BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T15:17B?mRNA-1273-P201ISmRNA-1273-P201-US206-1009B1EH44115985AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:34BmRNA-1273-P201ISmRNA-1273-P201-US206-1009B1EH08656901 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1010A`1EH05606426AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.3 ug/mL 21.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US206-1010Ap1EH39849121AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 222.5 ug/mL 222.5 Bހug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:37B2mRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH28640427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 175.9 ug/mL 175.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:52B?mRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH00366762AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH05609625AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.9 AU/mL 52.9 B4fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH39850144AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 879.9 AU/mL 879.9 C6fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:37B2mRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH20284425AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 573.4 AU/mL 573.4 C#fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:52B?mRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH35730610AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.4 AU/mL 98.4 BbfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:19BmRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH00366762BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1010A1EH05609625BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:30B$mRNA-1273-P201ISmRNA-1273-P201-US206-1010B1EH39850144BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:37B2mRNA-1273-P201ISmRNA-1273-P201-US206-1010B1EH20284425BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:52B?mRNA-1273-P201ISmRNA-1273-P201-US206-1010B1EH35730610AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:19BmRNA-1273-P201ISmRNA-1273-P201-US206-1010B1EH08723498 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1011A`1EH05603515AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.8 ug/mL 26.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:38B"mRNA-1273-P201ISmRNA-1273-P201-US206-1011Ap1EH47513601AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 213.8 ug/mL 213.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:51B1mRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH53741738AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.4 ug/mL 144.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T13:25BEmRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH00367785AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 72 AU/mL 72 BHAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH05607609AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 101.3 AU/mL 101.3 BeLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:38B"mRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH47514624AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1274.7 AU/mL 1274.7 CO33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:51B1mRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH53743754AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 506.3 AU/mL 506.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T13:25BEmRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH48595988AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71 AU/mL 71 BGAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T16:32BmRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH00367785BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.3 AU/mL 10.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1011A1EH05607609BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:38B"mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH47514624BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:51B1mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH53743754BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T13:25BEmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH48595988AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T16:32BmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH08721579 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies169.706 MN50 20 2560 169.706 Bj~MN50 BATTELLE SERUM B[A Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH05603513 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies339.411 MN50 20 2560 339.411 C6tjMN50 BATTELLE SERUM B[APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:38B"mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH39130144 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies4525.483 MN50 20 10240 4525.483 D{SMN50 BATTELLE SERUM B[ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:51B1mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH53779618 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies1810.193 MN50 20 2560 1810.193 Cq#+ MN50 BATTELLE SERUM B[AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T13:25BEmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH40210582 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies339.411 MN50 20 2560 339.411 C6tjMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T16:32BmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH08721579 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies120 MN Endpoint Titer20 2560 120 BxMN Endpoint Titer BATTELLE SERUM B(A Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH05603513 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies240 MN Endpoint Titer20 2560 240 BMN Endpoint Titer BATTELLE SERUM B(APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:38B"mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH39130144 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies3200 MN Endpoint Titer20 10240 3200 CMN Endpoint Titer BATTELLE SERUM B(ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:51B1mRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH53779618 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies1280 MN Endpoint Titer20 2560 1280 CPMN Endpoint Titer BATTELLE SERUM B(AVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T13:25BEmRNA-1273-P201ISmRNA-1273-P201-US206-1011B1EH40210582 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies160 MN Endpoint Titer20 2560 160 BMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T16:32BmRNA-1273-P201ISmRNA-1273-P201-US206-1013A1EH58720286AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T08:45AmRNA-1273-P201ISmRNA-1273-P201-US206-1013A 1EH05606459AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:34B mRNA-1273-P201ISmRNA-1273-P201-US206-1013A01EH47513600AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T16:18B.mRNA-1273-P201ISmRNA-1273-P201-US206-1013A@1EH28641448AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T10:21B=mRNA-1273-P201ISmRNA-1273-P201-US206-1013AP1EH58720286AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:45AmRNA-1273-P201ISmRNA-1273-P201-US206-1013A`1EH05606459AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.6 ug/mL 21.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:34B mRNA-1273-P201ISmRNA-1273-P201-US206-1013Ap1EH47513600AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 189.5 ug/mL 189.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T16:18B.mRNA-1273-P201ISmRNA-1273-P201-US206-1013A1EH28641448AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.4 ug/mL 186.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T10:21B=mRNA-1273-P201ISmRNA-1273-P201-US206-1013A1EH58722462AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:02AmRNA-1273-P201ISmRNA-1273-P201-US206-1015A`1EH05604506AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:26B"mRNA-1273-P201ISmRNA-1273-P201-US206-1015Ap1EH39848099AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T17:01B3mRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH28640297AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:28B@mRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH00365610AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T14:02AmRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH05609656AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:26B"mRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH39850016AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T17:01B3mRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH20284424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:28B@mRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH44113937AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T13:16BmRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH00365610BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:02AmRNA-1273-P201ISmRNA-1273-P201-US206-1015A1EH05609656BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:26B"mRNA-1273-P201ISmRNA-1273-P201-US206-1015B1EH39850016BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T17:01B3mRNA-1273-P201ISmRNA-1273-P201-US206-1015B1EH20284424BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:28B@mRNA-1273-P201ISmRNA-1273-P201-US206-1015B1EH44113937AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T13:16BmRNA-1273-P201ISmRNA-1273-P201-US206-1015B1EH00361481 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T15:43AmRNA-1273-P201ISmRNA-1273-P201-US206-1018A`1EH05605562AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 ug/mL 6.6 Aiug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US206-1018Ap1EH47513633AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:28B1mRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH05606555AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T16:45BEmRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH00366634AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T15:43AmRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH05607480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH47514752AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:28B1mRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH05608600AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T16:45BEmRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH48597173AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.6 AU/mL 10.6 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T11:24BmRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH00366634BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T15:43AmRNA-1273-P201ISmRNA-1273-P201-US206-1018A1EH05607480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:20B"mRNA-1273-P201ISmRNA-1273-P201-US206-1018B1EH47514752BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 AU/mL 9.3 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:28B1mRNA-1273-P201ISmRNA-1273-P201-US206-1018B1EH05608600BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T16:45BEmRNA-1273-P201ISmRNA-1273-P201-US206-1018B1EH48597173AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 AU/mL 7.9 A~fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T11:24BmRNA-1273-P201ISmRNA-1273-P201-US206-1018B1EH08723595 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:19AmRNA-1273-P201ISmRNA-1273-P201-US206-1019A`1EH28642475AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.3 ug/mL 27.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:23BmRNA-1273-P201ISmRNA-1273-P201-US206-1019Ap1EH47513729AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 211.1 ug/mL 211.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:47B0mRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH28640299AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.6 ug/mL 193.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH58820772AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T17:19AmRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH20285608AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.7 AU/mL 71.7 BG33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:23BmRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH47514784AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1156 AU/mL 1156 CH@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:47B0mRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH28645514AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 777.4 AU/mL 777.4 C0fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH35732498AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.2 AU/mL 75.2 BK333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:34BmRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH58820772BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T17:19AmRNA-1273-P201ISmRNA-1273-P201-US206-1019A1EH20285608BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:23BmRNA-1273-P201ISmRNA-1273-P201-US206-1019B1EH47514784BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:47B0mRNA-1273-P201ISmRNA-1273-P201-US206-1019B1EH28645514BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29T13:45B9mRNA-1273-P201ISmRNA-1273-P201-US206-1019B1EH35732498AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T14:34BmRNA-1273-P201ISmRNA-1273-P201-US206-1019B1EH50337823 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T17:24AmRNA-1273-P201ISmRNA-1273-P201-US206-1020A`1EH05604539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.9 ug/mL 29.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40BmRNA-1273-P201ISmRNA-1273-P201-US206-1020Ap1EH47515776AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 325.8 ug/mL 325.8 C\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B,mRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH28639402AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 233.5 ug/mL 233.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:14B:mRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH00365706AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T17:24AmRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH05607608AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 178.3 AU/mL 178.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40BmRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH47516672AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1315.2 AU/mL 1315.2 CR333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B,mRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH28646539AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1330.2 AU/mL 1330.2 CS#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:14B:mRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH35729459AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.8 AU/mL 124.8 B|AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:02BmRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH00365706BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T17:24AmRNA-1273-P201ISmRNA-1273-P201-US206-1020A1EH05607608BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:40BmRNA-1273-P201ISmRNA-1273-P201-US206-1020B1EH47516672BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B,mRNA-1273-P201ISmRNA-1273-P201-US206-1020B1EH28646539BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:14B:mRNA-1273-P201ISmRNA-1273-P201-US206-1020B1EH35729459AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:02BmRNA-1273-P201ISmRNA-1273-P201-US206-1020B1EH00361512 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:36AmRNA-1273-P201ISmRNA-1273-P201-US206-1021A`1EH28646409AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:14BmRNA-1273-P201ISmRNA-1273-P201-US206-1021Ap1EH39848097AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:30B0mRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH28640425AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T13:15B9mRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH00366602AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T15:36AmRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH20284552AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:14BmRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH39850114AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:30B0mRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH28643466AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T13:15B9mRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH35732659AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:15BmRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH00366602BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:36AmRNA-1273-P201ISmRNA-1273-P201-US206-1021A1EH20284552BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:14BmRNA-1273-P201ISmRNA-1273-P201-US206-1021B1EH39850114BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:30B0mRNA-1273-P201ISmRNA-1273-P201-US206-1021B1EH28643466BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30T13:15B9mRNA-1273-P201ISmRNA-1273-P201-US206-1021B1EH35732659AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T13:15BmRNA-1273-P201ISmRNA-1273-P201-US206-1021B1EH00360617 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1022A`1EH28639242AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 ug/mL 9.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:45BmRNA-1273-P201ISmRNA-1273-P201-US206-1022Ap1EH39132323AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.4 ug/mL 10.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T09:21B-mRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH28641450AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH08657925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T09:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH20284585AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:45BmRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH47513760AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T09:21B-mRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH20283400AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH48596149AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:09BmRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH08657925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T09:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1022A1EH20284585BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:45BmRNA-1273-P201ISmRNA-1273-P201-US206-1022B1EH47513760BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T09:21B-mRNA-1273-P201ISmRNA-1273-P201-US206-1022B1EH20283400BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:20B8mRNA-1273-P201ISmRNA-1273-P201-US206-1022B1EH48596149AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:09BmRNA-1273-P201ISmRNA-1273-P201-US206-1022B1EH08654853 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:35AmRNA-1273-P201ISmRNA-1273-P201-US206-1023A`1EH05606587AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 216.7 ug/mL 216.7 Bس33330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:43B mRNA-1273-P201ISmRNA-1273-P201-US206-1023Ap1EH39130146AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH28640267AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:37B<mRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH58722366AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T10:35AmRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH05609657AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 845.2 AU/mL 845.2 C433334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:43B mRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH47516800AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH20286473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:37B<mRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH44115984AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 523.3 AU/mL 523.3 C AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH58722366BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:35AmRNA-1273-P201ISmRNA-1273-P201-US206-1023A1EH05609657BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:43B mRNA-1273-P201ISmRNA-1273-P201-US206-1023B1EH47516800BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 AU/mL 9.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US206-1023B1EH20286473BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:37B<mRNA-1273-P201ISmRNA-1273-P201-US206-1023B1EH44115984AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T08:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1023B1EH50337855 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1024A`1EH28641323AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:16BmRNA-1273-P201ISmRNA-1273-P201-US206-1024Ap1EH39848096AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:12B2mRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH28640392AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:18B?mRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH00366763AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH28643467AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:16BmRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH39851008AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:12B2mRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH28646441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:18B?mRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH39846944AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:15BmRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH00366763BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1024A1EH28643467BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T15:16BmRNA-1273-P201ISmRNA-1273-P201-US206-1024B1EH39851008BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T16:12B2mRNA-1273-P201ISmRNA-1273-P201-US206-1024B1EH28646441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:18B?mRNA-1273-P201ISmRNA-1273-P201-US206-1024B1EH39846944AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T16:15BmRNA-1273-P201ISmRNA-1273-P201-US206-1024B1EH00363528 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:40AmRNA-1273-P201ISmRNA-1273-P201-US206-1025A`1EH28642442AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.2 ug/mL 38.2 B&333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:19BmRNA-1273-P201ISmRNA-1273-P201-US206-1025Ap1EH47515649AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 313.1 ug/mL 313.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:36B-mRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH28643497AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 199.4 ug/mL 199.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:55B;mRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH00367755AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T15:40AmRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH28646537AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 158.1 AU/mL 158.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:19BmRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH47516705AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1298.1 AU/mL 1298.1 CQ!AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:36B-mRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH28644490AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 976 AU/mL 976 C=AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:55B;mRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH14785579AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 118.1 AU/mL 118.1 BvAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T16:12BmRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH00367755BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T15:40AmRNA-1273-P201ISmRNA-1273-P201-US206-1025A1EH28646537BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:19BmRNA-1273-P201ISmRNA-1273-P201-US206-1025B1EH47516705BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:36B-mRNA-1273-P201ISmRNA-1273-P201-US206-1025B1EH28644490BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T13:55B;mRNA-1273-P201ISmRNA-1273-P201-US206-1025B1EH14785579AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T16:12BmRNA-1273-P201ISmRNA-1273-P201-US206-1025B1EH08721547 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:23AmRNA-1273-P201ISmRNA-1273-P201-US206-1026A`1EH05604507AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.9 ug/mL 21.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:11B!mRNA-1273-P201ISmRNA-1273-P201-US206-1026Ap1EH47513632AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.3 ug/mL 204.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:38B/mRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH28641321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 129 ug/mL 129 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:54B=mRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH58722335AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T10:23AmRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH05610520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.8 AU/mL 52.8 B4AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:11B!mRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH47516801AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 712.1 AU/mL 712.1 C,AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:38B/mRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH28644393AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 452.2 AU/mL 452.2 CC33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:54B=mRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH48598164AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.3 AU/mL 94.3 B^LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH58722335BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T10:23AmRNA-1273-P201ISmRNA-1273-P201-US206-1026A1EH05610520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:11B!mRNA-1273-P201ISmRNA-1273-P201-US206-1026B1EH47516801BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:38B/mRNA-1273-P201ISmRNA-1273-P201-US206-1026B1EH28644393BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:04AmRNA-1273-P201ISmRNA-1273-P201-US206-1027A`1EH05604411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.9 ug/mL 27.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:42B"mRNA-1273-P201ISmRNA-1273-P201-US206-1027Ap1EH47515648AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.5 ug/mL 225.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH28639243AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139.1 ug/mL 139.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:11B?mRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH00367659AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:04AmRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH05609624AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 181.9 AU/mL 181.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:42B"mRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH47514753AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 666.1 AU/mL 666.1 C)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH20284553AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 472.3 AU/mL 472.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:11B?mRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH35732627AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.3 AU/mL 50.3 B2LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:36BmRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH00367659BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:04AmRNA-1273-P201ISmRNA-1273-P201-US206-1027A1EH05609624BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:42B"mRNA-1273-P201ISmRNA-1273-P201-US206-1027B1EH47514753BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1027B1EH20284553BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:11B?mRNA-1273-P201ISmRNA-1273-P201-US206-1027B1EH35732627AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:36BmRNA-1273-P201ISmRNA-1273-P201-US206-1027B1EH00361608 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1032AP1EH50437254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:58AmRNA-1273-P201ISmRNA-1273-P201-US206-1032A`1EH05604379AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:15B!mRNA-1273-P201ISmRNA-1273-P201-US206-1032Ap1EH39132291AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH28642440AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:32B>mRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH58723391AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T08:58AmRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH05607481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:15B!mRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH47516832AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH28644523AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:32B>mRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH39846049AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T15:52BmRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH58723391BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T08:58AmRNA-1273-P201ISmRNA-1273-P201-US206-1032A1EH05607481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:15B!mRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH47516832BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:59B/mRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH28644523BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T16:32B>mRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH39846049AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T15:52BmRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH50336957 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH14778507 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1032B1EH14778507 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1035A`1EH05607448AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 ug/mL 5.7 A[333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-20T09:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1035Ap1EH44113936AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-03T09:38B'mRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH28641419AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:19B6mRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH00365611AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH05607449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-20T09:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH44113938AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-03T09:38B'mRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH28646440AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:19B6mRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH35730451AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:29BmRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH00365611BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1035A1EH05607449BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-20T09:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1035B1EH44113938BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-03T09:38B'mRNA-1273-P201ISmRNA-1273-P201-US206-1035B1EH28646440BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 AU/mL 6.8 AlAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T09:19B6mRNA-1273-P201ISmRNA-1273-P201-US206-1035B1EH35730451AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T09:29BmRNA-1273-P201ISmRNA-1273-P201-US206-1035B1EH00362664 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:38AmRNA-1273-P201ISmRNA-1273-P201-US206-1036A`1EH05605563AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12 ug/mL 12 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:36B mRNA-1273-P201ISmRNA-1273-P201-US206-1036Ap1EH44151856AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 231.4 ug/mL 231.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:26B.mRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH28640395AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 164 ug/mL 164 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T17:05B<mRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH00365739AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:38AmRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH05607577AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.6 AU/mL 47.6 B/AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:36B mRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH44151955AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 682.4 AU/mL 682.4 C*fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:26B.mRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH28643498AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 226.9 AU/mL 226.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T17:05B<mRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH39852032AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.3 AU/mL 96.3 B`LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T16:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH00365739BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:38AmRNA-1273-P201ISmRNA-1273-P201-US206-1036A1EH05607577BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:36B mRNA-1273-P201ISmRNA-1273-P201-US206-1036B1EH44151955BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:26B.mRNA-1273-P201ISmRNA-1273-P201-US206-1036B1EH28643498BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T17:05B<mRNA-1273-P201ISmRNA-1273-P201-US206-1036B1EH39852032AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T16:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1036B1EH00360584 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1037AP1EH58818724AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1037A`1EH28645416AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 104.7 ug/mL 104.7 Bh33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US206-1037Ap1EH35730482AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 310.4 ug/mL 310.4 Cffffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:37B0mRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH28645544AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 210.9 ug/mL 210.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:50B>mRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH58722463AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH28645547AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 440.5 AU/mL 440.5 CAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH44117041AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1865.8 AU/mL 1865.8 CtAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:37B0mRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH20285449AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1257.1 AU/mL 1257.1 CNAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:50B>mRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH39847968AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.2 AU/mL 132.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:31BmRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH58722463CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US206-1037A1EH28645547BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T08:40B"mRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH44117041BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:37B0mRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH20285449BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:50B>mRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH39847968AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:31BmRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH50335807 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH06396042 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies905.097 MN50 20 2560 905.097 C8O;dMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:31BmRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH50335807 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US206-1037B1EH06396042 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies640 MN Endpoint Titer20 2560 640 C(MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:31BmRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH58722334AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.1 AU/mL 18.1 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1043A 1EH28639274AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.6 AU/mL 17.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1043A01EH35730611AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 AU/mL 11.6 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:23B-mRNA-1273-P201ISmRNA-1273-P201-US206-1043A@1EH28639275AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.1 AU/mL 18.1 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:47B6mRNA-1273-P201ISmRNA-1273-P201-US206-1043AP1EH58722334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1043A`1EH28639274AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 ug/mL 3.9 A>ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1043Ap1EH35730611AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:23B-mRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH28639275AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:47B6mRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH58722495AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH28644521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH44115089AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:23B-mRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH20283433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:47B6mRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH48598036AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:40BmRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH58722495BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1043A1EH28644521BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T13:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1043B1EH44115089BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:23B-mRNA-1273-P201ISmRNA-1273-P201-US206-1043B1EH20283433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-29T16:00AmRNA-1273-P201ISmRNA-1273-P201-US206-1045A`1EH28640394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.7 ug/mL 21.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1045Ap1EH35732530AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.2 ug/mL 168.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:44B,mRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH28642313AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.8 ug/mL 151.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:50B5mRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH58818725AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T16:00AmRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH28644489AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 51.7 AU/mL 51.7 B333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH44114993AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1075 AU/mL 1075 CC0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:44B,mRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH20285576AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 743.5 AU/mL 743.5 C.xAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:50B5mRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH39846016AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.2 AU/mL 173.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH58818725BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T16:00AmRNA-1273-P201ISmRNA-1273-P201-US206-1045A1EH28644489BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T15:20BmRNA-1273-P201ISmRNA-1273-P201-US206-1045B1EH44114993BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T15:44B,mRNA-1273-P201ISmRNA-1273-P201-US206-1045B1EH20285576BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20T13:50B5mRNA-1273-P201ISmRNA-1273-P201-US206-1045B1EH39846016AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T16:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1045B1EH50435108 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1046A`1EH05604538AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:28BmRNA-1273-P201ISmRNA-1273-P201-US206-1046Ap1EH44151953AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:31B+mRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH28645545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH08656004AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH05608473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:28BmRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH44154035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:31B+mRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH20285609AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH39846914AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.1 AU/mL 54.1 B6AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:14BmRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH08656004BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:31AmRNA-1273-P201ISmRNA-1273-P201-US206-1046A1EH05608473BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T08:28BmRNA-1273-P201ISmRNA-1273-P201-US206-1046B1EH44154035BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T08:31B+mRNA-1273-P201ISmRNA-1273-P201-US206-1046B1EH20285609BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B9mRNA-1273-P201ISmRNA-1273-P201-US206-1046B1EH39846914AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.8 AU/mL 19.8 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:14BmRNA-1273-P201ISmRNA-1273-P201-US206-1046B1EH08654980 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:39AmRNA-1273-P201ISmRNA-1273-P201-US206-1051A`1EH28643464AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T15:22BmRNA-1273-P201ISmRNA-1273-P201-US206-1051Ap1EH35731507AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:33B+mRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH28644361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:27B8mRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH58819621AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T10:39AmRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH20284457AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.9 AU/mL 1.9 AffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T15:22BmRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH44115120AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:33B+mRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH20285481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:27B8mRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH39847075AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T15:12BmRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH58819621BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T10:39AmRNA-1273-P201ISmRNA-1273-P201-US206-1051A1EH20284457BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T15:22BmRNA-1273-P201ISmRNA-1273-P201-US206-1051B1EH44115120BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T09:33B+mRNA-1273-P201ISmRNA-1273-P201-US206-1051B1EH20285481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:27B8mRNA-1273-P201ISmRNA-1273-P201-US206-1051B1EH39847075AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T15:12BmRNA-1273-P201ISmRNA-1273-P201-US206-1051B1EH50435077 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:27AmRNA-1273-P201ISmRNA-1273-P201-US206-1053A`1EH28643368AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.7 ug/mL 13.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:51BmRNA-1273-P201ISmRNA-1273-P201-US206-1053Ap1EH44114064AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 120.2 ug/mL 120.2 Bx333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:02B-mRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH28640298AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.6 ug/mL 99.6 Bcug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:58B7mRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH08657924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T09:27AmRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH20285480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.3 AU/mL 29.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:51BmRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH44113939AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 701.3 AU/mL 701.3 C+AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:02B-mRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH20283528AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 465 AU/mL 465 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:58B7mRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH35730579AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.7 AU/mL 188.7 B33330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T11:51BmRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH08657924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:27AmRNA-1273-P201ISmRNA-1273-P201-US206-1053A1EH20285480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:51BmRNA-1273-P201ISmRNA-1273-P201-US206-1053B1EH44113939BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T11:02B-mRNA-1273-P201ISmRNA-1273-P201-US206-1053B1EH20283528CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T11:58B7mRNA-1273-P201ISmRNA-1273-P201-US206-1053B1EH35730579AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T11:51BmRNA-1273-P201ISmRNA-1273-P201-US206-1053B1EH08657028 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:08AmRNA-1273-P201ISmRNA-1273-P201-US206-1055A`1EH28641291AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:30BmRNA-1273-P201ISmRNA-1273-P201-US206-1055Ap1EH35730483AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH28643337AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:30B8mRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH58720447AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T09:08AmRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH28646443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:30BmRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH44116144AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH28643371AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:30B8mRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH48598165AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T09:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH58720447BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T09:08AmRNA-1273-P201ISmRNA-1273-P201-US206-1055A1EH28646443BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T08:30BmRNA-1273-P201ISmRNA-1273-P201-US206-1055B1EH44116144BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:47B+mRNA-1273-P201ISmRNA-1273-P201-US206-1055B1EH28643371BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:30B8mRNA-1273-P201ISmRNA-1273-P201-US206-1055B1EH48598165AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T09:13BmRNA-1273-P201ISmRNA-1273-P201-US206-1055B1EH50436260 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1057A`1EH28642345AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.5 ug/mL 11.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:44BmRNA-1273-P201ISmRNA-1273-P201-US206-1057Ap1EH35732626AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148 ug/mL 148 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:25B+mRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH28645385AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.3 ug/mL 108.3 BlLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:49B7mRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH08749064AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T13:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH28644394AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.3 AU/mL 38.3 B&LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:44BmRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH44114066AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 671.7 AU/mL 671.7 C)33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:25B+mRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH28643499AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 527.5 AU/mL 527.5 C AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:49B7mRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH48596148AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57.1 AU/mL 57.1 B9AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:10BmRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH08749064BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:30AmRNA-1273-P201ISmRNA-1273-P201-US206-1057A1EH28644394BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:44BmRNA-1273-P201ISmRNA-1273-P201-US206-1057B1EH44114066BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:25B+mRNA-1273-P201ISmRNA-1273-P201-US206-1057B1EH28643499BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:49B7mRNA-1273-P201ISmRNA-1273-P201-US206-1057B1EH48596148AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T10:10BmRNA-1273-P201ISmRNA-1273-P201-US206-1057B1EH00360489 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodiesffffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T16:14AmRNA-1273-P201ISmRNA-1273-P201-US206-1063A`1EH28640264AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1063Ap1EH28643369AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.1 ug/mL 41.1 B)ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T11:32B?mRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH58721342AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T16:14AmRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH20286504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15 AU/mL 15 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH28646538AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 371.2 AU/mL 371.2 C333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T11:32B?mRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH35729586AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 617 AU/mL 617 C&AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:26BmRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH58721342BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T16:14AmRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH20286504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T15:35BmRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH28646538BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T11:32B?mRNA-1273-P201ISmRNA-1273-P201-US206-1063A1EH35729586AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:26BmRNA-1273-P201ISmRNA-1273-P201-US206-1063B1EH50337854 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T15:57AmRNA-1273-P201ISmRNA-1273-P201-US206-1064A`1EH28639371AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.5 ug/mL 10.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T14:05BmRNA-1273-P201ISmRNA-1273-P201-US206-1064Ap1EH44114065AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.8 ug/mL 82.8 BRug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T13:19B+mRNA-1273-P201ISmRNA-1273-P201-US206-1064A1EH28642314AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.9 ug/mL 44.9 B,fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T13:18B8mRNA-1273-P201ISmRNA-1273-P201-US206-1064A1EH00364554AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T15:57AmRNA-1273-P201ISmRNA-1273-P201-US206-1064A1EH20285448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.9 AU/mL 29.9 BfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T14:05BmRNA-1273-P201ISmRNA-1273-P201-US206-1064A1EH44114961AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 355.8 AU/mL 355.8 CffffffA Visit 1 Day 1 ASCREENING 2020-06-30T08:41AmRNA-1273-P201ISmRNA-1273-P201-US206-1068A`1EH28642344AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.8 ug/mL 10.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:35B mRNA-1273-P201ISmRNA-1273-P201-US206-1068Ap1EH28646408AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.3 ug/mL 82.3 BRLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:13BAmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH58723358AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T08:41AmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH28644392AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.9 AU/mL 45.9 B-fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:35B mRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH28646442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 349.5 AU/mL 349.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:13BAmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH48595124AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105 AU/mL 105 BiAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T18:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH58723358BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T08:41AmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH28644392BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T08:35B mRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH28646442BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T08:13BAmRNA-1273-P201ISmRNA-1273-P201-US206-1068A1EH48595124AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T18:21BmRNA-1273-P201ISmRNA-1273-P201-US206-1068B1EH50335774 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1001A`1EH29661210AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37 ug/mL 37 B%ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:56B!mRNA-1273-P201ISmRNA-1273-P201-US207-1001Ap1EH63246471AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 264.1 ug/mL 264.1 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B2mRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH29662392AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 207.1 ug/mL 207.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH00036924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH21299217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.5 AU/mL 121.5 ByAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:56B!mRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH54888452AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 870.6 AU/mL 870.6 C6iAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B2mRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH29659194AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 810.2 AU/mL 810.2 C233334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH59877559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.6 AU/mL 137.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH00036924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1001A1EH21299217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:56B!mRNA-1273-P201ISmRNA-1273-P201-US207-1001B1EH54888452BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:00B2mRNA-1273-P201ISmRNA-1273-P201-US207-1001B1EH29659194BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1001B1EH59877559AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1001B1EH08394942 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:09AmRNA-1273-P201ISmRNA-1273-P201-US207-1002A`1EH21070853AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.6 ug/mL 79.6 BOug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:32BmRNA-1273-P201ISmRNA-1273-P201-US207-1002Ap1EH66391203AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 320.2 ug/mL 320.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T17:15B.mRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH29429927AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.1 ug/mL 193.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH00039069AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T10:09AmRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH21072903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 294.7 AU/mL 294.7 Ck33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:32BmRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH66392065AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1196.7 AU/mL 1196.7 CJ33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T17:15B.mRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH21069991AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 899.9 AU/mL 899.9 C8>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH59876404AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 177.1 AU/mL 177.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:47BmRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH00039069BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T10:09AmRNA-1273-P201ISmRNA-1273-P201-US207-1002A1EH21072903BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:32BmRNA-1273-P201ISmRNA-1273-P201-US207-1002B1EH66392065BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T17:15B.mRNA-1273-P201ISmRNA-1273-P201-US207-1002B1EH21069991BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US207-1002B1EH59876404AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:47BmRNA-1273-P201ISmRNA-1273-P201-US207-1002B1EH08392766 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:37AmRNA-1273-P201ISmRNA-1273-P201-US207-1003A`1EH29662233AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.9 ug/mL 22.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1003Ap1EH63247526AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 116 ug/mL 116 Btug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:56B,mRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH29432999AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 90 ug/mL 90 BZug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:24B9mRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH00037021AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:37AmRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH29660187AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.9 AU/mL 84.9 BTffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH54886437AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 603.4 AU/mL 603.4 C%fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:56B,mRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH21070983AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 378 AU/mL 378 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:24B9mRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH59877430AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.3 AU/mL 38.3 B&LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH00037021BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:37AmRNA-1273-P201ISmRNA-1273-P201-US207-1003A1EH29660187BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T12:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1003B1EH54886437BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T07:56B,mRNA-1273-P201ISmRNA-1273-P201-US207-1003B1EH21070983BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:24B9mRNA-1273-P201ISmRNA-1273-P201-US207-1003B1EH59877430AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1003B1EH08395807 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:46AmRNA-1273-P201ISmRNA-1273-P201-US207-1004A`1EH29432997AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.3 ug/mL 14.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:47B#mRNA-1273-P201ISmRNA-1273-P201-US207-1004Ap1EH29659163AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160 ug/mL 160 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:18B1mRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH56890418AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 116.1 ug/mL 116.1 Btug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T16:32B@mRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH00033982AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T08:46AmRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH21077125AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.3 AU/mL 28.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:47B#mRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH29660218AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 530.6 AU/mL 530.6 C!)AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:18B1mRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH65277072AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 437.7 AU/mL 437.7 CU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T16:32B@mRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH59877428AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.5 AU/mL 73.5 BIAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:46BmRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH00033982BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:46AmRNA-1273-P201ISmRNA-1273-P201-US207-1004A1EH21077125BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T08:47B#mRNA-1273-P201ISmRNA-1273-P201-US207-1004B1EH29660218BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:18B1mRNA-1273-P201ISmRNA-1273-P201-US207-1004B1EH65277072BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T16:32B@mRNA-1273-P201ISmRNA-1273-P201-US207-1004B1EH59877428AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T10:46BmRNA-1273-P201ISmRNA-1273-P201-US207-1004B1EH08392895 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:47AmRNA-1273-P201ISmRNA-1273-P201-US207-1005A`1EH21072932AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T14:27B#mRNA-1273-P201ISmRNA-1273-P201-US207-1005Ap1EH63246375AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:51B1mRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH63967376AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T08:55B<mRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH42046466AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T16:47AmRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH21071910AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T14:27B#mRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH54889509AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:51B1mRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH63968274AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T08:55B<mRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH59876372AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.5 AU/mL 151.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:21BmRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH42046466BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.1 AU/mL 14.1 AᙙAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T16:47AmRNA-1273-P201ISmRNA-1273-P201-US207-1005A1EH21071910BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.1 AU/mL 12.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T14:27B#mRNA-1273-P201ISmRNA-1273-P201-US207-1005B1EH54889509BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 AU/mL 10 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:51B1mRNA-1273-P201ISmRNA-1273-P201-US207-1005B1EH63968274BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 AU/mL 8.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T08:55B<mRNA-1273-P201ISmRNA-1273-P201-US207-1005B1EH59876372BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies . NOT DONETERMINATED PER CLIENT REQUEST PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:21BmRNA-1273-P201ISmRNA-1273-P201-US207-1005B1EH42042529 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1006A`1EH29659193AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 39.9 ug/mL 39.9 B'fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:45BmRNA-1273-P201ISmRNA-1273-P201-US207-1006Ap1EH63247367AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 322.8 ug/mL 322.8 C,ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:53B+mRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH24382618AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 266.8 ug/mL 266.8 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:37B8mRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH00036893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH21301264AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 236.5 AU/mL 236.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:45BmRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH54888485AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1761.3 AU/mL 1761.3 CnAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:53B+mRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH24380475AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1185.8 AU/mL 1185.8 CJAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:37B8mRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH59876532AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.2 AU/mL 128.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH00036893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1006A1EH21301264BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T08:45BmRNA-1273-P201ISmRNA-1273-P201-US207-1006B1EH54888485BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T08:53B+mRNA-1273-P201ISmRNA-1273-P201-US207-1006B1EH24380475BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T08:37B8mRNA-1273-P201ISmRNA-1273-P201-US207-1006B1EH59876532AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1006B1EH08395838 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:33AmRNA-1273-P201ISmRNA-1273-P201-US207-1007A`1EH21071877AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.9 ug/mL 35.9 B#fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:16B$mRNA-1273-P201ISmRNA-1273-P201-US207-1007Ap1EH63246502AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.9 ug/mL 168.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH56892466AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128.5 ug/mL 128.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:50BBmRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH00299150AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T10:33AmRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH21073956AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146 AU/mL 146 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:16B$mRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH54889605AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 706.4 AU/mL 706.4 C,&fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH65276049AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 569.2 AU/mL 569.2 C#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:50BBmRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH03255434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.8 AU/mL 73.8 BIAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:57BmRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH00299150BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T10:33AmRNA-1273-P201ISmRNA-1273-P201-US207-1007A1EH21073956BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:16B$mRNA-1273-P201ISmRNA-1273-P201-US207-1007B1EH54889605BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1007B1EH65276049BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:50BBmRNA-1273-P201ISmRNA-1273-P201-US207-1007B1EH03255434AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T15:57BmRNA-1273-P201ISmRNA-1273-P201-US207-1007B1EH00300076 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:54AmRNA-1273-P201ISmRNA-1273-P201-US207-1012A`1EH21072933AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1012Ap1EH29661368AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:20B2mRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH56890387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:25B@mRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH00036892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:54AmRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH21075972AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH29661339AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:20B2mRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH65275025AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:25B@mRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH59875511AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 55.9 AU/mL 55.9 B7fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:42BmRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH00036892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:54AmRNA-1273-P201ISmRNA-1273-P201-US207-1012A1EH21075972BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1012B1EH29661339BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:20B2mRNA-1273-P201ISmRNA-1273-P201-US207-1012B1EH65275025BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T08:25B@mRNA-1273-P201ISmRNA-1273-P201-US207-1012B1EH59875511AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 33.8 AU/mL 33.8 B!AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T09:42BmRNA-1273-P201ISmRNA-1273-P201-US207-1012B1EH08395935 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1013A`1EH29660312AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.6 ug/mL 32.6 B ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:32B&mRNA-1273-P201ISmRNA-1273-P201-US207-1013Ap1EH34965511AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 358.3 ug/mL 358.3 Cdug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:00B4mRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH49385607AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 290.6 ug/mL 290.6 C)ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH10487973AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH29662266AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.7 AU/mL 115.7 Bs33334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:32B&mRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH34968710AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1168 AU/mL 1168 CIAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:00B4mRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH49387559AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1088.3 AU/mL 1088.3 CDAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH03252395AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 128 AU/mL 128 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T13:59BmRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH10487973BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1013A1EH29662266BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T14:32B&mRNA-1273-P201ISmRNA-1273-P201-US207-1013B1EH34968710BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:00B4mRNA-1273-P201ISmRNA-1273-P201-US207-1013B1EH49387559BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T15:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1013B1EH03252395AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T13:59BmRNA-1273-P201ISmRNA-1273-P201-US207-1013B1EH02098342 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:44AmRNA-1273-P201ISmRNA-1273-P201-US207-1014A`1EH21071908AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:40B"mRNA-1273-P201ISmRNA-1273-P201-US207-1014Ap1EH63969297AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:38B2mRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH56892595AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:12B?mRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH00039068AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:44AmRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH21075077AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:40B"mRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH63970450AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:38B2mRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH65273905AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:12B?mRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH03255307AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T15:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH00039068BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:44AmRNA-1273-P201ISmRNA-1273-P201-US207-1014A1EH21075077BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T13:40B"mRNA-1273-P201ISmRNA-1273-P201-US207-1014B1EH63970450BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:38B2mRNA-1273-P201ISmRNA-1273-P201-US207-1014B1EH65273905BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:12B?mRNA-1273-P201ISmRNA-1273-P201-US207-1014B1EH03255307AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T15:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1014B1EH08395839 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1016AP1EH44074145AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1016A`1EH29430820AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.8 ug/mL 36.8 B$ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:18B$mRNA-1273-P201ISmRNA-1273-P201-US207-1016Ap1EH63248390AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 237.4 ug/mL 237.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T16:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH49387655AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.1 ug/mL 168.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:25B>mRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH44079265AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH21077156AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.4 AU/mL 154.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:18B$mRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH54886405AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1362 AU/mL 1362 CU AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T16:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH49385511AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 872.4 AU/mL 872.4 C6fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:25B>mRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH59877556AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.1 AU/mL 46.1 B.AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH44079265BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1016A1EH21077156BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T12:18B$mRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH54886405BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T16:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH49385511BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T17:25B>mRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH59877556AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH44045315 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH51488822 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies565.685 MN50 20 2560 565.685 C#Z\(MN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH44045315 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1016B1EH51488822 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies160 MN Endpoint Titer20 2560 160 BMN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH08391682AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.6 AU/mL 28.6 BAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1017A 1EH29430919AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.8 AU/mL 24.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1017A01EH63249446AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27 AU/mL 27 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:22B+mRNA-1273-P201ISmRNA-1273-P201-US207-1017A@1EH30475274AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27.8 AU/mL 27.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T17:48BNmRNA-1273-P201ISmRNA-1273-P201-US207-1017AP1EH08391682AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.9 ug/mL 9.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1017A`1EH29430919AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1017Ap1EH63249446AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.9 ug/mL 9.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:22B+mRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH30475274AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 ug/mL 9.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T17:48BNmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH08392864AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T15:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH21074085AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH54889476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:22B+mRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH30480393AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T17:48BNmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH59877399AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH08392864BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T15:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1017A1EH21074085BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T14:06BmRNA-1273-P201ISmRNA-1273-P201-US207-1017B1EH54889476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T15:22B+mRNA-1273-P201ISmRNA-1273-P201-US207-1017B1EH30480393BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 AU/mL 8.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18T17:48BNmRNA-1273-P201ISmRNA-1273-P201-US207-1017B1EH59877399AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T15:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1017B1EH42044544 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T11:23AmRNA-1273-P201ISmRNA-1273-P201-US207-1022A`1EH29432869AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.6 ug/mL 8.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1022Ap1EH43326502AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 ug/mL 8.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:26B-mRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH56889491AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:07BAmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH00038940AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T11:23AmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH21069959AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH34968742AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:26B-mRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH65277104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:07BAmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH59875349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH00038940BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T11:23AmRNA-1273-P201ISmRNA-1273-P201-US207-1022A1EH21069959BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T10:29BmRNA-1273-P201ISmRNA-1273-P201-US207-1022B1EH34968742BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T10:26B-mRNA-1273-P201ISmRNA-1273-P201-US207-1022B1EH65277104BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T11:07BAmRNA-1273-P201ISmRNA-1273-P201-US207-1022B1EH59875349AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1022B1EH08395934 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1024AP1EH00299023AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:15AmRNA-1273-P201ISmRNA-1273-P201-US207-1024A`1EH21070852AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:34B"mRNA-1273-P201ISmRNA-1273-P201-US207-1024Ap1EH63249414AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 93.3 ug/mL 93.3 B]Lug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:45B1mRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH27632808AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.4 ug/mL 47.4 B/ffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:18B>mRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH00299151AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T14:15AmRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH21076101AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.8 AU/mL 30.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:34B"mRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH54888612AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 313.9 AU/mL 313.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:45B1mRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH27634856AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188 AU/mL 188 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T09:18B>mRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH59878548AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.6 AU/mL 45.6 B-AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:17BmRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH00299151BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T14:15AmRNA-1273-P201ISmRNA-1273-P201-US207-1024A1EH21076101BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:34B"mRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH54888612BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:45B1mRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH27634856BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH59878548AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:17BmRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH00302220 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH51486775 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1024B1EH51486775 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1025A`1EH21072901AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.7 ug/mL 25.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:30B$mRNA-1273-P201ISmRNA-1273-P201-US207-1025Ap1EH29662361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.1 ug/mL 173.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH56892435AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.1 ug/mL 134.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T10:30B@mRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH00033854AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH21073030AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103 AU/mL 103 BgAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:30B$mRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH29659195AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1129.6 AU/mL 1129.6 CFAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH65276945AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 862.7 AU/mL 862.7 C533334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T10:30B@mRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH59876500AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.5 AU/mL 84.5 BTAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH00033854BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.7 AU/mL 9.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1025A1EH21073030BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T10:30B$mRNA-1273-P201ISmRNA-1273-P201-US207-1025B1EH29659195BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 AU/mL 8.8 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T10:08B2mRNA-1273-P201ISmRNA-1273-P201-US207-1025B1EH65276945BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.7 AU/mL 7.7 A{333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T10:30B@mRNA-1273-P201ISmRNA-1273-P201-US207-1025B1EH59876500AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1025B1EH08393918 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 A .mRNA-1273-P201ISmRNA-1273-P201-US207-1026Ap1EH29660345AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.9 ug/mL 11.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T14:06B$mRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH15796250AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.6 ug/mL 71.6 BGug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T14:25B5mRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH30476298AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.2 ug/mL 50.2 B2333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:49BBmRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH10485924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 A .mRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH29661242AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 37.1 AU/mL 37.1 B%AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T14:06B$mRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH15797275AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 338.2 AU/mL 338.2 C#33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T14:25B5mRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH30478377AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 117.8 AU/mL 117.8 BuAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:49BBmRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH59878549AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.4 AU/mL 29.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T11:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1026A1EH10485924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 A .mRNA-1273-P201ISmRNA-1273-P201-US207-1026B1EH29661242BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T14:06B$mRNA-1273-P201ISmRNA-1273-P201-US207-1026B1EH15797275BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T14:25B5mRNA-1273-P201ISmRNA-1273-P201-US207-1026B1EH30478377BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T14:49BBmRNA-1273-P201ISmRNA-1273-P201-US207-1026B1EH59878549AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T11:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1026B1EH02101252 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodiesffffff. . .mRNA-1273-P201ISmRNA-1273-P201-US207-1027A01EH29660314AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.2 AU/mL 190.2 B333330AU/mL PPD VACCINESERUMELISA A. . .mRNA-1273-P201ISmRNA-1273-P201-US207-1027A@1EH29660314BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffff. . .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A ISALL All Immunogenicity Assessments Serum SARS-CoV-2 Binding Antibodies . NOT DONE .ApVisit 6 Day 43 B+ .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A ISALL All Immunogenicity Assessments Serum SARS-CoV-2 Binding Antibodies . NOT DONE .AVisit 7 Day 57 B9 .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A01EH02103463AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T16:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1029A@1EH29661369AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22 AU/mL 22 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1029AP1EH24380570AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <9 AU/mL <9 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+ .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A`1EH02103463AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T16:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1029Ap1EH29661369AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.9 ug/mL 12.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH24380570AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.7 ug/mL 21.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+ .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH10487941AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T16:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH29662234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.7 AU/mL 30.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH24382522AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 53.9 AU/mL 53.9 B5fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+ .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH10487941BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T16:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH29662234BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH24382522BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+ .mRNA-1273-P201ISmRNA-1273-P201-US207-1029A1EH02098343 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1030A`1EH21069829AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.2 ug/mL 43.2 B+333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:55B"mRNA-1273-P201ISmRNA-1273-P201-US207-1030Ap1EH21071013AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 225.3 ug/mL 225.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T16:42B3mRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH30476299AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.9 ug/mL 154.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T16:35BFmRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH00301198AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T16:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH21074981AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 180.8 AU/mL 180.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:55B"mRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH21073062AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 811.9 AU/mL 811.9 C2fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T16:42B3mRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH30477451AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 519.6 AU/mL 519.6 C yAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T16:35BFmRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH59875510AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.5 AU/mL 80.5 BPAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH00301198BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T16:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1030A1EH21074981BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T16:55B"mRNA-1273-P201ISmRNA-1273-P201-US207-1030B1EH21073062BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T16:42B3mRNA-1273-P201ISmRNA-1273-P201-US207-1030B1EH30477451BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T16:35BFmRNA-1273-P201ISmRNA-1273-P201-US207-1030B1EH59875510AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T09:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1030B1EH00302124 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T18:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1032A`1EH29661241AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.4 ug/mL 20.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:18B!mRNA-1273-P201ISmRNA-1273-P201-US207-1032Ap1EH24382490AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218 ug/mL 218 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T15:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH30475304AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.3 ug/mL 115.3 BsLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:47BBmRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH21070982AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T18:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH21299216AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.4 AU/mL 84.4 BTfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:18B!mRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH24380571AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 755.9 AU/mL 755.9 C/>fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T15:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH30475306AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 528.4 AU/mL 528.4 C!fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:47BBmRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH59875509AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.7 AU/mL 54.7 B633334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:30BmRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH21070982BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T18:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1032A1EH21299216BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T08:18B!mRNA-1273-P201ISmRNA-1273-P201-US207-1032B1EH24380571BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 AU/mL 8.5 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T15:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1032B1EH30475306BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12T15:47BBmRNA-1273-P201ISmRNA-1273-P201-US207-1032B1EH59875509AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:30BmRNA-1273-P201ISmRNA-1273-P201-US207-1032B1EH21041157 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1033A`1EH21073029AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.2 ug/mL 38.2 B&333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:28B mRNA-1273-P201ISmRNA-1273-P201-US207-1033Ap1EH29429798AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.9 ug/mL 188.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T09:31B/mRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH30474411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 138.4 ug/mL 138.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T09:27BCmRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH00038972AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH21070854AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 158.7 AU/mL 158.7 B33330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:28B mRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH21069990AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 673.8 AU/mL 673.8 C*AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T09:31B/mRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH30475435AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 366.2 AU/mL 366.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T09:27BCmRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH59878581AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 122.5 AU/mL 122.5 BzAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T11:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH00038972BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1033A1EH21070854BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:28B mRNA-1273-P201ISmRNA-1273-P201-US207-1033B1EH21069990BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T09:31B/mRNA-1273-P201ISmRNA-1273-P201-US207-1033B1EH30475435BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T09:27BCmRNA-1273-P201ISmRNA-1273-P201-US207-1033B1EH59878581AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T11:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1033B1EH08393791 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1036A`1EH29659162AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.3 ug/mL 28.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1036Ap1EH15795224AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 272.4 ug/mL 272.4 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T14:35B4mRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH30477481AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 210.4 ug/mL 210.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:49BAmRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH44046524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH29660219AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.3 AU/mL 109.3 BmLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH15798424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1217.3 AU/mL 1217.3 CLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T14:35B4mRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH30478344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 655.2 AU/mL 655.2 C(33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:49BAmRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH03253258AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.6 AU/mL 137.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T10:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH44046524BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1036A1EH29660219BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1036B1EH15798424BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US207-1037AP1EH42048512AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:11AmRNA-1273-P201ISmRNA-1273-P201-US207-1037A`1EH29431943AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 ug/mL 13.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:32B#mRNA-1273-P201ISmRNA-1273-P201-US207-1037Ap1EH21071909AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.4 ug/mL 131.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T10:28B4mRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH63969457AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 116.6 ug/mL 116.6 Btug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:22B>mRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH08393728AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:11AmRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH21075973AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.4 AU/mL 48.4 B0ffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:32B#mRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH21076005AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 553.2 AU/mL 553.2 C"33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T10:28B4mRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH63968403AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 484.1 AU/mL 484.1 CAAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:22B>mRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH59875476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 86.4 AU/mL 86.4 BVfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:16BmRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH08393728BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 AU/mL 10.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:11AmRNA-1273-P201ISmRNA-1273-P201-US207-1037A1EH21075973BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:32B#mRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH21076005BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 AU/mL 10 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T10:28B4mRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH63968403BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.1 AU/mL 11.1 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:22B>mRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH59875476AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 AU/mL 8.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:16BmRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH08390816 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH51489974 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1037B1EH51489974 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:08AmRNA-1273-P201ISmRNA-1273-P201-US207-1038A`1EH29662232AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.1 ug/mL 100.1 Bdug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T08:34B(mRNA-1273-P201ISmRNA-1273-P201-US207-1038Ap1EH15796409AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 412.6 ug/mL 412.6 Cəug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T08:58B8mRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH30475305AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 314.2 ug/mL 314.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:50BEmRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH00037020AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T13:08AmRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH29659323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.6 AU/mL 203.6 B˙AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T08:34B(mRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH15796379AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1537.1 AU/mL 1537.1 C`AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T08:58B8mRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH30475403AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1365 AU/mL 1365 CUPAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:50BEmRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH03255435AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 394 AU/mL 394 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T11:19BmRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH00037020BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T13:08AmRNA-1273-P201ISmRNA-1273-P201-US207-1038A1EH29659323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T08:34B(mRNA-1273-P201ISmRNA-1273-P201-US207-1038B1EH15796379BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29T08:58B8mRNA-1273-P201ISmRNA-1273-P201-US207-1038B1EH30475403BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T14:50BEmRNA-1273-P201ISmRNA-1273-P201-US207-1038B1EH03255435AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T11:19BmRNA-1273-P201ISmRNA-1273-P201-US207-1038B1EH08393886 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T16:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1039AP1EH15796280AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T16:23B8mRNA-1273-P201ISmRNA-1273-P201-US207-1039A`1EH30476331AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 454.1 ug/mL 454.1 Caug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T17:07BFmRNA-1273-P201ISmRNA-1273-P201-US207-1039Ap1EH10485796AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T16:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH15795355AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1763.9 AU/mL 1763.9 Cn>ffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T16:23B8mRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH30480425AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1580.6 AU/mL 1580.6 CbəAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T17:07BFmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH59875508AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 292 AU/mL 292 C@AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH10485796BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T16:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH15795355BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30T16:23B8mRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH30480425BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T17:07BFmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH59875508AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1039A1EH02100390 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1040A`1EH29660217AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 76.9 ug/mL 76.9 BLffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:04B$mRNA-1273-P201ISmRNA-1273-P201-US207-1040Ap1EH63968400AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 220.7 ug/mL 220.7 Bܳ33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH30477353AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.7 ug/mL 193.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:37B@mRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH00038973AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T12:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH29660347AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 340.8 AU/mL 340.8 CLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:04B$mRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH63969298AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1390.4 AU/mL 1390.4 CVffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH30478473AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 937.9 AU/mL 937.9 C:fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:37B@mRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH59875350AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.7 AU/mL 109.7 Bm33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:12BmRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH00038973BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T12:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1040A1EH29660347BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T12:04B$mRNA-1273-P201ISmRNA-1273-P201-US207-1040B1EH63969298BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US207-1040B1EH30478473BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:37B@mRNA-1273-P201ISmRNA-1273-P201-US207-1040B1EH59875350AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T09:12BmRNA-1273-P201ISmRNA-1273-P201-US207-1040B1EH08395966 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:35AmRNA-1273-P201ISmRNA-1273-P201-US207-1041A`1EH29429799AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1041Ap1EH66389155AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH29432966AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH00036031AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T08:35AmRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH21074055AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH66394112AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH21076996AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH59878452AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.9 AU/mL 64.9 B@ffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:34BmRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH00036031BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T08:35AmRNA-1273-P201ISmRNA-1273-P201-US207-1041A1EH21074055BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T08:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1041B1EH66394112BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T08:32B.mRNA-1273-P201ISmRNA-1273-P201-US207-1041B1EH21076996BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:42B9mRNA-1273-P201ISmRNA-1273-P201-US207-1041B1EH59878452AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.4 AU/mL 96.4 B`fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T08:34BmRNA-1273-P201ISmRNA-1273-P201-US207-1041B1EH08393758 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1042A`1EH21072037AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1042Ap1EH34965509AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH56889394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:08BAmRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH00301199AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T14:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH21076100AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH34969605AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH65276048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:08BAmRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH03255338AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T10:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH00301199BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T14:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1042A1EH21076100BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:27B$mRNA-1273-P201ISmRNA-1273-P201-US207-1042B1EH34969605BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:09B2mRNA-1273-P201ISmRNA-1273-P201-US207-1042B1EH65276048CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:08BAmRNA-1273-P201ISmRNA-1273-P201-US207-1042B1EH03255338AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T10:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1042B1EH00302221 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1043AP1EH00034878AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:13AmRNA-1273-P201ISmRNA-1273-P201-US207-1043A`1EH21071876AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.4 ug/mL 12.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1043Ap1EH63247494AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.7 ug/mL 100.7 Bd33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:07B0mRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH49385510AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.9 ug/mL 45.9 B-fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:36B>mRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH00033855AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T12:13AmRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH21072038AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.6 AU/mL 24.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH54887460AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 515.5 AU/mL 515.5 C 8AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:07B0mRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH49387558AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 406.5 AU/mL 406.5 ChAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:36B>mRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH59877524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 38.3 AU/mL 38.3 B&LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH00033855BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T12:13AmRNA-1273-P201ISmRNA-1273-P201-US207-1043A1EH21072038BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T11:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH54887460BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T11:07B0mRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH49387558BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T11:36B>mRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH59877524AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:28BmRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH08393790 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH51490836 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1043B1EH51490836 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1044A`1EH29661211AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:39B mRNA-1273-P201ISmRNA-1273-P201-US207-1044Ap1EH24380443AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:34B/mRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH56891539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:32B<mRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH44044444AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH29662235AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:39B mRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH24382619AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:34B/mRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH65276081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:32B<mRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH59878420AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T14:52BmRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH44044444BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1044A1EH29662235BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:39B mRNA-1273-P201ISmRNA-1273-P201-US207-1044B1EH24382619BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:34B/mRNA-1273-P201ISmRNA-1273-P201-US207-1044B1EH65276081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:32B<mRNA-1273-P201ISmRNA-1273-P201-US207-1044B1EH59878420AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T14:52BmRNA-1273-P201ISmRNA-1273-P201-US207-1044B1EH35658814 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US207-1046A`1EH21069828AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:38B"mRNA-1273-P201ISmRNA-1273-P201-US207-1046Ap1EH63248422AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:22B0mRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH30474410AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T16:29BEmRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH00299054AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH21077124AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:38B"mRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH54889477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:22B0mRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH30480424AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T16:29BEmRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH03254442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-30T09:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH00299054BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T10:43AmRNA-1273-P201ISmRNA-1273-P201-US207-1046A1EH21077124BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:21AmRNA-1273-P201ISmRNA-1273-P201-US207-1049A`1EH29432967AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 ug/mL 10.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:07B#mRNA-1273-P201ISmRNA-1273-P201-US207-1049Ap1EH63249574AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.9 ug/mL 10.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:32B0mRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH56889363AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11 ug/mL 11 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:22B@mRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH44079232AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T09:21AmRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH21072006AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.9 AU/mL 2.9 A.ffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:07B#mRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH54886565AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.4 AU/mL 2.4 A&ffffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:32B0mRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH65275921AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.4 AU/mL 2.4 A&ffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:22B@mRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH59877558AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.2 AU/mL 2.2 A#333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH44079232BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:21AmRNA-1273-P201ISmRNA-1273-P201-US207-1049A1EH21072006BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:07B#mRNA-1273-P201ISmRNA-1273-P201-US207-1049B1EH54886565BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:32B0mRNA-1273-P201ISmRNA-1273-P201-US207-1049B1EH65275921BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:22B@mRNA-1273-P201ISmRNA-1273-P201-US207-1049B1EH59877558AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1049B1EH44045440 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:53AmRNA-1273-P201ISmRNA-1273-P201-US207-1050A`1EH29429926AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 ug/mL 8.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1050Ap1EH63247495AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:16B/mRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH56889522AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.4 ug/mL 9.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:19B@mRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH00036925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T12:53AmRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH21077029AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH54886436AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:16B/mRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH65276080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:19B@mRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH59877429AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.2 AU/mL 167.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:37BmRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH00036925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:53AmRNA-1273-P201ISmRNA-1273-P201-US207-1050A1EH21077029BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1050B1EH54886436BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:16B/mRNA-1273-P201ISmRNA-1273-P201-US207-1050B1EH65276080BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T08:19B@mRNA-1273-P201ISmRNA-1273-P201-US207-1050B1EH59877429AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.6 AU/mL 50.6 B2AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:37BmRNA-1273-P201ISmRNA-1273-P201-US207-1050B1EH08393759 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1051A`1EH29431846AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48.3 ug/mL 48.3 B0Lug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:42B!mRNA-1273-P201ISmRNA-1273-P201-US207-1051Ap1EH63246503AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 374.1 ug/mL 374.1 Caug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH63970480AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.9 ug/mL 193.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH44046493AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH21073063AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 245.3 AU/mL 245.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:42B!mRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH54887557AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1984.8 AU/mL 1984.8 C| AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH63969458AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1113.6 AU/mL 1113.6 CEAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH59877398AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 195 AU/mL 195 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:38BmRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH44046493BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1051A1EH21073063CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:42B!mRNA-1273-P201ISmRNA-1273-P201-US207-1051B1EH54887557BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T11:30B/mRNA-1273-P201ISmRNA-1273-P201-US207-1051B1EH63969458BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1051B1EH59877398AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T11:38BmRNA-1273-P201ISmRNA-1273-P201-US207-1051B1EH35658943 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1059A`1EH29432870AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:03BmRNA-1273-P201ISmRNA-1273-P201-US207-1059Ap1EH29660344AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 ug/mL 12.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T11:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH56890547AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.6 ug/mL 13.6 Aٙug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:26B:mRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH00035999AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH21076006AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:03BmRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH29662363AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T11:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH65276944AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:26B:mRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH59876405AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH00035999BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1059A1EH21076006BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:03BmRNA-1273-P201ISmRNA-1273-P201-US207-1059B1EH29662363BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T11:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1059B1EH65276944BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T11:26B:mRNA-1273-P201ISmRNA-1273-P201-US207-1059B1EH59876405AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1059B1EH08394943 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1062AP1EH02102407AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9 ug/mL 9 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1062A`1EH21069861AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.7 ug/mL 8.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1062Ap1EH66428042AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:31B0mRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH56889523AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH10487845AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T15:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH21072934AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH66425898AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:31B0mRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH65274928AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH59877396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.8 AU/mL 114.8 BrAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH10487845BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.7 AU/mL 16.7 B33333AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T15:50AmRNA-1273-P201ISmRNA-1273-P201-US207-1062A1EH21072934BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.8 AU/mL 13.8 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T14:20B"mRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH66425898BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.7 AU/mL 12.7 A333330AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T14:31B0mRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH65274928BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.6 AU/mL 14.6 A陙AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T12:33B>mRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH59877396AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 297 AU/mL 297 CAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH02103301 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH51486870 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies905.097 MN50 20 2560 905.097 C8O;dMN50 BATTELLE SERUM C\(AVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH02103301 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1062B1EH51486870 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies640 MN Endpoint Titer20 2560 640 C(MN Endpoint Titer BATTELLE SERUM BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1063A1EH44041247AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 21.4 AU/mL 21.4 BffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1063A 1EH29660216AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.8 AU/mL 19.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T15:53B$mRNA-1273-P201ISmRNA-1273-P201-US207-1063A01EH63969329AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.3 AU/mL 18.3 BLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T14:09B3mRNA-1273-P201ISmRNA-1273-P201-US207-1063A@1EH56891538AV58IGGENVAC58 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 AU/mL 17.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:29B@mRNA-1273-P201ISmRNA-1273-P201-US207-1063AP1EH44041247AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T16:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1063A`1EH29660216AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.6 ug/mL 19.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T15:53B$mRNA-1273-P201ISmRNA-1273-P201-US207-1063Ap1EH63969329AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 139 ug/mL 139 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T14:09B3mRNA-1273-P201ISmRNA-1273-P201-US207-1063A1EH56891538AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.6 ug/mL 106.6 Bjug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:29B@mRNA-1273-P201ISmRNA-1273-P201-US207-1063A1EH44046396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T16:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1063A1EH29659322AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.8 AU/mL 60.8 BffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:51AmRNA-1273-P201ISmRNA-1273-P201-US207-1064A`1EH29660313AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.8 ug/mL 6.8 Alug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T16:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1064Ap1EH63247366AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:11B.mRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH30476426AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:26B@mRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH44046365AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.1 AU/mL 11.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T14:51AmRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH29661371AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T16:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH54886564AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:11B.mRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH30478376AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:26B@mRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH59875348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.9 AU/mL 15.9 AfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:14BmRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH44046365BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T14:51AmRNA-1273-P201ISmRNA-1273-P201-US207-1064A1EH29661371BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T16:12B#mRNA-1273-P201ISmRNA-1273-P201-US207-1064B1EH54886564BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:11B.mRNA-1273-P201ISmRNA-1273-P201-US207-1064B1EH30478376BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T13:26B@mRNA-1273-P201ISmRNA-1273-P201-US207-1064B1EH59875348AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T12:14BmRNA-1273-P201ISmRNA-1273-P201-US207-1064B1EH35658911 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-09T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1066A`1EH29429766AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T14:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1066Ap1EH63249542AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.8 ug/mL 8.8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T10:55B*mRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH49385606AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 62.5 ug/mL 62.5 B>ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T12:24B8mRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH21073926AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-09T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH21073924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T14:10BmRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH54886532AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.2 AU/mL 2.2 A#333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T10:55B*mRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH49385638AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.8 AU/mL 67.8 BCAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T12:24B8mRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH59875381AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17 AU/mL 17 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T16:05BmRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH21073926BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-09T13:38AmRNA-1273-P201ISmRNA-1273-P201-US207-1066A1EH21073924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1067A`1EH29431942AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40 ug/mL 40 B(ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T16:57B"mRNA-1273-P201ISmRNA-1273-P201-US207-1067Ap1EH29662264AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 221.8 ug/mL 221.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH30475402AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157.1 ug/mL 157.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T12:24BFmRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH10487972AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T11:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH21073958AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.2 AU/mL 141.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T16:57B"mRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH29662394AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1594.3 AU/mL 1594.3 CcAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH30481416AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 733.2 AU/mL 733.2 C-33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T12:24BFmRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH59877527AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 59.7 AU/mL 59.7 B;33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH10487972BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:20AmRNA-1273-P201ISmRNA-1273-P201-US207-1067A1EH21073958BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T16:57B"mRNA-1273-P201ISmRNA-1273-P201-US207-1067B1EH29662394BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T12:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1067B1EH30481416BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13T12:24BFmRNA-1273-P201ISmRNA-1273-P201-US207-1067B1EH59877527AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1067B1EH02101253 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1068Ap1EH29431815AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 108.7 ug/mL 108.7 Bl33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:36BmRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH63246343AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >487 ug/mL >487 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:51B+mRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH65275920AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 314.8 ug/mL 314.8 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T14:49B:mRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH56892594AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies . NOT DONEVISIT CHANGED AFTER SAMPLE RECONCILIATIONPPD VACCINESERUMELISA A>ffffff. .PART A FOLLOW-UP 2020-08-04T14:49B:mRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH00035998AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH21073957AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 446.2 AU/mL 446.2 C33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:36BmRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH54888484AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:51B+mRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH65275920BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1978.4 AU/mL 1978.4 C{ffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T14:49B:mRNA-1273-P201ISmRNA-1273-P201-US207-1068A1EH03253291AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 260 AU/mL 260 C@AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T13:24BmRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH00035998BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH21073957CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:36BmRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH54888484BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 AU/mL 7.1 AqAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:51B+mRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH65275920CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 AU/mL 8 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T14:49B:mRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH03253291AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T13:24BmRNA-1273-P201ISmRNA-1273-P201-US207-1068B1EH08392767 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:16AmRNA-1273-P201ISmRNA-1273-P201-US207-1069A`1EH29659321AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.1 ug/mL 42.1 B*ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T10:25B$mRNA-1273-P201ISmRNA-1273-P201-US207-1069Ap1EH63968272AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 358.2 ug/mL 358.2 Cc33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:14B3mRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH30475432AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 271.9 ug/mL 271.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T11:01BGmRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH10486788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T10:16AmRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH29661370AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 212.5 AU/mL 212.5 BԀAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T10:25B$mRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH63970355AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1427 AU/mL 1427 CY0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:14B3mRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH30478505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1237.4 AU/mL 1237.4 CMVffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T11:01BGmRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH03253387AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 905.5 AU/mL 905.5 C8AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T13:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH10486788BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:16AmRNA-1273-P201ISmRNA-1273-P201-US207-1069A1EH29661370BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T10:25B$mRNA-1273-P201ISmRNA-1273-P201-US207-1069B1EH63970355BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28T11:14B3mRNA-1273-P201ISmRNA-1273-P201-US207-1069B1EH30478505BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17T11:01BGmRNA-1273-P201ISmRNA-1273-P201-US207-1069B1EH03253387AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T13:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1069B1EH02100391 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1070A`1EH29661240AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1070Ap1EH63248519AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:08B,mRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH56891411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:09B:mRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH00035871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.6 AU/mL 2.6 A)AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T10:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH29660315AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH54889508AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.7 AU/mL 2.7 A+333334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:08B,mRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH65275952AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:09B:mRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH59875383AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.5 AU/mL 190.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:53BmRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH00035871BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T10:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1070A1EH29660315BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T08:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1070B1EH54889508BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:08B,mRNA-1273-P201ISmRNA-1273-P201-US207-1070B1EH65275952CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:09B:mRNA-1273-P201ISmRNA-1273-P201-US207-1070B1EH59875383AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.8 AU/mL 30.8 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T14:53BmRNA-1273-P201ISmRNA-1273-P201-US207-1070B1EH08395806 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1071A`1EH29432998AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.9 ug/mL 44.9 B,fffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1071Ap1EH21069988AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.6 ug/mL 151.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T15:04B1mRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH30476330AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137 ug/mL 137 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T12:55BDmRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH10485797AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T11:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH21075975AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 179.4 AU/mL 179.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH21073959AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 845.6 AU/mL 845.6 C4ٙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T15:04B1mRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH30477355AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 464.6 AU/mL 464.6 C AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T12:55BDmRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH03254443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.5 AU/mL 77.5 BMAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:25BmRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH10485797BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1071A1EH21075975BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:25B!mRNA-1273-P201ISmRNA-1273-P201-US207-1071B1EH21073959BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T15:04B1mRNA-1273-P201ISmRNA-1273-P201-US207-1071B1EH30477355BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T12:55BDmRNA-1273-P201ISmRNA-1273-P201-US207-1071B1EH03254443AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:25BmRNA-1273-P201ISmRNA-1273-P201-US207-1071B1EH02100263 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1072Ap1EH34965638AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH29432965AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies . NOT DONEVISIT CHANGED AFTER SAMPLE RECONCILIATIONPPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH63246470AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 ug/mL 9.5 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH30477323AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T07:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH10487844AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T12:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH21076102AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH54887461AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH30479368AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T07:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1072A1EH59878422AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T07:57BmRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH34967590AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA A. .BLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH10487844BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T12:42AmRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH21076102BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH54887461BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH30479368BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31T07:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH59878422AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T07:57BmRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH34967590BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffff. .BLINDED TREATMENT 2020-07-06T08:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1072B1EH02103300 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:24AmRNA-1273-P201ISmRNA-1273-P201-US207-1073A`1EH21071012AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.2 ug/mL 64.2 B@333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:07BmRNA-1273-P201ISmRNA-1273-P201-US207-1073Ap1EH29660185AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 265.7 ug/mL 265.7 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:15B-mRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH56890546AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 157.7 ug/mL 157.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:50B:mRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH00033983AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:24AmRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH21070855AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.4 AU/mL 193.4 BfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:07BmRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH29662395AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 874.6 AU/mL 874.6 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T09:15B-mRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH65274033AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 461 AU/mL 461 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T09:50B:mRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH59877526AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 AU/mL 34.2 B"333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T14:30BmRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH00033983BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:24AmRNA-1273-P201ISmRNA-1273-P201-US207-1073A1EH21070855BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:07BmRNA-1273-P201ISmRNA-1273-P201-US207-1073B1EH29662395BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1074A`1EH29430949AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 106.5 ug/mL 106.5 Bjug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1074Ap1EH66392064AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 479.5 ug/mL 479.5 Cug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:38B+mRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH56891443AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 319.3 ug/mL 319.3 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B:mRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH10485893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH21072935AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 293.2 AU/mL 293.2 CS33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH66394113AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:38B+mRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH65276976AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1190.3 AU/mL 1190.3 CJdAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B:mRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH03253290AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.7 AU/mL 115.7 Bs33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:54BmRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH10485893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1074A1EH21072935BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:02B mRNA-1273-P201ISmRNA-1273-P201-US207-1074B1EH66394113BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:38B+mRNA-1273-P201ISmRNA-1273-P201-US207-1074B1EH65276976BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T08:20B:mRNA-1273-P201ISmRNA-1273-P201-US207-1074B1EH03253290AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:54BmRNA-1273-P201ISmRNA-1273-P201-US207-1074B1EH02101380 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1077A`1EH29659320AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.6 ug/mL 97.6 Baug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:10B!mRNA-1273-P201ISmRNA-1273-P201-US207-1077Ap1EH43323559AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 234.6 ug/mL 234.6 Bꙙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T12:10B.mRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH56890514AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 232.4 ug/mL 232.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04T16:26B:mRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH00036030AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH29659291AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 154.3 AU/mL 154.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:10B!mRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH34970628AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1001.1 AU/mL 1001.1 C>AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T12:10B.mRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH59875478AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1006.2 AU/mL 1006.2 C>33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T10:20BmRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH00036030BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:01AmRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH29659291BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10T09:10B!mRNA-1273-P201ISmRNA-1273-P201-US207-1077A1EH34970628BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T12:10B.mRNA-1273-P201ISmRNA-1273-P201-US207-1077B1EH59875478AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.3 AU/mL 28.3 BLAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T10:20BmRNA-1273-P201ISmRNA-1273-P201-US207-1077B1EH08392894 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1081A`1EH29431975AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.6 ug/mL 65.6 BAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1081Ap1EH29430791AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 217.6 ug/mL 217.6 Bٙug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH30474250AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 174.8 ug/mL 174.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T16:21B@mRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH44077187AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH21069863AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 286.4 AU/mL 286.4 CfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH21076132AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 811.8 AU/mL 811.8 C2AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH30477450AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 762.3 AU/mL 762.3 C/AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T16:21B@mRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH59875351AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.9 AU/mL 98.9 BbffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T12:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH44077187BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1081A1EH21069863BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T15:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1081B1EH21076132BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T12:15B/mRNA-1273-P201ISmRNA-1273-P201-US207-1081B1EH30477450BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T16:21B@mRNA-1273-P201ISmRNA-1273-P201-US207-1081B1EH59875351AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T12:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1081B1EH44045347 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1082AP1EH44043326AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:06AmRNA-1273-P201ISmRNA-1273-P201-US207-1082A`1EH29662360AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US207-1082Ap1EH19246089AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 27 ug/mL 27 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:23B/mRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH30509070AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.5 ug/mL 41.5 B)ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:47B>mRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH44047516AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T15:06AmRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH29661243AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH19244168AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.9 AU/mL 114.9 BrffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:23B/mRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH30508207AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 141.1 AU/mL 141.1 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:47B>mRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH59878453AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.4 AU/mL 20.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:14BmRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH44047516BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T15:06AmRNA-1273-P201ISmRNA-1273-P201-US207-1082A1EH29661243BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T09:17B!mRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH19244168BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T08:23B/mRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH30508207BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:47B>mRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH59878453AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T13:14BmRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH35658815 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH51487925 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1082B1EH51487925 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1083A`1EH66425994AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.6 ug/mL 11.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T09:04BmRNA-1273-P201ISmRNA-1273-P201-US207-1083Ap1EH63967281AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 217.7 ug/mL 217.7 Bٳ33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T08:50B*mRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH30475275AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140.4 ug/mL 140.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH06626323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH66428043AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.5 AU/mL 28.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T09:04BmRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH63968434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 767.6 AU/mL 767.6 C/AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T08:50B*mRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH30480520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 639.2 AU/mL 639.2 C'33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH03253259AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 178.4 AU/mL 178.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T10:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH06626323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 24.4 AU/mL 24.4 BffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1083A1EH66428043BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.6 AU/mL 28.6 BAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T09:04BmRNA-1273-P201ISmRNA-1273-P201-US207-1083B1EH63968434BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.4 AU/mL 23.4 BffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06T08:50B*mRNA-1273-P201ISmRNA-1273-P201-US207-1083B1EH30480520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29 AU/mL 29 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:50B<mRNA-1273-P201ISmRNA-1273-P201-US207-1083B1EH03253259AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.6 AU/mL 23.6 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T10:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1083B1EH06622384 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1084A`1EH21070884AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:33B mRNA-1273-P201ISmRNA-1273-P201-US207-1084Ap1EH15795385AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:49B0mRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH30474283AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B<mRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH06624274AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH21077157AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:33B mRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH15795387AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:49B0mRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH30480552AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B<mRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH59875477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:38BmRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH06624274BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1084A1EH21077157BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T10:33B mRNA-1273-P201ISmRNA-1273-P201-US207-1084B1EH15795387BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T08:49B0mRNA-1273-P201ISmRNA-1273-P201-US207-1084B1EH30480552BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T08:30B<mRNA-1273-P201ISmRNA-1273-P201-US207-1084B1EH59875477AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T08:38BmRNA-1273-P201ISmRNA-1273-P201-US207-1084B1EH06620336 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1085A`1EH29660184AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:43B!mRNA-1273-P201ISmRNA-1273-P201-US207-1085Ap1EH15797304AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:20B.mRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH30476459AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 ug/mL 6.5 Ahug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:38B<mRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH44046525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH29660346AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:43B!mRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH15794235AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:20B.mRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH30480553AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:38B<mRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH59877397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T14:58BmRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH44046525BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1085A1EH29660346BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:43B!mRNA-1273-P201ISmRNA-1273-P201-US207-1085B1EH15794235BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T13:20B.mRNA-1273-P201ISmRNA-1273-P201-US207-1085B1EH30480553BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:38B<mRNA-1273-P201ISmRNA-1273-P201-US207-1085B1EH59877397AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T14:58BmRNA-1273-P201ISmRNA-1273-P201-US207-1085B1EH44042300 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1086A`1EH30474379AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 ug/mL 10.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:53B"mRNA-1273-P201ISmRNA-1273-P201-US207-1086Ap1EH15794203AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.3 ug/mL 10.3 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH30477352AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 ug/mL 10 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH44046397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.4 AU/mL 20.4 BffffffAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T12:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH30477483AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.7 AU/mL 17.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:53B"mRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH15795226AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.6 AU/mL 25.6 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH30478472AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.2 AU/mL 22.2 B333333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH03253386AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.8 AU/mL 22.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH44046397CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T12:02AmRNA-1273-P201ISmRNA-1273-P201-US207-1086A1EH30477483CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:53B"mRNA-1273-P201ISmRNA-1273-P201-US207-1086B1EH15795226BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T09:28B0mRNA-1273-P201ISmRNA-1273-P201-US207-1086B1EH30478472BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:35B<mRNA-1273-P201ISmRNA-1273-P201-US207-1086B1EH03253386AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T08:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1086B1EH44040253 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1087A`1EH30476427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.5 ug/mL 12.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:30B#mRNA-1273-P201ISmRNA-1273-P201-US207-1087Ap1EH15794360AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 114.1 ug/mL 114.1 Brug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:10B2mRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH30507183AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 84.9 ug/mL 84.9 BTffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:18B@mRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH44047420AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH30477482AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.4 AU/mL 25.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:30B#mRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH15796410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 478.1 AU/mL 478.1 CᙙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:10B2mRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH30513164AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 353.7 AU/mL 353.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:18B@mRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH59876501AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.7 AU/mL 97.7 Ba33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T10:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH44047420CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1087A1EH30477482BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30T10:30B#mRNA-1273-P201ISmRNA-1273-P201-US207-1087B1EH15796410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 AU/mL 7.8 A|AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:10B2mRNA-1273-P201ISmRNA-1273-P201-US207-1087B1EH30513164BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 AU/mL 7.8 A|AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T10:18B@mRNA-1273-P201ISmRNA-1273-P201-US207-1087B1EH59876501AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T10:33BmRNA-1273-P201ISmRNA-1273-P201-US207-1087B1EH44042428 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1088A`1EH29432839AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.1 ug/mL 22.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:25B mRNA-1273-P201ISmRNA-1273-P201-US207-1088Ap1EH15796251AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.8 ug/mL 17.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH30477449AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.5 ug/mL 13.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH44047388AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T13:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH21072902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.8 AU/mL 135.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:25B mRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH15797274AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.3 AU/mL 73.3 BILAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH30475307AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.4 AU/mL 56.4 B8ffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH59876373AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.2 AU/mL 18.2 B333333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T10:52BmRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH44047388BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T13:41AmRNA-1273-P201ISmRNA-1273-P201-US207-1088A1EH21072902BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:25B mRNA-1273-P201ISmRNA-1273-P201-US207-1088B1EH15797274BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:37B0mRNA-1273-P201ISmRNA-1273-P201-US207-1088B1EH30475307BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T10:51B<mRNA-1273-P201ISmRNA-1273-P201-US207-1088B1EH59876373AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T10:52BmRNA-1273-P201ISmRNA-1273-P201-US207-1088B1EH44042396 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US207-1089A`1EH29429767AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.4 ug/mL 19.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:06B"mRNA-1273-P201ISmRNA-1273-P201-US207-1089Ap1EH15797273AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.2 ug/mL 197.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:44B1mRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH45198347AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.7 ug/mL 171.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH06623378AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH21073927AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.9 AU/mL 65.9 BAffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:06B"mRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH15795386AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1079.7 AU/mL 1079.7 CC{33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:44B1mRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH45198506AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 898.8 AU/mL 898.8 C8,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH59878580AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 353.2 AU/mL 353.2 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T13:20BmRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH06623378BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T08:52AmRNA-1273-P201ISmRNA-1273-P201-US207-1089A1EH21073927BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T15:06B"mRNA-1273-P201ISmRNA-1273-P201-US207-1089B1EH15795386BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:44B1mRNA-1273-P201ISmRNA-1273-P201-US207-1089B1EH45198506BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:27B?mRNA-1273-P201ISmRNA-1273-P201-US207-1089B1EH59878580AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T13:20BmRNA-1273-P201ISmRNA-1273-P201-US207-1089B1EH06620177 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1090A`1EH30475433AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.1 ug/mL 25.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:23BmRNA-1273-P201ISmRNA-1273-P201-US207-1090Ap1EH15794330AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.1 ug/mL 98.1 Bbug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH63970448AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.3 ug/mL 71.3 BGLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:10B:mRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH00033951AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T13:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH30478504AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 97.9 AU/mL 97.9 BaffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:23BmRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH15800344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 351.5 AU/mL 351.5 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH63967410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 335 AU/mL 335 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:10B:mRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH59875479AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.5 AU/mL 34.5 B"AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T16:34BmRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH00033951BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T13:27AmRNA-1273-P201ISmRNA-1273-P201-US207-1090A1EH30478504BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T14:23BmRNA-1273-P201ISmRNA-1273-P201-US207-1090B1EH15800344BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T14:20B-mRNA-1273-P201ISmRNA-1273-P201-US207-1090B1EH63967410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T16:10B:mRNA-1273-P201ISmRNA-1273-P201-US207-1090B1EH59875479AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T16:34BmRNA-1273-P201ISmRNA-1273-P201-US207-1090B1EH08394814 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1091A`1EH29429895AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.1 ug/mL 15.1 A񙙙ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:08B mRNA-1273-P201ISmRNA-1273-P201-US207-1091Ap1EH15796281AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.5 ug/mL 197.5 Bŀug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:45B+mRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH30474378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 148.5 ug/mL 148.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH44045373AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH21076133AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.5 AU/mL 80.5 BPAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:08B mRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH15794363AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1462.2 AU/mL 1462.2 C[c33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:45B+mRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH30480521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 695.3 AU/mL 695.3 C+tAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH59877557AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 161.2 AU/mL 161.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T13:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH44045373BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:14AmRNA-1273-P201ISmRNA-1273-P201-US207-1091A1EH21076133BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27T11:08B mRNA-1273-P201ISmRNA-1273-P201-US207-1091B1EH15794363BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07T09:45B+mRNA-1273-P201ISmRNA-1273-P201-US207-1091B1EH30480521BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:57B9mRNA-1273-P201ISmRNA-1273-P201-US207-1091B1EH59877557AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T13:43BmRNA-1273-P201ISmRNA-1273-P201-US207-1091B1EH44042397 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T10:36AmRNA-1273-P201ISmRNA-1273-P201-US207-1092A`1EH66425995AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T09:48BmRNA-1273-P201ISmRNA-1273-P201-US207-1092Ap1EH15797272AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-05T09:50B)mRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH30474251AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 ug/mL 5 APug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19T10:28B7mRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH44045469AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T10:36AmRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH66427946AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21T09:48BmRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH15794234AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-05T09:50B)mRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH30477354AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19T10:28B7mRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH03255339AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176.5 AU/mL 176.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-12T10:18BmRNA-1273-P201ISmRNA-1273-P201-US207-1092A1EH44045469BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-29T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1093A`1EH30477322AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.1 ug/mL 44.1 B,ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:49BmRNA-1273-P201ISmRNA-1273-P201-US207-1093Ap1EH56892563AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259.4 ug/mL 259.4 C6fffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:07B-mRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH45196298AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.5 ug/mL 186.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:26BAmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH44045340AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH30475434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.6 AU/mL 165.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:49BmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH65275024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1390.2 AU/mL 1390.2 CV33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:07B-mRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH45199401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1176.6 AU/mL 1176.6 CIAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:26BAmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH20199577AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.9 AU/mL 191.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T12:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH44045340BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T09:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1093A1EH30475434BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:49BmRNA-1273-P201ISmRNA-1273-P201-US207-1093B1EH65275024BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T10:07B-mRNA-1273-P201ISmRNA-1273-P201-US207-1093B1EH45199401BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 AU/mL 5.8 A\AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T10:26BAmRNA-1273-P201ISmRNA-1273-P201-US207-1093B1EH20199577AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T12:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1093B1EH44040380 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T08:56AmRNA-1273-P201ISmRNA-1273-P201-US207-1094A`1EH56892434AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.2 ug/mL 9.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T12:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1094Ap1EH15796378AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:24B+mRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH45195435AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:05B9mRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH00035903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T08:56AmRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH65273873AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T12:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH15795354AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:24B+mRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH45201417AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:05B9mRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH20194360AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:24BmRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH00035903BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T08:56AmRNA-1273-P201ISmRNA-1273-P201-US207-1094A1EH65273873BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T12:15BmRNA-1273-P201ISmRNA-1273-P201-US207-1094B1EH15795354BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:24B+mRNA-1273-P201ISmRNA-1273-P201-US207-1094B1EH45201417BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:05B9mRNA-1273-P201ISmRNA-1273-P201-US207-1094B1EH20194360AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:24BmRNA-1273-P201ISmRNA-1273-P201-US207-1094B1EH00032796 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1095A`1EH29430821AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 ug/mL 10 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1095Ap1EH15795384AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.7 ug/mL 82.7 BR33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B+mRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH56891570AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.9 ug/mL 36.9 B$fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:01B:mRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH44045468AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T10:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH21069862AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 49.1 AU/mL 49.1 B1AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH15800345AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 403.6 AU/mL 403.6 C9AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B+mRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH65275953AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 322.8 AU/mL 322.8 C,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:01B:mRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH59878421AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.1 AU/mL 73.1 BIAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:35BmRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH44045468BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:22AmRNA-1273-P201ISmRNA-1273-P201-US207-1095A1EH21069862BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T10:27BmRNA-1273-P201ISmRNA-1273-P201-US207-1095B1EH15800345BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B+mRNA-1273-P201ISmRNA-1273-P201-US207-1095B1EH65275953BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T15:01B:mRNA-1273-P201ISmRNA-1273-P201-US207-1095B1EH59878421AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T09:35BmRNA-1273-P201ISmRNA-1273-P201-US207-1095B1EH44040381 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:30AmRNA-1273-P201ISmRNA-1273-P201-US207-1096Ap1EH63970320AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 48 ug/mL 48 B0ug/mL PPD VACCINESERUMELISA A>ffffffA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-21T12:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH15795353AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 429.7 ug/mL 429.7 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T11:19B3mRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH45196427AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 300.4 ug/mL 300.4 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T10:37BAmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH44046492AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:30AmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH63967283AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.7 AU/mL 190.7 B33330AU/mL PPD VACCINESERUMELISA AA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-21T12:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH15795227AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1625.8 AU/mL 1625.8 CeAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T11:19B3mRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH45200520AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1129.3 AU/mL 1129.3 CFAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T10:37BAmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH20196538AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 99.1 AU/mL 99.1 BcAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:03BmRNA-1273-P201ISmRNA-1273-P201-US207-1096A1EH44046492CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies . NOT DONESAMPLE INTEGRITY ISSUE PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:30AmRNA-1273-P201ISmRNA-1273-P201-US207-1096B1EH63967283BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-21T12:55BmRNA-1273-P201ISmRNA-1273-P201-US207-1096B1EH15795227BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T11:19B3mRNA-1273-P201ISmRNA-1273-P201-US207-1096B1EH45200520BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T10:37BAmRNA-1273-P201ISmRNA-1273-P201-US207-1096B1EH20196538AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:03BmRNA-1273-P201ISmRNA-1273-P201-US207-1096B1EH44042269 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1098AP1EH44044316AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T10:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1098A`1EH56891571AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1098Ap1EH15797434AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 ug/mL 4.5 AHug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T08:56B2mRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH45195403AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T08:50B>mRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH44045341AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T10:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH65275056AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T16:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH15797434BV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T08:56B2mRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH45200393AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T08:50B>mRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH20196505AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH44045341BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T10:05AmRNA-1273-P201ISmRNA-1273-P201-US207-1098A1EH65275056BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AmRNA-1273-P201ISmRNA-1273-P201-US207-1098B1EH20196505AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1098B1EH35658942 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1098B1EH28621968 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US207-1098B1EH28621968 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-07T13:00AmRNA-1273-P201ISmRNA-1273-P201-US207-1099A`1EH63969424AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.2 ug/mL 35.2 B#333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1099Ap1EH15797433AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 342.5 ug/mL 342.5 Chug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:16B*mRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH45198346AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 191.7 ug/mL 191.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:20B;mRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH44044476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-07T13:00AmRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH63970354AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 133.5 AU/mL 133.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH15796411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1543.2 AU/mL 1543.2 C`s33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:16B*mRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH45200521AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 686.5 AU/mL 686.5 C*AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:20B;mRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH20193434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.4 AU/mL 115.4 BsfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:08BmRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH44044476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-07T13:00AmRNA-1273-P201ISmRNA-1273-P201-US207-1099A1EH63970354BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T14:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1099B1EH15796411BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:16B*mRNA-1273-P201ISmRNA-1273-P201-US207-1099B1EH45200521CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T14:20B;mRNA-1273-P201ISmRNA-1273-P201-US207-1099B1EH20193434AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:08BmRNA-1273-P201ISmRNA-1273-P201-US207-1099B1EH35656766 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1100A`1EH56892467AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1100Ap1EH15796408AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH45198379AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:49B<mRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH00038941AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T15:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH65273904AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH15797403AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH45201448AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:49B<mRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH20194489AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:11BmRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH00038941BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 AU/mL 6.3 AdAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T15:48AmRNA-1273-P201ISmRNA-1273-P201-US207-1100A1EH65273904BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04T10:22BmRNA-1273-P201ISmRNA-1273-P201-US207-1100B1EH15797403BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US207-1100B1EH45201448BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T10:49B<mRNA-1273-P201ISmRNA-1273-P201-US207-1100B1EH20194489AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T11:11BmRNA-1273-P201ISmRNA-1273-P201-US207-1100B1EH08395967 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1101A@1EH49387654AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.4 ug/mL 19.4 Bffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:45B$mRNA-1273-P201ISmRNA-1273-P201-US207-1101AP1EH00035902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1101A`1EH49387686AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 98.4 AU/mL 98.4 BbfffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:45B$mRNA-1273-P201ISmRNA-1273-P201-US207-1101Ap1EH00035902BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T15:40AmRNA-1273-P201ISmRNA-1273-P201-US207-1101A1EH49387686BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:45B$mRNA-1273-P201ISmRNA-1273-P201-US207-1101A1EH08393887 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1102A`1EH24382491AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.7 ug/mL 10.7 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:53BmRNA-1273-P201ISmRNA-1273-P201-US207-1102Ap1EH15794361AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 ug/mL 9.8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:01B.mRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH30477480AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.2 ug/mL 9.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:00B9mRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH44044445AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T12:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH24380474AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:53BmRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH15796283AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:01B.mRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH30479369AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:00B9mRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH59876374AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T14:02BmRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH44044445CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T12:39AmRNA-1273-P201ISmRNA-1273-P201-US207-1102A1EH24380474BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28T13:53BmRNA-1273-P201ISmRNA-1273-P201-US207-1102B1EH15796283BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T16:01B.mRNA-1273-P201ISmRNA-1273-P201-US207-1102B1EH30479369BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:00B9mRNA-1273-P201ISmRNA-1273-P201-US207-1102B1EH59876374AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-13T14:02BmRNA-1273-P201ISmRNA-1273-P201-US207-1102B1EH35656895 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1103A`1EH56890386AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:08B$mRNA-1273-P201ISmRNA-1273-P201-US207-1103Ap1EH15795256AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T14:05B3mRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH45197354AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-11T12:30BHmRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH44047389AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH65274001AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:08B$mRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH15798296AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T14:05B3mRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH45199528AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-11T12:30BHmRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH20197401AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:48BmRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH44047389BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:10AmRNA-1273-P201ISmRNA-1273-P201-US207-1103A1EH65274001BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T09:08B$mRNA-1273-P201ISmRNA-1273-P201-US207-1103B1EH15798296BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21T14:05B3mRNA-1273-P201ISmRNA-1273-P201-US207-1103B1EH45199528BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-11T12:30BHmRNA-1273-P201ISmRNA-1273-P201-US207-1103B1EH20197401AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T11:48BmRNA-1273-P201ISmRNA-1273-P201-US207-1103B1EH44040348 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:28AmRNA-1273-P201ISmRNA-1273-P201-US207-1104A`1EH30476458AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 ug/mL 8.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T10:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1104Ap1EH15794202AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.3 ug/mL 45.3 B-Lug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T10:19B4mRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH45197451AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.8 ug/mL 36.8 B$ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH00033950AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T12:28AmRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH30480392AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.9 AU/mL 26.9 BfffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T10:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH15798297AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 326.5 AU/mL 326.5 ChAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T10:19B4mRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH45199529AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 176 AU/mL 176 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH59877525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.8 AU/mL 56.8 B8AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH00033950BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:28AmRNA-1273-P201ISmRNA-1273-P201-US207-1104A1EH30480392BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T10:10B$mRNA-1273-P201ISmRNA-1273-P201-US207-1104B1EH15798297BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T10:19B4mRNA-1273-P201ISmRNA-1273-P201-US207-1104B1EH45199529BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T09:56B=mRNA-1273-P201ISmRNA-1273-P201-US207-1104B1EH59877525AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:13BmRNA-1273-P201ISmRNA-1273-P201-US207-1104B1EH08394815 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1105A`1EH30474282AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 ug/mL 8.1 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T11:12B$mRNA-1273-P201ISmRNA-1273-P201-US207-1105Ap1EH15795257AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T11:35B4mRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH45198475AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-09T12:41BBmRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH44044349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T12:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH30478345AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T11:12B$mRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH15797435AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T11:35B4mRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH45199496AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-09T12:41BBmRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH20197400AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH44044349BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T12:31AmRNA-1273-P201ISmRNA-1273-P201-US207-1105A1EH30478345BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T11:12B$mRNA-1273-P201ISmRNA-1273-P201-US207-1105B1EH15797435BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T11:35B4mRNA-1273-P201ISmRNA-1273-P201-US207-1105B1EH45199496BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-09T12:41BBmRNA-1273-P201ISmRNA-1273-P201-US207-1105B1EH20197400AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-25T10:50BmRNA-1273-P201ISmRNA-1273-P201-US207-1105B1EH44040252 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T16:19AmRNA-1273-P201ISmRNA-1273-P201-US207-1106A`1EH63970353AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.2 ug/mL 41.2 B)333334ug/mL PPD VACCINESERUMELISA A>ffffffA0QRVisit 2 Day 8 Unscheduled 2 .PART A FOLLOW-UP 2020-08-13T11:53B'mRNA-1273-P201ISmRNA-1273-P201-US207-1106Ap1EH15797432AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 41.6 ug/mL 41.6 B)ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-18T10:38B,mRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH30508045AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.2 ug/mL 35.2 B#333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:24B4mRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH44078083AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T16:19AmRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH63970323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.2 AU/mL 149.2 B333330AU/mL PPD VACCINESERUMELISA AA0QRVisit 2 Day 8 Unscheduled 2 .PART A FOLLOW-UP 2020-08-13T11:53B'mRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH15797307AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 136 AU/mL 136 BAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-18T10:38B,mRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH30513324AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 134.3 AU/mL 134.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:24B4mRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH20196408AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.8 AU/mL 47.8 B/AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH44078083BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T16:19AmRNA-1273-P201ISmRNA-1273-P201-US207-1106A1EH63970323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.8 AU/mL 16.8 BAU/mL PPD VACCINESERUMELISA A6ffffffA0QRVisit 2 Day 8 Unscheduled 2 .PART A FOLLOW-UP 2020-08-13T11:53B'mRNA-1273-P201ISmRNA-1273-P201-US207-1106B1EH15797307BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.7 AU/mL 16.7 B33333AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-18T10:38B,mRNA-1273-P201ISmRNA-1273-P201-US207-1106B1EH30513324BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.5 AU/mL 19.5 BAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:24B4mRNA-1273-P201ISmRNA-1273-P201-US207-1106B1EH20196408AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:00BmRNA-1273-P201ISmRNA-1273-P201-US207-1106B1EH35684352 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1001A`1EH20972595AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 60.7 ug/mL 60.7 B<33334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-24T07:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1001Ap1EH46209077AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 277.9 ug/mL 277.9 C^fffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-08T07:14B)mRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH20977840AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 206.3 ug/mL 206.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T08:55B8mRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH00330895AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH29363218AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 190.1 AU/mL 190.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-24T07:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH37848116AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1144.2 AU/mL 1144.2 CG33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-08T07:14B)mRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH29362227AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 667.8 AU/mL 667.8 C)AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T08:55B8mRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH59848762AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 119.6 AU/mL 119.6 BwAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T14:27BmRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH00330895BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1001A1EH29363218BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 AU/mL 8.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-24T07:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1001B1EH37848116BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-08T07:14B)mRNA-1273-P201ISmRNA-1273-P201-US208-1001B1EH29362227BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23T08:55B8mRNA-1273-P201ISmRNA-1273-P201-US208-1001B1EH59848762AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T14:27BmRNA-1273-P201ISmRNA-1273-P201-US208-1001B1EH00329774 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-05-29T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1002A`1EH20977808AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.1 ug/mL 20.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-25T08:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1002Ap1EH46210069AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.5 ug/mL 201.5 Bɀug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T11:12B*mRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH20971571AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.5 ug/mL 144.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T10:00B9mRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH00330894AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH29360177AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.3 AU/mL 45.3 B-LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-25T08:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH37850292AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 941.3 AU/mL 941.3 C:AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09T11:12B*mRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH20976819AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 499.9 AU/mL 499.9 C>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24T10:00B9mRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH26228924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 77.7 AU/mL 77.7 BM33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-08T10:12BmRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH00330894BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1002A1EH29360177BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-25T08:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1002B1EH37850292BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1003A`1EH20977680AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.2 ug/mL 25.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1003Ap1EH46209078AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 255.4 ug/mL 255.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:52B.mRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH20974642AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 161.2 ug/mL 161.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:05B<mRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH00328846AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH29360145AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.5 AU/mL 54.5 B6AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T09:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH37850135AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 767 AU/mL 767 C/AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13T11:52B.mRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH29360307AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 605.4 AU/mL 605.4 C%fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:05B<mRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH59849787AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 67.9 AU/mL 67.9 BCffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T11:00BmRNA-1273-P201ISmRNA-1273-P201-US208-1003A1EH08756262BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1004A`1EH20974610AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8 ug/mL 8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:20B mRNA-1273-P201ISmRNA-1273-P201-US208-1004Ap1EH46207028AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:20B0mRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH20973586AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.5 ug/mL 8.5 Aug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:12B<mRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH00328750AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-05-29T13:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH29361296AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:20B mRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH37848212AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:20B0mRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH20975794AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:12B<mRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH59846843AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH00328750BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-05-29T13:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1004A1EH29361296BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:20B mRNA-1273-P201ISmRNA-1273-P201-US208-1004B1EH37848212BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T10:20B0mRNA-1273-P201ISmRNA-1273-P201-US208-1004B1EH20975794BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T10:12B<mRNA-1273-P201ISmRNA-1273-P201-US208-1004B1EH59846843AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T11:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1004B1EH00327823 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1005A`1EH20978865AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1005Ap1EH46210102AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH20975635AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 ug/mL 5.2 AS333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:15B:mRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH27364493AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH20978835AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH37848087AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH20977843AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:15B:mRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH59847865AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:02BmRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH27364493BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1005A1EH20978835BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T13:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1005B1EH37848087BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17T11:40B/mRNA-1273-P201ISmRNA-1273-P201-US208-1005B1EH20977843BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T12:15B:mRNA-1273-P201ISmRNA-1273-P201-US208-1005B1EH59847865AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T13:02BmRNA-1273-P201ISmRNA-1273-P201-US208-1005B1EH18979983 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1007A`1EH20977713AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:07BmRNA-1273-P201ISmRNA-1273-P201-US208-1007Ap1EH46209173AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:11B-mRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH20977683AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.3 ug/mL 6.3 Adug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH18974871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T07:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH20977842AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:07BmRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH37847189AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:11B-mRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH29362193AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH51486872AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:44BmRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH18974871BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T07:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1007A1EH20977842BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T15:07BmRNA-1273-P201ISmRNA-1273-P201-US208-1007B1EH37847189BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T07:11B-mRNA-1273-P201ISmRNA-1273-P201-US208-1007B1EH29362193BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T07:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1007B1EH51486872AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T08:44BmRNA-1273-P201ISmRNA-1273-P201-US208-1007B1EH18944159 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1009A`1EH20976817AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10 ug/mL 10 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1009Ap1EH46207029AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 102.1 ug/mL 102.1 Bfug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH20978704AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.6 ug/mL 80.6 BPug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:35B:mRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH27364524AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH20978707AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.7 AU/mL 13.7 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH37848084AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 339.6 AU/mL 339.6 C9AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH29362353AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.2 AU/mL 202.2 B333330AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:35B:mRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH59847739AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 70.3 AU/mL 70.3 BFLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T14:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH27364524BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1009A1EH20978707BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02T13:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1009B1EH37848084BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T12:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1009B1EH29362353BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:35B:mRNA-1273-P201ISmRNA-1273-P201-US208-1009B1EH59847739AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T14:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1009B1EH18977807 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US208-1014A`1EH20973746AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23.7 ug/mL 23.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1014Ap1EH46209046AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 92 ug/mL 92 B\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B.mRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH20975761AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 82.6 ug/mL 82.6 BRug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B:mRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH58819717AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH29360273AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.6 AU/mL 12.6 AəAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH37849238AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 236.6 AU/mL 236.6 B왙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B.mRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH29363217AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 193.8 AU/mL 193.8 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B:mRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH59846811AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65 AU/mL 65 BAAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:48BmRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH58819717BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:35AmRNA-1273-P201ISmRNA-1273-P201-US208-1014A1EH29360273BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1014B1EH37849238BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T09:15B.mRNA-1273-P201ISmRNA-1273-P201-US208-1014B1EH29363217BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T09:13B:mRNA-1273-P201ISmRNA-1273-P201-US208-1014B1EH59846811AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T10:48BmRNA-1273-P201ISmRNA-1273-P201-US208-1014B1EH50435204 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:50AmRNA-1273-P201ISmRNA-1273-P201-US208-1015A`1EH20971570AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1015Ap1EH46209079AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH20976784AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH18974870AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T13:50AmRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH20977714AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH37850295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH29361169AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH59846682AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH18974870BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T13:50AmRNA-1273-P201ISmRNA-1273-P201-US208-1015A1EH20977714BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T09:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1015B1EH37850295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1015B1EH29361169BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 AU/mL 4.3 ADAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27T09:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1015B1EH59846682AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-16T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1015B1EH27332628 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1016A`1EH20972562AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.6 ug/mL 25.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1016Ap1EH46207031AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 243.6 ug/mL 243.6 B󙙙ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:23B,mRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH20972691AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 169.4 ug/mL 169.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH18973844AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.2 AU/mL 1.2 A333333AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-01T11:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH20978706AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 100.6 AU/mL 100.6 BdAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH37847063AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1120.3 AU/mL 1120.3 CFAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:23B,mRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH20976690AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 426.6 AU/mL 426.6 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH59846715AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 280.9 AU/mL 280.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-15T14:21BmRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH18973844BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-01T11:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1016A1EH20978706BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1016B1EH37847063BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14T14:23B,mRNA-1273-P201ISmRNA-1273-P201-US208-1016B1EH20976690BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T11:10B:mRNA-1273-P201ISmRNA-1273-P201-US208-1016B1EH59846715AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1017A`1EH20975793AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T15:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1017Ap1EH66421892AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:16B2mRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH25437211AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:58BBmRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH18975893AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH29361200AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T15:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH66421924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:16B2mRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH25442331AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:58BBmRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH51488793AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH18975893BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1017A1EH29361200BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T15:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1017B1EH66421924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:16B2mRNA-1273-P201ISmRNA-1273-P201-US208-1017B1EH25442331BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 AU/mL 4.1 AAAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:58BBmRNA-1273-P201ISmRNA-1273-P201-US208-1017B1EH51488793AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1017B1EH27331606 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:40AmRNA-1273-P201ISmRNA-1273-P201-US208-1019A`1EH20974770AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.4 ug/mL 13.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1019Ap1EH46208021AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 140.5 ug/mL 140.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:15B,mRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH20971667AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 122.9 ug/mL 122.9 Bzffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:10B9mRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH18972822AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:40AmRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH29362323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.6 AU/mL 45.6 B-AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30T09:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH37850293AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 490.9 AU/mL 490.9 CfffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:15B,mRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH29360304AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 477.7 AU/mL 477.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T10:10B9mRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH59848858AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.6 AU/mL 96.6 B`AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1019A1EH18972822BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1020A`1EH20978736AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.9 ug/mL 17.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1020Ap1EH46206998AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103.5 ug/mL 103.5 Bgug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:08B,mRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH20976657AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.4 ug/mL 47.4 B/ffffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH18975925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH29362194AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.1 AU/mL 29.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH37849270AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 304.8 AU/mL 304.8 C AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:08B,mRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH20978867AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 380.3 AU/mL 380.3 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH26228925AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 167.5 AU/mL 167.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T12:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH18975925BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1020A1EH29362194BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1020B1EH37849270BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15T13:08B,mRNA-1273-P201ISmRNA-1273-P201-US208-1020B1EH20978867BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T13:10B9mRNA-1273-P201ISmRNA-1273-P201-US208-1020B1EH26228925AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-14T12:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1020B1EH27330742 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:17AmRNA-1273-P201ISmRNA-1273-P201-US208-1023A`1EH20975665AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 23 ug/mL 23 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:21B#mRNA-1273-P201ISmRNA-1273-P201-US208-1023Ap1EH13668532AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.4 ug/mL 152.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:14B0mRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH25439387AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 47.9 ug/mL 47.9 B/fffffug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:40B@mRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH18973876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T13:17AmRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH29361329AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125.1 AU/mL 125.1 B}AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:21B#mRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH15730726AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 638.6 AU/mL 638.6 C'陙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:14B0mRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH25442490AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 425.6 AU/mL 425.6 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:40B@mRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH59847864AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 119.2 AU/mL 119.2 Bw333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T14:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH18973876BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T13:17AmRNA-1273-P201ISmRNA-1273-P201-US208-1023A1EH29361329BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:21B#mRNA-1273-P201ISmRNA-1273-P201-US208-1023B1EH15730726BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T09:14B0mRNA-1273-P201ISmRNA-1273-P201-US208-1023B1EH25442490BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:40B@mRNA-1273-P201ISmRNA-1273-P201-US208-1023B1EH59847864AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T14:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1023B1EH27329718 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:42AmRNA-1273-P201ISmRNA-1273-P201-US208-1025Ap1EH20973715AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 22.2 ug/mL 22.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH66420741AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 194.6 ug/mL 194.6 B™ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:20B1mRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH25439258AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 173.6 ug/mL 173.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:15BAmRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH18975796AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-03T10:42AmRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH29360176AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.5 AU/mL 159.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH66421894AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 897 AU/mL 897 C8AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:20B1mRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH25440313AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 662.8 AU/mL 662.8 C)lAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:15BAmRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH59847835AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.8 AU/mL 137.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T14:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1025A1EH18975796BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-03T10:42AmRNA-1273-P201ISmRNA-1273-P201-US208-1025B1EH29360176BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1025B1EH66421894BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:20B1mRNA-1273-P201ISmRNA-1273-P201-US208-1025B1EH25440313BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:15BAmRNA-1273-P201ISmRNA-1273-P201-US208-1025B1EH59847835AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T14:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1025B1EH27328695 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T07:06AmRNA-1273-P201ISmRNA-1273-P201-US208-1026A`1EH20977712AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T07:15B"mRNA-1273-P201ISmRNA-1273-P201-US208-1026Ap1EH58038311AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:13B0mRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH25438235AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:41B@mRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH18974900AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T07:06AmRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH29363377AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T07:15B"mRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH66423974AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:13B0mRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH25443352AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:41B@mRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH59846683AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:36BmRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH18974900BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.3 AU/mL 11.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T07:06AmRNA-1273-P201ISmRNA-1273-P201-US208-1026A1EH29363377BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.4 AU/mL 10.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T07:15B"mRNA-1273-P201ISmRNA-1273-P201-US208-1026B1EH66423974BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.1 AU/mL 10.1 AAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:13B0mRNA-1273-P201ISmRNA-1273-P201-US208-1026B1EH25443352BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.3 AU/mL 11.3 AAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:41B@mRNA-1273-P201ISmRNA-1273-P201-US208-1026B1EH59846683AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 AU/mL 6.7 Ak333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:36BmRNA-1273-P201ISmRNA-1273-P201-US208-1026B1EH27332629 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1028A`1EH20978705AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.2 ug/mL 46.2 B.333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1028Ap1EH66421765AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.9 ug/mL 201.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:10B2mRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH25440409AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.5 ug/mL 152.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:53BBmRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH27362476AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH29362195AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 149.1 AU/mL 149.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH66421766AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 939.6 AU/mL 939.6 C:AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:10B2mRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH25440312AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 667.2 AU/mL 667.2 C)33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:53BBmRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH59849882AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 277 AU/mL 277 CPAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH27362476BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1028A1EH29362195BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T09:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1028B1EH66421766CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T09:10B2mRNA-1273-P201ISmRNA-1273-P201-US208-1028B1EH25440312BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:53BBmRNA-1273-P201ISmRNA-1273-P201-US208-1028B1EH59849882AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T10:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1028B1EH18977838 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1029A`1EH20974643AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:07B$mRNA-1273-P201ISmRNA-1273-P201-US208-1029Ap1EH58037383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 ug/mL 8.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:11B2mRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH25436314AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 ug/mL 7.5 Axug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:20BBmRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH18975764AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH29360144AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:07B$mRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH66426885AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:11B2mRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH25440442AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:20BBmRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH59849786AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T12:54BmRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH18975764BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.5 AU/mL 9.5 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T13:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1029A1EH29360144BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.6 AU/mL 17.6 BAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:07B$mRNA-1273-P201ISmRNA-1273-P201-US208-1029B1EH66426885BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 AU/mL 13.9 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T15:11B2mRNA-1273-P201ISmRNA-1273-P201-US208-1029B1EH25440442BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 12.2 AU/mL 12.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T14:20BBmRNA-1273-P201ISmRNA-1273-P201-US208-1029B1EH59849786AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T12:54BmRNA-1273-P201ISmRNA-1273-P201-US208-1029B1EH27331766 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1030A`1EH20972722AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:15B#mRNA-1273-P201ISmRNA-1273-P201-US208-1030Ap1EH13671444AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 ug/mL 6.2 Ac333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:10B1mRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH25438234AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:15B?mRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH58720415AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.3 AU/mL 1.3 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T11:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH29361201AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.4 AU/mL 1.4 AffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:15B#mRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH15731877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.8 AU/mL 1.8 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:10B1mRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH25442491AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:15B?mRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH51488921AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH58720415BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.4 AU/mL 8.4 AfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T11:26AmRNA-1273-P201ISmRNA-1273-P201-US208-1030A1EH29361201BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.6 AU/mL 6.6 AiAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06T09:15B#mRNA-1273-P201ISmRNA-1273-P201-US208-1030B1EH15731877BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T08:10B1mRNA-1273-P201ISmRNA-1273-P201-US208-1030B1EH25442491BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03T08:15B?mRNA-1273-P201ISmRNA-1273-P201-US208-1030B1EH51488921AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T08:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1030B1EH50337822 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1033A`1EH20976689AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.6 ug/mL 16.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:00B$mRNA-1273-P201ISmRNA-1273-P201-US208-1033Ap1EH66422788AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 14.8 ug/mL 14.8 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:03B2mRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH25437338AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.7 ug/mL 16.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BBmRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH58821669AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH29360306AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:00B$mRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH66424965AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:03B2mRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH25442362AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BBmRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH59849754AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T10:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH58821669BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1033A1EH29360306BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T10:00B$mRNA-1273-P201ISmRNA-1273-P201-US208-1033B1EH66424965BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:03B2mRNA-1273-P201ISmRNA-1273-P201-US208-1033B1EH25442362BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T10:30BBmRNA-1273-P201ISmRNA-1273-P201-US208-1033B1EH59849754AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-22T10:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1033B1EH50335935 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1035A`1EH20977682AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1035Ap1EH46208053AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 64.4 ug/mL 64.4 B@fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T07:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH20978833AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 45.7 ug/mL 45.7 B-33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B9mRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH58721310AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3 AU/mL 3 A0AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH29362226AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.2 AU/mL 10.2 A333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH37849143AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 324.5 AU/mL 324.5 CHAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T07:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH20976691AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 182.4 AU/mL 182.4 BfffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B9mRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH59848763AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.1 AU/mL 65.1 BAAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH58721310BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-02T09:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1035A1EH29362226BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1035B1EH37849143BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16T07:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1035B1EH20976691BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28T08:00B9mRNA-1273-P201ISmRNA-1273-P201-US208-1035B1EH59848763AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1035B1EH50335902 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:47AmRNA-1273-P201ISmRNA-1273-P201-US208-1036A`1EH20973747AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13 ug/mL 13 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:17B$mRNA-1273-P201ISmRNA-1273-P201-US208-1036Ap1EH58039430AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 186.5 ug/mL 186.5 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B2mRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH25436347AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.6 ug/mL 151.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:32B@mRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH18973749AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T08:47AmRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH29362320AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.5 AU/mL 40.5 B(AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:17B$mRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH66421799AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 803.5 AU/mL 803.5 C28AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B2mRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH25440314AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 561 AU/mL 561 C#AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:32B@mRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH59847737AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1071.6 AU/mL 1071.6 CBAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH18973749BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T08:47AmRNA-1273-P201ISmRNA-1273-P201-US208-1036A1EH29362320BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:17B$mRNA-1273-P201ISmRNA-1273-P201-US208-1036B1EH66421799BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B2mRNA-1273-P201ISmRNA-1273-P201-US208-1036B1EH25440314BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T13:32B@mRNA-1273-P201ISmRNA-1273-P201-US208-1036B1EH59847737AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.2 AU/mL 43.2 B+333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T08:55BmRNA-1273-P201ISmRNA-1273-P201-US208-1036B1EH27331767 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:38AmRNA-1273-P201ISmRNA-1273-P201-US208-1038Ap1EH20976816AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH66421796AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T07:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH25438394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.2 ug/mL 11.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T07:38B@mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH18972853AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.3 AU/mL 2.3 A$AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T07:38AmRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH20978834AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.7 AU/mL 1.7 A333333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH66420871AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T07:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH25440315AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T07:38B@mRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH59846842AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1038A1EH18972853BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:38AmRNA-1273-P201ISmRNA-1273-P201-US208-1038B1EH20978834BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1038B1EH66420871BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T07:15B-mRNA-1273-P201ISmRNA-1273-P201-US208-1038B1EH25440315BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T07:38B@mRNA-1273-P201ISmRNA-1273-P201-US208-1038B1EH59846842AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1038B1EH27330710 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1039A`1EH20977810AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.7 ug/mL 18.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T11:22BmRNA-1273-P201ISmRNA-1273-P201-US208-1039Ap1EH66420740AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.9 ug/mL 124.9 B|ffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:51B.mRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH25436219AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.3 ug/mL 96.3 B`Lug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:10B<mRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH00066732AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T13:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH29361170AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.2 AU/mL 50.2 B2333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T11:22BmRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH66423972AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 515.7 AU/mL 515.7 C ;33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:51B.mRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH25441433AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 376.5 AU/mL 376.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:10B<mRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH20233271AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.7 AU/mL 75.7 BK33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T10:49BmRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH00066732BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T13:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1039A1EH29361170BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T11:22BmRNA-1273-P201ISmRNA-1273-P201-US208-1039B1EH66423972BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T11:51B.mRNA-1273-P201ISmRNA-1273-P201-US208-1039B1EH25441433BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:10B<mRNA-1273-P201ISmRNA-1273-P201-US208-1039B1EH20233271AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-04T10:49BmRNA-1273-P201ISmRNA-1273-P201-US208-1039B1EH08493063 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1041A`1EH20977811AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 57.5 ug/mL 57.5 B9ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1041Ap1EH13668405AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.9 ug/mL 147.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:08B/mRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH59025410AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 107.2 ug/mL 107.2 Bk333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:22BEmRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH18972695AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T12:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH29360272AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 164 AU/mL 164 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH15729671AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 866.9 AU/mL 866.9 C6.fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:08B/mRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH59023523AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 501.9 AU/mL 501.9 C^fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:22BEmRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH18972695BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T12:45AmRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH29360272BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T11:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1041A1EH15729671BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T12:08B/mRNA-1273-P201ISmRNA-1273-P201-US208-1041B1EH59023523BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11T10:22BEmRNA-1273-P201ISmRNA-1273-P201-US208-1041B1EH27329591 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-10T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1042A`1EH20976688AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 ug/mL 7.4 Avfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1042Ap1EH58038438AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH25436186AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:59B:mRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH58820614AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-10T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH29362322AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH66421927AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH25443513AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:59B:mRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH59849915AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH58820614BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-10T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1042A1EH29362322BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1042B1EH66421927BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T08:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1042B1EH25443513BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T07:59B:mRNA-1273-P201ISmRNA-1273-P201-US208-1042B1EH59849915AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1042B1EH50336798 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1045A`1EH20977809AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.3 ug/mL 30.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:25B"mRNA-1273-P201ISmRNA-1273-P201-US208-1045Ap1EH13670548AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 354.2 ug/mL 354.2 C#33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH25439259AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 246 ug/mL 246 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:45BAmRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH18975797AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2.1 AU/mL 2.1 A!AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-04T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH29363249AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 227.6 AU/mL 227.6 B㙙AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:25B"mRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH15731718AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 808.2 AU/mL 808.2 C233334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH25441464AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 718.9 AU/mL 718.9 C,fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:45BAmRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH20233366AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 151.3 AU/mL 151.3 BLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T11:09BmRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH18975797BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-04T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1045A1EH29363249BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07T13:25B"mRNA-1273-P201ISmRNA-1273-P201-US208-1045B1EH15731718CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20T13:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1045B1EH25441464BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T09:45BAmRNA-1273-P201ISmRNA-1273-P201-US208-1045B1EH20233366AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 AU/mL 6 A`AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-07T11:09BmRNA-1273-P201ISmRNA-1273-P201-US208-1045B1EH27331638 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1046A`1EH20978737AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:21B mRNA-1273-P201ISmRNA-1273-P201-US208-1046Ap1EH66420868AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T07:42B/mRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH25438362AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T07:52B=mRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH00068622AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH20976659AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:21B mRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH66422919AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T07:42B/mRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH25441336AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T07:52B=mRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH53490705AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-30T12:29BsmRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH59848891AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.1 AU/mL 32.1 B AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:53BmRNA-1273-P201ISmRNA-1273-P201-US208-1046A1EH00068622BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH20976659BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T07:21B mRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH66422919CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24T07:42B/mRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH25441336BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T07:52B=mRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH53490705BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-30T12:29BsmRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH59848891AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.3 AU/mL 46.3 B.LAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T08:53BmRNA-1273-P201ISmRNA-1273-P201-US208-1046B1EH08492164 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-09T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1049A`1EH20973618AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1049Ap1EH66421893AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:20B-mRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH20972594AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 ug/mL 7 Apug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:30B;mRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH27363343AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-09T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH29363376AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH66422951AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:20B-mRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH20976818AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:30B;mRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH20233270AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:32BmRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH27363343BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 AU/mL 5.3 ATAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-09T09:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1049A1EH29363376BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1049B1EH66422951CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5 AU/mL 5 APAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T09:20B-mRNA-1273-P201ISmRNA-1273-P201-US208-1049B1EH20976818BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 AU/mL 7.8 A|AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T15:30B;mRNA-1273-P201ISmRNA-1273-P201-US208-1049B1EH20233270AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-05T09:32BmRNA-1273-P201ISmRNA-1273-P201-US208-1049B1EH18977839 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1051A`1EH20974738AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.3 ug/mL 16.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1051Ap1EH66420773AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.9 ug/mL 132.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH25440281AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.7 ug/mL 88.7 BX33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:12BCmRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH58722494AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH20977715AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 49.7 AU/mL 49.7 B133334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH66423815AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 511.6 AU/mL 511.6 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH25441304AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 419 AU/mL 419 C0AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:12BCmRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH20231223AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 132.5 AU/mL 132.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T14:46BmRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH58722494BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1051A1EH20977715BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1051B1EH66423815BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T10:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1051B1EH25441304BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T14:12BCmRNA-1273-P201ISmRNA-1273-P201-US208-1051B1EH20231223AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T14:46BmRNA-1273-P201ISmRNA-1273-P201-US208-1051B1EH50335775 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:39AmRNA-1273-P201ISmRNA-1273-P201-US208-1052A`1EH20975633AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1052Ap1EH58037254AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 46.7 ug/mL 46.7 B.33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T13:25B0mRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH25442457AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 131.8 ug/mL 131.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:20B?mRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH58723487AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T11:39AmRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH29360146AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 15.8 AU/mL 15.8 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH66424869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 318.7 AU/mL 318.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T13:25B0mRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH25442489AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 507.8 AU/mL 507.8 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:20B?mRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH20231319AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.7 AU/mL 111.7 Bo33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T15:46BmRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH58723487BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T11:39AmRNA-1273-P201ISmRNA-1273-P201-US208-1052A1EH29360146BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T13:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1052B1EH66424869BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T13:25B0mRNA-1273-P201ISmRNA-1273-P201-US208-1052B1EH25442489BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T09:20B?mRNA-1273-P201ISmRNA-1273-P201-US208-1052B1EH20231319AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-08T15:46BmRNA-1273-P201ISmRNA-1273-P201-US208-1052B1EH50437124 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1054AP1EH27334838AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.1 ug/mL 9.1 Aug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1054A`1EH20971698AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.5 ug/mL 16.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1054Ap1EH66423941AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135.7 ug/mL 135.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH25437370AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 110.9 ug/mL 110.9 Bnffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:12B>mRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH18974903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH29363219AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 56.9 AU/mL 56.9 B8fffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH66420903AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 486 AU/mL 486 C`AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH25443512AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 569 AU/mL 569 C#AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:12B>mRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH59848731AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121 AU/mL 121 ByAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH18974903BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1054A1EH29363219BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T13:10B"mRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH66420903BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21T08:10B/mRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH25443512BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T15:12B>mRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH59848731AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-28T09:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH27330711 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH59843769 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1054B1EH59843769 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1057AP1EH27332663AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.8 ug/mL 5.8 A\ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1057A`1EH20977841AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 ug/mL 5.5 AXug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1057Ap1EH66422789AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B1mRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH25437243AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:21B>mRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH18974774AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-05T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH20978866AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH66426884AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B1mRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH25442363AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:21B>mRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH20231350AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH18974774BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-05T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1057A1EH20978866BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:18B#mRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH66426884BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T14:15B1mRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH25442363BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05T11:21B>mRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH20231350AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-29T11:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH27331734 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH20232342 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1057B1EH20232342 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1058Ap1EH20972563AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 ug/mL 6.1 Aaug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-06T10:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH58037255AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-21T11:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH25436187AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94.8 ug/mL 94.8 B^ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:32B<mRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH00065582AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH29362224AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-06T10:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH66423814AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-21T11:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH25441337AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 355.1 AU/mL 355.1 C1AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:32B<mRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH51486745AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1058A1EH00065582BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:23AmRNA-1273-P201ISmRNA-1273-P201-US208-1058B1EH29362224BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-06T10:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1058B1EH66423814BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-21T11:10B,mRNA-1273-P201ISmRNA-1273-P201-US208-1058B1EH25441337BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T12:32B<mRNA-1273-P201ISmRNA-1273-P201-US208-1058B1EH51486745AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-21T12:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1058B1EH08494084 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1059A`1EH20975666AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31 ug/mL 31 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T11:18B$mRNA-1273-P201ISmRNA-1273-P201-US208-1059Ap1EH58037286AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 356.1 ug/mL 356.1 CAug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T11:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH25440408AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 298.3 ug/mL 298.3 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:58B@mRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH00068623AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T14:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH29361328AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 80.8 AU/mL 80.8 BPAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T11:18B$mRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH66424837AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1363.7 AU/mL 1363.7 CU;33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T11:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH25441465AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 977.5 AU/mL 977.5 C=AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:58B@mRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH26227869AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 160.1 AU/mL 160.1 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH00068623BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 AU/mL 5.9 A^fffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T14:30AmRNA-1273-P201ISmRNA-1273-P201-US208-1059A1EH29361328BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 AU/mL 7.3 AtAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13T11:18B$mRNA-1273-P201ISmRNA-1273-P201-US208-1059B1EH66424837BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.7 AU/mL 5.7 A[333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27T11:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1059B1EH25441465BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10T11:58B@mRNA-1273-P201ISmRNA-1273-P201-US208-1059B1EH26227869AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1059B1EH08492197 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T09:03AmRNA-1273-P201ISmRNA-1273-P201-US208-1062A`1EH20975792AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 31 ug/mL 31 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1062Ap1EH66422916AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 417.9 ug/mL 417.9 Cfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:10B-mRNA-1273-P201ISmRNA-1273-P201-US208-1062A1EH25442456AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 342.2 ug/mL 342.2 Cc33333ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T08:15B<mRNA-1273-P201ISmRNA-1273-P201-US208-1062A1EH18973877AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T09:03AmRNA-1273-P201ISmRNA-1273-P201-US208-1062A1EH29360179AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 175.2 AU/mL 175.2 B333330AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T12:10B mRNA-1273-P201ISmRNA-1273-P201-US208-1062A1EH66420742AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1337.4 AU/mL 1337.4 CSffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:10B-mRNA-1273-P201ISmRNA-1273-P201-US208-1062A1EH25442361AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1331.8 AU/mL 1331.8 CSffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:59AmRNA-1273-P201ISmRNA-1273-P201-US208-1063A`1EH20973714AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.6 ug/mL 13.6 Aٙug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:12BmRNA-1273-P201ISmRNA-1273-P201-US208-1063Ap1EH58036390AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 224.7 ug/mL 224.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:35B-mRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH25439291AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 169 ug/mL 169 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T08:45B<mRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH00065711AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T07:59AmRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH29362354AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.1 AU/mL 52.1 B4AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:12BmRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH66426917AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 336.1 AU/mL 336.1 CAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:35B-mRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH25441305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 697.3 AU/mL 697.3 C+AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T08:45B<mRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH59849755AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 152.8 AU/mL 152.8 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:37BmRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH00065711BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-08T07:59AmRNA-1273-P201ISmRNA-1273-P201-US208-1063A1EH29362354BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08T09:12BmRNA-1273-P201ISmRNA-1273-P201-US208-1063B1EH66426917BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22T08:35B-mRNA-1273-P201ISmRNA-1273-P201-US208-1063B1EH25441305CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06T08:45B<mRNA-1273-P201ISmRNA-1273-P201-US208-1063B1EH59849755AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:37BmRNA-1273-P201ISmRNA-1273-P201-US208-1063B1EH08494117 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-08T11:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1064A`1EH20976785AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.4 ug/mL 10.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:35B mRNA-1273-P201ISmRNA-1273-P201-US208-1064Ap1EH66422948AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 171.7 ug/mL 171.7 B33330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T12:20B.mRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH25440280AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.8 ug/mL 111.8 Boug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T07:56B=mRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH00066575AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-08T11:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH29362352AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.6 AU/mL 35.6 B#AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09T09:35B mRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH66420743AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 388 AU/mL 388 C@AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23T12:20B.mRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH25440283AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 396.5 AU/mL 396.5 CAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07T07:56B=mRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH51486776AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 63.3 AU/mL 63.3 B?LAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-23T10:00BmRNA-1273-P201ISmRNA-1273-P201-US208-1064A1EH00066575BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1065A`1EH20971538AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1065Ap1EH59025442AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH25437371AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.3 ug/mL 5.3 ATug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:05B<mRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH18973845AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH29363344AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH59023395AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH25440443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.1 AU/mL 1.1 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:05B<mRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH20231318AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH18973845BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1065A1EH29363344BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T07:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1065B1EH59023395BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T11:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1065B1EH25440443CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T09:05B<mRNA-1273-P201ISmRNA-1273-P201-US208-1065B1EH20231318AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T13:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1065B1EH27331735 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1066A`1EH20975632AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6 ug/mL 6 A`ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1066Ap1EH59023490AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 ug/mL 5.6 AYug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T13:15B/mRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH34713656AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.9 ug/mL 5.9 A^fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:46B=mRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH18972726AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH29362321AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH59023522AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T13:15B/mRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH34714649AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:46B=mRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH51486744AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:27BmRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH18972726BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1066A1EH29362321BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T09:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1066B1EH59023522BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11T13:15B/mRNA-1273-P201ISmRNA-1273-P201-US208-1066B1EH34714649BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25T09:46B=mRNA-1273-P201ISmRNA-1273-P201-US208-1066B1EH51486744AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T09:27BmRNA-1273-P201ISmRNA-1273-P201-US208-1066B1EH27330614 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1069A`1EH20975762AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18 ug/mL 18 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1069Ap1EH66423940AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.8 ug/mL 188.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:11B.mRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH34713753AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.4 ug/mL 188.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:40B<mRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH58821796AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T14:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH20978739AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 94 AU/mL 94 B^AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH66422918AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1133.6 AU/mL 1133.6 CFٙAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:11B.mRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH34716728AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 885.3 AU/mL 885.3 C7TAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:40B<mRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH59847706AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 177.6 AU/mL 177.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T14:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH58821796BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T14:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1069A1EH20978739BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1069B1EH66422918BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:11B.mRNA-1273-P201ISmRNA-1273-P201-US208-1069B1EH34716728BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24T14:40B<mRNA-1273-P201ISmRNA-1273-P201-US208-1069B1EH59847706AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-06T14:45BmRNA-1273-P201ISmRNA-1273-P201-US208-1069B1EH50335934 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1070A`1EH20972721AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.9 ug/mL 8.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1070Ap1EH59023363AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.9 ug/mL 109.9 Bmffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:24B.mRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH27606149AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 103.6 ug/mL 103.6 Bgug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:40B9mRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH18974901AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH29362192AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 19.8 AU/mL 19.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH59025571AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 779.5 AU/mL 779.5 C0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:24B.mRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH27602983AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 529.9 AU/mL 529.9 C!fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:40B9mRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH18974901BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH29362192BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T13:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1070A1EH59025571BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T14:24B.mRNA-1273-P201ISmRNA-1273-P201-US208-1070B1EH27602983BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T14:40B9mRNA-1273-P201ISmRNA-1273-P201-US208-1070B1EH27328694 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1071A`1EH20974769AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.4 ug/mL 32.4 B ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:18BmRNA-1273-P201ISmRNA-1273-P201-US208-1071Ap1EH59024544AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 354.3 ug/mL 354.3 C$ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T12:36B,mRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH27606180AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 259 ug/mL 259 C0ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:40B:mRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH58819620AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH29360275AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 109.6 AU/mL 109.6 BmAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:18BmRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH59025570AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1956.1 AU/mL 1956.1 CzAAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T12:36B,mRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH27605158AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1231 AU/mL 1231 CLAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:40B:mRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH51488920AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.3 AU/mL 121.3 ByLAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:55BmRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH58819620BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1071A1EH29360275BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:18BmRNA-1273-P201ISmRNA-1273-P201-US208-1071B1EH59025570BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T12:36B,mRNA-1273-P201ISmRNA-1273-P201-US208-1071B1EH27605158BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T13:40B:mRNA-1273-P201ISmRNA-1273-P201-US208-1071B1EH51488920AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T14:55BmRNA-1273-P201ISmRNA-1273-P201-US208-1071B1EH50339005 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26T10:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1072A`1EH20976656AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 42.2 ug/mL 42.2 B*333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1072Ap1EH59026592AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 201.6 ug/mL 201.6 Bəug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:05B.mRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH27606148AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 184.4 ug/mL 184.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:03B9mRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH18974902AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 2 AU/mL 2 A AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26T10:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH29361297AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 156.6 AU/mL 156.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH59026434AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 719.2 AU/mL 719.2 C,33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:05B.mRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH27605127AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 696.2 AU/mL 696.2 C+33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:03B9mRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH18974902BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26T10:25AmRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH29361297CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:05BmRNA-1273-P201ISmRNA-1273-P201-US208-1072A1EH59026434BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:05B.mRNA-1273-P201ISmRNA-1273-P201-US208-1072B1EH27605127BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T10:03B9mRNA-1273-P201ISmRNA-1273-P201-US208-1072B1EH27332756 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1073Ap1EH20972690AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH59025539AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH27604132AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 ug/mL 4.6 AIug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH58720319AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH20976787AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH59024515AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH27603079AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH58720319BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1073A1EH20976787CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24T11:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1073B1EH59024515BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 AU/mL 4.2 AC333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10T09:00B.mRNA-1273-P201ISmRNA-1273-P201-US208-1073B1EH27603079BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21T09:42B9mRNA-1273-P201ISmRNA-1273-P201-US208-1073B1EH50437125 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1075A`1EH20974611AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.9 ug/mL 26.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1075Ap1EH59023491AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 165.6 ug/mL 165.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH27604998AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.1 ug/mL 143.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:42B:mRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH18975892AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH20975667AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 50.5 AU/mL 50.5 B2AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH59026435AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 949.6 AU/mL 949.6 C;YAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH27605030AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 544.1 AU/mL 544.1 C"AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T10:42B:mRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH26228796AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 58.5 AU/mL 58.5 B:AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T13:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH18975892BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1075A1EH20975667BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1075B1EH59026435BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T11:15B,mRNA-1273-P201ISmRNA-1273-P201-US208-1075B1EH27605030BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1076A`1EH25438266AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.9 ug/mL 13.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T14:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1076Ap1EH13669397AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.6 ug/mL 183.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T15:30B3mRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH34715705AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 168.6 ug/mL 168.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:17BAmRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH58818567AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH25441432AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 53.5 AU/mL 53.5 B5AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T14:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH15731719AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1360.3 AU/mL 1360.3 CUAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T15:30B3mRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH34714808AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 960.2 AU/mL 960.2 C<33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:17BAmRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH26229821AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 319.7 AU/mL 319.7 C33333AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T15:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH58818567BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T09:11AmRNA-1273-P201ISmRNA-1273-P201-US208-1076A1EH25441432BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05T14:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1076B1EH15731719BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T15:30B3mRNA-1273-P201ISmRNA-1273-P201-US208-1076B1EH34714808BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03T15:17BAmRNA-1273-P201ISmRNA-1273-P201-US208-1076B1EH26229821AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T15:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1076B1EH50337982 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1077A`1EH25436315AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1077Ap1EH66423812AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH27606181AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 ug/mL 5.4 AVfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:55B?mRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH58723486AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH25440441AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH66423973AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH27605126AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:55B?mRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH26229788AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T13:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH58723486BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T13:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1077A1EH25440441BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:10B#mRNA-1273-P201ISmRNA-1273-P201-US208-1077B1EH66423973BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T15:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1077B1EH27605126BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T14:55B?mRNA-1273-P201ISmRNA-1273-P201-US208-1077B1EH26229788AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T13:50BmRNA-1273-P201ISmRNA-1273-P201-US208-1077B1EH50436133 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:22AmRNA-1273-P201ISmRNA-1273-P201-US208-1080A`1EH20978864AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 ug/mL 4 A@ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:26BmRNA-1273-P201ISmRNA-1273-P201-US208-1080Ap1EH58037415AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:41B-mRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH27606052AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:37B;mRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH27364397AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T11:22AmRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH20975795AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:26BmRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH66423847AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:41B-mRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH27605031AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T08:37B;mRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH51488824AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-15T09:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH27364397BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.5 AU/mL 5.5 AXAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T11:22AmRNA-1273-P201ISmRNA-1273-P201-US208-1080A1EH20975795BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1081A`1EH20975634AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.8 ug/mL 9.8 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1081Ap1EH59025411AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 111.7 ug/mL 111.7 Bo33334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:26B.mRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH27604004AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 73.7 ug/mL 73.7 BI33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:42B<mRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH58720446AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T10:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH29360147AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 13.6 AU/mL 13.6 AٙAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH59024514AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 395.7 AU/mL 395.7 C33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:26B.mRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH27603078AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 292.2 AU/mL 292.2 CC33333AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:42B<mRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH26226748AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.8 AU/mL 52.8 B4AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T10:29BmRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH58720446BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T10:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1081A1EH29360147BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1081B1EH59024514BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T09:26B.mRNA-1273-P201ISmRNA-1273-P201-US208-1081B1EH27603078BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T10:42B<mRNA-1273-P201ISmRNA-1273-P201-US208-1081B1EH26226748AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T10:29BmRNA-1273-P201ISmRNA-1273-P201-US208-1081B1EH50338876 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1085A`1EH25436218AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 16.3 ug/mL 16.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T08:03B(mRNA-1273-P201ISmRNA-1273-P201-US208-1085Ap1EH09517201AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.2 ug/mL 35.2 B#333334ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T08:51B7mRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH34713657AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.8 ug/mL 34.8 B"ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:50BDmRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH58820773AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH25443385AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.7 AU/mL 26.7 B33333AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T08:03B(mRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH09518096AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 278.2 AU/mL 278.2 Cc33333AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T08:51B7mRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH34716697AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 197.9 AU/mL 197.9 BffffhAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:50BDmRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH59847834AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 63.9 AU/mL 63.9 B?fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH58820773BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T12:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1085A1EH25443385BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T08:03B(mRNA-1273-P201ISmRNA-1273-P201-US208-1085B1EH09518096BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T08:51B7mRNA-1273-P201ISmRNA-1273-P201-US208-1085B1EH34716697BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T09:50BDmRNA-1273-P201ISmRNA-1273-P201-US208-1085B1EH59847834AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-17T09:30BmRNA-1273-P201ISmRNA-1273-P201-US208-1085B1EH50434181 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-30T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1087A`1EH20971666AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1087Ap1EH59025538AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B-mRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH34715801AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 ug/mL 5.1 AQug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:38B:mRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH58819589AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH29363345AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH59026563AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.6 AU/mL 1.6 AAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B-mRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH34714776AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:38B:mRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH59847738AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1 AU/mL 1 AAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH58819589BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1087A1EH29363345BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1087B1EH59026563BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:12B-mRNA-1273-P201ISmRNA-1273-P201-US208-1087B1EH34714776BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T12:38B:mRNA-1273-P201ISmRNA-1273-P201-US208-1087B1EH59847738AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-11T08:25BmRNA-1273-P201ISmRNA-1273-P201-US208-1087B1EH50436229 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1088A`1EH20974739AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 28.2 ug/mL 28.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1088Ap1EH13665462AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 431.1 ug/mL 431.1 C񙙙ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T11:41B/mRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH34715833AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 347.6 ug/mL 347.6 Cug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:37B=mRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH18975924AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3 AU/mL 3 A0AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH29360178AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 125 AU/mL 125 B}AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH15730694AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies >2052 AU/mL >2052 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T11:41B/mRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH34716824AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1532.8 AU/mL 1532.8 C_AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:37B=mRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH26227868AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 335.6 AU/mL 335.6 CAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:35BmRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH18975924BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.4 AU/mL 7.4 AvfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1088A1EH29360178BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 10.6 AU/mL 10.6 AAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1088B1EH15730694BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.5 AU/mL 7.5 AxAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T11:41B/mRNA-1273-P201ISmRNA-1273-P201-US208-1088B1EH34716824BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 AU/mL 7.2 As333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T10:37B=mRNA-1273-P201ISmRNA-1273-P201-US208-1088B1EH26227868AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.6 AU/mL 5.6 AYAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T09:35BmRNA-1273-P201ISmRNA-1273-P201-US208-1088B1EH27334677 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T07:13AmRNA-1273-P201ISmRNA-1273-P201-US208-1090A`1EH20975760AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.4 ug/mL 11.4 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:31B"mRNA-1273-P201ISmRNA-1273-P201-US208-1090Ap1EH58039462AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 206.1 ug/mL 206.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:43B0mRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH34713784AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 146.6 ug/mL 146.6 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:55B@mRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH27361422AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T07:13AmRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH29362225AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 32.2 AU/mL 32.2 B 333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:31B"mRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH66421926AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 873.8 AU/mL 873.8 C6AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:43B0mRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH34716856AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 624.7 AU/mL 624.7 C' 33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:55B@mRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH59846714AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 126.5 AU/mL 126.5 B~AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:32BmRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH27361422BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T07:13AmRNA-1273-P201ISmRNA-1273-P201-US208-1090A1EH29362225BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T07:31B"mRNA-1273-P201ISmRNA-1273-P201-US208-1090B1EH66421926BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T08:43B0mRNA-1273-P201ISmRNA-1273-P201-US208-1090B1EH34716856CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02T10:55B@mRNA-1273-P201ISmRNA-1273-P201-US208-1090B1EH59846714AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:32BmRNA-1273-P201ISmRNA-1273-P201-US208-1090B1EH18979855 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-03T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1091A`1EH25439418AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.2 ug/mL 30.2 B333333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:06B mRNA-1273-P201ISmRNA-1273-P201-US208-1091Ap1EH13667479AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 308.6 ug/mL 308.6 CIug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:08B.mRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH27602951AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 232.2 ug/mL 232.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:20B<mRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH18975765AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-03T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH25440282AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 155.3 AU/mL 155.3 BLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:06B mRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH15730727AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1682.5 AU/mL 1682.5 Ci(AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:08B.mRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH27604999AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1200.3 AU/mL 1200.3 CKAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:20B<mRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH59846810AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 153.6 AU/mL 153.6 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:16BmRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH18975765BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1091A1EH25440282BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:06B mRNA-1273-P201ISmRNA-1273-P201-US208-1091B1EH15730727BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T15:08B.mRNA-1273-P201ISmRNA-1273-P201-US208-1091B1EH27604999BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T15:20B<mRNA-1273-P201ISmRNA-1273-P201-US208-1091B1EH59846810AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T08:16BmRNA-1273-P201ISmRNA-1273-P201-US208-1091B1EH27331639 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1092A`1EH20978832AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.8 ug/mL 30.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1092Ap1EH58039302AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 439.4 ug/mL 439.4 Cvfffffug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH34715800AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 348.6 ug/mL 348.6 Cəug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:46B:mRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH58723390AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH29360274AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 142.8 AU/mL 142.8 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH66426916AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1764.3 AU/mL 1764.3 CnDAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH34716825AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1231.7 AU/mL 1231.7 CL33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:46B:mRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH09517073AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 277.8 AU/mL 277.8 C\AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:35BmRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH58723390BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T09:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1092A1EH29360274BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1092B1EH66426916BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 AU/mL 4.9 ANfffffhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T09:16B,mRNA-1273-P201ISmRNA-1273-P201-US208-1092B1EH34716825BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.2 AU/mL 6.2 Ac333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:46B:mRNA-1273-P201ISmRNA-1273-P201-US208-1092B1EH09517073AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-21T10:35BmRNA-1273-P201ISmRNA-1273-P201-US208-1092B1EH50436261 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1093AP1EH27362444AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1093A`1EH25442329AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.3 ug/mL 9.3 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:32B!mRNA-1273-P201ISmRNA-1273-P201-US208-1093Ap1EH13670453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 150.6 ug/mL 150.6 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T14:02B1mRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH34715704AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 40.3 ug/mL 40.3 B(Lug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T11:29B>mRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH27364525AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH25442330AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25.5 AU/mL 25.5 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:32B!mRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH15729798AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 537.4 AU/mL 537.4 C!fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T14:02B1mRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH34714648AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 477.4 AU/mL 477.4 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T11:29B>mRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH20233239AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 54.9 AU/mL 54.9 B6fffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:39BmRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH27364525BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T11:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1093A1EH25442330BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T11:32B!mRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH15729798BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19T14:02B1mRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH34714648BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T11:29B>mRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH20233239AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:39BmRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH18979982 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH20230198 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1093B1EH20230198 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1097A`1EH20977681AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1097Ap1EH59023394AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH27604133AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.9 ug/mL <3.9 .ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:31B;mRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH27361295AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH29362355AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH59024387AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH27606022AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:31B;mRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH59847867AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:58BmRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH27361295BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1097A1EH29362355BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T09:19BmRNA-1273-P201ISmRNA-1273-P201-US208-1097B1EH59024387BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T08:45B-mRNA-1273-P201ISmRNA-1273-P201-US208-1097B1EH27606022BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T09:31B;mRNA-1273-P201ISmRNA-1273-P201-US208-1097B1EH59847867AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T11:58BmRNA-1273-P201ISmRNA-1273-P201-US208-1097B1EH18978991 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1099AP1EH27335862AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1099A`1EH20972723AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 20.7 ug/mL 20.7 B33333ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:28B"mRNA-1273-P201ISmRNA-1273-P201-US208-1099Ap1EH59026593AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 143.3 ug/mL 143.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:30B2mRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH34715673AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 96.6 ug/mL 96.6 B`ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:47B>mRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH18972823AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH29363216AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.3 AU/mL 43.3 B+LAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:28B"mRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH59025443AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 402.9 AU/mL 402.9 C.fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:30B2mRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH34716729AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183 AU/mL 183 BAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:47B>mRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH51486873AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.5 AU/mL 144.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH18972823BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-26T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1099A1EH29363216BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T07:28B"mRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH59025443BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T13:30B2mRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH34716729BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T09:47B>mRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH51486873AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-14T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH27328662 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH53488787 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies339.411 MN50 20 2560 339.411 C6tjMN50 BATTELLE SERUM C\(A(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-06T12:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH51461306 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH53488787 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodies240 MN Endpoint Titer20 2560 240 BMN Endpoint Titer BATTELLE SERUM BA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-06T12:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1099B1EH51461306 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1100A`1EH25438267AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.8 ug/mL 35.8 B#ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:20B!mRNA-1273-P201ISmRNA-1273-P201-US208-1100Ap1EH13670549AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 337.2 ug/mL 337.2 C33333ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B/mRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH27262986AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 202.2 ug/mL 202.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T11:41BGmRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH27362477AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH25442459AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.9 AU/mL 137.9 BffffhAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:20B!mRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH15729828AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1313.4 AU/mL 1313.4 CRffffhAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B/mRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH27266219AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 867.9 AU/mL 867.9 C6>fffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T11:41BGmRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH20233367AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 147.5 AU/mL 147.5 BAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:33BmRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH27362477BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1100A1EH25442459BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T09:20B!mRNA-1273-P201ISmRNA-1273-P201-US208-1100B1EH15729828BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T10:19B/mRNA-1273-P201ISmRNA-1273-P201-US208-1100B1EH27266219BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10T11:41BGmRNA-1273-P201ISmRNA-1273-P201-US208-1100B1EH20233367AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T11:33BmRNA-1273-P201ISmRNA-1273-P201-US208-1100B1EH18977934 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1103AP1EH27361453AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T07:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1103A`1EH25439419AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1103Ap1EH13670420AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 ug/mL 4.4 AFfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:49B2mRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH34713625AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.3 ug/mL 4.3 ADug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:50B>mRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH27364396AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T07:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH25440411AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH15731845AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:49B2mRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH34714680AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:50B>mRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH09514035AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T08:37BmRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH27364396BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.6 AU/mL 4.6 AIAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T07:12AmRNA-1273-P201ISmRNA-1273-P201-US208-1103A1EH25440411BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:10B$mRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH15731845BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.4 AU/mL 3.4 A6ffffffAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:49B2mRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH34714680BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:50B>mRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH09514035AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T08:37BmRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH18978990 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH09512080 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1103B1EH09512080 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1104AP1EH18974869AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.6 ug/mL 7.6 Ayug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1104A`1EH25436346AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.3 ug/mL 7.3 Atug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US208-1104Ap1EH13665334AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 ug/mL 8.2 A333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:44B2mRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH34715832AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.1 ug/mL 7.1 Aqug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:44B>mRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH18972694AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH25442488AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH15728647AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:44B2mRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH34714681AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:44B>mRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH09517072AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T08:42BmRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH18972694BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T07:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1104A1EH25442488BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.1 AU/mL 5.1 AQAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06T11:32B$mRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH15728647BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20T08:44B2mRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH34714681BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01T08:44B>mRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH09517072AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T08:42BmRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH27329687 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH09514128 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesmRNA-1273-P201ISmRNA-1273-P201-US208-1104B1EH09514128 MNET MN Endpoint Titer Serum SARS-CoV-2 Neutralizing Antibodiesffffffug/mL PPD VACCINESERUMELISA A>ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T09:16AmRNA-1273-P201ISmRNA-1273-P201-US208-1108A`1EH20973587AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 9.6 ug/mL 9.6 Aug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1108Ap1EH13668501AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 105.9 ug/mL 105.9 Biffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:52B.mRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH27604005AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 85.7 ug/mL 85.7 BU33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:48B9mRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH18973717AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-03T09:16AmRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH29360305AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 25 AU/mL 25 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH15728806AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 382.6 AU/mL 382.6 C陙AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:52B.mRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH27602982AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 200.5 AU/mL 200.5 BȀAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:48B9mRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH26227773AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 52.4 AU/mL 52.4 B4ffffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:43BmRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH18973717BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T09:16AmRNA-1273-P201ISmRNA-1273-P201-US208-1108A1EH29360305BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:15BmRNA-1273-P201ISmRNA-1273-P201-US208-1108B1EH15728806BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17T14:52B.mRNA-1273-P201ISmRNA-1273-P201-US208-1108B1EH27602982BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:48B9mRNA-1273-P201ISmRNA-1273-P201-US208-1108B1EH26227773AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-18T10:43BmRNA-1273-P201ISmRNA-1273-P201-US208-1108B1EH27331607 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-03T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1110A`1EH20971699AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 34.2 ug/mL 34.2 B"333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1110Ap1EH58038439AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 218.3 ug/mL 218.3 BLug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:54B+mRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH25438363AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 136.4 ug/mL 136.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH18973748AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-03T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH29363248AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 35.8 AU/mL 35.8 B#AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH66427012AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 779 AU/mL 779 C0AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:54B+mRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH25440410AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 514.8 AU/mL 514.8 C ,AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH26226749AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 43.7 AU/mL 43.7 B+33334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH18973748BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1110A1EH29363248BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T11:20BmRNA-1273-P201ISmRNA-1273-P201-US208-1110B1EH66427012BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T10:54B+mRNA-1273-P201ISmRNA-1273-P201-US208-1110B1EH25440410BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T14:11B9mRNA-1273-P201ISmRNA-1273-P201-US208-1110B1EH26226749AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-20T08:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1110B1EH27328566 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-03T11:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1112A`1EH25437242AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.5 ug/mL 17.5 Bug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T09:54B(mRNA-1273-P201ISmRNA-1273-P201-US208-1112Ap1EH09517105AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 174.8 ug/mL 174.8 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:44B7mRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH49548440AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 124.4 ug/mL 124.4 B|fffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-14T10:29BJmRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH18973716AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-03T11:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH25440440AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 75.3 AU/mL 75.3 BKLAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T09:54B(mRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH09518128AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 731.6 AU/mL 731.6 C-AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:44B7mRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH49545243AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 532 AU/mL 532 C!@AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-14T10:29BJmRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH26229789AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 79.9 AU/mL 79.9 BOffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T09:38BmRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH18973716BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.4 AU/mL 5.4 AVfffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-03T11:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1112A1EH25440440BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.5 AU/mL 3.5 A8AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T09:54B(mRNA-1273-P201ISmRNA-1273-P201-US208-1112B1EH09518128BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4 AU/mL 4 A@AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26T14:44B7mRNA-1273-P201ISmRNA-1273-P201-US208-1112B1EH49545243BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.7 AU/mL 3.7 A;333334AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-14T10:29BJmRNA-1273-P201ISmRNA-1273-P201-US208-1112B1EH26229789AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-27T09:38BmRNA-1273-P201ISmRNA-1273-P201-US208-1112B1EH27329590 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-08T08:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1113A`1EH25442328AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.7 ug/mL 6.7 Ak333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1113Ap1EH58036391AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 ug/mL 6.9 Anfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T10:35B0mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH49548313AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 ug/mL 7.8 A|ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:29B?mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH49547323AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-08T08:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH25443481AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH66424964AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T10:35B0mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH49545371AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:29B?mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH49547323BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-08T08:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH25443481BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 AU/mL 4.7 AK333334AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T09:17B"mRNA-1273-P201ISmRNA-1273-P201-US208-1113A1EH66424964BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T10:35B0mRNA-1273-P201ISmRNA-1273-P201-US208-1113B1EH49545371BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.4 AU/mL 4.4 AFfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T08:29B?mRNA-1273-P201ISmRNA-1273-P201-US208-1113B1EH41161915 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1116A`1EH20974771AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 44.4 ug/mL 44.4 B,ffffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1116Ap1EH59026465AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 253.4 ug/mL 253.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:20B.mRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH27602950AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 220.3 ug/mL 220.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:29B<mRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH27362348AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-29T14:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH20976658AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 180.6 AU/mL 180.6 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH59024386AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1148.3 AU/mL 1148.3 CGAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:20B.mRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH27603974AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 834.2 AU/mL 834.2 C4#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:29B<mRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH26226876AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 273.9 AU/mL 273.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T11:38BmRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH27362348BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-29T14:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1116A1EH20976658BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T11:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1116B1EH59024386BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13T11:20B.mRNA-1273-P201ISmRNA-1273-P201-US208-1116B1EH27603974BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27T11:29B<mRNA-1273-P201ISmRNA-1273-P201-US208-1116B1EH26226876AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-22T11:38BmRNA-1273-P201ISmRNA-1273-P201-US208-1116B1EH18976943 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1117A`1EH25438395AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 30.9 ug/mL 30.9 Bfffffug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T14:27B%mRNA-1273-P201ISmRNA-1273-P201-US208-1117Ap1EH09515153AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 228.6 ug/mL 228.6 B䙙ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T11:26B3mRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH34715672AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 188.8 ug/mL 188.8 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T11:58BAmRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH49547418AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH25443384AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 90.6 AU/mL 90.6 BZAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T14:27B%mRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH09516081AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1562.8 AU/mL 1562.8 CaAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T11:26B3mRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH34714777AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 916.3 AU/mL 916.3 C9DAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T11:58BAmRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH09515024AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 121.4 AU/mL 121.4 ByfffffhAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T11:31BmRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH49547418BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 AU/mL 4.8 ALAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T13:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1117A1EH25443384BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.1 AU/mL 6.1 AaAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T14:27B%mRNA-1273-P201ISmRNA-1273-P201-US208-1117B1EH09516081BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 5.2 AU/mL 5.2 AS333334AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T11:26B3mRNA-1273-P201ISmRNA-1273-P201-US208-1117B1EH34714777BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.5 AU/mL 4.5 AHAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T11:58BAmRNA-1273-P201ISmRNA-1273-P201-US208-1117B1EH09515024AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.9 AU/mL 3.9 A>ffffffAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T11:31BmRNA-1273-P201ISmRNA-1273-P201-US208-1117B1EH41163963 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1118A`1EH20975664AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 11.9 ug/mL 11.9 Afffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1118Ap1EH59024545AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 144.9 ug/mL 144.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:09B-mRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH27604101AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 115.7 ug/mL 115.7 Bs33334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:39B;mRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH58821637AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH20976786AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 26.4 AU/mL 26.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH59024418AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 513.9 AU/mL 513.9 C fffffAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:09B-mRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH27605159AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 505.9 AU/mL 505.9 CfffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:39B;mRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH20231222AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 71.2 AU/mL 71.2 BG333334AU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH58821637CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T13:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1118A1EH20976786BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31T13:10BmRNA-1273-P201ISmRNA-1273-P201-US208-1118B1EH59024418BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14T12:09B-mRNA-1273-P201ISmRNA-1273-P201-US208-1118B1EH27605159BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28T11:39B;mRNA-1273-P201ISmRNA-1273-P201-US208-1118B1EH20231222AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-19T10:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1118B1EH50437253 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1119Ap1EH25437339AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T07:10B%mRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH09512115AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.1 ug/mL 4.1 AAug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH49546265AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.2 ug/mL 4.2 AC333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:44BAmRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH18972727AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH25442360AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T07:10B%mRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH09518097AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH49547290AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:44BAmRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH18972727BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.4 AU/mL 6.4 AffffffhAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-06T07:10AmRNA-1273-P201ISmRNA-1273-P201-US208-1119A1EH25442360BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T07:10B%mRNA-1273-P201ISmRNA-1273-P201-US208-1119B1EH09518097BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.5 AU/mL 6.5 AhAU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25T14:03B3mRNA-1273-P201ISmRNA-1273-P201-US208-1119B1EH49547290BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T10:44BAmRNA-1273-P201ISmRNA-1273-P201-US208-1119B1EH27330615 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1120A`1EH20975763AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 29.3 ug/mL 29.3 BLug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1120Ap1EH59023362AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 274.3 ug/mL 274.3 C$ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:11B+mRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH27606053AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 182.4 ug/mL 182.4 Bfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:27B9mRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH58819749AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH29361171AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 88.2 AU/mL 88.2 BX333334AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH59026562AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1201.3 AU/mL 1201.3 CKAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:11B+mRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH27603110AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 733 AU/mL 733 C-AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:27B9mRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH58819749BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-01T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH29361171BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29T13:11BmRNA-1273-P201ISmRNA-1273-P201-US208-1120A1EH59026562BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12T13:11B+mRNA-1273-P201ISmRNA-1273-P201-US208-1120B1EH27603110BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26T11:27B9mRNA-1273-P201ISmRNA-1273-P201-US208-1120B1EH50434212 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-06T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1121Ap1EH25439386AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 36.1 ug/mL 36.1 B$ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T12:15B$mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH09512114AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 183.2 ug/mL 183.2 B333330ug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T12:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH27604100AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 137.9 ug/mL 137.9 Bffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T13:43B=mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH58721438AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 1.5 AU/mL 1.5 AAU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-06T09:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH25443353AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 135 AU/mL 135 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10T12:15B$mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH09516080AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 736.8 AU/mL 736.8 C. AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T12:35B2mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH27603111AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 546.2 AU/mL 546.2 C"#33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04T13:43B=mRNA-1273-P201ISmRNA-1273-P201-US208-1121A1EH58721438BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.8 AU/mL 3.8 AffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1123A`1EH49546296AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.9 ug/mL 7.9 A~fffffhug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T11:38B+mRNA-1273-P201ISmRNA-1273-P201-US208-1123Ap1EH09515025AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.1 ug/mL 8.1 Aug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-25T08:44B9mRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH49548472AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.2 ug/mL 7.2 As333334ug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T12:35BGmRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH27362349AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-06-30T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH49545370AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 18.4 AU/mL 18.4 BffffffAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T11:38B+mRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH09518129AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.3 AU/mL 17.3 BLAU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-25T08:44B9mRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH49547322AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 17.4 AU/mL 17.4 BffffffAU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T12:35BGmRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH09517104AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7 AU/mL 7 ApAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T08:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH27362349BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.3 AU/mL 8.3 AAU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-06-30T11:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1123A1EH49545370BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 7.8 AU/mL 7.8 A|AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11T11:38B+mRNA-1273-P201ISmRNA-1273-P201-US208-1123B1EH09518129BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 8.2 AU/mL 8.2 A333330AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-25T08:44B9mRNA-1273-P201ISmRNA-1273-P201-US208-1123B1EH49547322CV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 3.6 AU/mL 3.6 A9AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08T12:35BGmRNA-1273-P201ISmRNA-1273-P201-US208-1123B1EH09517104AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies 6.9 AU/mL 6.9 AnfffffhAU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-26T08:34BmRNA-1273-P201ISmRNA-1273-P201-US208-1123B1EH18979886 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1125A`1EH25437210AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.7 ug/mL 4.7 AK333334ug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:15B!mRNA-1273-P201ISmRNA-1273-P201-US208-1125Ap1EH13667383AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.8 ug/mL 4.8 ALug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:18B0mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH34713785AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 4.9 ug/mL 4.9 ANfffffhug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:25B=mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH27361294AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH25442458AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:15B!mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH15728678AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:18B0mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH34716696AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:25B=mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH27361294BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:20AmRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH25442458BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:15B!mRNA-1273-P201ISmRNA-1273-P201-US208-1125A1EH15728678BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18T10:18B0mRNA-1273-P201ISmRNA-1273-P201-US208-1125B1EH34716696BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T12:25B=mRNA-1273-P201ISmRNA-1273-P201-US208-1125B1EH18979854 MN50 MN50 Serum SARS-CoV-2 Neutralizing AntibodiesffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1129A`1EH25439290AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 65.6 ug/mL 65.6 BAug/mL PPD VACCINESERUMELISA A>ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1129Ap1EH09514163AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 203.1 ug/mL 203.1 Bug/mL PPD VACCINESERUMELISA A>ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T13:40B6mRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH34713752AV58IGGESVAC58 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 159.1 ug/mL 159.1 Bug/mL PPD VACCINESERUMELISA A>ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:56B=mRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH27363342AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies <1 AU/mL <1 .AU/mL PPD VACCINESERUMELISA AA Visit 1 Day 1 ASCREENING 2020-07-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH25443480AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 204.1 AU/mL 204.1 BAU/mL PPD VACCINESERUMELISA AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH09516048AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 698.2 AU/mL 698.2 C+33334AU/mL PPD VACCINESERUMELISA AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T13:40B6mRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH34714809AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 603.7 AU/mL 603.7 C%33334AU/mL PPD VACCINESERUMELISA AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:56B=mRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH26227740AV65IGGS VAC65 Spike IgG Antibody Serum SARS-CoV-2 Binding Antibodies 68.1 AU/mL 68.1 BDAU/mL PPD VACCINESERUMELISA AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T13:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH27363342BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffA Visit 1 Day 1 ASCREENING 2020-07-02T15:15AmRNA-1273-P201ISmRNA-1273-P201-US208-1129A1EH25443480BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03T13:23B!mRNA-1273-P201ISmRNA-1273-P201-US208-1129B1EH09516048BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24T13:40B6mRNA-1273-P201ISmRNA-1273-P201-US208-1129B1EH34714809BV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31T13:56B=mRNA-1273-P201ISmRNA-1273-P201-US208-1129B1EH26227740AV66IGGN VAC66 Nucleocapsid IgG Antibody Serum SARS-CoV-2 Binding Antibodies <3.4 AU/mL <3.4 .AU/mL PPD VACCINESERUMELISA A6ffffffAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-28T13:40BmRNA-1273-P201ISmRNA-1273-P201-US208-1129B1EH18977935 MN50 MN50 Serum SARS-CoV-2 Neutralizing Antibodies